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The use of measures of obesity in childhood for predicting
obesity and the development of obesity-related diseases
in adulthood: a systematic review and meta-analysis
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Background: It is uncertain which simple measures of childhood obesity are best for predicting future
obesity-related health problems and the persistence of obesity into adolescence and adulthood.
Objectives: To investigate the ability of simple measures, such as body mass index (BMI), to predict the
persistence of obesity from childhood into adulthood and to predict obesity-related adult morbidities.
To investigate how accurately simple measures diagnose obesity in children, and how acceptable these
measures are to children, carers and health professionals.
Data sources: Multiple sources including MEDLINE, EMBASE and The Cochrane Library were searched
from 2008 to 2013.
Methods: Systematic reviews and a meta-analysis were carried out of large cohort studies on the association
between childhood obesity and adult obesity; the association between childhood obesity and obesity-related
morbidities in adulthood; and the diagnostic accuracy of simple childhood obesity measures. Study quality was
assessed using Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) and a modified version of the
Quality in Prognosis Studies (QUIPS) tool. A systematic review and an elicitation exercise were conducted on
the acceptability of the simple measures.
Results: Thirty-seven studies (22 cohorts) were included in the review of prediction of adult morbidities.
Twenty-three studies (16 cohorts) were included in the tracking review. All studies included BMI.
There were very few studies of other measures. There was a strong positive association between high
childhood BMI and adult obesity [odds ratio 5.21, 95% confidence interval (CI) 4.50 to 6.02]. A positive
association was found between high childhood BMI and adult coronary heart disease, diabetes and a
range of cancers, but not stroke or breast cancer. The predictive accuracy of childhood BMI to predict any
adult morbidity was very low, with most morbidities occurring in adults who were of healthy weight in
childhood. Predictive accuracy of childhood obesity was moderate for predicting adult obesity, with a
sensitivity of 30% and a specificity of 98%. Persistence of obesity from adolescence to adulthood was
high. Thirty-four studies were included in the diagnostic accuracy review. Most of the studies used the
least reliable reference standard (dual-energy X-ray absorptiometry); only 24% of studies were of high
quality. The sensitivity of BMI for diagnosing obesity and overweight varied considerably; specificity was
less variable. Pooled sensitivity of BMI was 74% (95% CI 64.2% to 81.8%) and pooled specificity was
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95% (95% CI 92.2% to 96.4%). The acceptability to children and their carers of BMI or other common
simple measures was generally good.
Limitations: Little evidence was available regarding childhood measures other than BMI. No individual-level
analysis could be performed.
Conclusions: Childhood BMI is not a good predictor of adult obesity or adult disease; the majority of obese
adults were not obese as children and most obesity-related adult morbidity occurs in adults who had a
healthy childhood weight. However, obesity (as measured using BMI) was found to persist from childhood to
adulthood, with most obese adolescents also being obese in adulthood. BMI was found to be reasonably good
for diagnosing obesity during childhood. There is no convincing evidence suggesting that any simple measure is
better than BMI for diagnosing obesity in childhood or predicting adult obesity and morbidity. Further research
on obesity measures other than BMI is needed to determine which is the best tool for diagnosing childhood
obesity, and new cohort studies are needed to investigate the impact of contemporary childhood obesity on
adult obesity and obesity-related morbidities.
Study registration: This study is registered as PROSPERO CRD42013005711.
Funding: The National Institute for Health Research Health Technology Assessment programme.
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Plain English summary
Obesity in adults increases the risk of health problems such as diabetes, heart disease and cancer. It isunclear whether or not being obese as a child is also linked to these adult diseases. It is also unclear if
body mass index (BMI) is the best way of assessing whether or not a child is a healthy weight.
Our research investigated how useful it is to assess whether or not a child is obese. We also investigated if
there was any evidence that using other measures, such as waist-to-hip ratio or waist circumference, might
be better than BMI. We also assessed how accurate BMI and other measures are in children.
We performed systematically conducted reviews of the medical literature to find all the best research
evidence to address these questions.
Our research found that obesity frequently persists from childhood to adulthood and that BMI is a
reasonably accurate measure of obesity in children, which can help identify children who are likely to be
obese in adulthood and who may benefit from losing weight. However, it does not identify the many
healthy-weight children who will become obese or develop obesity-related diseases in adulthood. Most
obesity-related diseases occur in adults who were of healthy weight in childhood.
There is a lack of evidence to help determine whether or not any other measure is better or worse than
BMI for assessing childhood weight status. Children, parents and nurses found BMI was generally
acceptable and easy to use.
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Scientific summary
Background
It is generally accepted that adult obesity is associated with an increased risk of morbidity and premature
mortality in adults. However, the nature of the link between childhood obesity and adult morbidity and
obesity is less clear. Recent systematic reviews have indicated that childhood obesity is positively associated
with adult obesity and that childhood overweight and obesity are positively associated with an increased
risk of morbidity in adulthood. However, none has investigated the link between childhood weight status
and adult morbidity in terms of predictive accuracy. In addition, these reviews have primarily considered
body mass index (BMI) to determine the presence and level of obesity. The question remains of whether or
not another simple measure would be better for gauging the association between childhood obesity and
adult obesity and (separately) adult morbidity.
The decision problem addressed in this review is, ‘What is the best simple measure, or combination of
simple measures, of obesity in children for predicting the development of obesity-related health problems
such as type 2 diabetes, cardiovascular disease (CVD) and cancer in adolescence and/or adulthood?’
The abilities of these simple measures to correctly identify weight status in childhood, and to predict the
persistence of obesity from childhood into adolescence and adulthood, were also investigated.
Acceptability and ease of use of the measures were also addressed within the review.
Objectives
This research addressed, through systematic reviews, the questions raised in the decision problem.
1. Is obesity in children and adolescents a risk factor for CVD, type 2 diabetes and/or cancer in adults, and
do the results vary according to the simple measure of obesity employed?
2. To what degree do simple measures of obesity in childhood accurately predict the tracking of obesity
into adolescence and adulthood?
3. How accurately do simple measures of obesity reflect actual adiposity in children?
4. How acceptable are these simple measures of adiposity to children, their carers and health
professionals, and how easy is it for parents and health professionals to implement and
understand them?
Methods
The systematic reviews were conducted following the general principles recommended in the Centre for
Reviews and Dissemination guidance for undertaking reviews in health care and the reporting guidance of
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.
Literature search
Separate literature searches were undertaken to identify studies for each of the review questions. The
searches were limited to the date range 2008–13. A variety of sources was searched including MEDLINE,
EMBASE, PsycINFO and Cumulative Index to Nursing and Allied Health Literature (CINAHL), supplemented
with reference checking and citation searching.
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Inclusion criteria
For all review question studies, a range of simple obesity measures were considered, including BMI, waist
circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) and skinfold thickness (SFT).
For review question 1, prospective, large (n≥ 1000) longitudinal studies which measured obesity in
childhood were eligible. Adult outcomes considered were CVD, type 2 diabetes and cancer.
For review question 2, large (n≥ 1000) longitudinal studies recruiting children and/or adolescents (aged
2–18 years) which measured obesity in childhood and at a later time (at least 5 years later) were eligible.
For review question 3, diagnostic accuracy studies of obesity measurement in children were eligible for
inclusion, provided they used one of the following reference standards: a multicomponent model,
dual-energy X-ray absorptiometry (DEXA), deuterium dilution or densitometry.
For review question 4, on the acceptability and ease of use of childhood obesity measures, BMI, SFT, WHR and
WHtR were eligible for inclusion. Studies on the acceptability and ease of use of these measures, from the
perspective of the child, parent or health professional, were eligible. A simple survey was conducted to obtain
some indication of the attitudes of children, school nurses and parents to these four measures.
Quality assessment and statistical analysis
The quality of included studies was assessed using Quality Assessment of Diagnostic Accuracy Studies-2
(QUADAS-2) for studies of diagnostic accuracy and Quality in Prognosis Studies (QUIPS) for studies of
predictive value. A critical summary of recent relevant systematic reviews was undertaken.
For the review questions evaluating test accuracy, studies with sufficient data were included in meta-analyses
generating pooled odds ratios (ORs), and pooled estimates of diagnostic accuracy where possible. Otherwise,
results were synthesised narratively.
For the review and elicitation exercise on the acceptability and ease of use of childhood measures, results
were tabulated and summarised narratively.
Results
Review of prediction of adult morbidities
Thirty-seven studies (22 cohorts) met the inclusion criteria. Of these, 26 studies (13 cohorts) were included
in meta-analyses. All studies included BMI. Three measured WC, and one used WHR and the sum of SFT
measurements (sum SFT). No evidence was found for other simple childhood measures.
Elevated childhood BMI was modestly associated with an increased risk of adult morbidities. The
association between a 1-standard deviation (SD) increase in BMI and adult diabetes had an OR of 1.7
[95% confidence interval (CI) 1.30 to 2.22], approximately equivalent to a 24% increase in risk per BMI
unit in an adolescent. The association between a 1-SD increase in BMI and adult coronary heart disease
(CHD) had an OR of 1.2 (95% CI 1.20 to 1.31), approximately equivalent to an 8% increase in risk per
BMI unit in an adolescent. There was no convincing evidence of an association between childhood obesity
and stroke. Across a range of cancers, there was evidence that childhood obesity was associated with a
higher risk of cancer in adulthood. Increases in odds were generally around 20% per SD of BMI. There was
no evidence of an association between childhood BMI and breast cancer. These analyses were not
adjusted for adult BMI, in order to investigate whether or not childhood obesity alone can predict
adult morbidities.
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Despite the positive association between childhood BMI and morbidities, childhood BMI was not found to
be a good predictor of adult disease. Only 40% of adult diabetes and 20% of CHD and cancers would
occur in overweight or obese children. Hence, the majority of adult morbidity occurs in people who were
of healthy weight as children.
In the narrative review, childhood obesity was found to be associated with adult metabolic syndrome, and
there was some very limited evidence that BMI had poor sensitivity to predict this disorder. Evidence on
the association between childhood BMI and hypertension and hypercholesterolaemia was very limited.
Evidence was too limited to draw any firm conclusions on other childhood measures of obesity.
Review of tracking of obesity into adulthood
Twenty-three studies from 16 cohorts met the inclusion criteria for this review. All studies relied on BMI as
the measure of obesity, except one which used triceps SFT. The association between childhood obesity
(≥ 95th centile) and obesity in adults (age ≥ 20 years) was strong, with obese children being more than
five times more likely to be obese as adults than non-obese children [pooled relative risk (RR) 5.21, 95% CI
4.50 to 6.02]. There was no apparent difference in this RR between younger and older age groups.
Obesity tracked moderately well from childhood into adolescence; around half of obese children were still
obese in adolescence. It tracked well from adolescence to adulthood; about 80% of obese adolescents
were still obese in adulthood and 70% were still obese after age 30 years. No data were available for
tracking beyond age 40 years.
Body mass index was less effective at identifying who would be obese in adulthood; 70% of obese adults were
not obese as children or in adolescence, and 80% of obese people aged over 30 years were not obese in
adolescence, so childhood BMI has poor sensitivity to detect adult obesity. Analyses of the tracking of
childhood overweight (≥ 85th centile) to adult obesity or overweight gave broadly similar results.
Review of diagnostic accuracy of childhood measures of obesity
Thirty-four studies were included in the review of diagnostic accuracy. Thirty assessed BMI, 10 SFT,
seven WC, four WHR, two WHtR and six looked at other childhood measures of obesity. Most of the
studies used DEXA as the reference standard, which is the least reliable of the eligible reference standards.
Of the 34 studies, only eight were considered to be high quality.
Overall, the sensitivity of BMI for diagnosing both obesity and overweight varied considerably; specificity
was less variable. Meta-analyses showed that, of those who were obese according to the reference
standard, 74% were classified as obese using BMI, and of those who were not obese according to the
reference standard, 95% were not classified as obese.
Data on other measures of obesity were more limited. The most commonly evaluated non-BMI test
was SFT.
Most of the simple measures had high specificities. When fat mass index was evaluated alongside BMI
(one study), it looked like a promising alternative, but this would require further research. Sum SFT also
showed potential. Of the measures that incorporate a waist measurement, it seems that WHtR was more
accurate than WC alone or WHR, although WHtR was evaluated in fewer studies.
Review of acceptability and ease of use of childhood measures of obesity
Five studies were identified for the review of acceptability and ease of use, all eliciting opinions about BMI.
None of the studies elicited the opinions of children, three elicited the opinions of caregivers/guardians and
two those of health professionals (school nurses in one study and family doctors and paediatricians in the
other). The opinion of parents and nurses regarding the usefulness of BMI was generally positive. The
usefulness of measuring BMI in preschool children was less well accepted among doctors.
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In the elicitation exercise, although most children did not seem to have a problem with their height being
measured, a large proportion were embarrassed, or had other adverse reactions, to being weighed.
The 71 parents/caregivers questioned were generally unfamiliar with WHR, WHtR and SFT, and therefore
with their potential accuracy and usefulness. Many felt that BMI was a more meaningful indicator of a
child’s weight status than height and weight alone; age- and sex-adjusted BMI were considered valuable.
Limitations and uncertainties
Despite there being a reasonable number of studies identified for the three main review questions,
the number from which the necessary data could be obtained was small. Furthermore, across all reviews
the limited reporting of most studies and their heterogeneity further reduced the number of studies that
could be combined in meta-analyses, producing results with large uncertainty and wide CIs. There was
limited scope to test for the impact of important confounders such as age and sex.
A number of assumptions had to be made in order to conduct the analyses. These assumptions, especially
the assumption of normality for BMI, may not be accurate and this limits the reliability of the results.
Little evidence was available regarding childhood measures other than BMI. This greatly hampered the
review’s ability to address the project brief.
The cohort studies of the association between childhood obesity and adult morbidities were, of necessity,
long-term studies, with recruitment often occurring in the 1960s or earlier. As this was before the rise in
general obesity, it is unclear whether or not the findings from this part of the review apply to present-day
children living in societies where obesity is more prevalent.
Conclusions
The review found that childhood obesity (measured using BMI) was associated with moderately increased
risks of adult obesity-related morbidity. However, the increase in risk was not large enough for childhood
BMI to be a good predictor of the incidence of adult morbidities; the majority of adult obesity-related
morbidity occurs in adults who were of healthy weight in childhood.
The review of tracking studies found that childhood obesity (measured using BMI) is strongly associated
with adult obesity. This strong association was matched by a strong persistence of childhood obesity into
adulthood. Obese children, and particularly obese adolescents, are likely to still be obese in adulthood.
However, childhood BMI is not a good predictor of the incidence of adult obesity or overweight;
most obese adults were not obese in childhood, so overall adult obesity is not primarily determined by
childhood obesity. No information was available on tracking of obesity into later adulthood, when most
obesity-related morbidities are likely to occur.
The usefulness of BMI as a screening tool therefore depends upon the objectives of screening. It may be
useful for identifying a group of obese or overweight children who may benefit from intervention,
but does not identify all children who will go on to be obese or to develop obesity-related morbidities
in adulthood.
Body mass index was found to be reasonably good at diagnosing obesity during childhood, with around
75% of genuinely adipose children being classified as obese using BMI, and around 95% of non-obese
children also being correctly classified. This result was, however, based mostly on studies using DEXA,
which is not generally regarded as a gold standard for diagnosing obesity. BMI therefore appears to be a
reasonably good measure of obesity in children, as it effectively identifies childhood adiposity and children
likely to be obese in adulthood.
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There is a lack of evidence to help determine whether or not any simple measure is better or worse than
BMI for assessing childhood weight status, either for diagnosing obesity in childhood or for predicting
adult obesity or obesity-related morbidities.
The opinion of parents and nurses as to the usefulness of BMI was generally positive. However, its
usefulness in preschool children was less well accepted among doctors, although it was considered useful
for selected young children.
Recommendations for research
l Further investigation of individual-level data to avoid the limitations and assumptions made in this
review and, potentially, to analyse measures other than BMI that have not been reported.
l A full assessment of diagnostic accuracy, including identifying studies using magnetic resonance
imaging as the reference standard to assess abdominal obesity.
l Further primary studies of the diagnostic and predictive accuracy of measures other than BMI, should
the research described above suggest that they are merited.
l Cohort studies to assess tracking of obesity and incidence of obesity-related morbidities to investigate
the effect of contemporary childhood obesity on long-term obesity and morbidity. This could be
achieved through appropriate maintenance and analysis of NHS records.
Study registration
This study is registered as PROSPERO CRD42013005711.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Background
Obesity
Adiposity, or obesity, is defined as an accumulation of excess body fat to the extent that it may have an
adverse effect on health.1 Adult obesity prevalence in England has increased from approximately 16% in
1995 to approximately 26% in 2010, with the increase seemingly continuing.1 Obesity in adults has been
linked to increased mortality and morbidity.1 A meta-analysis of 26 cohort studies reported 60,374 deaths,
17,708 deaths from coronary heart disease (CHD) and 27,099 deaths from cardiovascular disease (CVD)
among 388,622 adults recruited in the studies.2 When the normal-weight people were compared with
those who were obese [using body mass index (BMI)], the risk of mortality was significantly increased
for the obese group. The pooled relative risks (RRs) reported were as follows: for overall mortality, 1.20
[95% confidence interval (CI) 1.12 to 1.29] for men and 1.28 (95% CI 1.18 to 1.37) for women; for death
from CHD, 1.51 (95% CI 1.36 to 1.67) for men and 1.62 (95% CI 1.46 to 1.81) for women; and for
death from CVD, 1.45 (95% CI 1.33 to 1.59) for men and 1.53 (95% CI 1.38 to 1.69) for women.2
Childhood obesity
The Health Survey for England 2012 reported that 14% of both boys and girls between the ages of 2 and
15 years were obese and that 28% of both boys and girls were classed as either overweight or obese.3
Data for younger children have been provided by the National Child Measurement Programme (NCMP),
which has been in progress for 6 years. The prevalence of obesity has been measured using BMI (using the
85th centile for overweight and 95th for obese) at two time points (aged 4/5 years and 10 years) using a
cross-sectional study design. In England, in the 2012–13 school year the NCMP recorded 1,076,824
measurements in children (a participation rate of 93%). At reception (aged 4–5 years), 22.2% of children
were either overweight or obese and 9.3% were obese. These figures increased in Year 6 (aged 10 years
by 1 September, the start of the school year) to 33.3% of children being either overweight or obese and
18.9% being obese.4 Data from the Health Survey for England3 show that the proportion of children aged
11–15 years in England who were obese was similar to adults (aged 16 years and over) up to 2004. Just
under 15% were obese in 1995, rising to just over 25% in 2004, but, unlike the figures for adults, there
has been a decrease since, with the proportion categorised as obese plateauing in 2010 at approximately
18%. In children aged 2–10 years, the proportion who were obese was lower: 10% were obese in 1995,
rising to a peak of approximately 17% in 2005, followed by a decrease to just under 15% in 2010.5
From these figures, it seems that the prevalence of overweight and obesity, and changes over time, vary
for different age groups of children. It has been projected that, by 2050, the prevalence of obesity will
increase in boys to over 35% of those aged 6–10 years and 23% of those aged 11–15 years, and in girls
to 20% of those aged 6–10 years and 35% of those aged 11–15 years.6 The prevalence of childhood
obesity varies depending upon ethnicity.4,7–9 It has been suggested that certain obesity metrics may
misrepresent these ethnic differences.9,10 Data on childhood obesity incidence are more limited, although
US evidence suggests that incident obesity between the ages of 5 and 14 years is more likely to occur at a
younger age, primarily among overweight 5-year-old children.11
The association between childhood obesity and adult obesity
and morbidity
It is generally accepted that adult obesity increases the risk of some morbidities, particularly CVD, type 2
diabetes mellitus and some types of cancer,7,12–14 and leads to a higher risk of associated mortality.15 It may
also be associated with other chronic conditions, such as rheumatological disorders, asthma, psychological
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illness, sleep disorders and reduced fertility.7 However, the link between childhood obesity and adult
morbidity is less clear. Recent systematic reviews have indicated that childhood obesity is associated with
adult obesity16,17 and adult morbidities.18–22 However, none of these reviews evaluated this association in
terms of predictive accuracy.
A recent systematic review of 25 studies stated that all the studies consistently reported that overweight
and obese children were at an increased risk of becoming overweight or obese adults, with the risk of
tracking into adulthood obesity increasing as the level of overweight/obesity in childhood increased.16 The
findings from that review suggested a moderate likelihood of persistence of overweight into adulthood for
children who were overweight or obese, but there were considerable variations in the predictive values
across studies. Regarding the link between childhood obesity and adult morbidity, recent systematic
reviews support the opinion that it is adult obesity, or the continued overweight/obesity from childhood
into adulthood,1,18,20,23,24 that increases the risk of adult morbidity, rather than obesity in childhood being
an independent risk factor for adult morbidities. However, there is some uncertainty and this may vary
across the morbidities.
Measuring obesity
Simple measures of obesity
There are a range of simple, anthropometric, indirect measures of adiposity.25,26 The simplest measure is
weight; however, on its own this provides little useful information, as confounding variables such as a
person’s height and body composition are not taken into consideration.
Body mass index is the most commonly used simple measure of obesity, and is also the only measure
recommended for use in children in the UK. It is calculated by dividing weight in kilograms by height in
metres squared (kg/m2). BMI increases sharply in infancy, peaking at around 9 months, and then falls to its
lowest at around 6 years.27 BMI (adjusted for age and sex) is recommended by the National Institute for
Health and Care Excellence (NICE) (CG43) as a practical estimate of overweight in children and young
people, but the guidance warns that the result needs to be interpreted with caution because BMI is not a
direct measure of adiposity.28 The main limitation of BMI is that it measures excess weight, rather than
excess fat, which is what determines whether someone is obese or not. Therefore, those with strong
bones and/or well-developed muscularity, but little fat, will have a high BMI and could be categorised as
obese, as bone and muscle are more dense than fat.29 Additionally, BMI is not consistent across the normal
height range, with shorter heights producing higher BMI values.30 BMI also does not give any indication as
to the distribution of fat in the body; in adults, central adiposity is more closely associated with health risks
than general adiposity,31,32 and the use of BMI and waist circumference (WC) is recommended in adults
in the UK.
Simple measures other than BMI include:
l WC A measure which gives an indication as to the distribution of excess body fat. However,
in isolation it provides insufficient information regarding overall adiposity. Based on a UK reference
population, 95th centile cut-off points range from 57.0 cm at age 5 years to 85.2 cm at age 16 years
in boys, and from 57.2 cm at age 5 years to 75.1 cm at age 16 years in girls.33
l Neck circumference (NC) The use of this measure has been investigated in children, and it is thought
to be reliable for identifying children with high adiposity.34–36 Based on a US population, thresholds for
obesity are suggested as 29 cm in prepubertal boys, 28 cm in prepubertal girls, 32.5 cm in pubertal
boys and 31 cm in pubertal girls.36
l Rohrer’s Ponderal Index (Rohrer’s Index, Ponderal Index or Corpulence Index) Similar to BMI, but
calculated by dividing weight in kilograms by height in metres cubed (kg/m3), rather than height in
metres squared.29 This has been compared with BMI in respect of its ability to predict percentage body
fat in children and adolescents, and its long-term associations with adult obesity.37,38
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l Benn’s Index Calculated by dividing weight in kilograms by heightp (kg/mp); p is a power index derived from the
weight-to-height ratio (p=bH0/W0), making the index independent of height.29,39 Benn’s Index is rarely used
as p is neither constant nor necessarily a whole number, which means the calculations are complicated.29
A study in boys from four countries showed that the power of p required to produce a correlation of zero
between the index and height varied with age and ethnicity. For US, Japanese and Singaporean boys, the
p value was <2.8 at age 6 years, increased to <3.5 at age 9–10 years and decreased to <2.0 by age 16 years.
For boys in the UK, p started at <2.3, increased to <2.6 then decreased to <2.0.40
l Waist-to-height ratio (WHtR) As with the waist-to-hip ratio (WHR), WHtR is a measure of fat distribution,
and primarily identifies those with abdominal obesity. A person is typically considered obese if their
WC is over half their height (threshold of 0.5 across multiple countries and ethnicities).41,42
l WHR A measure of regional fat distribution used as a marker for intra-abdominal fat in adults. A WHR
of ≥ 0.80 in females and ≥ 1.0 in males is considered to be indicative of a high risk of health problems.43
One of the limitations with ratios using waist measurement is the potential for measurement error,
as there is inconsistency in the actual site of the waist measurement.
l Body adiposity index (BAI) This was suggested by Bergman et al. (2011)44 as reflecting the percentage
body fat in adults regardless of sex or ethnicity without numerical correction, and it was therefore
considered an improvement on BMI. BAI is calculated by the equation [hip circumference/(height)x]− 18,
with x being a unitless power term. The correlation between BAI and percentage adiposity was highest
when x was between 1.47 and 1.5, and therefore the use of 1.5 as the power term in Mexican
American adults was suggested.44 The measure has not been validated in children, and a power term for
children has not been specified.
l Skinfold thickness (SFT) A direct anthropometric measure of adiposity. Skinfold measurements are
considered as good indicators as they are a direct measure of the fat layer, but the measurements are
site- and sex-specific.27 The most common sites are the subscapular and the triceps;25 other potential
sites include the chest, axilla, abdomen, suprailium and thigh.26 Scores can be presented adjusted for
age and sex. There are also a large number of equations available that can be used to obtain an
estimate of percentage subcutaneous fat from SFT measurements,25,26 although these may introduce
biases and have not been standardised for children over the age of 6 years.45 In adults, women with
30% or higher, and men with 25% or higher, body fat are classified as obese.46 One of the limitations
of SFT is that visceral fat (fat in the abdominal cavity) is not measured. As with waist measurements,
measurement error is a particular limitation of this method. There can be considerable variability across
practitioners, leading to the requirement for specific training.
l Bioelectrical impedance analysis (BIA) This measures the opposition to the flow of an electric current
applied to extremities of the body (usually the wrists or ankles; in children, foot-to-foot currents are
used as this only requires the child to stand barefoot on scales), using a low-level (below the threshold
of human perception; usually a single frequency of 50 kHz) alternating electrical current passing
through the body. This is used to estimate total body water. As fat contains little water compared with
other body tissues, impedance can be used as a proxy measure for fat-free body mass. Body fat can
then be calculated from the difference between fat-free body mass and overall weight. BIA has several
limitations. First, the body is a number of cylinders of different length and diameter (legs, torso, arms),
rather than a single cylinder, and given that resistance decreases as the cross-section of a cylinder
increases, the arms and legs contribute more to resistance than the torso. The limbs represent 50% of
body weight but 90% of the body’s impedance; this means that impedance is more closely related to
changes in the muscle mass of the limbs. In addition, as there is an assumption that fat-free mass is
73% water,26 factors such as dehydration, exercise, diuretics or a full bladder will affect the results.47
Furthermore, equations based on height and weight are used to determine overall adiposity and these
vary across manufacturers. The equations used by some instruments may be unknown, and results
may vary across different instruments and populations.48 Given these limitations, BIA is currently not
recommended for use in the UK.
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l Fat mass index (FMI) Calculated from fat mass as determined by BIA (kg) divided by height squared.
FMI plus the fat-free mass index (fat-free mass/height squared)= BMI.49,50
l Near-infrared interactance (NIR) A beam of infrared light is transmitted into the biceps; the light is
reflected by underlying muscle and absorbed by fat, and therefore the proportion of reflected light will
indicate the proportion of fat. The NIR light penetrates the tissues to a depth of 4 cm and is reflected
back to the detector, which measures the optical density at wavelengths of 940 nm (optical density 1)
and 950 nm (optical density 2). The underlying principle is that optical densities are linearly and
inversely related to percentage body fat, and thus, the smaller the optical density, the greater the
absorption of NIR light and the higher the fat composition.26
More complex measures of obesity
Apart from SFT, the anthropometric measures listed above are indirect measures of adiposity. There are a
number of more direct measures of adiposity available; these are not routinely available and need to be
conducted by those who have been specifically trained, and therefore they are not useful as population
measures. Such measures include:
l Densitometry [hydrostatic weighing; underwater (hydrostatic) weighting] This method measures
underwater weight. It distinguishes fat mass and fat-free mass, assuming specific densities of these two
tissues, and therefore requires measurement of total body density (body mass/body volume).51 Whereas
the density of fat is relatively constant, that of fat-free mass varies according to its composition. This
variability is partly explained by the process of chemical maturation that occurs before adulthood, but
interindividual variability is also significant, even in healthy children.
l Densitometry [air displacement plethysmography (ADP)] A new system that uses the displacement of
air rather than water. This is thought to have better precision than hydrodensitometry in children, and
is acceptable in children as young as 4 years.52 An infant ADP has become available, allowing the
measurement of body volume during the first 6 months of life. In general, densitometry is unsuitable
for application as a two-component technique in patients in whom the composition of lean mass may
be abnormal, such as those with excess fluid retention and undermineralisation, as these decrease the
density of lean mass and lead to an overestimation of fatness.52,53
l Multicomponent models These models combine the results of three, four or five different measures.
The three-component model divides body weight into fat, water and fat-free dry tissue, and requires
measurements of body weight, body water by hydrometry and body volume by densitometry. The
four-component (4-C) model further divides fat-free dry tissue into protein and mineral, and requires
the measurement of bone mineral by dual-energy X-ray absorptiometry (DEXA). Its advantage is that it
is the most accurate approach, with all the component measurements being acceptable. It has the
disadvantage of being expensive and thus generally limited to specialist research.51 Body volume index
is a new multicomponent measure that uses BMI, WC and WHR along with other volumetric and body
composition analyses. The method requires a three-dimensional full-body scanner.54
l DEXA DEXA51 is a three-component model, as it measures bone mineral, bone-free lean mass and fat
mass. For accurate estimation of body fat, the hydration of lean body mass needs to be established;
often, a constant for hydration of lean body mass (0.73ml/g) is assumed, which is based on non-elderly,
healthy, adult measurements. The use of this assumption can lead to an error in the amount of lean
tissue, particularly in children, the elderly and the sick; DEXA is likely to be more reliable in healthy adults
with a constant tissue hydration.55,56 DEXA may therefore have difficulty accurately assessing body mass in
infants, with increasing accuracy as body size increases. DEXA also has difficulty distinguishing between
bone and non-bone lean mass in high bony areas (thorax, forearm).55 In a review comparing DEXA with
4-C models, DEXA tended to underestimate body fat in most studies, with this underestimation usually
being greater in leaner people.57 Some studies did find DEXA overestimated body fat, and some no
difference; there seemed to be differences in accuracy with different DEXA technology.57
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l Deuterium dilution method (D2O) Deuterated water (2H2O) is currently the most accurate way of
measuring total body water. The difference in secreted markers (urine, saliva) between baseline and
post ingestion is used in an algorithm to calculate total body water and fat-free mass. The difference
between total body mass and fat-free mass gives fat mass, allowing body composition to be worked
out, but the method is most effective for total body water when used in a multi-(four-)component
model with body density [underwater (hydrostatic) weighting], BIA and DEXA. The method is safe and
has been validated in a wide range of populations but does have disadvantages; it is expensive,
time-consuming (requiring sample collections and analyses) and rather invasive because it requires
participants to ingest a dose of deuterium-enriched water.58
Challenges when measuring obesity in children
To monitor the trend in, and to reduce the prevalence of, overweight and obesity, several initiatives have
been introduced in the UK. Programmes that target obesity in general include the Department of Health’s
‘Call to Action’,59 the National Obesity Observatory60 and the International Obesity Taskforce (IOTF).61
Programmes aimed specifically at children include the NCMP, which measures the weight and height of
children in reception class (aged 4–5 years) and Year 6 (aged 10–11 years) in order to assess overweight
and obesity levels within primary schools.4 In order for such programmes to succeed, the measure of
obesity needs to be accurate and simple to implement. It is therefore important to investigate whether
or not BMI, the most commonly used simple measure, is the best measure for wide-ranging screening
programmes, and, if not, which measure (or combination of measures) should replace it in order to ensure
that children at risk of obesity-related morbidity are identified.
The assessment of childhood obesity using BMI and other anthropometric measures is more complicated
than that of adults.62 The major limitation of anthropometric measures to determine obesity in children is
that most are confounded by natural, age-related physiological variations in body composition.27,63 As a
result, actual measurements are compared with reference data to determine if a child is overweight or
obese. However, for BMI, the most commonly used anthropometric measure in children, there are
several reference data sets available, including the centiles of the UK 1990 growth reference (UK90),
IOTF thresholds and the World Health Organization (WHO) growth reference; the advantages and
disadvantages of each have been summarised elsewhere.64 This results in different thresholds being used
for defining overweight and obesity across organisations and countries, which makes the comparability of
data and the determination of the accuracy of these measures difficult.65 In the UK, BMI is related to the
UK90 BMI growth reference charts to determine whether or not a child is obese. For clinical purposes,
overweight is defined as a BMI ≥ 91st centile and obesity as a BMI ≥ 98th centile; however, many of
the data available have been collected within a research context, and for research and population
monitoring purposes the 85th and 95th centiles are recommended for classifying overweight and obesity,
respectively.1 The associated standardised scores, based on UK90 reference data, are 1.04 for the 85th
centile; 1.34 for the 91st centile; 1.64 for the 95th centile; and 2.0 for the 98th centile. Most of the
anthropometric measures being investigated in this review will be affected by a child’s age, sex and
ethnicity, and will therefore require standardisation. NC, NIR and WHtR are measures not subjected to
standardisation. The fact that they are not standardised may be attributable to the lack of appropriate
reference data.
A lack of requirement for standardisation for age and sex for a measure would afford that measure some
advantage over anthropometric measures that do require standardisation; whether or not this would be at
the cost of accuracy would need to be established.
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
5
A further challenge arises when an association needs to be made between childhood obesity and adult
morbidity, as very long-term studies are required. One study followed 1000 families from Newcastle upon
Tyne (UK), involving 1142 children recruited at birth in 1947; 412 were followed to the age of 50 years.66
The study concluded that there was little tracking of obesity from childhood to adulthood, that there was
no excess adult health risk from childhood or teenage overweight, and that being thin as a child offered no
protection against obesity in adulthood.66 This contrasts with the results of other studies and reviews;21,23,67,68
although this may be related to population differences owing to the age of the cohort, it may also be a result
of the study being underpowered. A comparison of two British birth cohorts, one of children born in 1946
and the other of children born in 1958, showed that girls in the 1958 cohort had a higher average BMI
during 7 years in childhood, and that both boys and girls in the 1958 cohort had a greater rate of increase
in BMI during adulthood.69 These studies illustrate that potential determinants and levels of adiposity in
childhood differ between these birth cohorts, and are likely to differ for the present-day child population.
However, the long-term relationships between childhood obesity and adult morbidity may not change as a
result of these differences, and standardisation of obesity scores is thought to mitigate some of the changes
observed over time.
Aims and objectives of the review
It is generally accepted that adult obesity is associated with an increased risk of morbidity (type 2 diabetes,
CVD and cancer) and premature mortality in adults. However, the link between childhood obesity and
adult morbidity is less clear. Recent systematic reviews have indicated that childhood obesity is associated
with adult obesity16,17 and a range of adult morbidities,18–22 but none has used formal methods to estimate
the accuracy (in terms of sensitivity and specificity) of childhood obesity to predict adult obesity and
morbidity. In addition, these reviews have primarily been based on studies that used BMI to determine the
presence and level of obesity. BMI is the most commonly used measure, but there are concerns regarding
its suitability in determining obesity in children, particularly in relation to the need for standardisation.
The question remains of whether or not another simple childhood measure, used either alone or in
combination with BMI or some other simple measure, would be better for predicting the risk of adult
obesity and (separately) adult morbidity. It is therefore important to determine the predictive accuracy of
the simple measures that are available in order to inform the decision as to which should be used for
screening children to identify those at risk of developing obesity and serious obesity-related morbidities
as adults.
The decision problem to be addressed was, ‘What is the best simple measure, or combination of simple
measures, of obesity in children for predicting the development of obesity-related health problems such as
type 2 diabetes, CVD and cancer in adolescence and/or adulthood?’ Given the relationship between adult
obesity and morbidity, the ability of these simple measures to predict the persistence of obesity from
childhood into adolescence and adulthood was investigated. Acceptability and ease of use of the measures
are also important when considering whether or not any one of these measures should be introduced
as the standard method for the assessment of childhood obesity; this will also be addressed within
the review.
The objective of our research was to address, through systematic reviews, the questions raised in the
decision problem.
1. Is obesity in children and adolescents a risk factor for CVD, type 2 diabetes and/or cancer in adults, and
do the results vary according to the simple measure of obesity employed?
2. To what degree do simple measures of obesity in children accurately predict the tracking of obesity into
adolescence and adulthood?
BACKGROUND
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In order to fully evaluate the predictive value of the simple measures of obesity, and therefore the
relationship between the measures and subsequent adult obesity and morbidity, the relationship between
the measure and classifying weight status needs to be established. Therefore, a third question
was addressed:
3. How accurately do simple measures of obesity reflect actual adiposity in children?
The review investigated how accurately the simple measures diagnosed a child’s weight status (overweight
or obese), rather than absolute adiposity, as this was the most relevant question.
Once the most promising measure(s) had been determined in terms of predictive accuracy, a fourth
question was addressed for that measure(s):
4. How acceptable are these measures of adiposity to children and their carers, and how easy is it for
health professionals to implement them?
This review has focused on differentiating between the association between childhood obesity and adult
morbidity and obesity, and the ability of childhood obesity to predict adult morbidity or obesity. The
analyses of association examine whether or not an increase in childhood obesity in the population as a
whole will lead to increased incidence of adult morbidity and obesity. This is distinct from prediction,
which examines whether or not childhood obesity could be used as a screening test for later morbidity or
obesity. The focus is on whether or not individual adults who have a morbidity or are obese were obese in
childhood, and, separately, whether or not obese children go on to become obese adults. This distinction
is necessary because an association between childhood obesity and adult obesity or morbidity does not
imply that childhood obesity is a good predictor of them.70
In the original protocol, question 1 above was ‘Is obesity in children and adolescents an independent risk
factor for CVD, type 2 diabetes and/or cancer in adults, and do the results vary according to the simple
measure of obesity employed?’ The aim of this review was to assess the ability of childhood obesity
specifically to predict adult morbidity such that appropriate action might be taken in childhood. Therefore,
no adjustment for adult morbidity was considered. To avoid any ambiguities, the term ‘independent’ was
therefore removed from the original question.
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Chapter 2 Methods
The systematic reviews were conducted following the general principles recommended in Centre forReviews and Dissemination (CRD) guidance for undertaking reviews in health care,71 and the reporting
guidance of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
statement.72 The protocol for the systematic review is registered on PROSPERO (PROSPERO registration
number: CRD42013005711).
Search strategy
Aim of the literature search
Three separate literature searches were undertaken to identify studies to answer the following questions:
1. How accurately do measures of childhood obesity predict CVD, diabetes and/or cancer in adulthood?
2. Which simple measure of obesity in children most accurately predicts the tracking of obesity into
adolescence and adulthood?
3. How accurately do simple measures of obesity reflect actual adiposity in children (actual adiposity in
terms of ability to correctly classify a child as normal weight, overweight or obese)?
The three search strategies were devised using a combination of indexed subject heading terms and
free-text search terms appearing in the title and/or abstract of database records. Search terms were
identified through discussion within the project team, by scanning background literature and ‘key articles’
already known to the project team and by browsing database thesauri. The search strategies were peer
reviewed for accuracy by other information specialists based at CRD (Lisa Stirk and Melissa Harden). Once
the MEDLINE search strategies were agreed and peer reviewed, they were adapted so that they could be
used in the other databases. Bibliographic records were managed using EndNote XI bibliographic
management software (Thomson Reuters, CA, USA).
Full details of the search strategies, dates of searches and results from all the databases and resources
searched are given in Appendix 1.
Concepts of the search strategy
All three search strategies included a set of search terms for the following three concepts: ‘obesity’,
‘children’ and a collection of ‘simple anthropometric measures’ (index tests). The ‘obesity’ concept included
search terms for ‘adiposity’. As BMI is the most widely used and recognised simple anthropometric
measure for obesity, using this as a search term inevitably increased the sensitivity of the search strategy
and the volume of literature retrieved.
The database searches were supplemented with reference checking and citation searching, as well as
additional targeted searches for any gaps in the literature identified after screening of the initial set of
literature search results.
The search strategy for the question on the prediction of adult morbidities was structured using the
following concepts:
(Obesity OR adiposity)
AND
(Children OR adolescents)
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AND
(CVD OR diabetes OR cancer)
An initial search to identify only systematic reviews was conducted, and the searches were limited to the
Database of Abstracts of Reviews of Effects (DARE), the Cochrane Database of Systematic Reviews (CDSR),
the Database of Promoting Health Effectiveness Reviews (DoPHER) and MEDLINE (with a methodological
search filter designed to retrieve systematic reviews).
Having assessed the systematic reviews of measures for predicting morbidity in adulthood, the team was
able to identify gaps in the literature and decided on the limits for the searches for primary studies.
Targeted searches were conducted for the combinations of measures and morbidities shown in Table 1.
For the review question on the tracking of obesity, the search strategy was structured using the
following concepts:
(Obesity OR adiposity)
AND
IT
AND
(Tracking OR Cohort studies OR longitudinal studies OR follow-up studies)
AND
(Children OR adolescents)
AND
Adults
AND
Date limit (2007–2013)
TABLE 1 Specification for targeted searches
Measures Morbidities Update from
BMI CVD, diabetes and cancer 2011
SFT CVD and diabetes 2008
SFT Cancer All dates
WC CVD and diabetes 2008
WC Cancer All dates
All other measures CVD, diabetes and cancer All dates
METHODS
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During the initial scoping searches, a systematic review about ‘tracking’ of childhood obesity into
adulthood was identified [Singh et al. (2008)],16 and it was therefore decided to limit the searches to run
from the date when the searches for this review were completed (2007). The final agreed search strategy
was unable to identify one of the Singh review included studies, owing to the absence of any terms for
‘tracking’ or study design in the title or abstract and inadequate subject heading indexing.
The diagnostic accuracy literature searches were designed to identify studies that compared index tests
with reference standards, so both concepts were combined alongside terms for ‘obesity’ and ‘children’.
The diagnostic accuracy search strategy was structured using the following concepts:
(Obesity OR adiposity)
AND
(Children OR adolescents)
AND
Index tests
AND
Reference standards
NOT
Animal studies
Initially, the search for studies on the acceptability of simple measures was to be conducted for those tests
previously determined to be the most promising measures in terms of predictive accuracy. However, given
the lack of non-BMI studies, searches were designed to retrieve qualitative studies about the accessibility
and ease of use of the following simple measures of obesity: BMI, SFT, WHR and WHtR. The searches were
limited to the following databases: MEDLINE, EMBASE, PsycINFO and Cumulative Index to Nursing and
Allied Health Literature (CINAHL). They were also limited by date range (2008–13).
Resources searched
The literature searches involved searching a wide range of databases. The following databases and
resources were searched:
l MEDLINE (OvidSP)
l MEDLINE In-Process & Other Non-Indexed Citations (OvidSP)
l PubMed (National Library of Medicine)
l EMBASE (OvidSP)
l PsycINFO (OvidSP)
l CINAHL (EBSCO)
l CDSR (Wiley Online Library)
l Cochrane Central Register of Controlled Trials (CENTRAL) (Wiley Online Library)
l DARE (CRD interface)
l Health Technology Assessment (HTA) Database (CRD interface)
l NHS Economic Evaluation Database (NHS EED) (CRD interface)
l Science Citation Index (SCI) [ISI Web of Science (WoS)]
l Conference Proceedings Citation Index – Science (CPCI-S) (ISI WoS)
l Health Management Information Consortium (OvidSP)
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l Trials Register of Promoting Health Interventions [Evidence for Policy and Practice Information and Co-
ordinating Centre (EPPI-Centre) interface]
l DoPHER (EPPI-Centre interface)
l Obesity and Sedentary Behaviour Database (EPPI-Centre interface)
l OAIster (http://oaister.worldcat.org/)
l OpenGrey (www.opengrey.eu/).
The following obesity-related organisation websites were searched:
l Public Health England – Obesity Knowledge and Intelligence (previously National Obesity Observatory)
(www.noo.org.uk/)
l Association for the Study of Obesity (www.aso.org.uk/)
l Obesity Learning Centre (www.obesitylearningcentre.org.uk/)
l National Obesity Forum (www.nationalobesityforum.org.uk/)
l British Dietetic Association (www.bda.uk.com/index.html)
l Centre for Diet and Activity Research (CEDAR) (www.cedar.iph.cam.ac.uk/)
l The Nutrition Society (www.nutritionsociety.org/)
l International Association for the Study of Obesity (www.iaso.org/)
l European Association for the Study of Obesity (EASO) (www.easoobesity.org/)
l European Congress on Obesity (www.easo.org/eco2013)
l European Childhood Obesity Group (ECOG) (www.ecog-obesity.eu/)
l Centers for Disease Control and Prevention (CDC) Division of Nutrition, Physical Activity, and Obesity
(USA) (www.cdc.gov/nccdphp/dnpao/index.html)
l Weight-control Information Network (USA) (http://win.niddk.nih.gov/)
l The Obesity Society (USA) (www.obesity.org/)
l myhealthywaist.org (International Chair on Cardiometabolic Risk of Université Laval – QC, Canada)
(www.myhealthywaist.org/).
Citation searches were conducted in SCI and Google Scholar. All sources proposed in the protocol are listed above.
Inclusion criteria
As systematic reviews had already been conducted for questions 1 and 2, good-quality systematic reviews
that could be used as a basis for the current review were sought for these questions. Given the nature of
the data required for meta-analysis, many studies included for these questions may be of cohorts recruited
when influences in childhood were most likely different to those experienced by the present-day child
population. However, reviews where such older cohorts are included were not excluded from the review.
Review of prediction of adult morbidities
l Outcomes The study had to report RRs, odds ratios (ORs), hazard ratios (HRs) or summary estimates of
predictive accuracy, or sufficient data from which these could be derived, for the association between
childhood obesity and adult CVD, type 2 diabetes or cancer. For the purposes of this review, CVD
incorporated major cardiovascular events such as cardiovascular death, myocardial infarction, stroke,
heart failure, hypertension, hypercholesterolaemia and metabolic syndrome.
l Interventions Data for the following simple measures were included: BMI, NC, WC, WHR, WHtR, BAI,
Rohrer’s Ponderal Index, Benn’s Index, FMI, SFT, BIA and NIR. Studies were included for each of these
measures, regardless of how the measurement was conducted (i.e. any level at which WC was
measured was eligible).
l Study design Prospective, longitudinal studies that were sufficiently powered (1000 participants) and
that evaluated any one of the interventions of interest used in childhood for the prediction of a
morbidity of interest in adolescence or adulthood were eligible; case–control studies and retrospective
studies were excluded.
METHODS
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There are many other types of morbidity where evidence of an association with obesity exists, including
mental health problems, respiratory conditions and musculoskeletal conditions, among others. This review
considered only cardiovascular conditions, diabetes, cancer and metabolic syndrome, in order to focus on
those conditions most likely to lead to mortality, where the evidence of association with obesity was
strongest, and where there was most likely to be long-term evidence in cohort studies of their association
with childhood obesity.
Tracking of childhood obesity into adolescence/adulthood or adolescent
obesity into adulthood
l Population Studies recruiting children and/or adolescents (up to the age of 18 years) were eligible for
inclusion. Studies recruiting a mixture of adults and children/adolescents were included if the results for
children/adolescents were reported separately. Studies had to recruit either population-based samples
of children or overweight/obese children; studies conducted only in children who were not overweight
or obese were excluded. We accepted the definition of obesity/adiposity used in the study.
l Interventions Data for the following simple measures were sought: BMI, NC, WC, WHR, WHtR, BAI,
Ponderal Index, Benn’s Index, FMI, SFT, BIA and NIR. Studies were included for each of these measures,
regardless of how the measurement was conducted (i.e. any level at which WC was measured
was eligible).
l Outcomes The study had to report estimates of test accuracy, or sufficient data from which these
could be derived, for the association between the weight status in childhood and/or adolescence and
the incidence of obesity/overweight in adulthood. This was a change from the protocol, required as
data on the association between weight status in childhood and adulthood would be insufficient to
assess the predictive accuracy of childhood obesity/overweight. Studies that reported only correlations
between the childhood and adult measures were also excluded.
l Study design Prospective, longitudinal studies that evaluate any one of the interventions of interest
were eligible; case–control studies and retrospective studies were excluded. Inclusion was initially
restricted to studies that recruited at least 100 children; this was increased to 1000 children in studies
of BMI given the volume of evidence available and so as to include only well-powered studies.
As inclusion was restricted to those studies where predictive accuracy of the anthropometric measure
could be established, only studies that used an acceptable reference standard in adulthood
[i.e. a multicomponent model, D2O, underwater (hydrostatic) weighting, ADP or DEXA] were included.
BMI was added to the list of reference standards as it is generally accepted as a suitable estimate
in adults and we expected it to be the most commonly used adult measure (see Appendix 2).
The diagnostic accuracy of childhood measures of obesity
l Population Studies recruiting children and/or adolescents (up to the age of 18 years as defined in the
NICE CG43 obesity guidelines) were eligible for inclusion. Studies recruiting a mixture of adults and
children/adolescents were included if the results for children/adolescents were reported separately.
Studies had to recruit either a population-based sample of children or overweight/obese children;
studies conducted only in children who were not overweight or obese were excluded.
l Interventions The following simple measures were evaluated: BMI, NC, WC, WHR, WHtR, BAI,
Ponderal Index, Benn’s Index, FMI, SFT, BIA and NIR.
l Reference standard A multicomponent model that measures four or five components was considered
the gold standard for assessing the accuracy of simple anthropometric measures of adiposity in
children, because the precision of such a model is considered to be higher than other complex
measures. The other complex measures, such as DEXA, D2O and densitometry [underwater (hydrostatic)
weighting or ADP], were accepted as reference standards as they are more commonly used in research
studies; these were considered imperfect reference standards.
l Outcomes The study had to report either summary estimates of diagnostic accuracy or sufficient data
from which these could be derived.
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l Study design Prospective single-gate (diagnostic cohort) studies that evaluated any one of the
interventions of interest in comparison with any one of the reference standards were eligible for
inclusion. For measures for which these are not available, prospective two-gate (diagnostic
case–control) studies were included; these had to match cases and controls on at least age and sex, or
provide estimates of sensitivity and specificity that had been adjusted for these variables.
The acceptability and ease of use of childhood measures of obesity
The original intention was to identify primary studies that undertook a robust evaluation (such as the use of
questionnaires or interviews) of the acceptability and ease of the most promising measure(s) in terms of
diagnostic and predictive accuracy. Given that the majority of the data identified were for BMI, this was
amended to a search for studies of acceptability and ease of use for the four measures most commonly used in
clinical practice: BMI, SFT, WHR and WHtR. Studies could be from the perspective of the child, parent or health
professional. Studies that discussed acceptability or ease of implementation with no direct measurement
were not included. Given the recent changes in distribution across the population, the emphasis placed on
education and intervention for obesity and general attitudes towards obesity, the inclusion of primary studies
was initially restricted to those conducted within the previous 5 years (search start date 2008). It was expected
that the number of studies addressing this issue would be small. Only one study was identified that met the
inclusion criteria.73 Two further studies were identified from the searches for questions 1, 2 and 3 that were
published in 200674 and 2007;75 given the paucity of evidence, the results of these are also presented.
To supplement the systematic review, a simple elicitation exercise (survey) was performed to obtain some
indication of the attitudes of children, school nurses and parents to the measures being evaluated. Ethical
approval from the Carnegie Faculty Committee, Leeds Metropolitan University, UK, was obtained. Overweight
and obese children attending a weight management summer camp, parents of the children attending the
weight management camp and school nurses were asked to complete a structured questionnaire developed
specifically for the project that was suitable for the age group concerned. Opinions were elicited for the same
four measures being evaluated in the systematic review of acceptability and ease of use: BMI, SFT, WHR
and WHtR.
Data extraction strategy
Data extraction was conducted by one reviewer using standardised data extraction forms and
independently checked by a second reviewer; separate forms were developed for the different review
questions. Discrepancies were resolved by discussion, with involvement of a third reviewer when necessary.
Data from multiple publications of the same study were extracted and reported as a single study, unless
there was no overlap. Extraction included data on study details (e.g. author, year, country, setting, number
of participants), patient characteristics (e.g. age, sex, ethnicity), details of intervention [measure used;
classification and reference data used; timing of measurement; threshold used for diagnosis of overweight
and obesity; variations in the method used when undertaking the measurement (e.g. equations used)],
study quality and reported outcomes as specified above. For the morbidity review, where studies reported
adjusted and non-adjusted outcome results, adjusted values were extracted, and where different levels of
adjustments were reported [e.g. adjusting for age and sex only vs. adjusting for age, sex and socioeconomic
status (SES)], results with the highest number of adjustments were generally preferred. However, results
where adult weight status was not adjusted for were preferred to estimates that were adjusted for this
variable. Full data extraction tables are given in Appendix 3.
Quality assessment strategy
The quality of the individual studies was assessed by one reviewer and independently checked by a second
reviewer. No primary study was excluded based on the result of the quality assessment; disagreements
were resolved by consensus and, if necessary, a third reviewer was consulted. The quality of included
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
14
studies was assessed using standard checklists suitable for the study design: Quality Assessment of
Diagnostic Accuracy Studies (QUADAS) was used for studies of diagnostic accuracy,76,77 and Quality in
Prognosis Studies (QUIPS) formed the basis of the assessment of the studies of predictive value.78,79 These
tools were adapted as necessary to be review question-specific and to incorporate topic-specific quality
issues; the most important of these adaptations was an assessment of measurement bias. Blinding of the
assessors to index tests and reference standards was not assessed in the review of diagnostic accuracy
owing to the visual clues at the time of the assessment.
The quality of the recent and relevant systematic reviews under consideration for inclusion in the current
review was assessed using the criteria used by CRD for inclusion on the DARE database. Those that were
included as a basis for the current review were assessed in terms of the strategy used to identify studies;
the clarity of the review question and reproducibility of the inclusion criteria; the use of methods to reduce
error and bias during the review process; the appropriateness of the quality assessment tool used to assess
primary studies and the reporting of the results, analyses undertaken and interpretation of the results;
the appropriateness of the conclusions drawn; and whether or not the patient population was
representative. Primary qualitative studies were assessed using the Critical Appraisal Skills Programme
Qualitative Research Checklist.80 Full results of the quality assessments and guidance for their completion
are given in Appendix 4.
Data analysis
Review of prediction of adult morbidities
The review of the association between childhood obesity and adult obesity-related morbidity, and the
prediction of adult morbidities from childhood obesity status, was based on the identified cohort studies.
Most cohorts were reported in multiple publications. Different publications concerning the same cohort
were all included, provided they reported on different morbidities or reported results at different
childhood ages.
Although studies reported many morbidity outcomes, only the following were considered in the
meta-analyses:
l diabetes (adult-onset, type 2)
l CHD
l stroke
l hypertension
l breast cancer
l all other cancers, combined.
These were the only protocol-specified morbidities reported in at least two cohorts. Cancers were
combined because a range of different cancers were reported within and across cohorts. In the narrative
review we also considered hypercholesterolaemia and metabolic syndrome.
As results were reported at different ages, we grouped ages as:
l under 7 years
l 7–11 years
l 12–18 years.
The first group represents young children who may experience adiposity rebound, where BMI declines up
to around age 7 years. The other two groups represent typical UK division between primary- and
secondary-level education.
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Studies reported results in a variety of ways, including numbers of morbidities in different BMI categories,
ORs comparing different categories of BMI, ORs between different centiles of BMI, ORs per standard
deviation (SD) increase in BMI (or, equivalently, per BMI z-score unit) and across different reference
populations. Given the diversity in reporting, a direct meta-analysis of results was not feasible. In order to
perform a meta-analysis, all results were converted into ORs per SD of BMI (with 95% CIs), and into
estimates of predictive performance in terms of sensitivity at specified obesity thresholds. The approach
used for this conversion followed the methods of Morris and Wald70 for converting reported ORs into
estimates of predictive performance. It requires some assumptions about the distributions of obesity in the
childhood population, specifically:
l that BMI follows a normal distribution
l that the SD of BMI is the same in people with and without the morbidity
l that the morbidity is rare.
It is acknowledged that the first assumption is invalid, as BMI is not normally distributed and has a positive
skew, but this assumption is required for a meta-analysis to be performed, and it is applied equally to all
studies, so any error applies uniformly across the analysis. The other assumptions are more reasonable in
this context. Tests on simulated data suggest that, for positively skewed distributions of BMI, these
assumptions may slightly overestimate ORs, but the overestimation is unlikely to exceed an absolute
increase of 0.1. Using these assumptions will therefore also lead to overestimates of predictive accuracy by
increasing estimates of sensitivity. The effect of the assumptions is uncertain, but tests on simulated data
suggest that the area under the summary receiver operating characteristic (ROC) curve could be
overestimated by up to 20%. As data in publications were presented as ORs without data on the
distribution of BMI, it was not possible to transform these data to better represent a skewed distribution.
For each morbidity outcome and within each age group, a DerSimonian–Laird random-effects meta-analysis
was performed to pool ORs per SD of BMI across cohorts. This produced a summary estimate of the
association between childhood obesity and adult morbidity. As the SDs are specific to each cohort, these
results should be interpreted as the OR per SD in a ‘typical’ population. To aid interpretation, some ORs
were converted into odds per kg/m2 of BMI, based on the SD of BMI in adolescents in the UK (about
2.5 kg/m2).81
Meta-analyses of the predictive accuracy of childhood obesity for predicting future morbidity were also
performed. For each study, the sensitivities for predicting the morbidity among overweight (85th centile
of BMI) and obese (95th centile) children were calculated using the methods of Morris and Wald70
described above. These sensitivities and their 95% CIs were then pooled across studies in standard
DerSimonian–Laird random-effects meta-analyses to summarise the predictive sensitivity of childhood
obesity to predict adult morbidity. These pooled estimates were converted into summary ROC curves.
The assumption that the disease is rare means that specificity cannot be calculated in these analyses; only
sensitivity at specified thresholds of BMI were presented, rather than true ROC curves. All analyses were
performed using the R version 3.1 software (The R Foundation for Statistical Computing, Vienna, Austria).
No analyses of potential for publication bias were performed given both the limited number of studies in
each meta-analysis and the uncertainty over the validity of such tests when reviewing predictive or
prognostic outcomes.
All cohort studies in this review reported single measurements of BMI rather than repeated measurements
over time. The use of single measurements may lead to regression to the mean, because children with an
extreme measurement at a particular time are more likely to have a less extreme result at some later time,
leading to underestimation of the association. Although regression to the mean is an acknowledged
problem in measurements that change rapidly over time, such as blood pressure or blood lipids,82 it is
unlikely to be a problem for BMI, which by its nature can vary little over short periods of time.
METHODS
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The aim of this review was to assess the ability of childhood obesity to predict adult morbidity; for this
reason, no adjustment for adult morbidity was considered.
Review of tracking of obesity into adulthood
The analysis of the studies tracking obesity from childhood to adulthood was based on the diagnostic
accuracy data extracted from these studies. Data were reported for tracking from childhood obesity
(defined as BMI above the 95th centile) or overweight (above the 85th centile) to adult obesity (defined as
BMI above the 95th centile or over 30 kg/m2) or adult overweight (above the 85th centile or over 25 kg/m2).
This allowed for four separate tracking analyses:
l childhood obesity to later obesity
l childhood obesity to later overweight or obesity
l childhood overweight or obesity to later obesity
l childhood overweight or obesity to later overweight or obesity.
Some studies reported data on only one of these comparisons, some on two and some on all four, so
certain studies contributed to only some of the analyses.
Ages were split into four categories:
l childhood (ages 7–11 years)
l adolescence (ages 12–18 years)
l adulthood (age 20 years and over)
l aged over 30 years (to examine longer-term obesity tracking).
Studies reporting on obesity below age 7 years were excluded to avoid including children with
adiposity rebound.
Given these ages, analyses were conducted to examine tracking:
l from childhood to adolescence
l from childhood to adulthood
l from adolescence to adulthood
l from adolescence to aged over 30 years.
Analyses were not stratified by sex as these data were too limited. Only BMI was considered as only two
studies reported data on any other obesity measure (WC).
To assess the association between childhood obesity and adult obesity, the risk of being obese in
adulthood given obesity status in childhood was calculated for each study from the diagnostic data. The
RR of adult obesity, with its 95% CI, when comparing obese and non-obese children was calculated.
These RRs were pooled in a DerSimonian–Laird random-effects meta-analysis, stratified by age group at
time of obesity measurement.
The diagnostic accuracy data were synthesised in meta-analyses to estimate summary sensitivity, specificity
and positive predictive values (PPVs) across the studies. As sensitivity and specificity are known to be
correlated, the bivariate model was used to jointly analyse sensitivity and specificity.83 Summary ROC curves
were produced using the hierarchical summary ROC (HSROC) model,84 which is mathematically equivalent
to the bivariate model. PPVs were similarly jointly modelled with negative predictive values (NPVs) using an
adaptation of the bivariate model. These analyses did not correct for differences in obesity prevalence,
which will lead to heterogeneity in PPVs and NPVs. The bivariate model requires full diagnostic accuracy
data (i.e. numbers of true and false positives, and true and false negatives); therefore, studies that only
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presented summary sensitivity and specificity data were excluded. All results were presented as summary
estimates with 95% CIs and HSROC curves, plotted in ROC space. The more formal 95% joint confidence
regions for sensitivity and specificity were not presented for reasons of clarity.
No analyses of potential for publication bias were performed given uncertainty over the validity of such
tests when reviewing predictive or prognostic outcomes.
All analyses were performed using the R software, using in-house code designed to be equivalent to the
metandi library available for Stata version 13 (StataCorp LP, College Station, TX, USA).
Review of diagnostic accuracy
The review of studies of diagnostic accuracy was primarily a narrative review owing to the substantial
clinical heterogeneity across the studies. The assessment of diagnostic accuracy was conducted as a
supportive question to the primary reviews of predictive accuracy. As a result, data extraction was planned
for those thresholds used by studies in the reviews of predictive accuracy. Given that the majority of
studies in the predictive accuracy reviews evaluated BMI, using a range of commonly used cut-off points
(85th centile, 95th centile, one and two SDs), these data were extracted from the diagnostic accuracy
studies evaluating BMI. The other index tests of interest were rarely evaluated in the studies of predictive
accuracy, and the thresholds for these tests are less well established. As a result, data were extracted for a
more diverse range of cut-off points. Where a study did not report the threshold used, these data were
extracted. Study details and results were tabulated.
For the analysis of BMI, inclusion was restricted to those studies that used a cut-off point of 85th centile
for overweight and 95th centile for obesity and were conducted in a population representative of the UK
child population. This gave us the most homogeneous data set that could be derived from the BMI studies,
and we considered these to be the most informative data and those that would be the most reflective of
the accuracy of BMI when used in a setting such as a school, where screening often takes place. To
produce summary estimates of accuracy for BMI, HSROC curves were produced and the bivariate model
fitted as described above for the tracking review using Stata version 13.
For the studies evaluating tests other than BMI, a narrative synthesis was presented, as there were fewer
studies that were too heterogeneous to pool. We considered the most robust data to be from those studies
that conducted direct comparisons of more than one test (two or more tests conducted in the same
patients, using the same reference standard in all patients). We therefore used these studies to gain an
insight into the comparative accuracy of the tests being evaluated. The results of these studies were
tabulated and a narrative synthesis provided; limited numbers of studies and the range of obesity measures
considered precluded any meta-analysis of these data. To aid interpretation of these data, estimates of
sensitivity and specificity from studies which compared the diagnostic accuracy of BMI with some other
simple obesity measure were plotted in ROC space, and diagnostic ORs (DORs) were calculated. This could
only be undertaken for those studies from which 2 × 2 data could be extracted or derived; therefore, there
are some test results in the tables of sensitivity and specificity that do not appear in the diagrams.
To help understand why one test may have a better predictive accuracy than another, we planned to
compare the sensitivities and specificities for predictive and diagnostic accuracy of those tests evaluated in
the predictive accuracy reviews. There were insufficient predictive accuracy data for non-BMI measures for
this to be completed.
Review of the acceptability and ease of use of simple childhood measures
of obesity
Study details and results have been summarised in tables and a narrative provided. The results of the
elicitation exercise have been summarised in a narrative, with the summary results presented in
tabulated form.
METHODS
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Chapter 3 Results
Flow of studies through the review
The screening process was undertaken in three stages. The initial stage was to screen for relevant
systematic reviews for the morbidity review, and reviews and primary studies for the tracking and
diagnostic accuracy reviews. After deduplication, there were 10,296 retrievals from the initial electronic
searches, which were supplemented by the searching of bibliographies of relevant reviews, and primary
diagnostic accuracy studies, which added 62 studies; seven studies were identified in the subsequent
search for primary studies for the morbidity review which were also screened for inclusion in the tracking
and diagnostic accuracy reviews (Figure 1).
Once the relevant systematic reviews were identified from the first screening stage for the morbidity
review,18–22 these were used to set the parameters of the second search for primary studies. After
deduplication, there were 5690 retrievals from the electronic searches, which were supplemented by the
searching of bibliographies of the previous reviews of the prediction of adult morbidities, which added
52 studies. A further 30 primary studies from the initial screening stage were also considered potentially
relevant and screened for the review of adult morbidities (Figure 2).
The third stage of screening was for the review of acceptability and ease of use review. From the focused
searches conducted, 1494 citations were retrieved from the electronic searches; three further studies were
screened that were identified during stage one of the screening process (Figure 3).
Across the three searches and screening stages, 12 papers were unobtainable; for eight, the review team
considered there to be sufficient information available to reliably exclude the study from the review,85–92
and for four a decision could not be made, but the study had to be excluded owing to lack of data.93–96
Twenty studies were excluded from the review as they were linked to included studies and did not provide
unique data.97–116
After completion of the screening process, 95 studies were included in the review; 23 evaluated the
tracking of obesity into adulthood,117–139 37 the association between obesity in childhood/adolescence and
morbidity in adolescence/adulthood,117,118,123,129,140–172 34 diagnostic accuracy173–206 and 5 acceptability and/or
ease of use.73–75,207,208
For the review of adult morbidities, 13 reviews were identified.18–22,209–217 One was an abstract for which
there was no full paper.210 Of the remaining 12, most evaluated only BMI.18–22,213–215,217 Only the review by
Whitlock et al. (2005)214 included studies of childhood measurements of interest other than BMI.
The review reported on weight-to-height ratios and SFT and their correlation with outcomes in adulthood
such as fasting insulin levels, cholesterol and blood pressure. Although the reviews by Park et al. (2011),18
Reilly et al. (2011),22 Owen et al. (2009),21 Lloyd et al. (2010)20 and Lloyd et al. (2012)19 were considered
the most recent relevant, the overlap in included studies across all of the identified reviews was poor. As a
result, no individual reviews were considered to be sufficiently complete. Therefore, the included studies
from all of the identified reviews were screened. In addition, the bibliographies of relevant reviews that
were identified by the searches but were not considered suitable for updating (mainly because they did not
appear to use systematic methodology) were also searched. All potentially relevant studies were retrieved
from these reviews, regardless of the age of the study.
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Full papers retrieved
(n = 794) 
(1 paper reported results of a
primary study and a systematic
review; 795 studies)  
Primary studies
(n = 592)  
Potential
diagnostic accuracy
studies 
Excluded (n = 99)
•  No obese children, n = 64 
•  No index test of interest, n = 11 
•  Not prospective, n = 20 
•  Unobtainable; unable to make
decision on information available, n = 4   
Potential tracking
studies
Excluded (n = 163)
•  No usable data, n = 78 
•  BMI studies with < 1000 
children in primary analysis, n = 52 
•  No adult reference standard
or test accuracy data, n = 29 
•  < 5 years between tests, n = 4   
Excluded (n = 341) 
•  < 20 children, n = 31 
•  No reference standard, n = 49 
•  No usable data, n = 261 
(n = 23)
Included
(n = 34)
Included
Primary studies also screened for the review of
adult morbidities
 
Studies identified for screening for the
acceptability and ease of use review   
From
electronic searches
From screening
for morbidity review 
From
bibliographies of 
tracking 
studies/reviews
Excluded (n = 52)
•  Did not report on tracking,
diagnostic accuracy or
acceptability or ease of use, n = 45
•  Duplicate studies, n = 7
From bibliographies of
diagnostic accuracy
studies/reviews 
From Brisbois et al.17 and
Singh et al.16 review
bibliographies not identified
in the electronic searches
Reviews (n = 103) 
•  Not relevant, n = 56 
•  Reference checked, n = 38 
•  Potential for updating, n = 9 
(n = 2 tracking; n = 7 adult morbidities)
(n = 10,269) 
(n = 22) 
(n = 7)
(n = 20)
(n = 186) (n = 375) 
(n = 30) 
(n = 3) 
(n = 20) 
n = 540
n = 695
FIGURE 1 Flow of studies through the initial screening period of the review to identify systematic reviews for the
tracking and adult morbidity reviews, and primary studies for the review of tracking and diagnostic accuracy.
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From these other
review bibliographies 
From electronic
searches
Studies identified from seven
reviews with potential for
updating not identified in
electronic searches
Full papers screened
Excluded (n = 130)
•  <1000 children, n = 50  
•  No obese children, n = 10 
•  All children under 2 years, n = 1 
•  No outcome of interest in adulthood, n = 22 
•  Not prospective, n = 1 
•  Incorrect relationship assessed, n = 1 
•  Wrong population association, n = 2 
•   < 5 years between tests, n = 5 
•  Index test not associated with outcome of
    interest in adulthood, n = 5 
•  No usable data (seven linked to included studies), n = 27 
•  Duplicate studies, n = 6 
Studies
included
Studies identified also
screened for tracking and
diagnostic accuracy  
Primary studies
•  Reference checking, n = 6 
•  Not relevant, n = 10 
Reviews (n = 16)From the initial
screening period
(n = 5690)
(n = 30)
(n = 83) (n = 22) 
(n = 30)
(n = 167)
(n = 37) 
(n = 7)
FIGURE 2 Flow of studies through the second screening period of the review to identify primary studies of the
relationship between childhood overweight and obesity and adult morbidities.
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Review of prediction of adult morbidities
Summary of the existing systematic reviews of the prediction of
adult morbidities
Of the 13 reviews with potential for being updated that were identified,18–22,209–217 the reviews by Park et al.
(2012),18 Reilly et al. (2011),22 Owen et al. (2009),21 Lloyd et al. (2010)20 and Lloyd et al. (2012)19 were the
most recent and relevant to our review of adult morbidities. This subsection presents a brief critical
summary of these five reviews.
Reilly et al. (2011)22 did not restrict their searches to any particular childhood measure of obesity, but only
found studies on BMI and self-reported/recalled ‘weight status’. All other reviews included only BMI as a
simple childhood measure of obesity. Most studies included in the reviews used cohort designs, although
a smaller number of case–control studies were also eligible. Population eligibility criteria varied across
the studies; Reilly et al. (2011)22 and Lloyd et al. (2010)20 included children from birth to age 18 years,
but Park et al. (2012)18 and Lloyd et al. (2012)19 excluded children aged under 2 years. The review by
Owen et al. (2009)21 reported on a significantly wider age range as it included individuals from birth up
to age 30 years. The large majority of the studies were conducted in general populations from Europe
(particularly Scandinavian countries and the UK) and the USA. None of the studies appeared to include
specifically selected populations of children (such as children with cancer or children undergoing a weight
reduction intervention). None of the reviews reported a restriction on sample size, and therefore the size of
the studies varied widely, from under 100 to over 1.1 million participants.
Eligible outcomes varied across the reviews. The reviews by Park et al. (2012)18 and Reilly et al. (2011)22
had the broadest scope as they focused on both adult mortality and morbidity. Lloyd et al. (2010)20
reported outcomes relating to CVD events and CVD risk, and Owen et al. (2009)21 focused on CHD events.
The review by Lloyd et al. (2012)19 was the only one to focus exclusively on metabolic syndrome and its
individual components [type 2 diabetes, total cholesterol, triglycerides, high-density lipoprotein (HDL-)
cholesterol, low-density lipoprotein (LDL-)cholesterol, fasting insulin, insulin resistance]. The number of
individual studies included in the reviews ranged from 11 [Lloyd et al. (2012)19] to 39 [Park et al. (2012)18].
Citations
n=1494
 
Full papers
retrieved 
n=3
 
Excluded
perceptions of
overweight rather than
index test evaluated
n=1
 
Included
n=2
Included
n=5
 
Identified in
original searches 
n=3
 
FIGURE 3 Flow of studies through the third screening period of the review to identify primary studies of the
acceptability and ease of use of four childhood measures of obesity.
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The quality of included studies was evaluated in three reviews.18–20 However, only Lloyd et al. (201020 and
201219) reported the results of their quality assessments, which were based on the Newcastle Ottawa
Scale. The key methodological limitations that they identified related to variation in type and number of
adjustments made in the analyses of the primary studies, and the relatively young age of adults at follow-up
in some studies. Quality relating to participant selection, comparability of study groups and measurement
of outcomes was generally considered acceptable.
Only Owen et al. (2009)21 combined studies in a meta-analysis, stratified by baseline age group. All others
reported the results of their included studies narratively by outcome. Lloyd et al. (201020 and 201219),
Park et al. (2012)18 and Owen et al. (2009)21 also grouped studies based on whether or not they adjusted
for adult BMI in their analyses.
In all reviews, a majority of studies reported a positive and statistically significant association between
childhood BMI and adult morbidity. However, results varied by outcome. Both Park et al. (2012)18 and
Reilly et al. (2011)22 found consistent evidence of a statistically significant positive association between
childhood BMI and diabetes in adulthood. Park et al. (2012)18 reported that ORs for a one-unit increase in
BMI SD score ranged from 1.22 (95% CI 1.10 to 1.36) at school entry (n= 5793) to 2.04 (95% CI 1.7 to
2.4) at 16 years of age (n= 10,683). Only 1 small study out of 10 found no association between the
two variables. However, all three studies that adjusted for adult BMI found that the association was no
longer significant after adjustment. In the review by Reilly et al. (2011),22 all three studies reporting
diabetes outcomes found a significant increase in risk of developing the morbidity in those who were
overweight or obese in childhood. Effect sizes were reported for only one study, showing significant
association between overweight and obesity at age 5 years and self-reported diabetes at age 21 years
(OR 2.6, 95% CI 1.3 to 5.2; n= 2639). Lloyd et al. (2012)19 found little evidence that childhood obesity is
an independent risk factor for diabetes mortality, although their result was based on a single study.
Evidence of an association between childhood BMI and adult CHD was somewhat more mixed. The pooled
analyses from Owen et al. (2009)21 showed that a 1-SD increase in BMI in early childhood [2–6 years
(three studies)] was associated with reduced CHD risk (RR 0.94, 95% CI 0.82 to 1.07), although the
association was not statistically significant. A weak positive association was found between later CHD risk
and a 1-SD increase in BMI in later childhood [7 to < 18 years; RR 1.09, 95% CI 1.00 to 1.20 (seven studies)].
Both analyses showed high levels of heterogeneity. In the review by Park et al. (2012),18 10 of the 15 studies
that explored the relationship between BMI in childhood and objective measures of CHD events reported
that increased BMI or overweight at ages 2–25 years was associated with increased risk of CHD in later life.
HRs ranged from 1.53 (95% CI not reported) for CHD mortality associated with high BMI at age 11 years to
5.43 (95% CI 2.77 to 10.62) for CHD associated with high BMI at age 17 years. One study (n= 181) found
that higher BMI at ages 13–18 years was associated with increased risk of CHD morbidity and mortality in
men but not in women. The remaining studies reported no association between BMI at ages 2–22 years and
CHD. Reilly et al. (2011)22 and Lloyd et al (2010)20 both found that two out of three studies which examined
the association between childhood BMI and CHD events reported a positive association.
Evidence of an association between childhood BMI and stroke in adulthood was mixed. Park et al. (2012)18
found that, out of nine relevant studies, only four found positive association between BMI and stroke in
adulthood. Four studies (including three British studies) reported no association and one showed an inverse
relationship between higher BMI at age 7 years and future stroke. Reilly et al. (2011)22 reported that two
out of three studies which reported on stroke found a significant association between childhood BMI and
morbidity in adulthood. Lloyd et al. (2010)20 found a pooled study from three historical cohorts and a
single study which reported no significantly increased risk of CHD and stroke incidence in adults who were
overweight or obese as children.
Evidence of an association between childhood BMI and the risk of developing metabolic syndrome in
adulthood was limited. Lloyd et al. (2012)19 found only three studies which considered the link between
the two variables. Two studies found that higher childhood BMI was associated with increased odds of
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developing metabolic syndrome in adulthood. The third study was the only one to adjust for adult BMI,
and found that higher childhood BMI was associated with lower risk of metabolic syndrome in adult life
when accounting for adult BMI.
Both Park et al. (2012)18 and Reilly et al. (2011)22 found consistent evidence of a statistically significant
positive association between overweight or increased BMI in childhood and hypertension in adulthood.
Park et al. (2012)18 reported ORs for overweight or increased BMI in childhood that ranged from 1.35
(95% CI 1.13 to 1.64) at age 7 years to 3.75 (95% CI 3.45 to 4.07) at ages 16–19 years in five studies.
In the four studies identified by Reilly et al. (2011),22 ORs ranged from 1.46 (95% CI 1.01 to 2.12) to 5.1
(95% CI 1.4 to 18.1). On the other hand, Lloyd et al. (2010)20 found less consistent evidence that
childhood obesity was an independent risk factor for hypertension.
None of the reviews reported studies focusing on hypercholesterolaemia as an outcome in adulthood.
Lloyd et al. (2012)19 reported on studies focusing on LDL- and HDL-cholesterol levels. The review found
little evidence to support the view that childhood obesity is an independent risk factor for higher LDL- and
HDL-cholesterol levels.
Significantly less evidence was found on cancer. Park et al. (2012)18 found limited evidence that childhood
BMI is associated with increased risk of colorectal and kidney cancers. Reilly et al. (2011)22 found a single
study on the association between BMI and cancer, which reported a significant 30% increase (95% CI
10% to 54%) in smoking-related cancers per 1-SD increase in childhood BMI (n= 2997).
Reviews differed in their interpretation of the strength and clinical significance of the associations found.
They also differed in the emphasis and importance placed on adjustments made for adult BMI. This, in
addition to the fact that there was relatively little overlap across the reviews in terms of included studies,
may explain why the conclusions of the reviews differed.
Reilly et al. (2011)22 concluded that there is a relatively large and highly consistent body of evidence which
shows that overweight and obesity in childhood and adolescence have substantial and adverse long-term
consequences for physical health. However, we feel that these conclusions were too strong; there was
some variation in the size and direction of the effect estimates reported. Additionally, there were concerns
about several aspects of the review methods and limited reporting of the study results. Therefore,
the conclusions of Reilly et al. (2011)22 appear insufficiently cautious and may not be reliable.
The conclusions of Park et al. (2012)18 were more nuanced and more accurately reflected the evidence
found. They stated that there is a consistent body of evidence for associations between childhood
overweight, unadjusted for adult BMI, and cardiovascular outcomes and mortality in adulthood. They also
concluded that evidence for stroke outcomes is mixed, and that there is limited evidence that childhood
BMI is associated with increased risk of colorectal and kidney cancers. They also remarked that few studies
have assessed the independent effects of childhood overweight on adult disease, and the results of these
have been inconclusive.
Owen et al. (2009)21 concluded that higher levels of BMI may be related to increased levels of CHD risk
from early childhood onwards. They stated that the control of obesity from childhood onwards may be an
important priority for long-term CHD prevention, although they noted that the independent contribution
of early obesity to CHD risk still needs to be established. The review by Owen et al. was the only one that
conducted a meta-analysis, and the choice of methods appeared appropriate in view of the evidence
found, although evidence of significant heterogeneity was reported. However, it is unclear why the
authors concluded that higher BMI was associated with an increased risk of morbidity from early childhood
even though they reported a weak inverse relationship with adult CHD risk in children under age 7 years.
Additionally, the small magnitude of the pooled estimates in later childhood suggests that their clinical
relevance may be limited in the context of adult CHD risk prediction. Therefore, the conclusions of the
review may not be sufficiently cautious.
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The conclusions from Lloyd et al. (2010)20 placed greater emphasis on the influence of adult BMI in the
association between childhood BMI and adult morbidity than those of Owen et al. (2009)21 or Park et al.
(2012).18 The authors stated that they found little evidence to suggest that childhood obesity is an
independent risk factor for CVD risk. They stated that, instead, relationships observed are dependent on
the tracking of BMI from childhood to adulthood. Although the evidence found by Lloyd et al. (2010)20
appears insufficient to support the notion that childhood obesity is an independent risk factor for CVD risk,
the review did not discuss the risks associated with standard adjustment for adult BMI, which may lead
to overadjustment bias.218 Additionally, the evidence presented by the review was insufficient to suggest
that the relationships observed were dependent on the tracking of BMI from childhood to adulthood.
Therefore, the conclusions of Lloyd et al. (2010)20 may not be reliable.
Lloyd et al. (2012)19 also concluded that there is little evidence to support the view that childhood obesity
is an independent risk factor for adult blood lipid status, insulin levels, metabolic syndrome or type 2
diabetes. The conclusions reflected the evidence found, although the volume of the evidence on diabetes
was significantly smaller than that reported by Park et al. (2012)18 or Reilly et al. (2011).22
Among all five reviews, it appeared that the review by Park et al. (2012)18 was better conducted and yielded
the most reliable conclusions. However, with the exception of the review by Owen et al. (2009),21 none of the
reviews conducted a meta-analysis, which limited the strength of their results. Additionally, none included
studies on childhood measurements other than BMI, which limits their relevance to our review questions.
Some reviews addressed the issue of BMI tracking into adulthood as a potential confounder in the association
between childhood BMI and adult morbidity. However, none formally evaluated the extent to which
childhood measures of obesity accurately predict the tracking of obesity into adulthood. Finally, all reviews
reported on the association between BMI and adult morbidities (generally expressed as ORs, RRs or HRs), but
none in terms of predictive accuracy, and none used formal methods to calculate the predictive performance
of childhood obesity for predicting future morbidity. This overview of recent systematic reviews highlights
important gaps in the evidence for the predictive power of childhood obesity as a predictor of adult morbidity.
Quality and assessment of bias of the included primary studies for the
prediction of adult morbidities
Thirty-seven studies (22 cohorts) met the inclusion criteria for the review of predictive accuracy.117,118,123,129,140–172
The assessment of risk of bias is presented in Table 2 and the full quality assessment in Appendix 4. The
most common methodological weaknesses were attrition bias and gaps in reporting about attrition rates,
followed by outcomes bias (due to self-reporting of morbidities). Biases associated with selection, childhood
measurements, use of confounders, reporting and analysis were low in most studies.
Seven studies used self-reported outcome measures and were considered at high risk of outcome
bias.118,123,129,148,155,160,168 One study used drug medication use as a proxy for hypertension and risk of outcome
bias was unclear.143 Bias associated with childhood weight status measurement was high in one study, where
BMI was calculated based on adolescents’ self-reporting of height and weight.129 One study did not report
sufficient information on the site of WC measurements,168 and the only study that used SFT as a childhood
measurement did not report how the sum of SFTs was calculated.171 Thirty-two studies adjusted for age and
sex in their analyses, and were therefore considered at low risk of confounding bias. Two studies did not
adjust for sex in their analyses;118,169 one adjusted for sex but not age;146 and one did not adjust for either sex
or age.168 One study had a high risk of reporting bias due to partial reporting of results.158
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Characteristics of studies included in the review of prediction of
adult morbidities
Study characteristics for prediction of adult morbidities
The study characteristics are presented in Table 3. All 37 studies117,118,123,129,140–172 included in the prediction
of adult morbidity review used BMI (calculated as kg/m2) as a childhood measurement (for details see
Appendix 3). Only three studies used a childhood measurement other than BMI. Three used WC in
childhood,117,168,171 and one study also measured the sum of SFTs and WHR.171 No other simple measure
of childhood obesity was investigated in relation to adult morbidity.
Definitions of overweight and obesity, methods of standardisation and references used to calculate weight
category varied across the studies. Details are given in Appendix 3 (see Table 49). Fifteen studies used an
external reference population to define overweight/obesity status and stratify the cohort according to
childhood weight status. Twenty-five studies used their own cohort as a reference population. Seven studies
reported using internally and externally derived reference populations in their analyses. Of the 15 studies
with external reference populations, 10 used a CDC (2000)219 reference population, four used Cole (2000),220
one used Cole (1990)221 and one used a Chinese reference population. Of the 25 studies with internal
reference populations, 16 standardised BMI measurements as z-scores. Of those, most (13) calculated
age- and sex-specific z-scores. Three studies calculated age-specific z-scores only and adjusted for sex in
their analyses.
TABLE 3 Prediction of adult morbidities review: study characteristics
Study/cohort name Study Country
Study dates Setting for
anthropometric
measure in childhoodStart Finish
Aberdeen
Children of the 1950s
cohort
Lawlor (2005)159
Lawlor (2006)160
Scotland 1950 2000 NR
Boyd Orr Gunnell (1998)153
Jeffreys (2004)158
England, Scotland 1937 1995 NR
British birth cohort
1958
Hypponen (2003)155
Li (2007)165
England, Wales,
Scotland
1958 2000 NR
MRC NSHD De Stavola (2004)148 UK 1946 1999 School, community
NCDS Cheung (2004)118 UK 1958 2000 NR
Copenhagen
CSHRR (born 1930–76)
Ahlgren (2004)140
Baker (2007)142
Baker (2007)141
Berentzen (2013)145
Denmark 1930 Up to 2011 School
Young Finns
Cardiovascular Risk in
Young Finns (born
approximately 1962–77)
Mattsson (2008)167
Magnussen (2010)166
Finland 1980 2001 NR
Helsinki 1924
University Central
Hospital (born 1924–33)
Forsen (2000)151
Hilakivi-Clarke
(2001)154
Finland 1924 Up to 1997 School
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TABLE 3 Prediction of adult morbidities review: study characteristics (continued )
Study/cohort name Study Country
Study dates Setting for
anthropometric
measure in childhoodStart Finish
Helsinki 1934
University Central
Hospital, born 1934–44
Barker (2002)143
Barker (2005)144
Eriksson (2001)150
Forsen (2004)152
Osmond (2007)169
Finland 1934 Up to 2003 School, outpatient clinics
Norway
1963–99
Bjorge (2004)146
Bjorge (2008)147
Engeland (2003)149
Norway 1963 Up to 2005 School
Bogalusa/Young Finns
Bogalusa and
Cardiovascular
Risk in Young Finns
(pooled)
Magnussen (2010)166 USA and Finland 1984 2007 NR
NLSAH Merten (2010)129 USA 1995 2001 NR
Bogalusa
Bogalusa Heart Study
Janssen (2005)157 USA 1976 1996 NR
NGHS/PFS Morrison (2010)168 USA PFS: 1973
NGHS: NR
PFS: 2003
NGHS: NR
NR
NLSY79, PSID,
NHANES
Goldhaber-Fiebert
(2013)123
USA 1970 2008 Community
ASHFS
1985 (born
approximately 1970–8)
Schmidt (2011)171 Australia 1985 2006 School
Israel SPEC
Medical Corps SPEC
Israeli (2007)156
Tirosh (2011)172
Israel 1976 NR Military medical
examination centre
Israeli army
(Born approximately
1948–89)
Leiba (2012)161
Levi (2012)164
Levi (2011)163
Leiba (2013)162
Israel 1967 2006 Military service
recruitment centres
Delhi
(Born from 1969)
Sachdev (2009)170 India 1969 2002 NR
BCAMSS Cheng (2011)117 China 2004 2010 School
ASHFS, Australian Schools Health Fitness Survey; BCAMSS, Beijing Child and Adolescent Metabolic Syndrome study;
CSHRR, Copenhagen Health Records Register; MRC NSHD, Medical Research Council National Survey of Health and
Development; NCDS, National Child Development Study; NGHS, National Growth and Health study; NHANES, National
Health and Nutrition Evaluation Surveys; NLSAH, National Longitudinal Study of Adolescent Health; NLSY79, National
Longitudinal Survey of Youth; NR, not reported; PFS, Princeton follow-up study; PSID, Population Study of Income
Dynamics; SPEC, Staff Periodic Examination Center.
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Studies were published between 1998 and 2013. Most studies (23 out of 36) were conducted in northern
Europe. Eight studies were conducted in the UK, eight in Finland, four in Denmark and three in Norway.
Six studies were from Israel, and four were conducted in the USA, one in Australia, one in China and
one in India. All studies were designed as longitudinal studies except for three that used data collected
as part of a tuberculosis screening programme,146,147,149 and six in the context of a military medical
examination.156,161–164,172 All childhood measurements were made directly, except for one which used recall.129
One-third of the studies made all their childhood measurements in school. Some studies collected
measurements in school as well as in the community148 or outpatient settings. In six studies, participants’
BMIs were measured in Israeli military centres. Further study characteristics are presented in Table 3.
Many of the identified cohorts were commenced between the 1920s and the 1950s, and social conditions
for children have changed considerably since that time. It is not clear, therefore, whether or not the
association between childhood obesity and adult morbidity from such cohorts accurately reflects
the association in present-day children.
Population characteristics for prediction of adult morbidities
The population characteristics are presented in Table 4 and Appendix 3. The size of the cohorts varied
widely, from 1889 to over 1.1 million individuals. Baseline age varied across the studies. Children aged
between 12 and 18 years were the most often represented, followed by those aged 7–11 years and
children aged 6 years or under. Twenty-eight studies measured weight status among children aged over
11 years. Twenty-three studies included children at ages 7–11 years, and seven studies included children at
age 6 years or under. Most studies (23 out 36) included more than one age group. Where reported, birth
year of participants ranged from 1924 to 1989.
Seven studies included male individuals only150,156,161–164,172 and five studies focused exclusively on
females.140,148,149,152,154 All other studies included mixed populations. Three USA-based studies included a
significant proportion of black American children.129,157,168 Two studies classed all or nearly all of their
participants as Caucasian.156,167 Four studies, which focused on the Israeli Army cohort, reported a varied
range of geographical origins.129,162–164 The remaining 27 studies did not report the ethnicity or origin of the
children they included.
Seven studies reported data on baseline SES. Of those, three were part of the Israeli army cohort,161,162,164
where most individuals were classed as having ‘medium’ SES. Most individuals in the Cardiovascular Risk in
Young Finns cohort were also classed as having medium SES,167 although SES definitions were not
provided in these studies. Children in the remaining three studies reported a majority of individuals whose
fathers were from a low SES.151,152,158
TABLE 4 Prediction of adult morbidities review: population characteristics
Study Cohort
Number at
baseline
Number at
follow-up
Childhood
age (years)
Adult age at
final follow
(years) Male (%)
Ahlgren (2004)140 Copenhagen – CSHRR 161,063 117,415 7–14 NR 0
Baker (2007)142 Copenhagen – CSHRR 276,835 NR 7–13 NR 51
Baker (2007)141 Copenhagen – CSHRR 276,835 NR 7–13 ≥ 25 51
Barker (2002)143 Helsinki (1934–44) 10,519 8760 1–12 27–63 53
Barker (2005)144 Helsinki (1934–44) 10,519 8760 0–11 27–64 53
Berentzen (2013)145 Copenhagen – CSHRR 372,636 285,884 7–13 31–80 51
Bjorge (2004)146 Norway 1963–99 227,224 227,221 14–19 47–52 51
Bjorge (2008)147 Norway 1963–99 227,000 226,682 14–19 Mean 52 51
Cheng (2011)117 Beijing – BCAMSS 2189 1184 6–16 16 (SD 1.8) 54
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TABLE 4 Prediction of adult morbidities review: population characteristics (continued )
Study Cohort
Number at
baseline
Number at
follow-up
Childhood
age (years)
Adult age at
final follow
(years) Male (%)
Cheung (2004)118 UK – NCDS 17,000 12,327 7, 11, 16 42 52
De Stavola (2004)148 UK – MRC NSHD 2547 2187 2–15 47–53 0
Engeland (2003)149 Norway 1963–99 NR 111,883 14–19 Mean 41 0
Eriksson (2001)150 Helsinki (1934–44) 5502 3544 0–12 27–63 100
Forsen (2000)151 Helsinki (1924–34) NR 7086 6–16 31–73 51
Forsen (2004)152 Helsinki (1934–44) 5486 3003 0–11 27–64 0
Goldhaber-Fiebert
(2013)123
USA – NLSY79/PSID/
NHANES
NR 2780 2–15 38–49 51
Gunnell (1998)153 England and Scotland
(Boyd Orr)
NR 2399 2–14 Up to 73 49
Hilakivi-Clarke (2001)154 Helsinki (1924–34) NR 3447 7–15 Minimum 38
(76% > 50)
0
Hypponen (2003)155 Great Britain – British
birth cohort
16,751 10,683 7, 11, 16 41 NR
Israeli (2007)156 Israel – SPEC 18,513 NR 16–19 26–45 100
Janssen (2005)157 USA – Bogalusa Heart
Study
3865 1709 4–15 19–38 44
Jeffreys (2004)158 England and Scotland
(Boyd Orr)
2997 2347 2–14 Up to 66 49
Lawlor (2005)159 Aberdeen cohort 12,150 11,106 Mean 4.9 48–54 NR
Lawlor (2006)160 Aberdeen cohort 12,150 5793 Mean 4.9 46–50 NR
Leiba (2012)161 Israeli army NR 1,110,835 16–19 Mean 35 100
Leiba (2013)162 Israeli army NR 1,110,835 16–19 Mean 44 100
Levi (2011)163 Israeli army NR 1,109,864 16–19 18.7–57.3 100
Levi (2012)164 Israeli army NR 720,927 16–19 29–56 100
Li (2007)165 Great Britain – British
birth cohort
13,294 9285 7–16 45 52
Mattsson (2008)167 Cardiovascular Risk in
Young Finns
4320 2195 3–18 24–39 46
Magnussen (2010)166 Cardiovascular Risk in
Young Finns/Bogalusa
20,745 10,439 12–19 19–26 51.1
Merten (2010)129 USA – NLSAH 1889 (PFS:
822; NGHS:
1067)
Up to 1058
(NGHS)
PFS: mean
12.4; NGHS:
NR
PFS: 32–44;
NGHS: 19
PFS: 47;
NGHS: 0
Morrison (2010)168 USA – NGHS and PFS NR 12,439 0–11 NR 52
Osmond (2007)169 Helsinki (1934–44) 8181 1492 2–14 26–33 58
Sachdev (2009)170 India (Delhi) 8498 2188 7–15 26–36 50
Schmidt (2011)171 Australia – ASHFS NR 37,674 Mean 17.1 Mean 34 100
Tirosh (2011)172 Israel – SPEC 161,063 117,415 Median
7.2–14.5
NR 0
ASHFS, Australian Schools Health Fitness Survey; BCAMSS, Beijing Child and Adolescent Metabolic Syndrome study;
CSHRR, Copenhagen Health Records Register; MRC NSHD, Medical Research Council National Survey of Health and
Development; NCDS, National Child Development Study; NGHS, National Growth and Health study; NHANES, National
Health and Nutrition Evaluation Surveys; NLSAH, National Longitudinal Study of Adolescent Health; NLSY79, National
Longitudinal Survey of Youth; NR, not reported; PFS, Princeton follow-up study; PSID, Population Study of Income
Dynamics; SPEC, Staff Periodic Examination Center.
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Sixteen studies reported baseline data on the proportion of children who were overweight and/or obese
according to BMI at baseline.117,118,123,146,147,149,156–165 Definitions of overweight and obese varied across these
studies. One study [Cheng et al. (2011)117] reported a high percentage of obese children at baseline (40.8%).
The percentage of obese children ranged from 1% to 6.4% in other studies.118,123,147,156,157,159,160,165 Where
reported, the percentage of overweight children ranged from 6% to 18% at baseline.118,123,146,147,156,157,159,160,165
In one study, the majority of children were overweight or obese at baseline [Cheng et al. (2011)117]. The percentage
of children who were overweight or obese ranged from 3.8% to 21% in other studies.118,123,147,149,156–165
Findings from the review of adult morbidity
Meta-analysis
The meta-analysis was based on 26 published articles representing 13 cohort studies,117,129,140–142,145,146,148–151,
153–155,158–166,168,169,172 which provided data that could be converted into an OR per 1-SD increase in BMI for
each morbidity. There were 32 different classifications of morbidity reported. This analysis considered only
those morbidities described in Chapter 2.
Analysis of the association between childhood obesity/overweight and
adult morbidity
A series of plots of the OR per SD increase in BMI for having a morbidity (with 95% CIs) are presented for each
cohort and each morbidity, according to the age at which BMI was measured. Figures 4–7 present results for
diabetes, CHD and cancers, as examples. A plot showing the results for all morbidities is provided in Appendix 5.
Figure 4 shows the ORs for having adult diabetes, according to age. This shows that most cohorts showed
a statistically significant association between childhood BMI and adult diabetes, with ORs ranging from
1.2 to 2.5 per SD BMI. Figure 5 shows the association with CHD. Results here were more varied, with
two cohorts (Helsinki,150 Aberdeen159) showing no association and the others showing a modest increase in
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FIGURE 4 Childhood BMI and incidence of adult diabetes. NGHS, National Growth and Health study; NLSAH, National
Longitudinal Study of Adolescent Health; PFS, Princeton follow-up study; SPEC, Staff Periodic Examination Center.
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odds of CHD with increased BMI. Figure 6 shows the association of BMI with breast cancer. In this case
there were no statistically significant results in any cohort. Figure 7 shows the results for other cancers.
The cohort studies reported on a large number of cancers, but the general trend appears to be that higher
BMI is associated with higher odds of most cancers.
The meta-analyses of ORs per SD BMI of these cohort studies are presented in forest plots, categorised by
age at BMI measurement (Figures 8–13).
Figure 8 shows the results of the meta-analysis of diabetes. There is a positive association, with an OR of
1.7 for every SD increase in BMI. That is approximately equivalent to a 24% increase in odds per kg/m2
increase in BMI for an adolescent. There is no evidence that this is different in the under-twelves and
over-twelves, although data for under-twelves are limited.
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FIGURE 5 Childhood BMI and incidence of adult CHD. SPEC, Staff Periodic Examination Center.
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FIGURE 6 Childhood BMI and incidence of adult breast cancer. MRC NSHD, Medical Research Council National
Survey of Health and Development.
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FIGURE 7 Childhood BMI and incidence of other cancers.
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FIGURE 8 Forest plot of the association between childhood BMI and diabetes. NGHS, National Growth and Health
study; NLSAH, National Longitudinal Study of Adolescent Health; PFS, Princeton follow-up study; SPEC, Staff
Periodic Examination Center.
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FIGURE 9 Forest plot of the association between childhood BMI and CHD. SPEC, Staff Periodic Examination Center.
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FIGURE 10 Forest plot of the association between childhood BMI and stroke.
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FIGURE 11 Forest plot of the association between childhood BMI and hypertension. BCAMSS, Beijing Child and
Adolescent Metabolic Syndrome study; NLSAH, National Longitudinal Study of Adolescent Health.
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FIGURE 12 Forest plot of the association between childhood BMI and breast cancer. MRC NSHD, Medical Research
Council National Survey of Health and Development.
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Figure 9 shows that there is a positive association between childhood BMI and CHD, but it is weak, with
an OR per SD BMI of 1.2 in those aged over 12 years (approximately equivalent to an 8% increase in odds
per kg/m2 increase in BMI for an adolescent). Again, there is no evidence that the association differs
between children aged under and over 12 years, although an increasing trend with age was observed in
two cohorts (see Figure 5).142,150
Figure 10 shows the association with stroke. There is little evidence of any association between childhood
BMI and stroke; the statistically significant result in those aged over 12 years is based on a single-cohort
study.142 Figure 11 shows the association with hypertension. There is some evidence that childhood BMI is
positively associated with odds of adult hypertension, but the results are based on only three cohorts.117,129,165
Figure 12 shows the relationship between childhood BMI and breast cancer. The results are not statistically
significant, but the trend is negative. Figure 13 shows the association between childhood BMI and other
cancers. No pooled result is presented because of the diversity of types of cancer and because more than
one cancer is reported in some cohorts, but the overall trend is for a modest positive association between
BMI and the odds of cancer. The results are comparatively homogeneous, with an increase in odds of
around 1.2 per SD increase in BMI.
It should be noted that, because of the incorrect assumption that BMI is normally distributed, all the
summary ORs presented in Figures 8–13 are likely to be overestimates.
Prediction of future morbidity from childhood body mass index
The analyses so far have examined the association between childhood BMI and adult morbidity. This
section considers how well childhood BMI predicts future morbidity.
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FIGURE 13 Forest plot of the association between childhood BMI and cancers.
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Given the normality assumptions made about the distribution of BMI described in Chapter 2, the
association between BMI and morbidity can be used to estimate the predictive performance of childhood
obesity for predicting future morbidity. This is because there is a simple relationship between OR per SD
and the sensitivity at a specified threshold of BMI (i.e. the proportion of adults with the morbidity who
were above the specified threshold of BMI in childhood). As noted in Chapter 2, this assumption is likely to
result in overestimation of these sensitivities.
Results for sensitivity at the 85th centile of childhood BMI and above are presented, that is what
proportion of adult morbidity occurs in children who might be considered overweight or obese, based on
their BMI. Figure 14 presents the results for diabetes, and Figure 15 those for CHD. Plots for other
morbidities are given in Appendix 5.
The pattern of these two figures is identical to that seen in Figures 4 and 5, although the scales differ. The
pattern of results is likewise the same for all other morbidities (see Appendix 5). These two examples show
that, despite the association between obesity and later morbidity, childhood obesity is a poor predictor of
morbidity. At best, around 40% of adults with diabetes were overweight or obese (above the 85th centile
of BMI) as children. Only around 20% of adult CHD morbidities occurred in the most overweight 15%
of children. Based on these findings, it appears that childhood BMI is not a useful predictor of future
heart disease.
Summary receiver operating characteristic curves
To summarise the ability of childhood BMI to predict future morbidity, summary ROC curves are presented,
based, again, on the assumptions of normally distributed BMI, and using the results from the analyses
presented in the forest plots above (see Figures 4–13). As noted in Chapter 2, these summary curves
probably overestimate predictive accuracy.
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FIGURE 14 Predicting future diabetes from childhood BMI. NGHS, National Growth and Health study; NLSAH, National
Longitudinal Study of Adolescent Health; PFS, Princeton follow-up study; SPEC, Staff Periodic Examination Center.
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There are two figures: Figure 16 shows summary ROC curves for predicting morbidities for ages 7–11 years,
and Figure 17 shows the ROC curves for children aged 12 years and over (these data are too sparse to
present ROCs for under-sevens). Breast cancer and stroke are not included, as the analyses above found no
evidence of an association between BMI and these morbidities.
The figures show that the power of BMI measurement to predict adult morbidities is poor. BMI cannot
adequately predict future CHD or cancer (the cancer ROC curve is hidden under the CHD curve in
Figure 17). Only around 20% of future CHD and cancer occurs in overweight or obese children.
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FIGURE 15 Predicting future CHD from childhood BMI. SPEC, Staff Periodic Examination Center.
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FIGURE 16 Receiver operating characteristic curves for predicting future morbidity from BMI at ages 7–11 years.
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If we consider only obese children (above the 95th centile), then obesity cannot predict CHD or cancer; the
results are no better than chance. Even for diabetes, which has the strongest association with obesity, only
around 35% of adult diabetics were obese or overweight as adolescents. The ROC curve for hypertension
is presented, but may not be reliable as it is based on very limited data (two cohorts). It should also be
noted that, because of the assumption that BMI is normally distributed, even these poor levels of predictive
accuracy may be overestimates.
Narrative review
Fourteen eligible studies reported relevant outcomes data that could not be included in the
meta-analyses.117,118,123,129,143,144,146,151,156,157,167,168,170,171 Of those, three also reported data that were included
in the quantitative synthesis.117,129,168
Thirteen studies included in the narrative review reported data on the association between childhood
measurements and adult morbidity expressed in terms of RR, OR, HR or cumulative incidence.117,123,129,143,
144,146,151,156,157,166,167,170,171 Predictive accuracy data [expressed in terms of sensitivity, specificity and area
under the curve (AUC)] were reported in four studies.118,168,170,171
The evidence presented below was generally consistent with the findings presented in the meta-analyses,
and provided relatively little additional evidence. However, unlike the meta-analyses, we were able to
present some additional findings on simple measures of obesity other than BMI (WC, WHR, sum of SFTs),
as well as the association between childhood weight status and future development of the metabolic
syndrome in adults.
Association between childhood measurements and adult morbidity (13 studies)
All 13 studies used BMI as a weight status measurement in childhood. Two studies used WC in addition to
BMI,117,171 and one study reported additional results for WHR and sum of SFTs.171 The following morbidities
were reported: type II diabetes (two studies),123,151 CHD (one study),144 renal cell carcinoma (one study),146
metabolic syndrome (five studies),157,166,167,170,171 hypertension (six studies),117,123,143,156,157,171 and
hypercholesterolaemia (one study).222 All studies found positive associations between childhood
measurements of weight status and morbidities in adulthood.
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FIGURE 17 Receiver operating characteristic curves for predicting future morbidity from BMI at ages 12 years
and over.
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Type 2 diabetes (two studies) Forsen et al. (2000)151 found a positive trend in cumulative incidence of
type 2 diabetes in adulthood associated with higher BMI at 11 years in a cohort of 7806 males and
females. Although statistically significant, the strength of the association was not reported. Subgroup
analyses found that in women, BMI at every age from 7 to 15 years was significantly associated with risk
of the disease, but not in men.
Goldhaber-Fiebert et al. (2013)123 found a weak association between BMI below age 10 years and
projected diabetes in adulthood. For those who were white and above the 85th centile (CDC 2000219) at
age 5 years, their model predicted that 7.9% of males would develop uncontrolled diabetes by their
mid-40s, compared with an estimated 4.9% below that threshold (RR 1.6 for males). At age 15 years, the
strength of the association was significantly higher. In this age group, it was estimated that 12.6% of
males above the 85th centile (CDC 2000219) would develop uncontrolled diabetes by their mid-40s,
whereas 2.8% of males below the threshold would develop the condition (RR 4.5 for males). RRs were not
reported for females or for other ethnicity groups.
Coronary heart disease (one study) Barker et al. (2005)144 found that low BMI at age 2 years and high
BMI at 11 years were both associated with higher risk of CHD events. The HRs associated with an increase
in BMI of 1 SD were 0.76 (95% CI 0.66 to 0.87) for boys and 0.62 (95% CI 0.46 to 0.82) for girls at age
2 years, and 1.14 (95% CI 1.00 to 1.31) for boys and 1.35 (95% CI 1.02 to 1.78) for girls at age 11 years.
Subgroup analyses stratified by BMI at ages 2 and 11 years found that the risk of developing CHD in
adulthood was highest among children with a low BMI at age 2 years who had a high BMI at 11 years
(HR 3.1, 95% CI 1.3 to 7.8), compared with children with a high BMI at age 2 years and a low BMI at 11 years.
Hypertension (six studies) There was consistent evidence of a positive association between childhood
weight status and hypertension in adulthood. The odds of developing hypertension in adulthood were higher
in male regular army personnel who were classed as overweight or obese according to BMI [Israeli et al. (2007)156].
Among individuals with normal baseline blood pressure, a BMI above 25 kg/m2 at ages 16.5–19 years was
associated with significantly higher odds of being hypertensive at ages 26–45 years than a BMI below that
threshold (OR 2.28, 95% CI 2.08 to 2.51 for a BMI of 25–30 kg/m2; OR 5.45, 95% 4.75 to 6.24 for a BMI
above 30 kg/m2). Associations were higher for adolescents who were hypertensive at baseline (OR 3.1,
95% CI 2.78 to 3.46 for a BMI of 25–30 kg/m2; OR 6.45, 95% CI 5.53 to 7.53 for a BMI above 30 kg/m2).
The Chinese study by Cheng et al. (2011)117 reported higher odds of developing hypertension in adulthood
among obese and overweight children measured at a mean age of approximately 11 years. Based on WC,
obese children had an OR of 3.9 (95% CI 2.8 to 5.3) of being hypertensive 9 years later compared with
non-obese children. When BMI was used to calculate weight status, the study also found increased odds
of being hypertensive at follow-up among overweight (OR 2.6, 95% CI 1.6 to 4.2) and obese children
(OR 4.9, 95% CI 3.4 to 7.0) compared with children with healthy weight status. Although associations
between childhood obesity and hypertension in adulthood were reported for both WC and BMI, the
comparators used for calculating ORs differed between the two measurements (obese vs. non-obese for
WC, obese vs. healthy weight for BMI), limiting the comparability of the estimates of association.
Additionally, the study did not assess the predictive accuracy of either of the childhood measurements.
Therefore, the predictive accuracy of BMI and WC could not be compared.
Schmidt et al. (2011)171 also found a positive association between childhood WC and hypertension in
adulthood. The risk of being hypertensive in adulthood was higher in girls for every 10-cm increase in WC
(RR 1.6, 95% CI 1.2 to 2.1) than in boys (RR 1.2, 95% CI 1.0 to 1.4). WC measurements were not
adjusted for age, although they were made in children aged from 7 to 15 years.
Barker et al. (2002)143 found a statistically significant association between high BMI from 8 to 12 years and
hypertensive drug use in adulthood. At age 12 years, the study reported a statistically significant increase in
the cumulative incidence of hypertension for each additional BMI point (14.2%, 95% CI 12.3% to 16.0%, for
an adjusted BMI of 16 kg/m2, and 19.9%, 95% CI 18.1% to 21.7%, for an adjusted BMI of > 18 kg/m2).
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Janssen et al. (2005)157 found a significant increase in the odds of developing hypertension measured with
BMI at ages 5–14 years in overweight and obese children, although the relationship was statistically
significant in obese children only (OR 4.39, 95% CI 1.83 to 9.72).
The model developed by Goldhaber-Fiebert et al. (2013)123 found that prevalence of hypertension in
adulthood would be higher among children above the 85th centile of a US population distribution
(CDC 2000219) at ages 5 and 15 years, irrespective of sex and ethnic group. However, the authors did not
report whether or not these differences were statistically significant, nor did they report sufficient data to
evaluate the extent to which higher childhood BMI may accurately predict hypertension among adults.
Hypercholesterolaemia (one study) Only one study reported an association between childhood obesity
and future development of hypercholesterolaemia in adulthood. Merten et al. (2010)222 found that
adolescents who were obese according to BMI had higher odds of developing hypercholesterolaemia
6 years later (OR 1.81, 95% CI 1.22 to 2.75). Further results are presented in Table 5.
Metabolic syndrome (five studies) The definitions of metabolic syndrome differed slightly among the
studies that reported this outcome. Three166,170,171 used the International Diabetes Federation (IDF) 2009
criteria,223 one167 used the IDF 2005 definition224 and one defined metabolic syndrome according to the
National Cholesterol Education Program.157 All studies reported a positive association between childhood
weight status and future metabolic syndrome.
Sachdev et al. (2009)170 reported a statistically significant association between BMI at all ages from 2 to
14 years and metabolic syndrome at ages 26–33 years. The strength of the association was greater in
adolescents (OR 1.87, 95% CI 1.65 to 2.12), followed by children at 11 (OR 1.63, 95% CI 1.43 to 1.85)
and 8 years (OR 1.36, 95% CI 1.21 to 1.53). The strength of the association was weaker among children
at 6 years or under (OR 1.19, 95% CI 1.05 to 1.35 at age 5 years; OR 1.2, 95% CI 1.04 to 1.37 at age
2 years).
Schmidt et al. (2011)171 reported the association between the risk of developing metabolic syndrome in
adults and four different childhood measurements (BMI, WC, WHR and sum of SFTs) taken at ages
7–15 years. The risk of developing metabolic syndrome in adulthood was significantly higher among
children within the highest quartile of the cohort than in the lowest quartile for all measurements, and the
strength of the association was systematically greater in girls than in boys. The strongest associations
between metabolic syndrome and childhood measurements were found with sum of SFT in girls (RR 11.2,
95% CI 1.4 to 91.3) and WC in boys (RR 4.8, 95% CI 2.5 to 9.2). The most conservative estimates were
found with WHR in girls (RR 4.6, 95% CI 1.5 to 14.1), as well as in boys (RR 2.1, 95% CI 1.3 to 3.6).
However, most results lacked precision (as evidenced by the wide CIs), making it difficult to compare the
extent to which the strength of the associations varied across obesity measures. Additionally, the study did
not report estimates of predictive accuracy for any of the childhood measurements. Therefore, the relative
predictive accuracy of these childhood measures cannot be evaluated.
Magnussen et al. (2010)166 pooled data from the Young Finns Study [also reported in Mattsson et al.
(2008)167] with results from the Bogalusa Heart Study on metabolic syndrome. The pooled analysis used the
91st centile as the threshold for obesity (based on Cole 2000220), and found a statistically significant
association between obesity at ages 9–18 years and metabolic syndrome at ages 24–41 years (RR 2.5,
95% CI 2.0 to 3.1).
Janssen et al. (2005)157 found a statistically significant increase in the odds of developing metabolic
syndrome in adulthood among overweight (OR 2.53, 95% CI 2.26 to 5.42) and obese children (OR 4.62,
95% CI 2.81 to 7.45) measured with BMI at ages 5–14 years. Similar results were reported for
hypertension, although the association was statistically significant in obese children only (OR 4.39, 95% CI
1.83 to 9.72).
RESULTS
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Mattsson et al. (2008)167 (Young Finns Study) reported a statistically significant association with metabolic
syndrome in adulthood among children with a BMI above the 80th centile of the cohort and those below
that threshold. Unlike the findings of Sachdev et al. (2009),170 the strength of the association tended to be
greater among younger children (OR 3.0, 95% CI 2.0 to 4.7 at ages 3–9 years; OR 2.1, 95% CI 1.4 to 3.1
at ages 12–15 years).
Cancer (one study) Bjorge et al. (2004)146 found a statistically significant association between BMI above
the 85th centile (CDC 2000219) and renal cell carcinoma at age 45 years in a sample of 115,267 adolescent
boys (RR 2.64, 95% CI 1.48 to 4.7). However, the association was not statistically significant in 111,954
adolescent girls (RR 1.48, 95% CI 0.57 to 3.85). The fact that Bjorge et al. (2004)146 found a statistically
significant association between BMI and renal cell carcinoma in adolescent boys but not in girls may be
explained by a lack of power. Although the sample was large, the outcome of interest was very rare and
therefore the subgroup of girls may not have been sufficiently large to show a statistically significant result.
Predicting future morbidity (four studies)
Four studies that were not included in the quantitative synthesis reported data on predictive accuracy
(Table 6).118,168,170,171 Overall, they confirmed the findings of the quantitative synthesis: obesity and
overweight are poor predictors of future morbidity in adulthood.
All reported weak estimates of predictive accuracy. Among the three studies that reported measures of
sensitivity and specificity,166,168,170 all found that childhood BMI had high specificity but poor sensitivity
when predicting adult morbidity. Of those, only one compared the predictive accuracy of more than one
childhood measurement.168 The study found that BMI and WC were equally accurate (high specificity and
poor sensitivity) in predicting future morbidity among 10-year-old girls. The following outcomes were
reported in adulthood: type 2 diabetes (two studies),118,168 metabolic syndrome (two studies)166,170 and
hypertension (one study).118
Diabetes (two studies) Cheung et al. (2004)118 reported that BMI values at ages 7, 11 and 16 years could
predict self-reported history of diabetes at age 42 years. However, estimates were weak, with AUCs
ranging from 0.58 to 0.61. Morrison et al. (2010)168 found that BMI and WC were equally accurate in
predicting early adulthood diabetes in a relatively small sample (n= 1067) of 10-year-old obese girls. Both
measurements had high specificity (96%) but low sensitivity (13%).
Hypertension (one study) Cheung et al. (2004)118 reported that BMI values at ages 11 and 16 years
could predict self-reported hypertension at age 42 years. However, as with diabetes, predictive estimates
of adult hypertension were weak (AUC 0.56 at age 11 years and 0.60 at age 16 years). Further results are
presented in Table 6.
Metabolic syndrome (two studies) Sachdev et al. (2009)170 found that BMI at 5, 8, 11 and 14 years had
very high specificity (97–99%) but very low sensitivity (1–7%) when predicting metabolic syndrome in
adulthood at ages 26–33 years. The pooled analysis from Magnussen et al. (2010)166 reported lower
specificity (80%) and higher sensitivity (50.8%) for predicting adult metabolic syndrome at ages
24–41 years (CIs were not reported). The differences between the two studies may be explained by the
use of different cut-off points. The pooled analysis from Magnussen et al. (2010)166 used a lower BMI
cut-off point than the study by Sachdev et al. (2009)170 [internally derived 75th centile vs. IOTF 85th centile
in Sachdev et al. (2009)170].
Cancer (one study) Cheung et al. (2004)118 found that BMI at ages 7, 11 and 16 years was a poor
predictor of self-reported cancer at age 42 years (AUC ranging from 0.46 to 0.53).
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
46
TA
B
LE
6
R
es
u
lt
s
o
f
st
u
d
ie
s
n
o
t
in
cl
u
d
ed
in
th
e
q
u
an
ti
ta
ti
ve
sy
n
th
es
is
:e
st
im
at
es
o
f
p
re
d
ic
ti
ve
ac
cu
ra
cy
St
u
d
y
A
g
e
at
b
as
el
in
e
(y
ea
rs
)
A
g
e
at
fo
llo
w
-u
p
(y
ea
rs
)
n
at
fo
llo
w
-u
p
O
u
tc
o
m
e
C
o
m
p
ar
is
o
n
C
h
ild
h
o
o
d
m
ea
su
re
m
en
t
Su
m
m
ar
y
es
ti
m
at
e
(9
5%
C
l)
A
d
ju
st
m
en
t
M
or
ris
on
(2
01
0)
16
8
10
19
10
67
T2
D
M
O
vs
.
no
n-
O
W
C
Se
ns
iti
vi
ty
:
13
Sp
ec
ifi
ci
ty
:
96
PP
V
:
2
N
PV
:
99
N
on
e
BM
I
Se
ns
iti
vi
ty
:
13
Sp
ec
ifi
ci
ty
:
96
PP
V
:
3
N
PV
:
99
C
he
un
g
(2
00
4)
11
8
7–
16
ye
ar
s
42
40
47
–
45
92
C
an
ce
r
N
A
BM
Ia
t
7
ye
ar
s
A
U
C
:
0.
46
(0
.4
1
to
0.
51
)
A
ge
BM
Ia
t
11
ye
ar
s
A
U
C
:0
.4
7
(0
.4
2
to
0.
51
3)
BM
Ia
t
16
ye
ar
s
A
U
C
:
0.
53
(0
.4
7
to
0.
58
)
H
yp
er
te
ns
io
n
BM
Ia
t
7
ye
ar
s
A
U
C
:
0.
51
(0
.4
8
to
0.
53
)
BM
Ia
t
11
ye
ar
s
A
U
C
:
0.
56
(0
.5
3
to
0.
59
)
BM
Ia
t
16
ye
ar
s
A
U
C
:
0.
6
(0
.5
7
to
0.
63
)
D
ia
be
te
s
BM
Ia
t
7
ye
ar
s
A
U
C
:
0.
58
(0
.5
1
to
0.
66
)
BM
Ia
t
11
ye
ar
s
A
U
C
:
0.
60
(0
.5
2
to
0.
67
)
BM
Ia
t
16
ye
ar
s
A
U
C
:
0.
61
(0
.5
4
to
0.
68
)
M
et
ab
ol
ic
sy
nd
ro
m
e
C
ut
-o
ff
:
≥
85
th
ce
nt
ile
(IO
TF
)
BM
Ia
t
5
ye
ar
s
Se
ns
iti
vi
ty
:
1
Sp
ec
ifi
ci
ty
:
98
A
ge
,
se
x
co
nt
in
ue
d
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
47
TA
B
LE
6
R
es
u
lt
s
o
f
st
u
d
ie
s
n
o
t
in
cl
u
d
ed
in
th
e
q
u
an
ti
ta
ti
ve
sy
n
th
es
is
:e
st
im
at
es
o
f
p
re
d
ic
ti
ve
ac
cu
ra
cy
(c
o
n
ti
n
u
ed
)
St
u
d
y
A
g
e
at
b
as
el
in
e
(y
ea
rs
)
A
g
e
at
fo
llo
w
-u
p
(y
ea
rs
)
n
at
fo
llo
w
-u
p
O
u
tc
o
m
e
C
o
m
p
ar
is
o
n
C
h
ild
h
o
o
d
m
ea
su
re
m
en
t
Su
m
m
ar
y
es
ti
m
at
e
(9
5%
C
l)
A
d
ju
st
m
en
t
BM
Ia
t
8
ye
ar
s
Se
ns
iti
vi
ty
:
1
Sp
ec
ifi
ci
ty
:
99
BM
Ia
t
11
ye
ar
s
Se
ns
iti
vi
ty
:
2
Sp
ec
ifi
ci
ty
:
99
BM
Ia
t
14
ye
ar
s
Se
ns
iti
vi
ty
:
7
Sp
ec
ifi
ci
ty
:
97
C
ut
-o
ff
:
≥
75
th
ce
nt
ile
(in
te
rn
al
ly
de
riv
ed
)
BM
I
Se
ns
iti
vi
ty
:
50
.8
Sp
ec
ifi
ci
ty
:
80
.0
Sa
ch
de
v
(2
00
9)
17
0
2–
14
26
–
33
M
et
ab
ol
ic
sy
nd
ro
m
e
C
ut
-o
ff
:
≥
85
th
ce
nt
ile
(IO
TF
)
BM
Ia
t
5
ye
ar
s
Se
ns
iti
vi
ty
:
1
Sp
ec
ifi
ci
ty
:
98
A
ge
,
se
x
BM
Ia
t
8
ye
ar
s
Se
ns
iti
vi
ty
:
1
Sp
ec
ifi
ci
ty
:
99
BM
Ia
t
11
ye
ar
s
Se
ns
iti
vi
ty
:
2
Sp
ec
ifi
ci
ty
:
99
BM
Ia
t
14
ye
ar
s
Se
ns
iti
vi
ty
:
7
Sp
ec
ifi
ci
ty
:
97
Sc
hm
id
t
(2
01
1)
17
1
7–
15
26
–
36
21
88
M
et
ab
ol
ic
sy
nd
ro
m
e
(ID
F
20
09
22
3 )
4t
h
qu
ar
til
e
vs
.
1s
t
qu
ar
til
e
Su
m
SF
T:
bo
ys
Se
ns
iti
vi
ty
:
30
(1
6
to
47
)
Sp
ec
ifi
ci
ty
:
82
(7
7
to
86
)
A
U
C
:
0.
62
4
Su
m
SF
T:
gi
rls
Se
ns
iti
vi
ty
:
58
(2
8
to
85
)
Sp
ec
ifi
ci
ty
:
83
(7
9
to
87
)
A
U
C
:
0.
77
7
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
48
St
u
d
y
A
g
e
at
b
as
el
in
e
(y
ea
rs
)
A
g
e
at
fo
llo
w
-u
p
(y
ea
rs
)
n
at
fo
llo
w
-u
p
O
u
tc
o
m
e
C
o
m
p
ar
is
o
n
C
h
ild
h
o
o
d
m
ea
su
re
m
en
t
Su
m
m
ar
y
es
ti
m
at
e
(9
5%
C
l)
A
d
ju
st
m
en
t
Su
m
SF
T:
un
se
le
ct
ed
Se
ns
iti
vi
ty
:
37
(2
3
to
52
)
Sp
ec
ifi
ci
ty
:
82
(7
9
to
85
)
A
U
C
:
N
R
4t
h
qu
ar
til
e
vs
.
1s
t
qu
ar
til
e
W
C
:
bo
ys
Se
ns
iti
vi
ty
:
45
(3
6
to
55
)
Sp
ec
ifi
ci
ty
:
80
(7
7
to
82
)
A
U
C
:
0.
68
6
W
C
:
gi
rls
Se
ns
iti
vi
ty
:
49
(3
3
to
65
)
Sp
ec
ifi
ci
ty
:
81
(7
8
to
83
)
A
U
C
:
0.
72
1
W
C
:
un
se
le
ct
ed
Se
ns
iti
vi
ty
:
46
(3
8
to
54
)
Sp
ec
ifi
ci
ty
:
80
(7
8
to
82
)
A
U
C
:
N
R
4t
h
qu
ar
til
e
vs
.
1s
t
qu
ar
til
e
W
H
R:
bo
ys
Se
ns
iti
vi
ty
:
34
(2
5
to
43
)
Sp
ec
ifi
ci
ty
:
79
(7
7
to
82
)
A
U
C
:
0.
61
2
W
H
R:
gi
rls
Se
ns
iti
vi
ty
:
33
(1
9
to
49
)
Sp
ec
ifi
ci
ty
:
79
(7
7
to
82
)
A
U
C
:
0.
67
2
W
H
R:
un
se
le
ct
ed
Se
ns
iti
vi
ty
:
33
(2
6
to
41
)
Sp
ec
ifi
ci
ty
:
79
(7
8
to
81
)
A
U
C
:
N
R
N
A
,
no
t
ap
pl
ic
ab
le
;
N
R,
no
t
re
po
rt
ed
;
O
,
ob
es
e;
T2
D
M
,
ty
pe
2
di
ab
et
es
m
el
lit
us
.
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
49
Comparison of ‘simple’ measures of childhood obesity for prediction of
adult morbidities
The evidence comparing BMI with alternative ‘simple’ measures of childhood obesity for predicting adult
morbidity was very limited; the available studies are summarised in Table 7. As seen in the previous
sections, only three studies evaluated relevant measures other than BMI.117,168,171 All studies were relatively
small (n= 1067 to n= 2188). All were subject to high risk of attrition bias117,168,171 and one was at high risk
of bias associated with confounding factors and outcomes.168
The available studies provide data only on WC, WHR and the sum of SFT measurements at more than one
site (sum SFT). Accuracy data were only available for WC for predicting of diabetes.168 Measures of
association (RR, OR) between childhood measurements and adult morbidities were available for WC (for
hypertension117,171 and metabolic syndrome171), and for WHR and sum SFT (metabolic syndrome only).171
Schmidt et al. (2011)171 reported the association between the risk of developing the metabolic syndrome in
adults and four different childhood measurements (BMI, WC, WHR and sum SFTs) between the ages of 7
and 15 years. As seen earlier, the association between the risk of developing the metabolic syndrome in
adulthood and childhood weight status was consistently positive and statistically significant across all four
childhood measures, and the strength of the associations was systematically greater in girls than in boys.
However, most results lacked precision (as evidenced by the wide CIs), making it difficult to compare the
strength of the associations across obesity measures.
The Chinese study by Cheng et al. (2011)117 reported higher odds of developing hypertension in adulthood
among obese and overweight children measured at a mean age of approximately 11 years with both WC
and BMI. Although associations between childhood obesity and hypertension in adulthood were reported for
both WC and BMI, the comparators used for calculating ORs differed between the two measurements (obese
vs. non-obese for WC, obese vs. healthy weight for BMI), which limits the comparability of the estimates of
association. Additionally, as with Schmidt et al. (2011),171 the study did not assess the predictive accuracy
of either of the childhood measurements. Therefore, their relative predictive accuracy cannot be compared.
Two studies compared the predictive accuracy of more than one childhood measure; one evaluated BMI
and WC for predicting type 2 diabetes,168 and the other WC, SFT and WHR for predicting metabolic
syndrome.171 The study evaluating BMI and WC found that they were equally accurate in predicting early
adult diabetes when conducted in 10-year-old girls; both had equally high specificity (96%) and poor
sensitivity (13%).168 However, the study had several limitations: the outcome of interest was collected
through self-report and may have been contaminated by type 1 diabetes, follow-up duration was limited
to only 9 years and the study did not report how WC was measured (including measurement site).
The other study171 that categorised the most obese 25% as the ‘at-risk’ group reported poor sensitivity,
which was generally below 50%, and moderate specificity; SFT appeared to be the most accurate of the
three obesity measures (see Table 7).
Review of morbidities: summary of findings and conclusions
This review identified 37 cohort studies on the association between childhood weight status and adult
morbidities. Of these, 26 were included in the meta-analyses. All the studies were large or very large
cohort studies, most being from large national or community data sets. However, large proportions of
participants were lost at final follow-up in many studies, making attrition the most common source of bias.
Although most studies adjusted for key confounders such as age and sex, the observational design of the
studies means that confounding bias cannot be ruled out. Studies were very diverse, with weight status
measured at different ages and in different populations. Most studies tended to focus on older cohorts.
Follow-up duration and age at final follow-up also varied significantly between the studies. In addition,
relatively few studies were found for some outcomes. Given the range of morbidity-related outcomes that
could be reported (particularly the large number of types of cancer), there is a possibility of selective
reporting, where cohorts reported only outcomes showing a positive association between BMI and the
outcome. These limitations should be considered when interpreting the results.
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Overall, most studies reported a positive, statistically significant association between measures of childhood
weight status and adult morbidity, but the findings varied by morbidity. There was consistent evidence of
a statistically significant but modest association between childhood BMI and adult diabetes; there was
insufficient evidence to show whether or not the association is stronger among older children. Results for
CHD were more mixed, with some cohorts showing a negative association (in early childhood) or no
association, and others showing a modest increase in odds of CHD with increased BMI. There is
insufficient evidence to show whether or not the association differs significantly between under- and
over-twelves. However, evidence from some cohorts suggests an increasing trend with age. There is little
evidence of any association between obesity and stroke; the statistically significant result in the
over-twelves is based on a single cohort study.
There was some consistent evidence that childhood obesity and overweight are positively associated with
metabolic syndrome in adulthood. There was some very limited evidence suggesting that the strength
of the associations may vary according to age and measurement tool. There was also some consistent
evidence that childhood obesity and overweight are positively associated with odds of adult hypertension,
although the results are based on a relatively limited number of cohorts. There was some evidence of a
statistically significant positive association between BMI in adolescence and hypercholesterolaemia in early
adulthood, although the evidence is based on a single cohort with limited follow-up.
The cohorts reported on a large number of cancers (although few cohorts were found for each site-specific
cancer), and the general trend appears to be that obesity leads to a modest increase in risk for most
cancers for which evidence was available (except for breast cancer and rectal cancer).
Despite the association between obesity and later morbidity, childhood BMI is a poor predictor of adult
morbidity. At best, around 40% of adults with diabetes were overweight or obese (above the 85th centile
of BMI) as children. There was some evidence from a single cohort that BMI and WC had equally high
specificity and poor sensitivity when used to predict future diabetes. At most, 20% of future CHD and
cancers occur in overweight or obese children. If we consider only obese children (above the 95th centile),
then obesity cannot predict CHD or cancer; the results are no better than chance. Therefore, childhood
BMI is not a good predictor of future heart disease or cancer.
There was some evidence that BMI has good specificity but poor sensitivity when used to predict metabolic
syndrome in adults, although this finding is based on very few and small cohorts. This means that most
adults who do not develop metabolic syndrome as adults were also not obese as children; however, this
tells us nothing about obese children. There is some evidence from a relatively small cohort that BMI values
at ages 11 and 16 years were weakly predictive of hypertension in adulthood. No evidence was found
on the predictive value or association between childhood weight status and hypercholesterolaemia
in adulthood.
The evidence for the predictive accuracy of simple measures other than BMI was limited, and could not be
included in the meta-analyses. Only three relatively small studies used WC, and only one used WHR and
measurements of SFT. Based on this evidence, the extent to which these simple measures of childhood
weight status can be compared is very limited. Only one study reported predictive accuracy data on WC
and BMI, and found that both had equally high specificity and low sensitivity when predicting future
adult morbidity.
Overall, there was consistent evidence of positive associations between childhood measurements of weight
status and morbidities in adulthood. Although higher childhood BMI tends to be associated with a higher
risk of morbidity in adulthood, overall it is a poor predictor of adult morbidity. This is because the
association between obesity and morbidity would need to be strong (i.e. a large RR) in order for obesity to
be an effective predictor of later morbidity.225 There is also no evidence favouring the accuracy of any of
the other simple measures of childhood weight status for predicting future adult morbidity.
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Review of tracking of obesity into adulthood
For the review of tracking of obesity into adulthood, five systematic reviews (across six publications) with
potential for being updated were identified.16,17,211,214,215,226 None of the reviews specifically evaluated the
accuracy of simple childhood measures of obesity in predicting adult obesity. The most recent and relevant
reviews were by Singh et al. (2008)16 and Brisbois et al. (2012).17 The bibliographies of all the systematic
reviews and other relevant reviews were screened for potentially relevant studies, regardless of the age of
the study.
Summary of the existing systematic reviews by Singh et al. (2008) and
Brisbois et al. (2012)
The systematic review by Singh et al. (2008)16 examined the evidence of the persistence of childhood
overweight. The review included prospective or retrospective longitudinal studies that made at least one
anthropometric measurement during youth (age ≤ 18 years) and one during adulthood (age ≥ 19 years),
using BMI, SFT or WC. Eighteen studies in 25 articles were included in the review. The quality of the
included studies was assessed in duplicate by the two reviewers and 52% of the articles were rated as
being of high methodological quality.
All the included studies reported that overweight or obese youths were at increased risk of becoming
overweight or obese adults. Four studies that stratified for different levels of youth overweight suggested
that persistence of overweight was greater with increased level of overweight. It was unclear if persistence
varied with sex. When only high-quality studies were included in the analysis, the risk of overweight
children becoming overweight adults was at least double that for normal-weight children. Overall, the
percentage of obese adolescents becoming overweight or obese adults was higher than that of obese
children (24–90% based on three high-quality studies). The review concluded that there is strong evidence
of moderate persistence of overweight in both overweight and obese children. A significant limitation of
the review was that it was unclear how comprehensive the searches had been, and whether or not
relevant studies may have been missed. Furthermore, it presented only a narrative synthesis of the results
from the included studies and focused on the association between childhood and adult obesity rather than
the predictive accuracy of childhood obesity. In addition, as the review’s searches had been conducted in
February 2007 the list of included studies was potentially out of date. Therefore, this review was used only
as a source of relevant studies for the current review.
The systematic review by Brisbois et al. (2012)17 evaluated a number of factors in children aged 5 years or
under which are the most significant predictors of the development of obesity in adulthood. Studies were
eligible if they included healthy individuals, performed child and adult measurements for each individual
and reported quantitative results. The searching appeared adequate but the lack of overlap with
Singh et al. (2008)16 raised questions over how comprehensive it had been.
The review included 24 studies, and almost all reported a significant association between childhood
overweight or obesity and adult obesity. The review concluded that early childhood obesity was a probable
marker of adult obesity.
The main limitations of this review were that only early childhood was considered and it was possible
that studies had been missed. Furthermore, many of the studies included reported only correlation
coefficients, and only a narrative synthesis of study results was conducted. Therefore, as with the review
by Singh et al. (2008),16 this review was used as a source of relevant studies for the current review.
Quality and assessment of bias of the included primary studies of tracking
of obesity into adulthood
In total, 23 studies were identified for the review of the tracking of childhood obesity into adulthood.
These are listed in Table 8.
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TABLE 8 Tracking review: risk of bias assessment
Study
Risk of
selection
bias
Risk of
attrition
bias
Risk of bias
associated
with the
prognostic
factor
Risk of bias
associated
with
outcome
Risk of
bias due to
confounders
Risk of
reporting or
analysis bias
Cheng (2011)117 Low High Low Low UC Low
Cheung (2004)118 Low High Low High High Low
Engeland (2004)119 Low Mod/UC Mod/UC Mod/UC Low Low
Freedman (2001)120 Low Low Mod/UC Mod/UC Mod/UC Low
Freedman (2005)122 Low Mod/UC Low Low Low Low
Freedman (2005)121 Low Low Low Low Low Low
Goldhaber-Fiebert
(2013)123
Low Mod/UC Mod/UC Mod/UC Low Low
Gordon-Larsen (2004)124 Low Mod/UC Low High Low Low
Juhola (2011)125 Low Mod/UC Mod/UC Mod/UC Low Low
Juonala (2006)126 Low High Mod/UC Mod/UC High Low
Liddle (2012)127 Low Mod/UC Low High Mod/UC Low
Mamun (2005)128 Low Mod/UC Low Low Mod/UC Low
Merten (2010)129 Low Mod/UC Mod/UC Mod/UC Mod/UC Low
Nakano (2010)131 Low Mod/UC Low Low Low Low
Nakano (2010)130 Low Mod/UC Low Low Low Low
Patton (2011)132 Low Mod/UC Mod/UC Mod/UC Low Low
Power (1997)133 Low Mod/UC Low Low Low Low
Reilly (2011)134 Low Mod/UC Low Low Mod/UC Low
Starc (2011)135 Low Low Low Low Low Low
Stovitz (2010)136 Low Mod/UC Low Low Mod/UC Low
Thompson (2007)137 Low Mod/UC Low Mod/UC Low Low
Venn (2007)138 Low Mod/UC Mod/UC Mod/UC Mod/UC Low
Wang (2008)139 Low Low Mod/UC Mod/UC Low Low
All studies All low 16 mod/UC
3 high
4 low
14 low
9 mod/UC
10 mod/UC
10 low
3 high
13 low
2 high
8 mod/UC
All low
Mod, moderate; UC, unclear.
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The results of the quality and risk of bias assessment are summarised in Table 8 and given in full in
Appendix 4. All the studies were cohort studies, and so they are already subject to greater bias than a
randomised controlled trial would be. However, all the studies were large, most being from national or
community data sets. The main potential source of bias arises from the lack of control in retaining
participants in the cohorts; thus, although the initial cohorts were very large, many thousands of
participants were not followed up at the final assessment. In itself this might not be a source of bias, but
the majority of study reports did not confirm that the final cohort followed up was representative of the
complete initial sample. Confounding was another significant potential source of bias in these studies.
Although some presented results by age and sex, most did not, and the wide age ranges included in some
studies increased the potential for age-associated effects that could not be accounted for.
Characteristics of studies included the review of tracking of obesity
into adulthood
There was some overlap between a number of the studies, as they were based on the same initial cohorts.
Three were based on the Bogalusa cohort in the Southern States of the USA, and two each were based on
the National Child Development Study (1958 British birth cohort) (NCDS), the National Longitudinal Study
of Adolescent Health (NLSAH) cohort, the Young Finns cohort, Tokushima Prefecture and the Mater-University
Study of Pregnancy (MUSP) cohort in Australia (Table 9). Each study included in the review provided some
unique data in terms of age of childhood assessment, adult assessment or analysis by age, sex or race.
Only unique data are included in the meta-analysis and narrative synthesis.
Study characteristics for tracking of obesity into adulthood
The study characteristics are summarised in Table 10 and presented in full in Appendix 3. The included
studies were all longitudinal cohort studies in which these data were collected prospectively. They were
conducted in various countries: the USA (nine studies), UK (three studies), other European countries
(four studies: two in Finland, one in Norway and one in Slovenia), Australia (four studies), Japan (two studies)
and China (one study). The start dates of the studies ranged from 1958 to 2008, with follow-up between
6 and 42 years; 11 of the 23 studies had follow-up of 20 years or longer.
The setting for studies was not always completely clear, although not surprisingly most involved
schoolchildren measured in school or the community. The childhood measures are listed in Appendix 3.
In all studies, BMI was assessed in childhood (or adolescence), and in all but one study127 BMI was the only
measure in childhood. In all studies, childhood BMI was routinely reported in kg/m2, and was sometimes
standardised to reference data. Ten studies used IOTF61/Cole 2000220/WHO45 reference populations.
Others used the CDC 2000219 reference growth charts or the UK90 reference.221 All were extracted as
equivalent to the 85th and 95th centile cut-off points in childhood to determine overweight and obesity
respectively. The Bogalusa cohort used the 95th centile to define overweight. However, data at the 85th
and 95th centiles were used to define overweight and obesity, in accordance with other studies. One study
[Juonola et al. (2006)126] used the 80th and 90th centiles as the cut-off points for overweight and obesity;
this study was included in the analyses as if it had used the 95th centile.
Skinfold thickness was the childhood measurement in only one included study127 (and was used in addition
to BMI); it was measured at one site and measurements were converted to a z-score internally adjusted for
age and sex. Cut-off points were generated from proportions of overweight/obese similar to Cole 2000220
BMI subgroups (BMI was also measured).
Details of the BMI measure used in adults are listed in Appendix 3. In summary, all assessments of adult
weight status used the BMI cut-off points for overweight and obesity of 25 kg/m2 and 30 kg/m2. For
adolescents, all studies used the cut-off points for overweight and obesity of the 85th and 95th centiles
respectively, with the exception of Juonola et al. (2006),126 based on the Young Finns cohort, which used
the 80th and 90th centiles respectively.
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TABLE 9 Tracking review: overlap of studies based on the same cohorts
Cohort
name Study
Country in
which study
conducted
Study dates
Details of individual ‘study’ (paper)From To
Bogalusa Freedman (2001)120 USA 1973 1996 This analysis based on 2617 participants
re-examined as adults (age 27 years)
Freedman (2005)122 1973 1994 This analysis based on 2610
participants re-examined as adults
(age 27 years)
Freedman (2005)121 1973 1996 This analysis based on 2392
participants re-examined as adults
(age 27 years)
Young Finns Juhola (2011)125 Finland 1980 2007 Cohort followed up in 2001 (age
30–45 years). Results presented
stratified by different age at baseline,
but only summary data presented
Juonala (2006)126 Finland 1980 2001 Cohort followed up in 2007 (age
24–39 years). Data presented across
broad age groups
MUSP Liddle (2012)127 Australia 1986 NR (follow-up
for 18 years)
Tracked children from age 5 to age
21 years (range 18.2–23.1 years)
Mamun (2005)128 Australia 1986–90 2000–4 Tracked children from age 5 to age
14 years
NCDS (1958
British birth
cohort)
Power (1997)133 UK 1958 1991 Tracked participants from age 7 to
age 33 years
Cheung (2004)118 UK 1958 2000 Tracked participants from age 7 to
age 33 years; calculated sensitivity and
specificity, etc. Compare with results
from Power (1997)133
NLSAH Gordon-Larsen
(2004)124
USA 1996 2002 Tracking of wave II participants to
wave III participants, stratified by age
in wave II
Merten (2010)129 USA 1995 2001 Tracking of wave I participants to
wave III participants
Tokushima
Prefecture
Nakano (2010)131 Japan 2001 2008 Participants followed up for 7 years.
Only included children who were aged
7 years at first measure [i.e. a subset
of participants in Nakano (2010)130]
Nakano (2010)130 Japan 2001 2007 Participants followed up for 6 years.
Although whole cohort overlaps with
Nakano (2010),131 the extracted data
were only for a cohort aged 8 years at
first measure (n= 5697) and so study
does not overlap with other Nakano
study
NR, not reported.
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TABLE 10 Tracking review: study characteristics
Cohort name Study
Country in
which study
conducted
Study dates Setting for
anthropometric
measure in
childhoodStart Finish
1988–90 Slovenian
cohort
Starc (2011)135 Slovenia 1997 2008 School
ALSPAC Reilly (2011)134 UK 1998/1999 2003/2004 Research clinic
ASHFS Venn (2007)138 Australia 1985 2005 School
BCAMSS Cheng (2011)117 China 2004 2011 School
Bogalusa Freedman (2001)120 USA 1973 1996 School
Freedman (2005)122 USA 1973 1994 School
Freedman (2005)121 USA 1973 1996 School
Cardiovascular Risk
in Young Finns
Juhola (2011)125 Finland 1980 2007 NR
Juonala (2006)126 Finland 1980 2001 NR
CATCH Stovitz (2010)136 USA 1991 2001 School
MUSP Liddle (2012)127 Australia 1986 NR (follow-up
for 18 years)
NR
Mamun (2005)128 Australia 1986–90 2000–4 NR
NCDS (1958 British
birth cohort)
Power (1997)133 UK 1958 1991 Community
Cheung (2004)118 UK 1958 2000 Community
NGHS/PFS Thompson (2007)137 USA 1986 1997 School
NHANES, NLSY79 Goldhaber-Fiebert
(2013)123
USA 1970 2008 Community
NLSAH Gordon-Larsen
(2004)124
USA 1996 2002 School
Merten (2010)129 USA 1995 2001 School
NLSY79 Wang (2008)139 USA 1981 2002 Interview/survey
None Engeland (2004)119 Norway 1963 1999 Community
None Patton (2011)132 Australia 1992 2003 School
Tokushima Prefecture Nakano (2010)131 Japan 2001 2008 School
Nakano (2010)130 Japan 2001 2007 School
ALSPAC, Avon Longitudinal Study of Parents and Children; ASHFS, Australian Schools Health Fitness Survey; BCAMSS, Beijing
Child and Adolescent Metabolic Syndrome study; CATCH, Child and Adolescent Trial for Cardiovascular Health; NGHS, National
Growth and Health study; NHANES, National Health and Nutrition Evaluation Surveys; NLSY79, National Longitudinal Survey of
Youth; NR, not reported; PFS, Princeton follow-up study.
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Population characteristics for tracking of obesity into adulthood
The sample sizes of the cohorts at baseline ranged from 1943 to 227,003 (Table 11; see also Appendix 3),
and at follow-up from 1309 to 128,121. The age range for the baseline measurements varied across the
studies, with the youngest age being 2 years and the oldest 19 years. Of the 23 studies, nine included a
mix of children and adolescents at baseline, five just children and six just adolescents.
Four studies128,130,131,134 tracked weight status from childhood to adolescence, in two studies123,135 the
latest follow-up age was 18 years and five studies included participants as young as 18 years in their
follow-up.117,120–122,127,136 The oldest cohorts at final follow-up included participants aged 24–54 years119 and
in one case participants aged 37–38 years.139 The cohorts generally included equal proportions of males
and females; the Bogalusa cohort had a slightly lower proportion of males (43%). The ethnicity and mix of
ethnicities within the cohorts varied by country. The SES of participants was reported in only four of the
studies.127,132,134,139 Of those, one reported that 47% had achieved college-level education or above,139 and
the other three reported that maternal/parental education levels were post high school for 20–50%.127,132,134
Where reported, the proportion of overweight or obese children at baseline varied considerably; overweight
ranged from 5% to 18% and obesity from 2% to 17%, with generally higher rates in girls and
older children.
Findings of the review of tracking of obesity into adulthood
Data extracted from the included studies, and calculated sensitivity, specificity and PPV by study, are
presented in Appendix 3.
Overview of the studies of tracking of obesity into adulthood
To give an overview of these data, we present three figures showing sensitivity, specificity and PPV
according to childhood age of BMI measurement and sex for each study. These plots show the diagnostic
performance of using obesity in children (> 95th centile), according to age at measurement, to predict
obesity in adults (aged ≥ 20 years).
Figure 18 shows that sensitivity is generally low – less than 40% – with the exception of one study
[Thompson et al. (2007)137]. Most obese adults were therefore not obese in childhood. There is no obvious
trend in sensitivity with age or sex. There appears to be considerable heterogeneity across studies, with
sensitivities ranging from 10% to over 60% at age 16 years. Figure 19 shows that specificity is much
higher and more consistent, ranging from 93% to nearly 100%. This means that nearly all non-obese
adults were also not obese as children; however, this tells us nothing about the obese adults and children
who are of concern. The PPV tells us what proportion of obese children go on to become obese adults.
This is shown in Figure 20. The results are very heterogeneous, ranging from 40% to over 90%. The PPV
depends on the prevalence of obesity, so some of this heterogeneity may be a result of varying obesity
prevalence across studies.
The results do suggest that obesity is moderately persistent, at least between adolescence and adulthood.
Meta-analysis of tracking of obesity into adulthood
All tracking studies that reported full diagnostic data (i.e. numbers of true and false positives, and true
and false negatives) were included in the meta-analyses, except for the study by Liddle et al. (2012),127,128
which was of children aged 5 years only and therefore did not fall into the lowest age category of the
meta-analysis (7–11 years); the results of this study are presented in the previous section. Different studies
reported data on different comparisons between childhood and adult obesity or overweight, and at
different ages. Table 12 gives a summary of which studies were included in which analyses; not all
publications provided data for the meta-analysis. Studies reported tracking in a variety of ways, with some,
for example, examining tracking of childhood obesity to adult obesity, some adolescent overweight to
adult obesity and some childhood overweight to adolescent overweight, and therefore most meta-analyses
include few studies.
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TABLE 11 Tracking review: population characteristics
Study
Number at
baseline
Number at final
follow-up
Childhood
age (years)
Adult (final
follow-up)
age (years)
Percentage overweight or
obese in childhood
Cheng (2011)117 2189 1184 6–16 12–22 Overweight: 15.3
Obese: 40.8
Cheung (2004)118 17,000 12,327; analysis on
randomly selected
50% sample
7, 11, 16 33 Overweight: 10.4
Obese: 2.2
Engeland (2004)119 227,003 128,121 14–19 24–54 Overweight: 4.9 for boys and
7.3 for girls
Freedman (2001)120 9597 2617 2–17 18–37 Obese: 7
Freedman (2005)122 11,411 2610 2–17 18–37 Overweight: 7 for boys and
6 for girls
Freedman (2005)121 7923 2392 5–14 18–37 Overweight: ≈7
Goldhaber-Fiebert
(2013)123
NR 4884 (tracking) 2–15 18 Overweight: 9–10 for 5-year-olds;
14–15 for 15-year-olds
Obese: 12–13 for 5-year-olds;
11–17 for 15-year-olds
Gordon-Larsen
(2004)124
14,438 9795 (including
total population
at 13–15 years,
16–17 years and
18–20 years)
13–20 19–26 Obese: 10.9
Juhola (2011)125 3596 2204 3–18 30–45 NR
Juonala (2006)126 3596 2260 3–18 24–39 Overweight: 10.5
Obese: 8.6
Liddle (2012)127 3960 1755 5 18.2–23.1 NR
Mamun (2005)128 NR 2794 5 14 Overweight/obese: 17
Merten (2010)129 20,745 10,439 12–19 22 NR
Nakano (2010)130 22,827 16,245 8 14 Overweight: 18.28 for boys and
17.09 for girls
Obese: 5.94 for boys and
4.13 for girls
Nakano (2010)131 7506 5024 7 14 NR
Patton (2011)132 1943 1520 Mean 15 24 NR
Power (1997)133 17,733 11,407 7–16 33 NR
Reilly (2011)134 7759 5175 7 13 Overweight: 8.1 for males and
9.6 for females
Obese: 8.2 for males and
6.8 for females
Starc (2011)135 21,777 4833 Mean 7 18 Overweight: 13.2 for males and
13.1 for females
Obese: 5.7 for males and
4.4 for females
continued
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
59
Sex
Study
60
40
20
0
Both
Boys
Girls
Freedman 2005121
Gordon-Larsen 2004124
Juonala 2006126
Liddle 2012127
Power 1997133
Thompson 2007137
Venn 2007138
Wang 2008139
4 8 12 16
Age (years) of childhood measure
Se
n
si
ti
vi
ty
 (
%
)
FIGURE 18 Sensitivity for predicting adult obesity from childhood obesity.
TABLE 11 Tracking review: population characteristics (continued )
Study
Number at
baseline
Number at final
follow-up
Childhood
age (years)
Adult (final
follow-up)
age (years)
Percentage overweight or
obese in childhood
Stovitz (2010)136 5106 2802 Mean 8 Mean 18.3 Overweight: 14.9
Obese: 10.5
Thompson
(2007)137
1963 1669 10–16 21–23 Overweight: at baseline,
7.4–8.7 for Caucasian;
17.4–18.2 for AA
Venn (2007)138 8498 4571 7–15 24–34 Overweight: 8.3 for boys and
9.7 for girls
Obese: 1.5 for boys and
1.4 for girls
Wang (2008)139 2513 1309 16–17 37–38 Overweight: 8
Obese: 3
AA, African American; NR, not reported.
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FIGURE 19 Specificity for predicting adult obesity from childhood obesity.
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FIGURE 20 Positive predictive value for predicting adult obesity from childhood obesity.
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Association between childhood weight status and adult obesity
Figure 21 shows the forest plot for the meta-analysis of RR of being obese as an adult among children
who were obese. The association is strong, with obese children being more than five times more likely to
be obese as adults than non-obese children. There is no apparent difference in this RR between younger
and older age groups.
Tracking from childhood weight status to adult obesity
Childhood obesity to later obesity Figure 22 shows the results of the joint meta-analyses of sensitivity
and specificity when predicting adult obesity (≥ 95th centile or > 30 kg/m2) from childhood obesity
(≥ 95th centile of BMI). Four results are shown: child to adolescent (three studies), child to adult (four studies),
Effect (95% Cl)Study
Estimates (RRs) with 95% CI
3
4.17 (3.61 to 4.82)
4.93 (4.37 to 5.57)
5.62 (4.82 to 6.55)
4.86 (3.87 to 6.09)
4.86 (4.29 to 5.51)
4.00 (3.43 to 4.65)
5.35 (4.92 to 5.81)
6.21 (4.93 to 7.83)
6.37 (5.67 to 7.16)
8.87 (7.41 to 10.62)
3.58 (3.08 to 4.16)
5.45 (4.34 to 6.85)
5.21 (4.50 to 6.02)
Freedman 2005121
Freedman 2005121
Gordon-Laser 2004124
Power 1997133
Power 1997133
Juonala 2006126
Thompson 2007137
Thompson 2007137
Wang 2008139
Venn 2007138
Pooled
Pooled
Overall pooled
4 5 6 7 9 11
7- to 11-year olds
> 12  years
FIGURE 21 Forest plot of the association between childhood obesity and adult obesity.
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FIGURE 22 Tracking of childhood obesity to adult obesity.
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adolescent to adult (six studies) and adolescent to over 30 years (three studies). The points show the summary
sensitivities and specificities with their 95% CIs; the curves are the summary HSROC curves.
Figure 22 shows that obesity tracking is strongest over short time periods. Childhood obesity does track
reasonably well to adolescent obesity; 62% of obese adolescents were obese in earlier childhood. A high
specificity of 95% means that nearly all non-obese adolescents were non-obese children. For tracking into
adulthood, the specificities of around 98% mean that nearly all non-obese adults were not obese in
childhood or adolescence. However, by contrast, the low sensitivities mean that most obese adults were
not obese as children. About 70% of obese adults were not obese in childhood or adolescence and 80%
of over-thirties were not obese in adolescence.
Childhood overweight or obesity to later obesity Figure 23 shows the results for whether or not
childhood obesity or overweight (≥ 85th centile of BMI) tracks to later obesity (≥ 95th centile or ≥ 30 kg/m2).
Four results are shown: child to adolescent (three studies), child to adult (two studies), adolescent to adult
(five studies) and adolescent to age over 30 years (three studies). The pattern of results is similar to that for
childhood obesity, with low sensitivity to detect adult obesity; around 60% of obese adults were neither
overweight nor obese as adolescents. Childhood overweight is, however, a good predictor of adolescent
obesity; 90% of obese adolescents were overweight or obese in earlier childhood.
Tracking from childhood to adult overweight or obesity
Childhood overweight or obesity to later overweight or obesity Figure 24 shows the results of the
joint meta-analyses examining whether or not childhood overweight or obesity (≥ 85th centile of BMI)
tracks to later overweight or obesity (≥ 85th centile or > 25 kg/m2). Three results are shown: child to
adolescent (six studies), child to adult (two studies) and adolescent to adult (two studies). There was only
one study with data from adolescence to age over 30 years, so no analysis could be performed. We note
that there were few data here for tracking into adulthood.
The results for childhood to adolescence suggest that 65% of obese or overweight adolescents were
obese or overweight at younger ages. The limited data for tracking to adulthood suggest very low
sensitivity; about three-quarters of overweight adults were not overweight in younger childhood.
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FIGURE 23 Tracking of childhood overweight or obesity to adult obesity.
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Childhood obesity to later overweight or obesity Figure 25 shows how childhood obesity (excluding
overweight) tracks to adult obesity or overweight. Three results are shown: child to adolescent (three studies),
child to adult (three studies) and adolescent to adult (two studies). The results are broadly similar to those
obtained for using childhood overweight to predict adult overweight. The results for childhood to
adolescence suggest that 35% of obese or overweight adolescents were obese at younger ages. The
substantial majority of overweight adults (around 90%) were not obese as children.
Positive predictive values
Meta-analyses of the PPV, which estimates the proportion of obese children who will go on to become
obese adults, are presented in Figures 26 and 27. The analyses are similar to those presented above,
with the same studies in each analysis as for the equivalent analyses given above.
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FIGURE 25 Tracking of childhood obesity to adult overweight or obesity.
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FIGURE 24 Tracking of childhood overweight or obesity to adult overweight or obesity.
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FIGURE 27 Positive predictive value for childhood overweight and obesity when tracking to adult obesity.
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FIGURE 26 Positive predictive value for childhood obesity when tracking to adult obesity.
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Figure 26 shows the PPV and NPV for predicting adult obesity from childhood obesity, classified according
to age as before. This shows that obesity is moderately persistent into adulthood; just under 80% of obese
adolescents were still obese as adults, although that declines to 70% when adult ages are restricted to
over 30 years. Childhood obesity does not track so strongly into adolescence, however, with just over half
of all children still obese as adolescents, although data were limited and therefore CIs are wide. The NPV
results show that non-obesity does track into adulthood; more than 85% of non-obese children will still
be non-obese in adulthood. However, this does mean that a small proportion (10–15%) of non-obese
children will be obese by early adulthood.
Figure 27 shows the equivalent PPV and NPV for tracking of childhood overweight or obesity to later
obesity. The pattern of results is similar, but the PPVs are smaller as many overweight children will not
become obese adults. Around 66% of obese or overweight adolescents will be obese in early adulthood,
dropping to around 55% by age 30 years. Only about 30% of obese or overweight children will go on to
be obese in adolescence.
As both PPV and NPV depend on the prevalence of obesity, the results of these analyses should be
interpreted as predictive values in a population with average obesity prevalence.
Additional information from studies that could not be included in the
meta-analysis
Four studies reported data that could not be included in the meta-analyses: Goldhaber-Fiebert et al.
(2013),123 Cheung et al. (2004),118 Juhola et al. (2011)125 and Liddle et al. (2012).127 The extracted data are
presented in Appendix 3. The results of these studies were broadly consistent with the findings of the
meta-analyses.
The study by Goldhaber-Fiebert et al. (2013)123 could not be included in any meta-analysis, as it was not a
straightforward analysis of cohort data, but included microsimulations based on combined data sets in
order to estimate how well childhood obesity predicts adult obesity and to forecast the obesity-related
health of future US adults. Data were sourced from the National Longitudinal Survey of Youth (NLSY79),
Population Study of Income Dynamics (PSID) and National Health and Nutrition Evaluation Surveys
(NHANES). The authors estimated test characteristics and predictive values of childhood BMI to identify
2-, 5-, 10- and 15-year-olds who will become obese at age 18 years (12% of 18-year-olds in the study were
obese). The analysis found that screening at age 15 years would miss 9% of those who become obese
adults, but screening at age 5 years would miss 50%. The predictive value of obesity screening below age
10 years was low even when maternal obesity was included as a predictor. It should be noted that the
main results do not include Hispanics, owing to sample size. The authors concluded that ‘Early childhood
obesity assessment adds limited information to later childhood assessment. Targeted later childhood
approaches or universal strategies to prevent unhealthy weight gain should be considered’.
In the context of the present review, the results for measurement at age 15 years were not included as the
distance between ages 15 and 18 years was considered too short. The results for measurements taken at
ages 2, 5 and 10 years are presented in Appendix 3. The results reflect those of the meta-analysis in that
childhood overweight or childhood obesity did not accurately predict obesity or overweight/obesity at age
18 years. Sensitivity did increase with increasing age of assessment in childhood, with the highest found to
be the sensitivity of overweight in unselected boys at age 10 years (sensitivity 88%, 95% CI 80% to 93%)
and unselected black and Hispanic children at age 10 years (sensitivity 88%, 95% CI 82% to 92%) to
predict obesity. Surprisingly, the sensitivity of obesity at age 18 years to predict later obesity or overweight
was lower. Specificity increased less with age, but generally the highest specificities were achieved at age
10 years (compared with younger ages); at this age, the specificity of childhood obesity for obesity and for
overweight/obesity at age 18 years was 90% or more in boys, girls, black children and white children,
whereas that for childhood overweight was lower, at around 80%. Thus, non-obesity in childhood
accurately predicts non-obesity in adulthood. This study’s findings were consistent with the findings of the
meta-analyses.
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The analysis of the British birth cohort by Cheung et al. (2004)118 reported AUC data that could not be
included in the meta-analysis (Table 13). These authors’ analysis of the British birth cohort data found that
the AUC for the prediction of adult obesity from childhood obesity was slightly higher than that for
predicting adult overweight from childhood overweight/obesity. Neither varied with sex but both increased
slightly with childhood age.
The sensitivities and specificities reported by Cheung et al. (2004)118 for overweight and obesity at age
11 years indicate that the sensitivity of overweight (BMI) for adult obesity was low (7.7% in boys and
6.9% in girls), as was its sensitivity for adult overweight (13.9% in boys and 23.0% in girls). The sensitivity
of childhood obesity for adult obesity was higher but still low (21.9% in boys and 20.2% in girls), as was
its sensitivity for adult overweight (23.3% in boys and 28.8% in girls). The specificities of overweight and
obesity were high for both adult overweight and adult obesity in both boys and girls (ranging from 92.7%
to 99.3%). The PPVs for childhood obesity in predicting adult obesity or overweight were low, ranging
from 42% to 56%; those for childhood overweight were higher (68% to 83%). The NPVs for childhood
obesity were high at around 90%, but those for childhood overweight were lower (52% to 70%).
The study by Juhola et al. (2011)125 reported summary data; these findings reflect that of the meta-analysis.
Obesity across all ages of childhood (3–18 years) had very low sensitivity (15.8%) but high specificity
(97.9%) for adult (age 30–45 years) obesity. This finding was not modified by age of child, but sensitivity
was increased when boys (30.9%) and girls (22.9%) were analysed separately. The PPV and NPV were
61.5% and 84.7% respectively. PPV did tend to improve with increasing age, being 91.7% at age 15 years,
whereas NPV remained roughly constant.
The cohort studied by Liddle et al. (2012)127 and Mamun et al. (2005)128 was followed from age 5 years
and therefore was not included in the meta-analysis. Data from these studies are given in Appendix 3 and
the calculated sensitivities and specificities are given in Table 14.
The MUSP cohort of Australian children was followed from age 5 years, first to age 14 and then to age
21 years. The sensitivity and specificity of weight status, as determined using BMI at age 5 years to predict
weight status at ages 14 and 21 years, are presented in Table 14. The results for the prediction of
overweight at age 14 years are similar to those at age 21 years. The sensitivity of overweight or obesity at
age 5 years to predict either obesity or overweight/obesity at age 21 years is low, and the sensitivity of
TABLE 13 Area under the curve data from Cheung et al. (2004)118
Population
Timing of first
measure Cut-off point
Total
N AUC
Upper
CI
Lower
CI
Childhood obesity
(age 11 years) to adult
obesity (age 33 years)
Male 7 ROC curve BMI= 17.9 2174 0.72 0.68 0.76
11 2085 0.78 0.75 0.81
16 1903 0.82 0.78 0.85
Female 7 ROC curve BMI= 18.3 2174 0.69 0.65 0.72
11 2085 0.8 0.77 0.83
16 1903 0.83 0.8 0.86
Childhood overweight/
obesity (age 11 years)
to adult overweight
(age 33 years)
Male 7 ROC curve BMI= 17.9 2174 0.66 0.64 0.68
11 2085 0.73 0.71 0.75
16 1903 0.75 0.73 0.77
Female 7 ROC curve BMI= 18.3 2174 0.66 0.63 0.68
11 2085 0.75 0.72 0.77
16 1903 0.79 0.77 0.81
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obesity at age 5 years is particularly low. These results reflect those of the meta-analysis for older age
ranges, although they might suggest that diagnosis of obesity at age 5 years does not track to adult
obesity. The findings from the study by Liddle et al. (2012)127 on the predictive ability of triceps SFT reflect
those for BMI, except that the sensitivity and specificity results are slightly poorer. This study does not
provide evidence that SFT might be a better measure in children than BMI.
Conclusions of the tracking review
This review identified 23 studies117–139 which tracked childhood obesity or overweight into adolescence or
adulthood. Of these, 20 were included in the meta-analyses. These studies were very diverse, including
studies from Europe, the USA and Asia, with widely differing sample sizes. The age at which childhood
assessment was carried out ranged from 7 to 18 years. Most studies included in the meta-analysis were at
an unclear risk of attrition bias and confounding was considered only in terms of age and sex, if at all.
BMI was measured at various ages in childhood, adolescence and adulthood, and in various populations.
As a result of this diversity, very few studies were included in each specific meta-analysis, leading to
considerable uncertainty in the results and wide CIs. This uncertainty should be considered when
interpreting the results.
The analysis found a strong association between childhood obesity and adult obesity, with obese children
being about five times more likely to be obese as adults than similar, non-obese children. This strong
association is reflected in the high PPVs: just under 80% of obese adolescents go on to be obese adults.
This drops to 70% when only adults over age 30 years are considered, so consequently around 30% of
obese adolescents will not be obese 20 years later. Tracking of obesity from childhood to adolescence was
generally good, with around 60% of obese adolescents having been obese as children, and around half of
obese children still being obese in adolescence.
TABLE 14 Mater-University Study of Pregnancy cohort results of following weight status from age 5 years
Weight status categories Sensitivity
95% CI
Specificity
95% CI
Upper Lower Upper Lower
Liddle (2012)127 MUSP cohort from age 5 years to age 21 years
BMI Obesity at age 5 years to predict obesity at
age 21 years
8.7 4.86 12.53 98.32 97.68 98.96
Obesity at age 5 years to predict overweight or
obesity at age 21 years
5.69 3.8 7.57 99.06 98.51 99.61
Overweight or obesity at age 5 years to predict
obesity at age 21 years
41.06 34.36 47.76 87.79 86.16 89.42
Overweight or obesity at age 5 years to predict
overweight or obesity at age 21 years
31.9 28.1 35.69 92.43 90.91 93.94
SFT Obesity at age 5 years to predict obesity at
age 21 years
4.83 1.91 7.75 97.55 96.77 98.32
Obesity at age 5 years to predict overweight or
obesity at age 21 years
4.48 2.8 6.17 98.13 97.35 98.9
Overweight or obesity at age 5 years to predict
obesity at age 21 years
30.92 24.62 37.21 85.66 83.91 87.4
Overweight or obesity at age 5 years to predict
overweight or obesity at age 21 years
25.86 22.3 29.43 88.43 86.6 90.25
Mamun (2005)128 MUSP cohort from age 5 years to age 14 years
BMI Overweight or obesity at age 5 years to predict
overweight or obesity at age 14 years
42.23 38.57 45.88 91.73 90.55 92.91
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
69
By contrast, most obese adults were not obese as children or adolescents: just 30% of obese adults were
obese in adolescence, and around 60% of obese adults were of healthy weight during childhood and
adolescence. Using childhood obesity to predict adult obesity will therefore fail to identify most adult obesity.
No data were available for tracking beyond age 40 years, but given the available data it seems that many
obese children will not be obese by their forties or later (when obesity-related morbidities are most
common), and most people who are obese at later ages will not have been obese in childhood.
Review of diagnostic accuracy of childhood measures
of obesity
Of the 794 full papers screened, 375 were potential includes for the diagnostic accuracy review. Of these,
341 were excluded, primarily because they were correlation studies and therefore reported only
associations rather than diagnostic accuracy.
Quality of the evidence for diagnostic accuracy of childhood measures
of obesity
Thirty-four studies met the inclusion criteria for the review of diagnostic accuracy.173–206 The full results of the
quality assessment, along with the guidance for scoring each criterion, are given in Appendix 4. There were
some duplicate papers for some cohorts, where more than one paper provided unique data. Three papers
reported data from the NHANES study;101,103,180 data were extracted from the one that provided 5 × 5 data in
the largest population (n= 7356) for both BMI and SFT using DEXA as the reference standard.180 The other
two NHANES papers were not extracted; one reported only PPV for BMI,103 and the other 3 × 3 tables using
cut-off points < 5th, 5th–85th and > 85th internally derived centiles, so providing 2 × 2 data for overweight
only, for a small subgroup of children (n= 58) with cerebral palsy and ‘reference children’ (n= 6754).101 Three
papers were identified from the Stockholm Weight Development Study.102,192,193 One of these was a summary
of the results presented in the other two papers, and was therefore excluded.102 Data were extracted from
both of the other studies; one provided data for BMI, WC and hip circumference (HC),193 and the other for a
further three classification systems of BMI.192 Two studies reported results from the Pediatric Rosetta Body
Composition study.179,190 Both studies were included in the review as one reported sensitivity and specificity
for BMI of the entire population, along with SFT for boys and girls separately and for the entire population,190
and the other reported a contingency table for boys and girls separately for BMI only, from which summary
measures were calculated for those subgroups.179
All 34 studies avoided differential verification bias and incorporation bias; only one study was subject to
partial verification bias, with the results of DEXA being imputed for some children.180 Only two studies
used the gold standard, a multicomponent model;175,182 the other studies used an imperfect reference
standard. Of the 32 using an imperfect reference standard, three used D2O,173
,204,205 one used ADP193 and
four used underwater (hydrostatic) weighting,186,187,189,197 but most used the least reliable of the eligible
reference standards, DEXA.174,176–181,183–185,188,190–192,194–196,198–203,206 Brief study details are provided in Table 15.
Eighteen studies recruited either consecutive or randomly selected children from populations representative
of the UK population who would be eligible for the test in clinical practice.173,177–181,186,189–195,201,202,205,206 One
study recruited a population representative of the country in which the study was conducted.188 Thirteen
studies did not recruit a representative population, for either the country in which the study was
conducted or the UK;174–176,184,185,187,196–200,203,204 these studies generally focused on specific subgroups of
children. The representativeness of the population was unclear in two studies.182,183
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TABLE 15 Brief study characteristics
Study details Population details Tests conducted
Alvero-Cruz (2010)173
Esccola study
Europe
Study dates October–December
2006
n= 150
Age (years): mean 14.8 years
(range 12–18 years)
Sex: male 50%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
l fat mass
Reference standard
l D2O
Outcomes reported
l sens/spec
l PPV/NPV
l LR+/−
l AUC
Bartok (2011)174
USA/Canada
Study dates 2000–7
n= 197 at baseline; 160 at final follow-up
Age: 9–15 years
Sex: male 0%
Ethnicity: white 100%
Weight distribution: overweight 30–42%
depending on age; obese 17–29% depending
on age
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
l AUC
Bray (2002)175
USA/Canada
Study dates NR
n= 131 at baseline; 114 at final follow-up
Age: mean 12.7 years (SD 0.11 years)
Sex: male 53.5%
Ethnicity: white 48.2%; black 51.8%
Weight distribution: NR
Index tests
l BMI
l sum SFT
Reference standard
l multicomponent
¢ fat
¢ bone mineral
¢ water
¢ body weight and density
Outcomes reported
l sens/spec
Dung (2006)176
Europe
Study dates April 1998–September
2003
n= 393
Age: mean 12 years (range 0.4–18 years)
Sex: male 48.6%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l contingency table
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TABLE 15 Brief study characteristics (continued )
Study details Population details Tests conducted
Ellis (1999)177
USA/Canada
Study dates 1994–8
n= 979
Age: 3–18 years
Sex: male 41.5%
Ethnicity: white 44.7%; black 28.9%;
Hispanic 26.4%
Weight distribution: NR
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l contingency table
Field (2003)178
USA/Canada
Study dates NR
n= 596
Age: mean 10 years (SD 2.2 years)
Sex: male 39.8%
Ethnicity: white 55.4%; AA 40.1%; Hispanic,
Asian and other 4.5%
Weight distribution: healthy weight 36.7%;
overweight 12.3%; obese 51%
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
l PPV
Freedman (2009)179
Pediatric Rosetta Body Composition
study
USA/Canada
Study dates 1995–2000
n= 1196
Age: 5–18 years
Sex: male 52.3%
Ethnicity: white 25%, Asian 30%, black 23%,
Hispanic 14%, unclassified 8%
Weight distribution: healthy weight 67%,
overweight 17%, obese 16%
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l contingency table
Freedman (2013)180
NHANES
USA/Canada
Study dates 1999–2004
n= 7365
Age: mean 13.9 years (range 9.8–18.2 years)
Sex: male 61%
Ethnicity: white 61.5%, black 14.5%,
Hispanic 11%
Weight distribution: overweight 16.5%,
obese 17.5%
Index tests
l BMI
l SFT
Reference standard
l DEXA
Outcomes reported
l contingency table
Fujita (2011)181
UK
Study dates 2008–10
n= 466 at baseline; 422 at final follow-up
Age: mean 10 years
Sex: male 53.6%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
l WC
l WHtR
Reference standard
l DEXA
Outcomes reported
l sens/spec
l AUC
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TABLE 15 Brief study characteristics (continued )
Study details Population details Tests conducted
Fuller (2001)182
UK
Study dates NR
n= 41 at baseline; 38 in analysis
Age: mean 9.4 years (SD 1.4 years)
Sex: male 50%
Ethnicity: NR
Weight distribution: NR
Index tests
l sum SFT
l NIR
Reference standard
l multicomponent
¢ bone mineral
¢ water
¢ fat-free dry tissue
¢ body density (kg/l)
Outcomes reported
l contingency table (tertiles)
Fuller (2002)183
UK
Study dates NR
n= 41 at baseline; 37 in analysis
Age: mean 9.4 years (range 8–12 years)
Sex: male 48.6%
Ethnicity: NR
Weight distribution: 32.4% in upper tertile
Index tests
l BIA
Reference standard
l DEXA
Outcomes reported
l contingency table (tertiles)
Guntsche (2010)184
Argentina
Study dates 2005–7
n= 108
Age: mean 11 years (range 6–16 years)
Sex: male 63%
Ethnicity: NR
Weight distribution: healthy weight 36%,
overweight 13.0%, obese 50.9%
Index tests
l BMI
l sum SFT
l WC
l WHtR
l WHR
Reference standard
l DEXA
Outcomes reported
l sens/spec
l AUC
Harrington (2013)185
USA/Canada
Study dates NR
n= 423 at baseline; 369 at final follow-up
Age: 5–18 years
Sex: male 46.9%
Ethnicity: white 48%, black 52%
Weight distribution: obese 33%
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
l AUC
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TABLE 15 Brief study characteristics (continued )
Study details Population details Tests conducted
Himes (1989)186
USA/Canada
Study dates NR
n= 316
Age: 8.4–18.99 years
Sex: male 50.3%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
l sum SFT
Reference standard
l Underwater (hydrostatic)
weighting
Outcomes reported
l sens/spec
l PPV
Johnston (1985)187
USA/Canada
Study dates NR
n= 235
Age: 12–17 years
Sex: male 71.9%
Ethnicity: white 97.4%, black 2.6%
Weight distribution: obese 20.4%
Index tests
l SFT
l relative weight
Reference standard
l Underwater (hydrostatic)
weighting
Outcomes reported
l contingency table
Khadgawat (2013)188
Asia
Study dates NR
n unclear at baseline; 1640 at final follow-up
Age: 7–17 years
Sex: male 50.3%
Ethnicity: Asian 100% (presumed)
Weight distribution: healthy weight 81.8%,
overweight 13.8%, obese 4.5%
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l contingency table
Marshall (1991)189
Canadian Fitness Survey 1985
USA/Canada
Study start date 1981
n= 600 at baseline; 540 at final follow-up
Age: mean 10.9 years (range 7–14 years)
Sex: male 49.3%
Ethnicity: NR
Weight distribution: obese 14.1%
Index tests
l BMI
l sum SFT
l relative weight
Reference standard
l Underwater (hydrostatic)
weighting
Outcomes reported
l sens/spec
l PPV/NPV
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TABLE 15 Brief study characteristics (continued )
Study details Population details Tests conducted
Mei (2006)190
Pediatric Rosetta Body Composition
study
USA/Canada
Study dates 1995–2000
n= 1208 at baseline; 1196 at final follow-up
Age: mean 12 years (range 5–18 years)
Sex: male 52.3%
Ethnicity: white 25.3%, Asian 29.9%,
black 22.5%, Hispanic 20.9%
Weight distribution: healthy weight 25.6%,
overweight 33.9%, obese 40.5%
Index tests
l BMI
l SFT
Reference standard
l DEXA
Outcomes reported
l sens/spec
l AUC
Moreno (2006)191
AVENA study
Europe
Study dates NR
n= 348 at baseline; 286 in analysis
Age: 13–17.9 years
Sex: male 40.6%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
Neovius (2004)192
Stockholm Weight Development
Study
Europe
Study dates NR
n= 481 at baseline; 474 had data available
Age: mean 16.9 years (SD 0.4 years)
Sex: male 42.2%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
Reference standard
l ADP
Outcomes reported
l sens/spec
l LR+/−
l AUC
Neovius (2005)193
Stockholm Weight Development
Study
Europe
Study dates NR
n= 481 at baseline; 474 had data available
Age: mean 16.8 years (SD 0.4 years)
Sex: male 42.2%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
l WC
l WHR
Reference standard
l ADP
Outcomes reported
l sens/spec
l LR+/−
l AUC
continued
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TABLE 15 Brief study characteristics (continued )
Study details Population details Tests conducted
Pandit (2009)194
Asia
Study dates NR
n= 566
Age: 6–17 years
Sex: male 55.8%
Ethnicity: NR
Weight distribution: overweight 38.5% of
boys and 54% of girls
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
l PPV/NPV
l AUC
Reilly (2010)195
ALSPAC
UK
Study dates NR
n= 7779 at baseline; 7722 had data available
Age: mean 9.9 years (SD 0.5 years)
Sex: male 49.3%
Ethnicity: NR
Weight distribution: overweight 25.5%,
obese 13%
Index tests
l BMI
l WC
Reference standard
l DEXA
Outcomes reported
l sens/spec
Sardinha (1999)196
USA/Canada
Study dates NR
n= 328
Age: 10–15 years
Sex: male 50.3%
Ethnicity: white 100%
Weight distribution: obese 27.3% of boys
and 44.8% of girls
Index tests
l BMI
l SFT
Reference standard
l DEXA
Outcomes reported
l AUC
Sarria (2001)197
Europe
Study dates NR
n= 175 (173 with WC measurements)
Age: 7.2–16.9 years
Sex: male 100%
Ethnicity: NR
Weight distribution: overweight 21.1%
Index tests
l BMI
l SFT
l WC
Reference standard
l Underwater (hydrostatic)
weighting
Outcomes reported
l sens/spec
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TABLE 15 Brief study characteristics (continued )
Study details Population details Tests conducted
Sproule (2009)198
USA/Canada
Study dates NR
n= 25 (with spinal muscular atrophy)
Age: mean 9.1 years (range 5–18 years)
Sex: male 56%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
Taylor (2000)199
Australia/New Zealand
Study dates NR
n= 580
Age: mean 12.2 years (range 3.1–19.9 years)
Sex: male 52.1%
Ethnicity: white 100%
Weight distribution: NR
Index tests
l WC
l WHR
l conicity index
Reference standard
l DEXA
Outcomes reported
l sens/spec
l LR+/−
l AUC
Taylor (2003)200
Australia/New Zealand
Study dates NR
n= 368
Age: mean 11.9 years (range 8.5–15.5 years)
Sex: male 48.6%
Ethnicity: white 100%
Weight distribution: obese 25%
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
l AUC
Telford (2008)201
Commonwealth Institute LOOK
Australia/New Zealand
Study dates NR
n= 741
Age: mean 8 years (SD 0.3 years)
Sex: male 50.7%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
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TABLE 15 Brief study characteristics (continued )
Study details Population details Tests conducted
Vitolo (2007)202
Brazil
Study start date 1998
n= 427 at baseline; 418 at final follow-up
Age: mean 13.4 years (range 10–19 years)
Sex: male 52.4%
Ethnicity: NR
Weight distribution: overweight
approximately 25%
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
l PPV/NPV
Warner (1997)203
UK
Study dates NR
n= 143
Age: mean 13.5 years (SD 2.7 years)
Sex: male 55.2%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l sens/spec
Wickramasinghe (2005)204
Australia/New Zealand
Study dates NR
n= 138
Age: mean 9.4 years (range 5–14.99 years)
Sex: male 51.4%
Ethnicity: white 69.6%, Asian 30.4%
Weight distribution: obese 51.4%
Index tests
l BMI
Reference standard
l D2O
Outcomes reported
l sens/spec
Wickramasinghe (2009)205
Asia
Study dates September 2004–
April 2005
n= 282
Age: mean 9.8 years (range 5–15 years)
Sex: male 56%
Ethnicity: NR
Weight distribution: NR
Index tests
l BMI
l WC
l WHR
Reference standard
l D2O
Outcomes reported
l sens/spec
Zhang (2004)206
Asia
Study dates NR
n= 1068 at baseline; 751 at final follow-up
Age: 9–14 years
Sex: male 15.3%
Ethnicity: Asian 100%
Weight distribution: obese 28%
Index tests
l BMI
Reference standard
l DEXA
Outcomes reported
l contingency table
AA, African American; ALSPAC, Avon Longitudinal Study of Parents and Children; AVENA, Alimentacion y Valoracion del
Estado Nutricional en Adolescentes; LOOK, lifestyle of our kids; LR+/−, positive/negative likelihood ratio; NR, not reported;
sens, sensitivity; spec, specificity.
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Most of the studies were single-gate diagnostic cohort studies undertaken specifically to determine the
accuracy of a simple anthropomorphic measure (the index test).173,175–179,181–184,186–189,193,194,196–205 Although
the time lag between the index test and reference standard test was not stated, it is unlikely that this was
sufficiently long for progression bias to be present. Five studies were cross-sectional, with aims beyond the
determination of the diagnostic accuracy of an index test, and had either a prospective185,190,191,206 or
retrospective/post-hoc180 analysis; these were also considered to have a low likelihood of progression bias.
Three studies were longitudinal, and the timing of the index and reference standard tests was not
specifically reported; therefore, the potential for progression bias was unclear.174,192,195
The description of the index tests was adequate in most studies; the details provided for the reference
standards were generally more poorly reported, making reproducibility of the reference standard tests
more difficult. Most of the studies apparently had no uninterpretable results and no withdrawals. The
number and expertise of the assessors for both the index tests and reference standards were unclear in
most studies.
Owing to the poorer accuracy of DEXA compared with the other reference standards, none of the studies
using DEXA was considered to be of high quality. Of the 10 studies that used a reference standard
other than DEXA, eight were considered to be high quality,173,186,187,189,193,197,204,205 one did not explain
withdrawals175 and another excluded withdrawals from the study.182
Diagnostic accuracy of body mass index
A total of 30 diagnostic accuracy studies evaluated BMI. The study and population characteristics varied
across these studies. In clinical practice, weight status is commonly defined using the cut-off points of 85th
centile for overweight and 95th centile for obesity. In addition, the measures tend to be used in a diverse
population of children. Several of the studies did not report the thresholds used, used other thresholds to
define overweight and obesity or conducted the study in a population that was not representative of the
UK child population. This section therefore concentrates on the 11 diagnostic accuracy studies of BMI that
used the 85th centile for diagnosing overweight and the 95th centile for diagnosing obesity (regardless of
the reference population used to standardise the measure for age) in unselected boys, girls or children of
both sexes reflective of the UK child population (see Table 16). Results for the other studies of BMI are
presented in Appendix 3, which includes the findings of all the included diagnostic accuracy studies.
The sensitivities and specificities of the 11 BMI studies are presented in Table 16. Of these, only one study
was considered to be of high quality (results shown in italics in Table 16).186 Sensitivity varied considerably
across these studies, ranging from 23% to 96% for diagnosing obesity and 19% to 94% for diagnosing
overweight. Specificity was less variable, ranging from 89.4% to 100% for diagnosing obesity and 82%
to 100% for diagnosing overweight. Data were available as 2 × 2 contingency tables for eight studies
diagnosing overweight177,179,180,188,191,192,197,203 and six studies diagnosing obesity;177,179,180,186,188,195 2 × 2 tables
were not available for two studies.181,190
Using the 2 × 2 data, the pooled sensitivity, specificity, positive likelihood ratio (LR+) and negative
likelihood ratio (LR−) were calculated using the HSROC model (Figure 28); analyses were conducted for
boys and girls separately and combined (Table 17). Two analyses were conducted for boys and girls
combined; one used the separate boy and girl subgroups,177,179,180,186,188,191,192,195,197 adding data for the one
study that did not report for girls and boys separately,203 and in the other, data from the within-study boy
and girl subgroups were combined to create ‘all children’ populations prior to analysis.177,179,180,186,188,191,192,203
The former included the one study that reported results for boys only;197 this study was excluded from the
latter analysis.
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FIGURE 28 Hierarchical summary ROC curves for BMI for (a) unselected boys; (b) unselected girls; (c) all children
(boy and girl subgroups kept separate); and (d) all children (within-study boy and girl subgroups combined prior
to analysis).
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The results of these analyses (see Table 17) show that BMI has a relatively low sensitivity, but a high
specificity, across the different subgroups for diagnosing overweight/obesity. With such high specificities,
there are few false-positive results; therefore, BMI is better at ruling obesity in than ruling it out, hence the
moderately high LR+ but poorer LR−. These summary estimates should be treated with caution, as they
are based on a subset of the BMI studies, and heterogeneity was substantial (see Figure 28); there were
insufficient studies to investigate the impact of this heterogeneity. The analyses also combined data from
the same population using different thresholds from some studies. As a result, the uncertainty surrounding
the pooled estimates (95% prediction region) is large.
Two studies provided insufficient data to derive 2 × 2 tables. Of these, one reported sensitivity of 92.5%
and specificity of 89.4% for diagnosing obesity (95th centile, CDC 2000219),190 and the other reported an
AUC of 0.983 (95% CI 0.968 to 0.999) for boys and 0.981 (95% CI 0.961 to 1.00) for girls for diagnosing
obesity (95th centile, reference population unclear).181
Diagnostic accuracy of skinfold thickness
Of the 34 included studies, 10175,180,182,184,186,187,189,190,196,197 evaluated SFT. Where reported, the most
commonly used cut-off point was the 85th centile. Most of the studies used the measure to diagnose
obesity; data for diagnosing overweight were more limited. Four studies reported the sensitivity and
specificity of triceps SFT, or data to calculate these outcomes, for the diagnosis of overweight or
obesity (Table 18);186,187,189,190 of these, three were considered to be high quality (results shown in italics
in Table 18).186,187,189 Sensitivity ranged from 23% to 98.5%, and specificity from 78% to 100%,
across the populations and thresholds.
TABLE 17 Results from the HSROC analysis for BMI using 85th and 95th centile cut-off points in unselected populations
Population
n studies/
data sets
Sensitivity
(95% CI), %
Specificity
(95% CI), % LR+ (95% CI) LR− (95% CI)
Boys 8/19 77.8 (69.6 to 84.2) 93.4 (91.2 to 95.1) 11.8 (9.05 to 15.5) 0.238 (0.172 to 0.329)
Girls 8/18 73.5 (61.4 to 82.8) 96.1 (92.8 to 97.9) 18.7 (11.07 to 31.5) 0.276 (0.186 to 0.408)
Boys and girls 10/38 75.5 (68.7 to 81.3) 94.7 (92.9 to 96.1) 14.4 (11.01 to 18.74) 0.258 (0.201 to 0.331)
All children 9/19 73.9 (64.2 to 81.8) 94.7 (92.2 to 96.4) 13.9 (10.02 to 19.24) 0.275 (0.199 to 0.381)
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Two studies evaluated subscapular SFT.186,190 Sensitivity ranged from 30% to 98.5%, and specificity from
79.1% to 99% across the two studies (Table 19). Six studies evaluated sum SFT (Table 20), where more
than one site was measured and an overall percentage body fat was determined.175,180,184,186,189,197 As with
the single-site SFT measurements, sensitivity varied across the six studies, but was, on the whole, higher
than that for triceps and subscapular SFT individually, ranging from 57% to 98% across populations and
thresholds. Most had a sensitivity of 80% or over. Specificity was more variable for the sum SFT than for
the individual SFT measures, ranging from 47% to 96%, but was still reasonably high for most population
and threshold combinations (see Table 20).
Diagnostic accuracy of waist circumference
Four studies reported sensitivity and specificity for WC for diagnosing obesity,181,193,195,205 and four studies
for diagnosing overweight184,193,197,199 (Table 21); of these, three were considered to be of high quality
(results shown in italics in Table 21).193,197,205 As with BMI, there was substantial variation in sensitivity
across the studies, ranging from 34.7% to 100% for diagnosing obesity and 53% to 90.9% for
diagnosing overweight. Specificity was less variable, ranging from 81% to 100% for diagnosing obesity
and 92% to 100% for diagnosing overweight.
Diagnostic accuracy of waist-to-hip ratio and waist-to-height ratio
Three studies evaluated WHR184,193,199 and two evaluated WHtR.181,184 Sensitivity for WHR across the studies
was relatively poor, ranging from 0% to 78.8% across populations and thresholds; specificities were
generally high, ranging from 70.6% to 100% (Table 22). Sensitivity for WHtR was high, ranging from
90.9% to 100% across populations and thresholds, with specificities also high, ranging from 95% to
100% (Table 23).
Diagnostic accuracy of bioelectrical impedance analysis
The only diagnostic accuracy study to evaluate BIA used the test to distinguish between children who were
fat and those who were not, using different models to calculate the level of adiposity.175 The study
characteristics and results are presented in Table 24. No cut-off values were reported; therefore, it is
unclear whether ‘fat’ means obese or overweight/obese. This study used the gold-standard 4-C model to
confirm adiposity. The results are mixed across the different models. Where sensitivity is 100%, this is at
the expense of specificity, which is very low (45% and 11%). Two of the models give similar sensitivities
and specificities of between 80% and 90%. The Deurenberg model has the highest specificity (93%), but
as expected, this is at the expense of sensitivity (65%). The choice of model would therefore depend on
whether it was more important to rule in (high specificity) or rule out (high sensitivity) being fat or whether
neither extreme was desirable (a closer balance between sensitivity and specificity).
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Other childhood measures
There were a small number of studies that evaluated some less common simple measures of childhood
obesity: the conicity index,199 relative BMI,189 relative weight187,189 and FMI.173 The results for FMI appeared
good, with sensitivity of 100% and specificity of over 90%, but these were derived from only one study of
only 150 children.173 As with the childhood measures discussed in the previous section, specificity of these
tests is generally high, with sensitivity being more variable (Table 25).
Direct comparisons of the diagnostic accuracy of simple childhood measures
of obesity
The studies of diagnostic accuracy were extremely heterogeneous, assessing different populations,
measurements at a range of different ages, different cut-off points for the index tests and different
reference standards with different cut-off points. Several studies made direct comparisons, with each index
test conducted in all study participants along with the reference standard; these are more robust when
determining relative accuracy than indirect comparisons.
Diagnosing obesity
Eleven studies reported direct comparisons of childhood measures for diagnosing obesity.178,180,181,186,187,
189,190,193,195,204,205 Different reference standards were used to determine the adiposity of the children in the
studies. One used ADP (Table 26),193 two used D2O (Table 27),204
,205 three used underwater (hydrostatic)
weighting (Table 28)186,187,189 and five used DEXA (Table 29).178,180,181,190,195 Of the 11 studies, six were
considered to be of high quality (results are shown in italics within the tables).186,187,189,193,204,205
Where SFT was measured in the same children as BMI, sum SFT consistently had higher sensitivity than BMI
with similar specificity (see Tables 28 and 29); measuring SFT at only a single location seemed to be less
accurate than using the sum of several locations. When comparing the use of different BMI reference data,
results were variable, with no one reference source being consistently better (see Tables 27 and 29). In
studies comparing WC with BMI, the sensitivity of WC was generally better than or similar to that of BMI;
specificity was similar for the two measures (see Tables 26, 27 and 29). One study showed a substantial
difference between boys and girls; sensitivity was higher with BMI in girls and with WC in boys.193
This difference was not seen in the other studies where data for boys and girls were reported separately.
The results of these studies are presented graphically, with results plotted in ROC space in Figure 29 and
the DOR shown in Figure 30 for each test for which 2 × 2 tables of test performance were available.
TABLE 24 Sensitivity and specificity from the studies evaluating the accuracy of BIA for the diagnosis of fat or not
fat as reported in Bray et al. (2002)175
Population
Age at
assessment
(years)
Index test
model
Index test
cut-off
point
Reference
standard
Reference
standard
cut-off
point Total n
Sensitivity
(95% CI), %
Specificity
(95% CI), %
White and
AA children
12 Deurenberg NR 4-C NR 114 65 (NR) 93 (NR)
White and
AA children
12 Goran NR 4-C NR 114 100 (NR) 45 (NR)
White and
AA children
12 Pennington NR 4-C NR 114 87 (NR) 84 (NR)
White and
AA children
12 Schaefer NR 4-C NR 114 89 (NR) 84 (NR)
White and
AA children
12 Suprasongsin NR 4-C NR 114 100 (NR) 11 (NR)
AA, African American; NR, not reported.
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TABLE 29 Sensitivity and specificity (95% CI where reported or calculated) from the direct comparison of BMI, SFT,
WHtR and WC using DEXA as the reference standard for the diagnosis of obesity
Study Population
Age at
assessment
(years)
Reference
standard
cut-off
point Total n
Sensitivity (95% CI), %
BMI
(reference
data NR)
BMI
(z-/SD
scores)
BMI
(UK90)
BMI
(CDC/WHO)
BMI
(optimal)
SFT
(sum)
SFT
(triceps)
SFT
(subscapular)
Freedman
(2013)
180
Boys 8–19 ? 4518 – – – 75
(72 to 78)
– 80
(77 to 83)
– –
Freedman
(2013)
180
Girls 8–19 ? 2847 – – – 76
(72 to 80)
– 79
(75 to 83)
– –
Reilly
(2010)
195
Boys 9.9 90th centile 3809 – – 96
(94 to 98)
– – – – –
Reilly
(2010)
195
Girls 9.9 90th centile 3913 – – 94
(91 to 96)
– – – – –
Field
(2003)
178
Unselected 10 90th centile 596 65 51 – – – – – –
Mei
(2006)
190
Unselected 5–18 95th centile 1196 – – – 92.5 – – 89.6 89.6
Fujita
(2011)
181
Boys 10 95th centile 226 – – – – 100 – – –
Fujita
(2011)
181
Girls 10 95th centile 196 – – – – 100 – – –
NR, not reported.
Specificity (95% CI), %
WHtR (WC
umbilical)
WC
(umbilical)
WC
(UK 1988
reference)
BMI
(reference
data NR)
BMI
(z-/SD
scores)
BMI
(UK90)
BMI
(CDC/WHO)
BMI
(optimal)
SFT
(sum)
SFT
(triceps)
SFT
(subscapular)
WHtR (WC
umbilical)
WC
(umbilical)
WC
(UK 1988
reference)
– – – – – – 95
(94 to 95)
– 96
(95 to 96)
– – – – –
– – – – – – 95
(94 to 96)
– 96
(95 to 96)
– – – – –
– – 97
(95 to 99)
– – 95
(94 to 95)
– – – – – – – 81
(79 to 82)
– – 98
(95 to 99)
– – 96
(96 to 97)
– – – – – – – 81
(79 to 82)
– – – 99 100 – – – – – – – – –
– – – – – – 89.4 – – 93.2 94 – – –
100 100 – – – – – 96 – – – 95 97 –
100 100 – – – – – 92 – – – 95 96 –
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
101
100
90
80
70
60
50
40
30
20
10
0
100 95 90 85 80
Specificity
Se
n
si
ti
vi
ty
Study
Index test
Freedman 2013180
Fujita 2011181
Himes 1989186
Johnston 1985187
Marshall 1991189
Mei 2007190
Neovius 2005193
Reilly 2010195
Wickramasinghe 
2005204 and 2009205
BMI
RWt
SFT
WC
WHR
WHtR
FIGURE 29 Results of the tests reported in the direct comparisons plotted in ROC space. RWt, relative weight.
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FIGURE 30 Diagnostic OR for the tests in the studies reporting direct comparisons. RWt, relative weight.
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Figure 29 demonstrates the difficulty in comparing BMI with other obesity measures, because of the
trade-off between sensitivity and specificity. In the Freedman et al. (2013)180 study (in red), for example,
SFT has a marginally higher sensitivity and specificity than BMI, so may be better at diagnosing obesity.
Himes et al. (1989)186 (green) used several forms of SFT measurement (the green squares). These vary
considerably in their sensitivity and specificity, with some having much higher sensitivity, but at a cost of
reduced specificity.
The DOR provides a simpler means of comparing obesity measures, as a higher DOR indicates better
diagnostic performance. As seen in Figure 30, the DORs vary enormously across studies, from 3 to nearly
4000, demonstrating the considerable heterogeneity across studies. Both Freedman et al. (2013)180 and
Mei et al. (2006)190 suggest that SFT may be more accurate than BMI, but Himes et al. (1989)186 does not
show that SFT is better. There is no evidence that WC, WHtR or WHR have better diagnostic performance
than BMI.
Diagnosing overweight
Ten studies reported direct comparisons of childhood measures for diagnosing obesity.173,175,180,184,191–193,197,199,202
A range of reference standards were used across the studies; one used a gold-standard 4-C model (Table 30),175
two used ADP (Table 31),192,193 one used D2O (Table 32),173 one used underwater (hydrostatic) weighting
(Table 33)197 and five used DEXA (Tables 34 and 35).180,184,191,199,202 Of the 10 studies, three were considered to
be high quality (results shown in italics within the tables).173,193,197
The difference between BMI and SFT was less pronounced for diagnosing overweight than for diagnosing
obesity; one study reported a higher sensitivity with BMI,184 but most reported similar accuracy (see
Tables 33–35). In one study,173 FMI outperformed BMI in boys and girls for both sensitivity and specificity
(see Table 32). On the whole, BIA and SFT had similar, relatively high, sensitivity. Specificity was more
variable; tests with the highest sensitivities had poorer specificity. The two tests with relatively high
sensitivity and specificity were BIA using the Schaefer model and sum SFT using the Pennington optimal
SFT model (see Table 30). WHR seemed to perform poorly compared with BMI or WC alone (see
Tables 31, 34 and 35); WHtR seemed to outperform WHR for both sensitivity and specificity, and WC
alone in terms of sensitivity (see Tables 34 and 35).
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TABLE 30 Sensitivity and specificity from the direct comparison of BIA and SFT using a 4-C gold standard for the
diagnosis of fat or not fat
Study Population
Age at
assessment
(years)
Reference
standard
cut-off
point Total n
Sensitivity (%)
BIA
Deurenberg
BIA
Goran
BIA
Pennington
BIA
Schaefer
BIA
Suprasongsin
SFT
(sum Ellis)
Bray
(2002)175
White and
AA children
12 ? 114 65 100 87 89 100 96
AA, African American.
TABLE 31 Sensitivity and specificity from the direct comparison of BMI, WHR and WC using ADP as the reference
standard for the diagnosis of overweight
Study Population
Age at
assessment
(years)
Reference
standard
cut-off
point Total n
Sensitivity (%)
BMI
(IOTF)
BMI
(CDC/WHO)
BMI
(optimal)
Neovius (2005)193 Boys 17 25% BF 200 – – 72
Neovius (2005)193 Girls 17 30% BF 274 – – 65
Neovius (2004)192 Boys 16.9 (SD 0.4) 25% BF 200 80 68 92
Neovius (2004)192 Girls 16.9 (SD 0.4) 30% BF 274 24 19 77
BF, body fat.
Italics denote high-quality study.
TABLE 32 Sensitivity and specificity (including 95% CI) from the direct comparison of BMI and FMI using D2O as
the reference standard for the diagnosis of overweight
Study Population
Age at assessment
(years)
Reference standard
cut-off point Total n
Alvero-Cruz (2010)173 Boys 12–18 ? 75
Alvero-Cruz (2010)173 Girls 12–18 ? 75
NR, not reported.
Italics denote high-quality study.
TABLE 33 Sensitivity and specificity (including 95% CI) from the direct comparison of BMI, SFT and WC using
underwater (hydrostatic) weighting as the reference standard for the diagnosis of overweight
Study Population
Age at assessment
(years)
Reference standard
cut-off point Total n
Sarria (2001)197 Boys 7–16.9 85th centile 175
Italics denote high-quality study.
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
104
Specificity (%)
SFT (sum
Pennington)
SFT (sum
Slaughter)
BIA
Deurenberg
BIA
Goran
BIA
Pennington
BIA
Schaefer
BIA
Suprasongsin
SFT
(sum Ellis)
SFT (sum
Pennington)
SFT (sum
Slaughter)
94 98 93 45 84 84 11 47 82 71
Specificity (%)
BMI
(Göteborg,
Sweden)
WHR (WC
smallest
between
ribs and
iliac crest)
WC
(smallest
between
ribs and
iliac crest)
BMI
(IOTF)
BMI
(CDC/WHO)
BMI
(optimal)
BMI
(Göteborg,
Sweden)
WHR (WC
smallest
between
ribs and
iliac crest)
WC
(smallest
between
ribs and
iliac crest)
– 24 68 – – 98 – 98 99
– 17 53 – – 88 – 98 89
92 – – 95 98 92 93 – –
39 – – 100 100 76 97 – –
Sensitivity (95% CI), % Specificity (95% CI), %
BMI (reference data NR) FMI BMI (reference data NR) FMI
75.8 (57.7 to 88.9) 100 (89.3 to 100) 83.3 (68.6 to 93) 90.5 (77.4 to 97.3)
88.9 (51.7 to 98.2) 100 (66.2 to 100) 77.3 (65.3 to 86.7) 97 (89.5 to 99.5)
Sensitivity (95% CI), % Specificity (95% CI), %
BMI (z-/SD scores) SFT (sum)
WC: smallest
between
ribs/iliac crest
BMI (z-/SD
scores) SFT (sum)
WC: smallest
between
ribs/iliac crest
50 (30 to 70) 58 (37 to 77) 58 (37 to 77) 91 (85 to 95) 93 (87 to 96) 93 (87 to 96)
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TABLE 34 Sensitivity (including 95% CI where reported or calculated) from the direct comparison of BMI, SFT,
WHR, WHtR, WC and the conicity index using DEXA as the reference standard for the diagnosis of overweight
Study Population
Age at
assessment
(years)
Reference
standard
cut-off
point Total n
Sensitivity (95% CI), %
BMI
(IOTF)
BMI
(CDC/WHO)
BMI
(Conde and
Monteiro)
BMI
(AVENA)
BMI
(z-/SD
scores)
Freedman
(2013)180
Boys 8–19 ? 4518 – 83 (81 to 84) – – –
Freedman
(2013)180
Girls 8–19 ? 2847 – 80 (77 to 82) – – –
Taylor
(2000)199
White girls 3.1–19.8 1 SD 278 – – – – –
Taylor
(2000)199
White boys 3.3–19.9 1 SD 302 – – – – –
Guntsche
(2010)184
Pubertal
obese and
siblings
6–16 10 kg/m2 58 – – – – 97.2
Guntsche
(2010)184
Prepubertal
obese and
siblings
6–16 10 kg/m2 50 – – – – 96.9
Vitolo
(2007)202
Boys 10–19 25% BF 219 79.5 – 84.1 – –
Vitolo
(2007)202
Boys 10–14 25% BF 128 84.2 – 84.2 – –
Vitolo
(2007)202
Boys 15–19 25% BF 91 50 – 83.3 – –
Vitolo
(2007)202
Girls 10–19 30% BF 199 26.6 – 34.5 – –
Vitolo
(2007)202
Girls 10–14 30% BF 132 32.6 – 44.2 – –
Vitolo
(2007)202
Girls 15–19 30% BF 67 17 – 18.9 – –
Moreno
(2006)191
Boys 13–17.9 85th centile 116 71
(44 to 90)
– – 53
(28 to 77)
–
Moreno
(2006)191
Girls 13–17.9 85th centile 170 75
(53 to 90)
– – 79
(58 to 93)
–
AVENA, Alimentacion y Valoracion del Estado Nutricional en Adolescentes; BF, body fat.
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SFT (sum)
WHR (WC
smallest
between
ribs and
iliac crest)
WHR
(umbilical)
WHR (WC
mid-point
between
ribs and
iliac crest)
WHtR (WC
umbilical)
WHtR (WC
mid-point
between
ribs and
iliac crest)
WC
(smallest
between
ribs and
iliac crest)
WC
(mid-point
between
ribs and
iliac crest)
WC
(umbilical)
Conicity
index
85
(83 to 87)
– – – – – – – – –
81
(78 to 83)
– – – – – – – – –
– 47
(32 to 62)
– – – – 89
(77 to 96)
– – 57
(42 to 72)
– 46
(31 to 61)
– – – – 87
(74 to 95)
– – 61
(45 to 75)
75 – 77.8 72.2 97.2 97.2 – 88.9 88.9 –
57.6 – 66.7 78.8 93.9 90.9 – 84.8 90.9 –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
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TABLE 35 Specificity (95% CI where reported or calculated) from the direct comparison of BMI, SFT, WHR, WHtR,
WC and the conicity index using DEXA as the reference standard for the diagnosis of overweight
Study Population
Age at
assessment
(years)
Reference
standard
cut-off
point Total n
Specificity (95% CI), %
BMI
(IOTF)
BMI
(CDC/WHO)
BMI
(Conde and
Monteiro)
BMI
(AVENA)
BMI
(z-/SD
scores)
Freedman
(2013)180
Boys 8–19 ? 4518 – 91 (90 to 92) – – –
Freedman
(2013)180
Girls 8–19 ? 2847 – 90 (88 to 91) – – –
Taylor
(2000)199
White girls 3.1–19.8 1 SD 278 – - – – –
Taylor
(2000)199
White boys 3.3–19.9 1 SD 302 – – – – –
Guntsche
(2010)184
Pubertal
obese and
siblings
6–16 10 kg/m2 58 – – – – 100
Guntsche
(2010)184
Prepubertal
obese and
siblings
6–16 10 kg/m2 50 – – – – 100
Vitolo
(2007)202
Boys 10–19 25% BF 219 86.9 – 84.6 – –
Vitolo
(2007)202
Boys 10–14 25% BF 128 86.7 – 82.2 – –
Vitolo
(2007)202
Boys 15–19 25% BF 91 87.1 – 87.1 – –
Vitolo
(2007)202
Girls 10–19 30% BF 199 96.7 – 98.3 – –
Vitolo
(2007)202
Girls 10–14 30% BF 132 95.7 – 97.8 – –
Vitolo
(2007)202
Girls 15–19 30% BF 67 100 – 100 – –
Moreno
(2006)191
Boys 13–17.9 85th centile 116 86
(77 to 92)
– – 88
(79 to 94)
–
Moreno
(2006)191
Girls 13–17.9 85th centile 170 90
(84 to 95)
– – 92
(86 to 96)
–
AVENA, Alimentacion y Valoracion del Estado Nutricional en Adolescentes; BF, body fat.
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
108
SFT (sum)
WHR (WC
smallest
between
ribs and
iliac crest)
WHR
(umbilical)
WHR (WC
mid-point
between
ribs and
iliac crest)
WHtR (WC
umbilical)
WHtR (WC
mid-point
between
ribs and
iliac crest)
WC
(smallest
between
ribs and
iliac crest)
WC
(mid-point
between
ribs and
iliac crest)
WC
(umbilical)
Conicity
index
92
(91 to 93)
– – – – – – – – –
90
(89 to 92)
– – – – – – – – –
- 85
(80 to 90)
– – – – 94
(91 to 97)
– – 88
(83 to 92)
– 85
(80 to 89)
– – – – 92
(88 to 95)
– – 88
(83 to 91)
77.3 – 95.5 90.9 100 100 – 95.5 100 –
76.5 – 94.1 70.6 100 100 – 100 100 –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
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The results of these studies are presented graphically, with results plotted in ROC space in Figure 31 and
the DOR shown in Figure 32 for each test for which 2 × 2 tables of test performance were available.
The results are similar to those seen for diagnosing obesity. From Figure 32, two studies [Freedman et al.
(2013),180 Sarria et al. (2001)197] suggest that SFT may have better diagnostic performance than BMI, but
results cannot be considered to be statistically significant. Neovius et al. (2004)192 found SFT to have the
worst diagnostic performance of any measure. There is no evidence to suggest that any other measure can
improve on BMI.
Comparisons of predictive and diagnostic accuracy
In order to understand why one childhood measure of obesity had a better predictive accuracy than
another, we planned to compare the estimates of predictive accuracy from the tracking and adult
morbidity reviews with estimates of diagnostic accuracy in similar studies from the diagnostic accuracy
review. Unfortunately, the vast majority of data from the two predictive accuracy reviews were for BMI.
Only one study in the review of tracking and two in the review of adult morbidities used a measure other
than BMI: triceps SFT in the tracking review,127 and WC,117 and WC, sum SFT and WHR,171 in the studies
from the adult morbidity review. There were therefore insufficient predictive accuracy data for us to make
such comparisons.
Summary of the diagnostic accuracy data
In terms of diagnostic accuracy, there was little evidence to suggest that any obesity measure has better
diagnostic performance than BMI. Direct comparisons suggest that sum SFT may have promise as an
alternative to BMI, especially for the diagnosis of obesity. Generally, BMI has a similar level of accuracy to
SFT for the diagnosis of overweight. With the limited data available, WHR seems to be a poor measure,
and does not improve on BMI, with WC alone or WHtR being more promising. These relationships need to
be confirmed with a full evaluation of the available diagnostic accuracy data, including searching for
studies using magnetic resonance imaging (MRI) to determine abdominal fat in order to investigate the
impact of the distribution of fat more fully, and contacting authors to retrieve tables of test performance
for those studies where this could not be extracted or derived. Further well-designed primary studies are
likely to be required for some of the measures once the full systematic review has identified the most
promising diagnostic measures.
We considered a model with at least four components as the gold standard for determining actual
adiposity in children; this requires the conduct of a range of tests to determine the contribution of the
different components of body composition. ADP, underwater (hydrostatic) weighting, D2O and DEXA were
all considered imperfect reference standards compared with four- or more-component models. Several
studies have been published that have highlighted the shortcomings of these tests as reference standards,
but DEXA may be a poorer reference standard than the others.55–57,227–235 The majority of the diagnostic
studies considered used DEXA as a reference standard, and we note that the diagnostic performance of all
the obesity measures may be poorer if a 4-C model is used as the reference standard. Therefore, any
future primary studies should ideally use a four- or more-component model to determine weight status.
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FIGURE 31 Results of the tests from studies of direct comparisons plotted in ROC space.
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FIGURE 32 Diagnostic OR of the tests from studies that report direct comparisons.
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Review of acceptability and ease of use of childhood measures
of obesity
Children’s assessment of acceptability and ease of use
No previous studies of the opinions of children regarding simple measures of childhood obesity
were identified.
The de novo study conducted as part of this review is presented here. This took the form of an elicitation
exercise conducted by colleagues at Leeds Metropolitan University, during a weight management summer
camp for children. A total of 72 (out of 147) children completed the questionnaire (see Appendix 3). All
children who attended the summer camp were overweight or obese (> 85th centile using UK90). The
characteristics of the children who completed the questionnaire are given in Table 36. As can be seen from
Table 37, the vast majority of the children said that they had previously had their height and weight
measured, but only 58% said they had experienced BMI being measured; this is likely to be a result of a
lack of feedback of the result of the height and weight measurement, or a lack of understanding of what
BMI is. The other measures were, as expected, less commonly experienced, with SFT being the
least common.
For the survey of children, it was considered most appropriate to obtain information on a child’s reaction to
the individual components of the four measures being evaluated, as it is the conduct of these individual
components that will elicit a response, good or bad, from the child. Responses to the individual
components of the simple childhood measures of interest were mixed (Table 38). The vast majority of
children had no problem with having their height measured, but a significant proportion had a negative
reaction to being weighed [either embarrassment (39%) or a more extreme negative reaction such as anger
or crying]. Of those who had experienced the measurement of WC, HC and/or SFT, similar proportions of
children were embarrassed by WC and HC, although fewer were embarrassed by SFT (Table 39).
TABLE 36 Population characteristics of overweight or obese children attending summer camp (n= 72)
Age (years) School year Sex
Are you concerned
about your weight?
Do you feel it is important
to measure your growth?
Mean 12.6
Range 9–17
9: 8.3%
10: 5.6%
11: 25.0%
12: 13.9%
13: 13.9%
14: 9.7%
15: 11.1%
16: 6.9%
17: 5.6%
Range 4–13
4: 2.8%
5: 6.9%
6: 4.2%
7: 16.7%
8: 13.9%
9: 12.5%
10: 8.3%
11: 9.7%
12: 4.2%
13: 2.8%
Other: 4.2%
NR: 13.9%
Male: 51.4%
Female: 48.6%
Yes: 79.2%
No: 19.4%
NR: 1.4%
Yes: 81.9%
No: 16.7%
NR: 1.4%
NR, not reported.
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TABLE 38 The proportion of the children who reported experiencing a particular emotion/reaction to the different
simple measures of childhood obesity (n= 72)
Measure
Never had
this (%)
Hurt
(%)
Embarrassed
(%)
Liked it/fun
(%)
Did not let
them do it
(%)
Did not have
a problem
(%)
Angry
(%)
Cried
(%)
Height 1.4 2.8 6.9 29.2 0 63.9 0 0
Weight 0 2.8 38.9 11.1 2.8 43.1 5.6 1.4
WC 37.5 1.4 19.4 13.9 2.8 26.4 1.4 0
HC 59.7 1.4 12.5 6.9 2.8 12.5 0 0
SFT 80.6 0 1.4 4.2 2.8 6.9 0 0
TABLE 39 The number and proportion of children who had reported experiencing the measurement of WC,
HC and/or SFT who did not have a problem, experienced embarrassment or reported a positive response
Measure Had measure (n) Embarrassed, n (%) Liked it/fun, n (%) Did not have a problem, n (%)
WC 45 14 (31) 10 (22) 19 (42)
HC 29 9 (31) 5 (17) 9 (31)
SFT 14 1 (7) 3 (10) 5 (36)
TABLE 37 The proportion of overweight or obese children attending summer camp who have experienced
different simple measures of childhood obesity (n= 72)
Measure Yes (%) No (%) Don’t know (%) NR (%)
Height 91.7 6.9 1.4 0
Weight 93.1 5.6 1.4 0
BMI 58.3 23.6 16.7 1.4
WC 58.3 31.9 8.3 1.4
HC 34.7 48.6 15.3 1.4
WHtR 25.0 52.8 20.8 1.4
WHR 18.1 58.3 20.8 0
SFT 9.7 66.7 20.8 2.8
NR, not reported.
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Over 50% of children considered a weight measurement to accurately reflect their weight status, and
approximately 30% thought BMI and WC did so. Similar, smaller proportions (ranging from 11% to 19%
of the overall population) considered HC, WHR, WHtR and SFT to be accurate (Table 40). Of those who
had actually reported experiencing the measurement of HC, WHR, WHtR and/or SFT, between 31% and
46% considered the measure to accurately reflect their weight status; the majority of the remaining
children reported either not understanding the measure or never being told about it (Table 41).
Parents’ and caregivers’ assessment of acceptability and ease of use
Three previous studies were identified that elicited opinions about BMI from guardians (parents in two
studies74,75 and mothers and grandparents in one study207). All three studies were generally considered to
be of good quality; all had clearly stated aims, appropriate methodology, research designs and recruitment
strategies, data that were collected and analysed appropriately, clear statements of findings, appropriate
ethical considerations and the research was considered to be of value. Brief study details are given in
Table 42; the full data extraction is presented in Appendix 3. None of the studies considered the
relationship between researcher and participants.
One study sent questionnaires to 1186 parents whose children attended school between kindergarten and
Grade 6.74 Of the 790 parents who returned questionnaires, 78% thought it was very (39%) or somewhat
(39%) important for schools to screen height and weight (with parents of girls being less likely to think
height/weight screening was important); 78% of parents wanted to receive results of such screening every
year. Approximately 50% of the parents had received a letter informing them of their child’s BMI, of which
79% read the entire letter and 16% most of the letter; 55% of these parents did not discuss the letter
with their child. Parents who worked full time were less likely to think screening was important than those
who worked part time or stayed at home, and parents of older students and girls were less likely to want
information than parents of younger students or boys. Most parents were either not uncomfortable (68%)
or only slightly uncomfortable (12%) with their child’s BMI results; most thought their children were also
either not uncomfortable (68%) or only slightly uncomfortable (15%). Parents found the results of weight/
BMI measurements more helpful than information on physical activity, nutrition, screen time, health-related
websites and community resources. Of the parents who expressed a concern for their child’s weight after
receiving a BMI letter, 8% planned to seek medical services, 8% to make diet-related changes, 27% to
increase exercise and/or sign up their child for sports and 24% to sign up to other physical activity.74
A second study used videotaped focus groups to elicit opinions about BMI screening from 71 parents
whose children attended school between kindergarten and Grade 6.75 This may be a subset of the parents
who were sent questionnaires in the larger study by Kibik et al.74 Nearly 50% of the parents were unaware
that annual health screening was done at school; however, of the parents familiar with the screening
process, most were supportive of height and weight screening. Several parents queried the value of such
screening when the results were not shared with them; most felt that the results of screening should be
reported to the parents, and several parents thought that this would aid with the early detection of
important health conditions.75 Some parents expressed concerns about the screening process for height
and weight. These included the maintenance of privacy and confidentiality, the children’s behaviour during
screening – particularly the potential for teasing – and the accuracy of the results. Parents also expressed
opinions as to who should be screened. Several said that screening was more important where there was a
lack of health insurance or limited access to health care, and others felt that screening was less important
in younger children as overweight usually resolves as children age.75
Opinions of the 71 parents about BMI specifically were generally positive. Many parents felt that BMI
was a more meaningful indicator of a child’s weight status than height and weight alone; age- and
sex-adjusted BMI were considered valuable as parents felt that they could not easily calculate these
themselves. Several parents thought that BMI would be a ‘wake-up call’ or ‘warning sign’ for parents of an
emerging weight problem that needed attention, and others thought that children overly concerned about
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TABLE 40 The proportion of children who thought that a particular measure did or did not accurately reflect their
weight status (n= 72)
Measure
Never had
this (%)
Overestimated
(%)
Underestimated
(%)
About right
(%)
Do not
understand (%)
Never been told
(%)
Weight 1.4 12.5 11.1 54.2 11.1 1.4
BMI 25.0 8.3 9.7 29.2 13.9 5.6
WC 30.6 4.2 5.6 31.9 12.5 5.6
HC 51.4 2.8 4.2 19.4 8.3 5.6
WHtR 55.6 1.4 5.6 13.9 6.9 6.9
WHR 59.7 1.4 2.8 13.9 6.9 5.6
SFT 66.7 0 0 11.1 8.3 5.6
TABLE 41 The number and proportion of children who had reported experiencing the measurement of WC, HC,
WHR, WHtR and/or SFT who thought that the measure overestimated or underestimated their weight status,
or got it about right
Measure Had measure (n) Overestimated, n (%) Underestimated, n (%) About right, n (%)
WC 50 3 (6) 4 (8) 23 (46)
HC 35 2 (6) 3 (9) 14 (40)
WHtR 32 1 (3) 4 (12.5) 10 (31)
WHR 29 1 (3) 2 (7) 10 (35)
SFT 24 0 0 8 (33)
TABLE 42 Brief details of the elicitation studies in parents and caregivers
Study details Population characteristics Children’s details
Cloutier (2013)207
Country in which study
conducted: USA/Canada
Study dates: start October
2009, finish March 2010
Whose opinion?: 83% mothers;
17% grandparents
Source of sample: primary care clinics; family
centres; head start and child care centres
Method of obtaining opinion: focus groups
(n= 27); interview (n= 251)
Method of recording opinions: paper
questionnaire; videotapes in focus groups
Simple childhood measure: BMI
(CDC growth chart); ‘My weight ruler’
School grade of children: 2–4
Sex of children: NR
Weight status of children: NR
Kubik (2006)74
Country in which study
conducted: USA/Canada
Study dates: start 2004,
finish 2005
Whose opinion?: parents
Source of sample: elementary school
Method of obtaining opinion:
self-administered survey
Method of recording opinions: paper
questionnaire
School grade of children: kindergarten
to Grade 6
Sex of children: male 54%
Weight status of children: normal
weight 73%; overweight/obese 27%
Kubik (2007)75
Country in which study
conducted: USA/Canada
Study dates: start 2004,
finish 2005
Whose opinion?: parents
Source of sample: elementary school
Method of obtaining opinion: focus groups
Method of recording opinions: videotapes
School grade of children:
kindergarten to Grade 6
Sex of children: NR
Weight status of children: NR
NR, not reported.
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weight issues could be reassured if they were within the normal weight range. Most parents wanted to be
notified about the BMI results, although some suggested that only parents of children with BMI values
outside a healthy weight range need receive notification, to keep costs down. The preferred method of
feedback to parents varied; most preferred results to be mailed directly, whereas others preferred feedback
at teacher–parent conferences, parents calling the school nurse or the child bringing the information home
in a sealed envelope. Few wanted the information via e-mail or the child’s report card.75
The third study elicited opinions of caregivers (the mother or grandparent) on the ease of use of the CDC
growth charts and a new presentation of BMI called ‘My Weight Ruler’.207 The ruler was designed to
simplify the presentation of results of BMI. There were two parts to this study. The first was to obtain
opinions about the My Weight Ruler from 27 Hispanic and African American caregivers in order to decide
descriptors for the different categories during videotaped focus groups. The Hispanic participants decided
on the terms ‘underweight’, ‘healthy weight’, ‘slightly overweight’ and ‘unhealthy weight’; the African
American participants decided on the terms ‘too little’, ‘just right’, ‘big’ and ‘too big’ (Figure 33).
All participants of the focus groups preferred the My Weight Ruler to the CDC growth charts.207
The second part of the study involved 251 caregivers who completed a questionnaire which asked them to
interpret two plots on the My Weight Ruler and the CDC BMI growth chart. One plot was equivalent to
the 50th centile and the other to the 97th centile. Of the 251 participants, 92% had previously seen a
CDC BMI growth chart; none had seen the My Weight Ruler.
More respondents correctly classified both plotted measurements on the My Weight Ruler (92%) than
on the CDC growth chart (37%); significantly more participants provided incorrect answers to both
measurements on the CDC growth chart (32%) than on the My Weight Ruler (1%); and significantly more
responded ‘I don’t know’ to the CDC growth chart (12% compared with 0.5%). Those who correctly
interpreted the CDC BMI growth chart plots were more likely to have a higher level of education and
higher household incomes; there were no significant trends for level of education, household income,
ethnicity or first language for the My Weight Ruler. The need to take action when the result was at the
97th centile was understood by 61% of participants on the My Weight Ruler compared with 1% on
the CDC growth chart. Overall, 79% of participants preferred the My Weight Ruler and 17% preferred the
CDC BMI growth chart.207
Leeds Metropolitan University’s de novo study of overweight or obese
children attending summer camp
To supplement the information identified for the systematic review, the parents of the children attending
the obesity management summer camp reported in Children’s assessment of acceptability and ease of use
were also asked to give their opinion about simple measures of childhood obesity. Sixty-four parents
completed a questionnaire. The opinions of the parents can only be generalised to those with an
overweight or obese child, owing to the setting in which the survey was undertaken. The characteristics of
the parents who completed the questionnaire are given in Table 43.
Underweight/too little
Slightly overweight/big
Healthy weight/just right
Unhealthy weight/too big
FIGURE 33 The ‘My Weight Ruler’.
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Most of the parents said that their child had experienced height and weight measurements (Table 44).
A proportion of these did not believe that their children had experienced their BMI being calculated,
possibly as a consequence of the result not being fed back to them. Nearly 50% were aware that
their children had had their WC measured, although, again, far fewer said that their children had
experienced the composite measures that utilise WC. Only a small proportion of parents/caregivers
were aware that their child had experienced SFT measurements, and one parent said that their child had
undergone a measurement of muscle mass, although how this was measured is uncertain (see Table 44).
When considering the usefulness of a measure, responses were generally positive, although the value
of HC and SFT was uncertain for a large proportion of parents (Table 45). Nearly all of the parents were
happy for their children to undergo any of the measures (see Table 45), although a large proportion
considered the measurement of weight to be embarrassing for their child (Table 46).
The measure that parents considered most useful was a child’s weight, with BMI and WC considered to be
useful by over 40% of parents. Parents were less certain about the usefulness of HC, WHtR, WHR and SFT;
most were either unfamiliar with the measure, or had not had the results fed back to them in order to
form an opinion (Table 47).
TABLE 43 Population characteristics (64 parents with a total of 69 children)
Parents Children
Age (years) Sex (%) Concerned about child’s weight? (%) Age (years) Sex (%)
Mean 40.7
Range 20–69
Male: 17.2
Female: 79.7
NR: 3.1
Yes: 89.1
No: 4.7
NR: 3.1
Sort of/slightly: 3.1
Mean 12
Range 9–17
Male: 40.6
Female: 59.4
NR, not reported.
TABLE 44 The proportion of parents who said that their children had experience of the different simple childhood
measures of obesity (n= 64)
Measure Yes (%) No (%) Don’t know (%) NR (%)
Height 87.5 3.1 7.8 1.6
Weight 92.2 3.1 3.1 1.6
BMI 67.2 15.6 15.6 1.6
WC 48.4 26.6 23.4 1.6
HC 26.6 40.6 31.3 1.6
WHtR 25.0 40.6 32.8 1.6
WHR 23.4 43.8 31.3 1.6
SFT 14.1 45.3 34.4 6.3
Muscle mass 1.6 0 0 0
NR, not reported.
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
117
TABLE 45 The proportion of parents who considered that a particular measure was useful, and whether or not
they were happy for their child to undergo the measure (n= 64)
Do you think the measure is useful?
Measure Yes (%) No (%) Don’t know (%) NR (%) What is it? (%)
Height 85.9 1.6 10.9 1.6 0
Weight 89.1 0 7.8 3.1 0
WC 73.4 1.6 21.9 3.1 0
HC 57.8 1.6 35.9 3.1 1.6
SFT 48.4 4.7 40.6 4.7 1.6
Are you happy for your child to have the measure?
Measure Yes (%) No (%) Don’t know (%) NR (%) What is it? (%)
Height 98.4 0 1.6 0 0
Weight 98.4 0 1.6 0 0
WC 98.4 0 1.6 0 0
HC 96.9 0 3.1 0 0
SFT 96.9 0 3.1 0 0
NR, not reported.
TABLE 46 The proportion of parents who said that their children experienced a certain emotion/reaction to a
simple childhood measure of obesity (n= 64)
Measure
Not had
measure
(%)
I don’t
know
(%)
Physical
pain
(%)
Embarrassed
(%)
Fun/liked
it (%)
Opted
out (%)
Didn’t
have a
problem
(%)
Anger
(%)
Crying
(%)
Other
(%)
Height 3.1 17.2 0 1.6 12.5 0 60.9 0 0 0
Weight 1.6 15.6 0 31.3 6.3 0 29.7 3.1 9.4 3.1
WC 23.4 26.6 0 7.8 6.3 0 25.0 1.6 0 0
HC 42.2 25.0 0 3.1 3.1 0 17.2 0 0 0
SFT 46.9 26.6 0 0 3.1 0 10.9 0 0 0
Note
Total percentages do not necessarily add to 100% as some parents may not have answered all questions.
TABLE 47 The proportion of parents who thought that a particular measure did or did not accurately reflect their
child’s weight status (n= 64)
Measure
Child had
not had
measure (%)
Agreed that
measure was
accurate (%)
Measure
overestimated
child’s weight (%)
Measure
underestimated
child’s weight (%)
Didn’t
understand the
information (%)
Didn’t receive
any information
(%)
Weight 4.7 68.8 7.8 1.6 0 10.9
BMI 12.5 46.9 12.5 1.6 0 20.3
WC 25.0 40.6 1.6 0 1.6 20.3
HC 45.3 17.2 3.1 0 4.7 17.2
WHtR 48.4 17.2 1.6 0 4.7 17.2
WHR 50.0 12.5 3.1 0 4.7 17.2
SFT 54.7 9.4 3.1 0 6.3 15.6
Note
Total percentages do not necessarily add to 100% as some parents may not have answered all questions.
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Health professionals’ assessment of acceptability and ease of use
Two previous studies were identified that elicited opinions about BMI from health-care professionals, one
of school nurses73 and the other of family doctors and paediatricians.208 Both of the studies were generally
considered to be of good quality; both had clear aims and appropriate methodology, research designs
and recruitment strategies, findings were clearly stated and the research was considered to be of value.
One study had data that were collected and analysed appropriately; the other was only an abstract, and
therefore data relating to analysis were limited. Neither study considered the relationship between
researcher and participants or stated that ethical approval was gained. Brief study details are given in
Table 48; the full data extraction is given in Appendix 3.
The study of school nurses was an online survey.73 Of the 2629 school nurses who completed the survey
(97% of whom were female), 67% said that BMI should be measured in school, with 62% believing that
BMI results should be sent home to parents. Most respondents stated that school nurses should be
designing programmes to help overweight children (81%), that BMI helped create awareness of a problem
(73%) and that BMI provided evidence to change policies to reduce obesity levels (72%). There were some
concerns expressed over the use of BMI, with 31% believing that measuring BMI could be psychologically
or socially damaging to the child.73 A number of barriers to the use of BMI were highlighted, the most
common of which was inadequate school resources (57.6%). Other barriers included inadequate or
inappropriate parental responses (55.2%) and insufficient time for the measure (42%). Most of the school
nurses were confident or very confident in measuring height and weight (94%), calculating BMI (74%)
and helping parents interpret BMI results (93%). Over 50% of nurses agreed or strongly agreed that
tracking BMI would help administrators to address the childhood overweight/obesity issue.73
The study of family doctors and paediatricians took the form of a questionnaire aimed at eliciting
opinions on the use of BMI in preschool children aged 2–5 years; 267 completed the survey.208 Of the
267 respondents, 37% generally did not use BMI charts for children between 2 and 5 years old;
24% did generally use BMI charts for this age group and 39% endorsed the use of BMI charts for
selected 2- to 5-year-olds. Of the 39% who used BMI charts for selected children, 87% indicated that this
was for children who appear overweight from height and weight curves, 72% for children who appear
overweight by visual inspection and 68% for children who have crossed upwards between weight centiles.208
TABLE 48 Brief details of the elicitation studies conducted in health professionals
Study details Population characteristics Children’s details
Hendershot (2008)73
Country in which study
conducted: USA
Study dates: NR
Whose opinion?: school nurses
Source of sample: National Association of School Nurses
database
Method of obtaining opinion: electronic survey
Method of recording opinions: electronic/online
School grade of children:
NR
Sex of children: NR
Weight status of children:
NR
Woolford (2008)208
Country in which study
conducted: USA/Canada
Study dates: start 2006,
finish 2006
Whose opinion?: GPs, paediatricians
Source of sample: American Medical Association
Masterfile
Method of obtaining opinion: self-administered survey
(12-item Likert scales and multiple-choice questions)
Method of recording opinions: paper questionnaire
School grade of children:
preschool (age 2–5 years)
Sex of children: NR
Weight status of children:
NR
GP, general practitioner; NR, not reported.
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Barriers to the use of BMI included the time taken to calculate and plot BMI (65% of all respondents; 75% of
those who did not use BMI or who used it selectively); the time and complexity of explaining the findings to
parents (70% of all respondents; 76% of those who did not use BMI or who used it selectively); and parental
familiarity with height and weight curves (57% of all respondents; 59% of those who did not use BMI or
who used it selectively). Physicians who did not use BMI charts were more likely to report these as major
barriers than physicians who did use BMI charts generally or selectively. Colour-coded charts were considered
by 60%, and the inclusion of management recommendations on BMI charts by 61%, as strong influences in
increasing the likelihood of using BMI charts at preschool well-child visits; 35% considered that computerised
calculation and plotting of results would also improve use. Recommendations for addressing obesity were
workshops at national and regional medical conferences (47%), online websites (45%) and DVD training
(43%); 30% said they would participate in a 2-day behaviour management course, with paediatricians
significantly more likely than family physicians to endorse this option (38% vs. 17%). Just 5% indicated
that they probably would not participate in any training activities related to behaviour management skills to
address obesity.208
In order to supplement the information identified in the systematic review, we attempted to elicit the
opinions of school nurses on the simple childhood measures most commonly used during screening in
schools. We have no responses from school nurses to report.
Summary of acceptability and ease of use
The evidence identified from the systematic searches was limited. Three studies elicited opinions about BMI
from parents/grandparents, one from school nurses and one from family doctors and paediatricians; no
studies were identified that elicited the opinions of children on BMI or any other measure. The opinion of
parents regarding the usefulness of BMI was generally positive; on the whole, parents considered height
and weight screening useful and wanted to be made aware of the results of the screening of their
children, although probably in a more user-friendly format than CDC growth charts, which were evaluated
in one of the studies. School nurses were also generally positive about the usefulness of BMI, and most
agreed with parents that the results of screening should be fed back to the child’s parent. The usefulness
of measuring BMI in preschool children was less well accepted among doctors; however, it was considered
by many to be useful for selected children aged 2–5 years who appear overweight from height and weight
curves or visual inspection, or who have crossed upwards between weight centiles.
From the elicitation exercise, it seems that parents are generally unfamiliar with measurements such as
WHR, WHtR and SFT, and therefore their potential accuracy and usefulness. This highlights the need
to increase parents’ awareness of these measures if they are to be introduced as screening tools for
school-aged children. The children who completed a questionnaire were most familiar with measurements
of height and weight. Although most did not seem to have a problem with their height being measured,
a large proportion were embarrassed by, or had other adverse reactions to, being weighed. This was,
however, a small sample of children who were attending a weight management summer camp, and may
not be representative of a more diverse population of children. Of those who experienced WC, HC and
SFT measurements, a large proportion were also embarrassed when WC and HC were measured.
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Chapter 4 Discussion
Summary of findings
This review sought to answer the question ‘What is the best simple measure, or combination of simple
measures, of obesity in children for predicting the development of obesity-related health problems in
adulthood?’ To answer this question, the review focused on four areas: the prediction of adult morbidity
from childhood obesity; the tracking of obesity from childhood into adolescence and adulthood; the
diagnosis of obesity in childhood; and the acceptability and ease of use of obesity measures. The review
identified 37 studies on the prediction of adult morbidities, 23 studies on the tracking of obesity into
adolescence and adulthood, 34 relevant diagnostic accuracy studies and five studies on acceptability,
along with the elicitation exercise performed as part of the review.
Prediction of adult obesity-related morbidities
Thirteen existing systematic reviews were identified, of which four were judged to be of direct relevance to
this review. These reviews generally concluded that there was a positive association between childhood
BMI and adult obesity-related morbidities, with high BMI leading to greater incidence of diabetes, CHD
and hypertension. One review found that the association between childhood obesity and morbidity was a
consequence of obese children becoming obese adults and that childhood obesity was not an independent
predictor of morbidity once adult obesity had been accounted for.18
A total of 37 studies representing 22 distinct cohorts met the inclusion criteria for this review. Of these,
26 studies (13 cohorts) were included in meta-analyses. All studies included BMI. Three measured WC, and
one used WHR and sum SFT. No evidence was found for other simple childhood measures.
In general, elevated childhood BMI was found to be modestly associated with an increased risk of adult
morbidity. The association between a 1-SD increase in BMI and adult diabetes had an OR of 1.7 (95% CI
1.30 to 2.22), approximately equivalent to a 24% increase in risk per BMI unit in an adolescent. The
association between a 1-SD increase in BMI and adult CHD had an OR of 1.2 (95% CI 1.20 to 1.31),
approximately equivalent to obese children having an odds of CHD 44% higher than normal-weight
children. There was no convincing evidence of an association between childhood obesity and stroke.
Across a range of cancers, there was evidence that childhood obesity was associated with a higher risk of
cancer in adulthood. Increases in odds were generally around 20% per SD of BMI. However, there was no
evidence of an association between childhood BMI and breast cancer.
Despite the positive association between childhood BMI and morbidities, childhood BMI was not found to
be a good predictor of adult disease. Given the associations identified, only 40% of adult diabetes and
only 20% of CHD and cancers would occur in overweight or obese children (above the 85th centile for
BMI). Hence, the majority of adult morbidity occurs in people who were of normal weight as children.
This poor predictive accuracy is a consequence of the comparatively small magnitude of the association
between childhood BMI and morbidities. As noted above, a large association would be required for BMI to
be a useful predictor of adult morbidity.
In the narrative review, childhood obesity was found to be associated with adult metabolic syndrome, and there
was some very limited evidence that BMI had poor sensitivity to predict adult metabolic syndrome. The existence
and nature of metabolic syndrome remains controversial, with no standard definition. Most definitions of
metabolic syndrome include obesity measurement, so the strong association between childhood BMI and
metabolic syndrome may be a consequence of tracking of obesity into adulthood. Evidence on the association
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between childhood BMI and hypertension and hypercholesterolaemia was very limited. The number of studies
was too small to draw conclusions about the effect of variables such as age and sex on adult morbidity.
Evidence was too limited to draw any firm conclusions about other childhood measures of obesity.
The studies included in the review tended to focus on older cohorts of children, who were born before the
modern obesity epidemic in most cases. Earlier obesity onset and more extreme forms of childhood obesity
are more common in contemporary populations than in the recent past.236 This should be considered when
interpreting the findings of this review.
Tracking of childhood obesity into adulthood
Two directly relevant systematic reviews of the tracking of overweight/obesity into adulthood had already
been conducted prior to our review. Both reviews looked at correlations or associations between childhood
and adult weight status. One of these reviews16 found that there was strong evidence of moderate
persistence of overweight in both overweight and obese children, and that this association was possibly
stronger for adolescent than for childhood overweight or obesity. The other, which focused on early
childhood, found that childhood obesity (at age 5 years or earlier) was a probable marker of adult obesity.17
From existing systematic reviews and searches for primary studies, a total of 23 studies from 16 cohorts
met the inclusion criteria for this review. Only one study evaluated a childhood measure other than BMI
(SFT). The association between childhood obesity (≥ 95th centile) and obesity in adults (age ≥ 20 years)
was strong, with obese children being more than five times more likely to be obese as adults than
non-obese children (pooled RR 5.21, 95% CI 4.50 to 6.02). There was no apparent difference in this RR
between younger and older age groups.
Obesity tracked moderately well from childhood into adolescence; around half of obese children were still
obese in adolescence. Obesity tracked well from adolescence to adulthood; about 80% of obese
adolescents were still obese in adulthood and 70% were still obese after age 30 years. No data were
available for tracking beyond the age of 40 years.
Body mass index was less effective at identifying those who would be obese in adulthood; 70% of obese
adults were not obese as children or in adolescence, and 80% of obese people aged over 30 years were not
obese in adolescence, so childhood BMI has poor sensitivity to detect adult obesity. Analyses of the tracking
of childhood overweight (≥ 85th centile) to adult obesity or overweight gave broadly similar results.
Four studies reported data that could not be included in the meta-analyses; the results of these studies
were broadly consistent with the findings of the meta-analyses. There were insufficient data on any simple
measure other than BMI to suggest that any might improve the ability of childhood obesity to predict
adult obesity.
Diagnostic accuracy of simple measures for childhood obesity
Thirty-four studies met the inclusion criteria for the review of diagnostic accuracy, of which 30 assessed
the diagnostic accuracy of BMI, 10 of SFT, seven of WC, four of WHR, two of WHtR, one of BIA and
five of other childhood measures of obesity. Sixteen studies reported direct comparisons of two or more
childhood measures. Most of the studies used DEXA, which is the least reliable of the eligible reference
standards. Of the 34 studies, only eight were considered to be high quality.
Overall, the sensitivity of BMI for diagnosing both obesity and overweight varied considerably; specificity
was less variable. The most homogeneous subset of studies evaluating BMI were meta-analysed, that is
those using the cut-off points most commonly used in clinical practice (85th centile for overweight and
95th centile for obesity), in a population of children representative of the UK child population who would
receive the measure in practice. The resulting pooled sensitivity was approximately 74% (95% CI 64.2%
to 81.8%) and pooled specificity was approximately 95% (95% CI 92.2% to 96.4%) for diagnosing
overweight or obesity.
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Data on other measures of obesity were more limited, with insufficient numbers of studies that were
sufficiently homogeneous to undertake a meta-analysis. The most commonly evaluated non-BMI test was
SFT. Sensitivity ranged from 23% to 98.5% and specificity from 78% to 100% across the populations and
thresholds for triceps SFT (four studies). Sensitivity ranged from 30% to 98.5% and specificity from 79.1%
to 99% for subscapular SFT (two studies). Sensitivity ranged from 57% to 98% and specificity from
47% to 96% for sum SFT (six studies). Several studies evaluated WC, either alone or in association with HC
or height. Across populations and thresholds, sensitivity ranged from 34.7% to 100% and specificity from
81% to 100% for WC alone, sensitivity from 0% to 78.8% and specificity from 70.6% to 100% for WHR,
and sensitivity from 90.9% to 100% and specificity from 95% to 100% for WHtR.
Using the studies reporting direct comparisons, there was little evidence to suggest that any measure that
reported 2 × 2 tables of test performance to allow plotting into ROC would have substantially better
diagnostic performance than BMI. FMI was evaluated alongside BMI in one study and looks promising, but
would require further research. Sum SFT also shows potential as an alternative or supplementary measure
to BMI. Of the measures that incorporate a WC measurement, it seems that WHtR was more accurate
than WC alone or WHR, although WHtR was evaluated in fewer studies.
Acceptability and ease of use of simple measures for childhood obesity
Five studies were identified for the review of acceptability and ease of use, all eliciting opinions about BMI.
None of the studies elicited the opinions of children; three elicited the opinions of caregivers/guardians,
and two those of health professionals (one of school nurses and one of family doctors and paediatricians).
The opinion of parents regarding the usefulness of BMI was generally positive. Most parents considered
height and weight screening useful and wanted to be made aware of the results for their children, although
in a more user-friendly format than CDC growth charts. School nurses were also generally positive about
the usefulness of BMI, and most agreed with parents that the results of screening should be fed back
to the child’s parent. The usefulness of measuring BMI in preschool children was less well accepted among
doctors; however, it was considered by many to be useful for selected children aged 2–5 years who appear
overweight from height and weight curves or visual inspection, or who have crossed upwards between
weight centiles.
An elicitation exercise was conducted to obtain the views of children, parents/guardians and school nurses
on four of the measures of childhood obesity: BMI, SFT, WHR and WHtR. The 72 children questioned,
who were attending a weight management summer camp, were most familiar with height and weight
measurement. Although most did not seem to have a problem with their height being measured, a large
proportion were embarrassed by, or had other adverse reactions to, being weighed. Of those who
experienced measurements of WC, HC and SFT, a large proportion were also embarrassed when WC and
HC were measured. The 71 parents/caregivers questioned were generally unfamiliar with measures of
WHR, WHtR and SFT, and therefore their potential accuracy and usefulness. Many felt that BMI was a
more meaningful indicator of a child’s weight status than height and weight alone; age- and sex-adjusted
BMI were considered valuable as parents/caregivers felt that they could not easily calculate these
themselves. We had no data to report from school nurses.
Strengths and limitations of the review
Strengths
This review was conducted according to the PRISMA guidelines and provided a comprehensive analysis of
the link between childhood obesity and adult obesity and morbidity by considering the four review areas
described above. For each subreview, extensive searching was undertaken to identify published and
unpublished studies, so that all relevant, appropriately powered studies were included.
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Most previous systematic reviews in this field have been narrative reviews; this is the first review to
combine results across studies in meta-analyses. In addition, unlike previous systematic reviews, this review
has focused on the accuracy of childhood obesity to predict adult obesity or morbidity, rather than on
estimating correlations or associations between test results and outcomes, and has used meta-analysis to
calculate estimates of predictive accuracy for the ability of childhood obesity/overweight to predict adult
morbidities and obesity/overweight. This is particularly important as an association between obesity and
adult morbidity or obesity does not imply that childhood obesity will be a useful predictor of adult
morbidity or obesity. In general, the association between a risk factor (such as obesity) and a subsequent
medical condition has to be substantial before the risk factor can usefully be used to predict the future
incidence of the condition.70,237
The results of this review complement the findings of previous reviews rather than superseding them.
Limitations
Despite a large number of studies being identified for the morbidity and tracking review questions, the
number from which the necessary data could be obtained was small. Furthermore, the limited reporting of
most studies and the diversity in the reporting of morbidities, assessments of BMI and ages at which
obesity was measured further reduced the number of studies that could be combined in any particular
meta-analysis. This meant that most results have a high degree of uncertainty, with wide CIs, and it also
limited the ability of the analyses to test for the impact of important confounders such as age and sex.
The diversity of reporting across studies also meant that most meta-analyses required a number of
assumptions to be made to permit analysis. This was particularly the case for the prediction of morbidities,
especially the assumption of normality for BMI, which is acknowledged to be inaccurate. Without
individual patient data, there was no way for us to transform the BMI to meet the assumption of a normal
distribution. This will have limited the reliability of the pooled estimate, and so the results should be taken
as indicating general trends rather than providing precise estimates of association or predictive accuracy.
The number of studies of the prediction of adult morbidities or adult obesity that used a childhood
measure of weight status other than BMI was surprisingly low: only four studies. This greatly hampered the
review’s ability to address the original review question.
The cohort studies of the association between childhood obesity and adult morbidities included in the
review were, of necessity, long-term studies, with recruitment often occurring in the 1960s or earlier. As
this was before the rise in general obesity, it is unclear whether or not the findings from this part of the
review apply to present-day children, among whom obesity is more prevalent.
Very few studies compared simple measures of obesity with our ‘gold standard’ measurement tool.
In addition, several studies included in the review of diagnostic tools used internally derived,
distribution-based cut-off points rather than set thresholds of adiposity. This limited the extent to which
our third objective (to answer the question ‘how accurately do simple measures of obesity reflect actual
adiposity in children?’) could be addressed.
Our review on the acceptability of simple measures of childhood obesity identified gaps in the evidence
regarding the views of children, parents and health professionals. The elicitation exercise did contribute to
filling some of these gaps. However, we acknowledge that this primary study only included a small,
self-selected sample of children and parents, and did not include the views of health-care professionals.
Therefore, the applicability of its findings to the broader population of children, parents and health
professionals is unclear.
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Chapter 5 Conclusions
In general, the review found that childhood obesity (when measured using BMI) was associated withmoderately increased risks of adult obesity-related morbidity, but the increase in risk was not large
enough for childhood BMI to be a good predictor of the incidence of adult morbidities; the majority of
adult obesity-related morbidity occurs in adults who were of healthy weight in childhood.
Owing to lack of data, the review was unable to determine whether or not other simple measures of
obesity might improve the prediction of adult morbidities.
The review of tracking studies found that obese children, and particularly obese adolescents, are likely to
become obese adults. This is because childhood obesity (again when measured using BMI) is strongly
associated with adult obesity. This strong association was matched by a strong persistence of childhood
obesity into adulthood. However, childhood BMI is not a good predictor of the incidence of adult obesity
or overweight; most obese adults were not obese in childhood, so overall adult obesity is not primarily
determined by childhood obesity.
No information was available on tracking of obesity into later adulthood, when most obesity-related
morbidities are likely to occur.
The usefulness of BMI as a screening tool therefore depends upon the objectives of screening. It may be
useful for identifying a group of obese or overweight children who may benefit from intervention, but
does not identify all children who will go on to be obese or to develop obesity-related morbidities
in adulthood.
Body mass index was found to be reasonably good at diagnosing obesity during childhood, with around
75% of genuinely adipose children being classified as obese using BMI, and around 95% of non-obese
children also being correctly classified. This result was, however, based mostly on studies using DEXA,
which is not generally regarded as a gold standard for diagnosing obesity.
There is a lack of evidence to help determine whether or not any simple measure is better or worse than
BMI for assessing childhood weight status, either for diagnosing obesity in childhood or for predicting
adult obesity or obesity-related morbidities. If a simple childhood measure of obesity is to be introduced as
a screening tool, its usefulness will depend upon the objectives of screening. If the objective is to identify a
group of children who will benefit from intervention, then screening would be useful, as long as there are
efficacious interventions available. If, however, the objective is to identify all children who will go on to
become obese adults, then screening in childhood using one of these measures is unlikely to be useful.
When considering the acceptability and ease of use of the childhood measures of obesity, the opinion of
parents and nurses on the usefulness of BMI was generally positive; however, its usefulness in preschool
children was less well accepted among doctors, although it was considered useful for selected young
children. From the elicitation exercise, the acceptability to children and their carers of BMI or other
common simple measures was generally good, although adverse reactions were not uncommon when
children had their weight measured. Parents were unfamiliar with measurements such as WHR, WHtR and
SFT and therefore their potential usefulness, highlighting the need to increase the awareness of these
measures if they are to be introduced as screening tools for school-aged children.
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Implications for practice
This review has found evidence that childhood obesity (when measured using BMI) is strongly associated
with increased adult obesity, but more weakly associated with increased adult obesity-related morbidity.
Childhood overweight and obesity is therefore a genuine public health problem, and reducing the overall
prevalence of obesity and overweight in childhood should reduce obesity and morbidities in later life.
Most obese children (when measured using BMI) will still be obese in early adulthood, so BMI is useful for
identifying that group of children at higher risk of adult obesity. Whether or not this obesity persists into
later adulthood (> 30 years) is uncertain.
However, most obese adults were of healthy weight in childhood, and the substantial majority of
obesity-related morbidities occur in adults who were of healthy weight in childhood. Using BMI to identify
obese children as being at risk of later obesity or morbidity, and targeting weight-reduction interventions
specifically at these obese children, is therefore unlikely to have a meaningful impact on reducing the
overall morbidity or obesity burden in adulthood.
This review suggests that, given the modest size of the association between childhood obesity and later
morbidity, it may not be appropriate to categorise obese children as being at ‘high risk’ of later adult morbidity.
The evidence on measures of obesity other than BMI was too limited to draw any conclusions regarding
whether such measures are better or worse than BMI when used to assess childhood obesity.
Issues around applicability may be considered alongside the question of parental interpretation of simple
measures of overweight and obesity. There is evidence to suggest that some parents may not perceive
their child as being overweight or at higher risk of health problems in later life.238,239 Reasons for these
misperceptions may be considered when communicating with parents of overweight and obese children.239
Further research
There is limited evidence of the accuracy of childhood measures of obesity to predict adult obesity and
morbidity. This suggests the following areas for future research:
1. To seek to review and analyse the individual-level raw data from the identified cohort studies. This
could greatly enhance understanding of the association between childhood BMI and adult obesity and
obesity-related morbidity, by avoiding the limitations found when using published results and reducing
the need for making inaccurate assumptions in the analyses. It may also allow for examination of other
simple measures, such as WC or WHtR, that may have been recorded but not reported in publications.
2. A high research priority is to determine which childhood measure is the most accurate for diagnosing
childhood obesity. A full assessment is required of the diagnostic accuracy of childhood measures of
obesity, at a range of ages from 2 to 18 years, particularly of studies using MRI as the reference
standard. Primary diagnostic accuracy studies may need to be undertaken for those childhood measures
for which data are sparse or missing completely. Any future diagnostic accuracy studies of other simple
childhood measures should include BMI as a comparator and use at least a 4-C model as the reference
standard, as this is the gold standard.
3. Primary predictive accuracy studies of measures other than BMI may be appropriate once it is clear that the
required data are currently unavailable, and when the most accurate simple childhood measure for
diagnosing childhood obesity has been determined, as such studies would be time-consuming and expensive.
4. Cohort studies to assess tracking of obesity and incidence of obesity-related morbidities should be
undertaken to investigate the effect of contemporary childhood obesity on long-term obesity and
morbidity. This could be achieved through appropriate maintenance and analysis of NHS records.
5. Any future assessment of simple measures of obesity should consider assessment of acceptability and
ease of use of these measures.
CONCLUSIONS
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Appendix 1 Literature searches
Review of adult morbidities: search for systematic reviews
Cochrane Database of Systematic Reviews (Wiley Online Library)
2013: Issue 6/12. Searched 11 June 2013. Retrieved four records.
#1 Medical subject heading (MeSH) descriptor: [Obesity] explode all trees (6452)
#2 MeSH descriptor: [Overweight] this term only (1072)
#3 MeSH descriptor: [Weight Gain] this term only (1416)
#4 MeSH descriptor: [Weight Loss] this term only (2918)
#5 obes*:ti,ab,kw (9909)
#6 (overweight or (over next weight)):ti,ab,kw (3234)
#7 ((weight next gain) or (weight next loss)):ti,ab,kw (9014)
#8 #1 or #2 or #3 or #4 or #5 or #6 or #7 (15,983)
#9 MeSH descriptor: [Adiposity] explode all trees (203)
#10 MeSH descriptor: [Body Composition] explode all trees (2773)
#11 MeSH descriptor: [Body Weight] explode all trees (14,255)
#12 (adiposity or adipose):ti,ab,kw (2114)
#13 (body near/2 (composition or fat or weight)):ti,ab,kw (18,126)
#14 fatness:ti,ab,kw (86)
#15 #8 or #9 or #10 or #11 or #12 or #13 or #14 (30,161)
#16 MeSH descriptor: [Child] explode all trees (64)
#17 MeSH descriptor: [Infant] explode all trees (12,099)
#18 MeSH descriptor: [Adolescent] this term only (69,925)
#19 MeSH descriptor: [Young Adult] this term only (112)
#20 (child* or infant* or pediat* or paediat* or schoolchild* or (school next age*) or schoolage*):ti,ab,
kw (83,102)
#21 (adolescen* or juvenile* or youth* or teenage* or youngster*):ti,ab,kw (83,300)
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#22 (girl or girls or boy or boys or kid or kids):ti,ab,kw (3932)
#23 ((young next people) or (young next person) or (young next persons) or (young next adult*)):ti,ab,
kw (21,801)
#24 #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 (149,550)
#25 MeSH descriptor: [Body Mass Index] this term only (5044)
#26 MeSH descriptor: [Skinfold Thickness] this term only (269)
#27 MeSH descriptor: [Waist Circumference] this term only (261)
#28 MeSH descriptor: [Waist-Hip Ratio] this term only (158)
#29 MeSH descriptor: [Electric Impedance] this term only (313)
#30 ((“body mass” near/3 (index* or indices)) or bmi or quetelet*):ti,ab,kw (11,870)
#31 ((“fat mass” near/3 (index* or indices)) or fmi):ti,ab,kw (49)
#32 ((“fat free mass” near/3 (index* or indices)) or fmi):ti,ab,kw (35)
#33 (“body adipos*” near/3 (index* or indices)):ti,ab,kw (1)
#34 (“body fat” near/2 percentage*):ti,ab,kw (328)
#35 ((“skin fold” or skinfold) near/3 (thickness* or test* or measure*)):ti,ab,kw (590)
#36 ((waist or hip or neck) near/3 circumference*):ti,ab,kw (1244)
#37 ((waist-to-hip or waist-hip or “waist to hip” or “waist hip”) near/3 ratio*):ti,ab,kw (542)
#38 ((waist-to-height or waist-height or “waist to height” or “waist height”) near/3 ratio*):ti,ab,kw (16)
#39 (((bioelectric* or electric*) near/3 (impedance or resistance)) or bia):ti,ab,kw (598)
#40 (“near infrared interactance” or NIR):ti,ab,kw (49)
#41 ((benn* or rohrer* or ponderal or corpulence) near/3 (index* or indices)):ti,ab,kw (32)
#42 (“sagittal abdominal diameter*” or “supine abdominal diameter*”):ti,ab,kw (8)
#43 #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38
or #39 or #40 or #41 or #42 (13,412)
#44 #15 and #24 and #43 (2163)
#45 MeSH descriptor: [Cardiovascular Diseases] explode all trees (68,582)
#46 ((cardiovascular or cardio or vascular or peripheral) near/3 (disease* or disorder* or failure*)):ti,ab,
kw (11,739)
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#47 ((heart or cardiac or myocardial) near/3 (disease* or disorder* or failure* or attack* or arrest*)):ti,ab,
kw (19,972)
#48 (coronary near/3 (disease* or disorder* or failure* or attack* or arrest* or syndrome*)):ti,ab,
kw (14,665)
#49 (circulatory near/3 (disease* or disorder* or failure*)):ti,ab,kw (139)
#50 CVD or CHD:ti,ab,kw (2049)
#51 (myocardial near/3 (infarc* or disease* or disorder* or failure* or attack* or arrest*)):ti,ab,
kw (13,949)
#52 (ami or mi):ti,ab,kw (3681)
#53 (angina* or “atrial fibril*”):ti,ab,kw (11,114)
#54 MeSH descriptor: [Stroke] explode all trees (4414)
#55 (stroke* or poststroke*):ti,ab,kw (18,467)
#56 (cerebrovascular or (cerebral next vascular)):ti,ab,kw (4312)
#57 ((brain* or cerebral* or lacunar) near/3 (accident* or infarc*)):ti,ab,kw (2049)
#58 (apoplexy or CVA):ti,ab,kw (305)
#59 MeSH descriptor: [Hypertension] this term only (12,874)
#60 MeSH descriptor: [Blood Pressure] explode all trees (21,914)
#61 (hypertens* or (blood next pressure*) or bloodpressure* or diastolic or systolic):ti,ab,kw (55,771)
#62 MeSH descriptor: [Cholesterol] this term only (5091)
#63 MeSH descriptor: [Hypercholesterolemia] this term only (2311)
#64 (cholesterol or hypercholesterol?emia* or hypercholester?emia*):ti,ab,kw (16,019)
#65 #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56 or #57 or #58
or #59 or #60 or #61 or #62 or #63 or #64 (134,104)
#66 MeSH descriptor: [Diabetes Mellitus, Type 2] explode all trees (7712)
#67 (diabetes near/2 “type 2”):ti,ab,kw (9307)
#68 (diabetes near/2 “type II”):ti,ab,kw (599)
#69 (diabetes near/2 (“non insulin” or noninsulin)):ti,ab,kw (1744)
#70 (NIDDM or T2DM):ti,ab,kw (1353)
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#71 MeSH descriptor: [Metabolic Syndrome X] explode all trees (689)
#72 ((metabolic or dysmetabolic or reaven or insulin resistance) near/2 syndrome*):ti,ab,kw (1211)
#73 #66 or #67 or #68 or #69 or #70 or #71 or #72 (11,163)
#74 MeSH descriptor: [Neoplasms] explode all trees (46,049)
#75 (cancer* or neoplas* oncolog* or malignan* or tumo?r* or carcinoma* or adenocarcinoma*):ti,ab,
kw (62,530)
#76 #74 or #75 (74,856)
#77 #65 or #73 or #76 (210,175)
#78 #44 and #77 (712)
Database of Abstracts of Reviews of Effects (Centre for Reviews and
Dissemination public interface)
7 June 2013. Searched 11 June 2013. Retrieved 56 records.
1. MeSH DESCRIPTOR Obesity EXPLODE ALL TREES (685)
2. MeSH DESCRIPTOR Overweight EXPLODE ALL TREES (698)
3. MeSH DESCRIPTOR Weight Gain EXPLODE ALL TREES (108)
4. MeSH DESCRIPTOR Weight Loss EXPLODE ALL TREES (310)
5. (obes* or overweight or “over weight” or “weight gain” or “weight loss”) (1772)
6. MeSH DESCRIPTOR Adiposity EXPLODE ALL TREES (11)
7. MeSH DESCRIPTOR Body Composition EXPLODE ALL TREES (72)
8. MeSH DESCRIPTOR Body Weight EXPLODE ALL TREES (1005)
9. (adiposity or adipose or fatness) (70)
10. ((body NEAR2 (composition or fat or weight))) (723)
11. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10) (2222)
12. MeSH DESCRIPTOR Body Mass Index EXPLODE ALL TREES (220)
13. MeSH DESCRIPTOR Skinfold Thickness EXPLODE ALL TREES (4)
14. MeSH DESCRIPTOR Waist Circumference EXPLODE ALL TREES (14)
15. MeSH DESCRIPTOR Waist-Hip Ratio EXPLODE ALL TREES (0)
16. MeSH DESCRIPTOR Electric Impedance EXPLODE ALL TREES (14)
17. (((“body mass” NEAR3 (index* or indices)) or bmi or quetelet*)) (927)
18. (((“fat mass” NEAR3 (index* or indices)) or fmi)) (5)
19. (((“fat free mass” NEAR3 (index* or indices)) or ffmi)) (0)
20. ((“body adipos*” NEAR3 (index* or indices))) (1)
21. ((“body fat” NEAR2 percentage*)) (9)
22. (((“skin fold” or skinfold) NEAR3 (thickness* or test* or measure*))) (48)
23. (((waist or hip or neck) NEAR3 circumference*)) (66)
24. (((waist-to-hip or waist-hip) NEAR3 ratio*)) (22)
25. (((waist-to-height or waist-height) NEAR3 ratio*)) (2)
26. ((((bioelectric* or electric*) NEAR3 (impedance or resistance)) or bia)) (28)
27. (((benn* or rohrer* or ponderal or corpulence) NEAR3 (index* or indices))) (6)
28. ((“infrared interactance” or NIR)) (7)
29. ((“sagittal abdominal diameter*” or “supine abdominal diameter*”)) (0)
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30. (#12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
or #26 or #27 or #28 or #29) (983)
31. MeSH DESCRIPTOR Child EXPLODE ALL TREES (3665)
32. MeSH DESCRIPTOR Infant EXPLODE ALL TREES (2258)
33. MeSH DESCRIPTOR Adolescent EXPLODE ALL TREES (3456)
34. MeSH DESCRIPTOR Young Adult EXPLODE ALL TREES (1124)
35. ((child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*)) (9033)
36. ((adolescen* or juvenile* or youth* or teenage* or youngster*)) (4300)
37. ((girl or girls or boy or boys or kid or kids)) (278)
38. ((“young people” or “young person” or “young persons” or “young adult*”)) (1492)
39. (#31 or #32 or #33 or #34 or #35 or #36 or #37 or #38) (11,234)
40. MeSH DESCRIPTOR Cardiovascular Diseases EXPLODE ALL TREES (7964)
41. (((cardiovascular or cardio or vascular or peripheral) NEAR3 (disease* or disorder* or failure*))) (1837)
42. (((heart or cardiac or myocardial) NEAR3 (disease* or disorder* or failure* or attack* or arrest*)) )
(2805)
43. ((coronary NEAR3 (disease* or disorder* or failure* or attack* or arrest* or syndrome*)) ) (1970)
44. ((circulatory NEAR3 (disease* or disorder* or failure*)) ) (4)
45. (CVD or CHD ) (351)
46. ((myocardial NEAR3 (infarc* or disease* or disorder* or failure* or attack* or arrest*)) ) (2211)
47. ( (ami or mi) ) (838)
48. ((angina* or “atrial fibril*”) ) (1288)
49. MeSH DESCRIPTOR Stroke EXPLODE ALL TREES (909)
50. (stroke* or poststroke*) (2514)
51. (cerebrovascular or “cerebral vascular”) (479)
52. (((brain* or cerebral* or lacunar) NEAR3 (accident* or infarc*)) ) (94)
53. ((apoplexy or CVA) ) (31)
54. MeSH DESCRIPTOR Hypertension EXPLODE ALL TREES (687)
55. MeSH DESCRIPTOR Blood Pressure EXPLODE ALL TREES (384)
56. ((hypertens* or “blood pressure*” or bloodpressure* or diastolic or systolic) ) (2854)
57. MeSH DESCRIPTOR Cholesterol EXPLODE ALL TREES (301)
58. MeSH DESCRIPTOR Hypercholesterolemia EXPLODE ALL TREES (149)
59. ((cholesterol or hypercholesterol?emia* or hypercholester?emia*)) (962)
60. MeSH DESCRIPTOR Diabetes Mellitus, Type 2 EXPLODE ALL TREES (0)
61. ((diabetes NEAR2 “type 2”) or (diabetes NEAR2 “type II”) or (diabetes NEAR2 (“non insulin” or
noninsulin)) or NIDDM or T2DM ) (890)
62. MeSH DESCRIPTOR Metabolic Syndrome X EXPLODE ALL TREES (34)
63. (((metabolic or dysmetabolic or reaven or insulin resistance) NEAR2 syndrome*) ) (88)
64. MeSH DESCRIPTOR Neoplasms EXPLODE ALL TREES (8227)
65. ((cancer* or neoplas* or oncolog* or malignan* or tumo?r* or carcinoma* or adenocarcinoma*) )
(9628)
66. #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR #51 OR
#52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR
#64 OR #65 (22,000)
67. #11 AND #30 AND #39 AND #66 (66)
68. * IN DARE (31,884)
69. #67 AND #68 (56)
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Database of Abstracts of Reviews of Effects (Centre for Reviews and
Dissemination internal administration database)
7 June 2013. Searched 11 June 2013. Retrieved 149 records.
Search term
Number
retrieved
#1 MeSH DESCRIPTOR Obesity 333
#2 MeSH DESCRIPTOR Overweight 69
#3 MeSH DESCRIPTOR Weight Gain 97
#4 obes* or overweight or over weight or weight gain or weight loss 10,755
#5 MeSH DESCRIPTOR Adiposity 10
#6 MeSH DESCRIPTOR Body Composition 51
#7 MeSH DESCRIPTOR Body Weight 118
#8 adiposity or adipose or fatness 646
#9 (body NEAR2 composition) 438
#10 (body NEAR2 fat) or (body NEAR2 weight) 1634
#11 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 11,151
#12 MeSH DESCRIPTOR Body Mass Index 126
#13 MeSH DESCRIPTOR Skinfold Thickness 3
#14 MeSH DESCRIPTOR Waist Circumference 13
#15 MeSH DESCRIPTOR Waist-Hip Ratio 2
#16 MeSH DESCRIPTOR Electric Impedance 3
#17 (body mass NEAR3 index*) or (body mass NEAR3 indices) or bmi or quetelet*“fat mass index*”
or “fat free mass index*” or adiposity index*
2306
#18 fat mass index* or fat free mass index* or adiposity index* 2
#19 body fat NEAR3 percentage* 16
#20 skinfold or skin fold 62
#21 waist circumference or hip circumference or neck circumference 222
#22 waist-to-hip or waist-hip 112
#23 waist-to-height or waist-height 10
#24 bioelectric* impedance or bioelectric* resistance or electric* impedance or electric* resistance 51
#25 (benn* or rohrer* or ponderal or corpulence) and (index* or indices) 209
#26 infrared interactance or NIR or sagittal abdominal diameter* or supine abdominal diameter* 26
#27 #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25
OR #26
2655
#28 MeSH DESCRIPTOR Child 1756
#29 MeSH DESCRIPTOR Infant 582
#30 MeSH DESCRIPTOR Adolescent 1525
#31 MeSH DESCRIPTOR Young Adult 441
#32 child* or infant* or pediat* or paediat* or schoolchild* or school age* or schoolage* 27,579
#33 adolescen* or juvenile* or youth* or teenage* or youngster* 9836
#34 girl or girls or boy or boys or kid or kids 929
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Search term
Number
retrieved
#35 young people or young person or young persons or young adult* 2092
#36 #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 31,535
#37 MeSH DESCRIPTOR Cardiovascular Diseases 471
#38 cardiovascular NEAR3 disease* 5050
#39 cardiovascular disease* or cardiovascular disorder* or cardiovascular failure* 4981
#40 cardio disease* or cardio disorder* or cardio failure* 5046
#41 vascular disease* or vascular disorder* or vascular failure* 1097
#42 peripheral disease* or peripheral disorder* or peripheral failure* 7
#43 heart disease* or heart disorder* or heart failure* or heart attack* or heart arrest* 6301
#44 cardiac disease* or cardiac disorder* or cardiac failure* or cardiac attack* or cardiac arrest* 939
#45 myocardial disease* or myocardial disorder* or myocardial failure* or myocardial attack*
or myocardial arrest*
14
#46 coronary disease* or coronary disorder* or coronary failure* or coronary attack* or coronary arrest*
or coronary syndrome*
2251
#47 ami or mi or angina* or atrial fibril* 5266
#48 MeSH DESCRIPTOR Stroke 554
#49 stroke* or poststroke* or cerebrovascular or cerebral vascular 7127
#50 (brain* or cerebral* or lacunar) NEAR3 (accident* or infarc*) 315
#51 MeSH DESCRIPTOR Hypertension 357
#52 MeSH DESCRIPTOR Blood Pressure 270
#53 hypertens* or blood pressure* or bloodpressure* or diastolic or systolic 8581
#54 MeSH DESCRIPTOR Cholesterol 95
#55 MeSH DESCRIPTOR Hypercholesterolemia 66
#56 cholesterol or hypercholesterol?emia* or hypercholester?emia* 2501
#57 MeSH DESCRIPTOR Diabetes Mellitus, Type 2 424
#58 (diabetes NEAR2 “type 2”) or (diabetes NEAR2 “type II”) or (diabetes NEAR2 (“non insulin” or
noninsulin)) or NIDDM or T2DM
1314
#59 MeSH DESCRIPTOR Metabolic Syndrome X 26
#60 (metabolic or dysmetabolic or reaven or insulin resistance) NEAR2 syndrome* 895
#61 MeSH DESCRIPTOR Neoplasms 584
#62 cancer* or neoplas* or oncolog* or malignan* or tumo?r* or carcinoma* or adenocarcinoma* 31,338
#63 #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48
OR #49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60
OR #61 OR #62
55,949
#64 #11 AND #27 AND #36 AND #63 149
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MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations (OvidSP)
1946–2013, May week 5. Searched 11 June 2013. Retrieved 687 records in MEDLINE and 27 records in
MEDLINE In-Process & Other Non-Indexed Citations.
1. review.ab. (636,359)
2. review.pt. (1,830,463)
3. meta-analysis as topic/ (13,280)
4. meta-analysis.ab. (34,787)
5. meta-analysis.pt. (42,681)
6. meta-analysis.ti. (23,835)
7. or/1-6 (2,076,188)
8. (letter or editorial or comment).pt. (1,197,336)
9. animals/ not humans/ (3,811,795)
10. 7 not (8 or 9) (1,910,614)
11. exp Obesity/ (133,014)
12. Overweight/ (10,556)
13. Weight Gain/ (21,776)
14. Weight Loss/ (22,903)
15. obes$.ti,ab. (152,384)
16. (overweight or over weight).ti,ab. (32,167)
17. (weight gain or weight loss).ti,ab. (82,180)
18. or/11-17 (267,262)
19. Adiposity/ or Adipose Tissue/ (63,489)
20. exp Body Composition/ (35,563)
21. Body Weight/ (159,038)
22. (adiposity or adipose).ti,ab. (56,647)
23. (body adj2 (composition or fat or weight)).ti,ab. (168,451)
24. fatness.ti,ab. (2834)
25. or/18-24 (541,557)
26. exp child/ (1,510,589)
27. exp Infant/ (916,662)
28. Adolescent/ (1,568,189)
29. Young Adult/ (310,115)
30. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,
ab. (1,205,015)
31. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (236,539)
32. (girl or girls or boy or boys or kid or kids).ti,ab. (155,309)
33. (young people or young person or young persons or young adult$).ti,ab. (67,202)
34. or/26-33 (3,198,543)
35. body mass index/ (75,019)
36. Skinfold Thickness/ (5476)
37. Waist Circumference/ (3842)
38. Waist-Hip Ratio/ (2713)
39. Electric Impedance/ (11,165)
40. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (113,321)
41. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (823)
42. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (343)
43. (body adipos$ adj3 (index$ or indices)).ti,ab. (35)
44. (body fat adj2 percentage$).ti,ab. (3469)
45. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$ or ratio$)).ti,ab. (4808)
46. ((waist or hip or neck) adj3 circumference$).ti,ab. (13,184)
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47. ((waist-to-hip or waist-hip) adj3 (ratio$ or test$ or measure$)).ti,ab. (6364)
48. ((waist-to-height or waist-height) adj3 (ratio$ or test$ or measure$)).ti,ab. (522)
49. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (10,288)
50. (near infrared interactance or NIR).ti,ab. (4634)
51. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (999)
52. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (108)
53. or/35-52 (168,981)
54. exp Cardiovascular Diseases/ (1,817,863)
55. ((cardiovascular or cardio or vascular or peripheral) adj3 (disease$ or disorder$ or failure$)).
ti,ab. (145,737)
56. ((heart or cardiac or myocardial) adj3 (disease$ or disorder$ or failure$ or attack$ or arrest$)).
ti,ab. (257,933)
57. (coronary adj3 (disease$ or disorder$ or failure$ or attack$ or arrest$ or syndrome$)).ti,ab. (116,718)
58. (CVD or CHD).ti,ab. (28,240)
59. (myocardial adj3 (infarc$ or disease$ or disorder$ or failure$ or attack$ or arrest$)).ti,ab. (141,002)
60. (ami or mi).ti,ab. (37,701)
61. (circulatory adj3 (disease$ or disorder$)).ti,ab. (4164)
62. angina$.ti,ab. (43,678)
63. atrial fibril$.ti,ab. (33,386)
64. exp Stroke/ (79,531)
65. (stroke$ or poststroke$).ti,ab. (132,480)
66. (cerebrovascular or cerebral vascular).ti,ab. (38,448)
67. ((brain$ or cerebral$ or lacunar) adj3 (accident$ or infarc$)).ti,ab. (19,623)
68. apoplexy.ti,ab. (2150)
69. CVA.ti,ab. (1653)
70. Hypertension/ (187,947)
71. exp Blood Pressure/ (243,419)
72. hypertens$.ti,ab. (294,407)
73. (blood pressure$ or bloodpressure$).ti,ab. (209,312)
74. (diastolic or systolic).ti,ab. (143,044)
75. Cholesterol/ (102,941)
76. Hypercholesterolemia/ (21,568)
77. cholesterol.ti,ab. (166,494)
78. (hypercholesterol?emia$ or hypercholester?emia$).ti,ab. (21,597)
79. or/54-78 (2,328,244)
80. Diabetes Mellitus, Type 2/ (81,449)
81. (diabetes adj2 type 2).ti,ab. (56,501)
82. (diabetes adj2 type II).ti,ab. (5757)
83. (diabetes adj2 (non insulin or noninsulin)).ti,ab. (9422)
84. (NIDDM or T2DM).ti,ab. (11,346)
85. Metabolic Syndrome X/ (17,954)
86. ((metabolic or dysmetabolic or reaven or insulin resistance) adj2 syndrome$).ti,ab. (25,583)
87. or/80-86 (122,953)
88. exp Neoplasms/ (2,503,418)
89. cancer$.ti,ab. (983,533)
90. (neoplas$ or oncolog$ or malignan$ or tumo?r$ or carcinoma$ or adenocarcinoma$).
ti,ab. (1,593,573)
91. or/88-90 (2,907,785)
92. 79 or 87 or 91 (5,088,112)
93. 10 and 25 and 34 and 53 and 92 (687)
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
153
PubMed (National Library of Medicine)
1946–11 June 2013. Searched 11 June 2013. Retrieved 174 records.
#51 Search (#1 AND #10 AND #16 AND #29 AND #50) (174)
#50 Search (#41 or #46 or #49) (5,156,219)
#49 Search (#47 or #48) (2,973,617)
#48 Search cancer*[tiab] or neoplas*[tiab] or oncolog*[tiab] or malignan*[tiab] or tumour*[tiab] or tumor*
[tiab] or carcinoma* [tiab] or adenocarcinoma*[tiab] (2,088,303)
#47 Search “Neoplasms”[Mesh] (2,448,239)
#46 Search (#42 or #43 or #44 or #45) (105,866)
#45 Search metabolic syndrome*[tiab] or dysmetabolic syndrome*[tiab] or reaven syndrome*[tiab] or
insulin resistance syndrome*[tiab] (26,957)
#44 Search “Metabolic Syndrome X”[Mesh] (16,908)
#43 Search diabetes type 2[tiab] or diabetes type II[tiab] or diabetes non insulin[tiab] or diabetes noninsulin
[tiab] or NIDDM [tiab] or T2DM[tiab] (12,728)
#42 Search “Diabetes Mellitus, Type 2”[Mesh] (77,427)
#41 Search (#30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40) (2,333,774)
#40 Search cholesterol[tiab] or hypercholesterolaemia*[tiab] or hypercholesteraemia*[tiab] or
hypercholesterolemia*[tiab] or hypercholesteremia*[tiab] (183,386)
#39 Search “Cholesterol”[Mesh] or “Hypercholesterolemia”[Mesh] (141,654)
#38 Search hypertens*[tiab] or blood pressure*[tiab] or bloodpressure*[tiab] or diastolic[tiab] or systolic
[tiab] (503,837)
#37 Search “Hypertension”[Mesh] or “Blood Pressure”[Mesh] (386,155)
#36 Search stroke*[tiab] or poststroke*[tiab] or cerebrovascular[tiab] or cerebral vascular[tiab] or brain*
accident*[tiab] or cerebral* accident*[tiab] or lacunar accident*[tiab] or cerebral infarc*[tiab] or brain*
infarc*[tiab] or cerebral* infarc*[tiab] or lacunar infarc*[tiab] or apoplexy[tiab] or CVA[tiab] (44,293)
#35 Search “Stroke”[Mesh] (76,757)
#34 Search CVD[tiab] or CHD[tiab] or ami[tiab] or mi[tiab] or angina*[tiab] or atrial fibril*[tiab] (144,210)
#33 Search coronary disease*[tiab] or coronary disorder*[tiab] or coronary failure*[tiab] or coronary
attack*[tiab] or coronary arrest*[tiab] or coronary syndrome*[tiab] (53,502)
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#32 Search heart disease*[tiab] or cardiac disease*[tiab] or myocardial disease*[tiab] or heart disorder*
[tiab] or cardiac disorder*[tiab] or myocardial disorder*[tiab] or heart failure*[tiab] or cardiac failure*[tiab]
or myocardial failure*[tiab] or heart failure*[tiab] or cardiac failure*[tiab] or myocardial failure*[tiab] or
heart attack*[tiab] or cardiac attack*[tiab] or myocardial attack*[tiab] or heart attack*[tiab] or cardiac
attack*[tiab] or myocardial attack*[tiab] or heart arrest*[tiab] or cardiac arrest*[tiab] or myocardial arrest*
[tiab] or heart arrest*[tiab] or cardiac arrest*[tiab] or myocardial arrest*[tiab] (252,579)
#31 Search cardiovascular disease*[tiab] or cardio disease*[tiab] or vascular disease*[tiab] or peripheral
disease*[tiab] or cardiovascular disorder*[tiab] or cardio disorder*[tiab] or vascular disorder*[tiab] or
peripheral disorder*[tiab] or cardiovascular failure*[tiab] or cardio failure*[tiab] or vascular failure*[tiab] or
peripheral failure*[tiab] (272,760)
#30 Search “Cardiovascular Diseases”[Mesh] (1,788,644)
#29 Search (#17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR
#28) (168,726)
#28 Search “bioelectric impedance”[tiab] or “bioelectrical impedance”[tiab] or “electric impedance”[tiab]
or “electrical impedance”[tiab] or “bioelectric resistance”[tiab] or “bioelectrical resistance”[tiab] or “electric
resistance”[tiab] or “electrical resistance”[tiab] or bia[tiab] (10,600)
#27 Search “waist-to-height ratio”[tiab] or “waist-to-height ratios”[tiab] or “waist-height ratio”[tiab] or
“waist-height ratios”[tiab] (600)
#26 Search “waist-to-hip ratio”[tiab] or “waist-to-hip ratios”[tiab] or “waist-hip ratio”[tiab] or “waist-hip
ratios”[tiab] (6377)
#25 Search “waist circumference”[tiab] or “hip circumference”[tiab] or “neck circumference”[tiab] (13,577)
#24 Search (“skinfold thickness”[tiab] or “skinfold test”[tiab] or “skinfold tests”[tiab] or “skinfold
measure”[tiab] or “skinfold measurement”[tiab] or “skinfold measures”[tiab] or “skinfold
measurements”[tiab]) (3357)
#23 Search (“skin fold thickness”[tiab] or “skin fold test”[tiab] or “skin fold tests”[tiab] or “skin fold
measure”[tiab] or “skin fold measurement”[tiab] or “skin fold measures”[tiab] or “skin fold
measurements”[tiab]) (658)
#22 Search ((“body fat percentage”[tiab] or “body fat percentages”[tiab])) (1222)
#21 Search “body adiposity index”[tiab] or “body adiposity indices”[tiab] or “body adiposie index”[tiab] or
“body adipose indices”[tiab] (47)
#20 Search (“fat free mass index”[tiab] or “fat free mass indices”[tiab] or ffmi[tiab]) (248)
#19 Search “fat mass index”[tiab] or “fat mass indices”[tiab] or fmi[tiab] (434)
#18 Search (“body mass index”[tiab] or “body mass indices”[tiab] or bmi[tiab] or quetelet*[tiab]) (119,706)
#17 Search ((((“Body Mass Index”[Mesh]) OR “Skinfold Thickness”[Mesh]) OR “Waist Circumference”[Mesh])
OR “Waist-Hip Ratio”[Mesh]) OR “Electric Impedance”[Mesh] (86,627)
#16 Search (#11 OR #12 OR #13 OR #14 OR #15) (3,221,920)
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
155
#15 Search “young people”[tiab] or “young person”[tiab] or “young persons”[tiab] or young adult*
[tiab] (69,376)
#14 Search girl[tiab] or girls[tiab] or boy[tiab] or boys[tiab] or kid[tiab] or kids[tiab] (163,334)
#13 Search adolescen*[tiab] or juvenile*[tiab] or youth*[tiab] or teenage*[tiab] or youngster*
[tiab] (248,889)
#12 Search child*[tiab] or infant*[tiab] or pediat*[tiab] or paediat*[tiab] or schoolchild*[tiab] or school
age*[tiab] or schoolage*[tiab] (1,254,419)
#11 Search (((“Child”[Mesh]) OR “Infant”[Mesh]) OR “Adolescent”[Mesh]) OR “Young Adult”[Mesh] (2,849,606)
#10 Search (#7 OR #8 OR #9) (583,003)
#9 Search adiposity[tiab] or adipose[tiab] or “body composition”[tiab] or “body fat”[tiab] or “body
weight”[tiab] or fatness[tiab] (216,116)
#8 Search (((“Adiposity”[Mesh]) OR “Adipose Tissue”[Mesh]) OR “Body Composition”[Mesh]) OR “Body
Weight”[Mesh] (386,174)
#7 Search (#2 OR #3 OR #4 OR #5 OR #6) (281,116)
#6 Search “weight gain”[tiab] or “weight loss”[tiab] (86,556)
#5 Search overweight[tiab] or “over weight*”[tiab] (34,320)
#4 Search obes*[tiab] (160,601)
#3 Search ((“Overweight”[Mesh]) OR “Weight Gain”[Mesh]) OR “Weight Loss”[Mesh] (160,439)
#2 Search “Obesity”[Mesh] (127,351)
#1 Search ((systematic review [ti] OR meta-analysis [pt] OR meta-analysis [ti] OR systematic literature review
[ti] OR (systematic review [tiab] AND review [pt]) OR consensus development conference [pt] OR practice
guideline [pt] OR cochrane database syst rev [ta] OR acp journal club [ta] OR health technol assess [ta] OR
evid rep technol assess summ [ta] OR drug class reviews [ti]) OR (clinical guideline [tw] AND management
[tw]) OR ((evidence based[ti] OR evidence-based medicine [mh] OR best practice* [ti] OR evidence synthesis
[tiab]) AND (review [pt] OR diseases category[mh] OR behavior and behavior mechanisms [mh] OR
therapeutics [mh] OR evaluation studies[pt] OR validation studies[pt] OR guideline [pt] OR pmcbook)) OR
((systematic [tw] OR systematically [tw] OR critical [tiab] OR (study selection [tw]) OR (predetermined [tw] OR
inclusion [tw] AND criteri* [tw]) OR exclusion criteri* [tw] OR main outcome measures [tw] OR standard of
care [tw] OR standards of care [tw]) AND (survey [tiab] OR surveys [tiab] OR overview* [tw] OR review [tiab]
OR reviews [tiab] OR search* [tw] OR handsearch [tw] OR analysis [tiab] OR critique [tiab] OR appraisal [tw]
OR (reduction [tw]AND (risk [mh] OR risk [tw]) AND (death OR recurrence))) AND (literature [tiab] OR articles
[tiab] OR publications [tiab] OR publication [tiab] OR bibliography [tiab] OR bibliographies [tiab] OR
published [tiab] OR unpublished [tw] OR citation [tw] OR citations [tw] OR database [tiab] OR internet [tiab]
OR textbooks [tiab] OR references [tw] OR scales [tw] OR papers [tw] OR datasets [tw] OR trials [tiab] OR
meta-analy* [tw] OR (clinical [tiab] AND studies [tiab]) OR treatment outcome [mh] OR treatment outcome
[tw] OR pmcbook)) NOT (letter [pt] OR newspaper article [pt] OR comment [pt])) (206,739)
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Database of Promoting Health Effectiveness Reviews (Evidence for Policy
and Practice Information and Co-ordinating Centre)
12 June 2013. Searched 12 June 2013. Retrieved 13 records.
1. Freetext: “obes*” OR overweight OR “over weight” OR “weight gain” OR “weight loss” (429)
2. Freetext: adiposity OR adipose OR fatness OR “body composition” or “body fat” or “body
weight” (93)
3. 1 OR 2 (348)
4. Freetext: “body mass index*” OR “body mass indices” OR bmi OR quetelet* (85)
5. Freetext: “fat mass” NEAR “index*” OR “fat mass” NEAR “indices*” OR fmi (1)
6. Freetext: “fat free mass” NEAR “index*” OR “fat free mass” NEAR “indices*” OR ffmi (0)
7. Freetext: “body adipos*” NEAR “index*” OR “body adipos*” NEAR “indices*” (1)
8. Freetext: “body fat” NEAR “percentage*” (11)
9. Freetext: “skin fold” or skinfold (10)
10. Freetext: “waist” NEAR “circumference*” OR “hip” NEAR “circumference*” OR “neck” NEAR
“circumference*” (6)
11. Freetext: “waist-to-hip” OR “waist-hip” OR “waist-to-height” OR “waist-height” (4)
12. Freetext: “bioelectric*” NEAR “impedance” OR “electric*” NEAR “impedance” OR “bioelectric*”
NEAR “resistance” OR “electric*” NEAR “resistance” (2)
13. Freetext: “benn*” NEAR “index*” OR “rohrer*” NEAR “index*” OR “ponderal” NEAR “index*” OR
“corpulence” NEAR “index*” OR “benn*” NEAR “indices*” OR “rohrer*” NEAR “indices*” OR
“ponderal” NEAR “indices*” OR “corpulence” NEAR “indices*” (2)
14. Freetext: “infrared interactance” OR NIR OR “sagittal abdominal diameter*” OR “supine abdominal
diameter*” (0)
15. 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 (87)
16. Freetext: cardiovascular OR cardio OR vascular OR peripheral OR heart OR cardiac OR myocardial OR
coronary OR circulatory OR CVD OR CHD OR AMI OR MI OR “angina*” OR atrial (239)
17. Freetext: “stroke*” OR “poststroke*” OR cerebrovascular OR “cerebral vascular” (21)
18. Freetext: “brain*” NEAR “accident*” OR “cerebral*” NEAR “accident*” OR “lacunar” NEAR
“accident*” OR “brain*” NEAR “infarc*” OR “cerebral*” NEAR “infarc*” OR “lacunar” NEAR
“infarc*” OR apoplexy OR CVA (1)
19. Freetext: “hypertens*” OR “blood pressure*” OR “bloodpressure*” OR diastolic OR systolic (114)
20. Freetext: cholesterol OR “hypercholesterolemia*” OR “hypercholesterolaemia*” OR
“hypercholesteremia*” OR “hypercholesteraemia*” (58)
21. Freetext: diabetes OR NIDDM OR “T2DM” (113)
22. Freetext: “metabolic” NEAR “syndrome*”OR “dysmetabolic” NEAR “syndrome*”OR “reaven” NEAR
“syndrome*”OR “insulin resistance” NEAR “syndrome*” (9)
23. Freetext: “cancer*” OR “neoplas*” OR “oncolog*” OR “malignan*” OR “tumor*” OR “tumour*”
OR “carcinoma*” OR “adenocarcinoma*” (180)
24. 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 (501)
25. 3 AND 15 AND 24 (40)
26. Freetext: “child*” OR “infant*” OR “pediat*” OR “paediat*” OR “schoolchild*” OR “school age*”
OR “schoolage*” OR “adolescen*” OR “juvenile*” OR “youth*” OR “teenage*” OR “youngster*”
OR girl OR girls OR boy OR boys OR kid OR kids OR “young people” OR “young person” OR “young
persons” OR “young adult*” (1249)
27. 25 AND 26 (13)
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Internet sites searched
Organisation websites were browsed (publications and/or research) and searched. Searches were
conducted in June 2013.
Public Health England – Obesity Knowledge and Intelligence (previously National Obesity Observatory)
(www.noo.org.uk/)
Association for the Study of Obesity (www.aso.org.uk/)
Obesity Learning Centre (www.obesitylearningcentre.org.uk/)
National Obesity Forum (www.nationalobesityforum.org.uk/)
British Dietetic Association (www.bda.uk.com/index.html)
CEDAR (www.cedar.iph.cam.ac.uk/)
The Nutrition Society (www.nutritionsociety.org/)
International Association for the Study of Obesity (www.iaso.org/)
EASO (www.easoobesity.org/)
European Congress on Obesity (www.easo.org/eco2013)
ECOG (www.ecog-obesity.eu/)
CDC Division of Nutrition, Physical Activity, and Obesity (USA) (www.cdc.gov/nccdphp/dnpao/index.html)
Weight-control Information Network (USA) (http://win.niddk.nih.gov/)
The Obesity Society (USA) (www.obesity.org/)
myhealthywaist.org (International Chair on Cardiometabolic Risk of Université Laval – Quebec, Canada)
(www.myhealthywaist.org/)
Citation searches: Web of Science and Google Scholar
1. Singh AS, Mulder C, Twisk JW, van Mechelen W, Chinapaw MJ. Tracking of childhood overweight into
adulthood: a systematic review of the literature. Obesity Reviews 2008 9(5):474-88.
WoS: 210 records (database updated 12 June 2013; searched 13 June 2013)
Google Scholar: 391 records (13 June 2013)
2. Falaschetti E, Hingorani AD, Jones A, Charakida M, Finer N, Whincup P, Lawlor DA, Davey Smith G,
Sattar N, Deanfield JE. Adiposity and cardiovascular risk factors in a large contemporary population of
pre-pubertal children. European Heart Journal 2010;31(24):3063-72.
WoS: 18 records (database updated 19 June 2013; searched 21 June 2013)
Google Scholar: 30 records (21 June 2013)
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3. Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F.
Diagnostic performance of body mass index to identify obesity as defined by body adiposity:
a systematic review and meta-analysis. International Journal of Obesity 2010;34(5):791-9.
WoS: 52 records (database updated 19 June 2013; searched 21 June 2013)
Google Scholar: 99 records (21 June 2013)
4. Nimptsch K, Giovannucci E, Willett WC, Fuchs CS, Wei EK, Wu K. Body fatness during childhood and
adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prevention Research
(Philadelphia, PA) 2011;4(10):1710-8.
WoS: 3 records (database updated 21 June 2013; searched 24 June 2013)
Google Scholar: 5 records (24 June 2013)
5. Cameron AJ, Magliano DJ, Söderberg S. A systematic review of the impact of including both waist and
hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obesity Reviews
2013;14(1):86-94.
WoS: 0 records (database updated 21 June 2013; searched 24 June 2013)
Google Scholar: 1 record (24 June 2013)
6. Clarke WR, Lauer RM. Does childhood obesity track into adulthood? Critical Reviews in Food Science
and Nutrition 1993;33(4-5):423-30.
WoS: 110 records (database updated 21 June 2013; searched 24 June 2013)
Google Scholar: 152 records (24 June 2013)
7. Liddle K, O’Callaghan M, Mamun A, Najman J, Williams G. Comparison of body mass index and triceps
skinfold at 5 years and young adult body mass index, waist circumference and blood pressure. Journal
of Paediatrics and Child Health 2012;48(5):424-9.
WoS: 0 records (database updated 21 June 2013; searched 24 June 2013)
Google Scholar: 0 records (24 June 2013)
8. Freedman DS, Ogden CL, Blanck HM, Borrud LG, Dietz WH. The Abilities of Body Mass Index and
Skinfold Thicknesses to Identify Children with Low or Elevated Levels of Dual-Energy X-Ray
Absorptiometry-Determined Body Fatness. Journal of Pediatrics 2013 Feb 11. pii: S0022-3476(13)
00005-X. [Epub ahead of print].
WoS: 0 records (database updated 21 June 2013; searched 24 June 2013)
Google Scholar: 1 record (24 June 2013)
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9. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other
cardiovascular risk factors, and premature death. New England Journal of Medicine 2010;11;362
(6):485-93.
WoS: 180 records (database updated 21 June 2013; searched 24 June 2013)
Google Scholar: 344 records (24 June 2013)
10. Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH. Cardiovascular risk factors and excess
adiposity among overweight children and adolescents: the Bogalusa Heart Study. Journal of Pediatrics
2007;150(1):12-17.e2.
WoS: 30 records (database updated 21 June 2013; searched 25 June 2013)
Google Scholar: 491 records (25 June 2013)
11. Conway JM, Norris KH, Bodwell CE. A new approach for the estimation of body composition: infrared
interactance. American Journal of Clinical Nutrition 1984;40(6):1123-30.
WoS: 221 records (database updated 21 June 2013; searched 25 June 2013)
Google Scholar: 306 records (25 June 2013)
12. Freedman DS, Kahn HS, Mei Z, Grummer-Strawn LM, Dietz WH, Srinivasan SR, Berenson GS. Relation
of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and
adolescents: the Bogalusa Heart Study. American Journal of Clinical Nutrition 2007;86(1):33-40.
WoS: 81 records (database updated 21 June 2013; searched 26 June 2013)
Google Scholar: 161 records (26 June 2013)
13. Goldhaber-Fiebert JD, Rubinfeld RE, Bhattacharya J, Robinson TN, Wise PH. The utility of childhood and
adolescent obesity assessment in relation to adult health. Medical Decision Making 2013;33(2):163-75.
WoS: 1 record (database updated 21 June 2013; searched 26 June 2013)
Google Scholar: 2 records (26 June 2013)
14. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Davey Smith G. Childhood obesity and adult
cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. American Journal of
Clinical Nutrition 1998;67(6):1111-8.
WoS: 232 records (database updated 21 June 2013; searched 26 June 2013)
Google Scholar: 453 records (26 June 2013)
15. Fayter D, Nixon J, Hartley S, Rithalia A, Butler G, Rudolf M, Glasziou P, Bland M, Stirk L, Westwood M.
A systematic review of the routine monitoring of growth in children of primary school age to identify
growth-related conditions. Health Technology Assessment 2007;11(22):1-163.
WoS: 8 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 23 records (27 June 2013)
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
160
16. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, Srinivasan SR, Daniels SR,
Davis PH, Chen W, Sun C, Cheung M, Viikari JS, Dwyer T, Raitakari OT. Childhood adiposity, adult
adiposity, and cardiovascular risk factors. New England Journal of Medicine 2011;365(20):1876-85.
WoS: 73 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 136 records (27 June 2013)
17. Lazarus R, Baur L, Webb K, Blyth F. Body mass index in screening for adiposity in children and
adolescents: systematic evaluation using receiver operating characteristic curves. American Journal of
Clinical Nutrition 1996;63(4):500-6.
WoS: 77 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 154 records (27 June 2013)
18. Li L, Law C, Power C. Body mass index throughout the life-course and blood pressure in mid-adult life:
a birth cohort study. Journal of Hypertension 2007;25(6):1215-23.
WoS: 32 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 42 records (27 June 2013)
19. Li L, Hardy R, Kuh D, Lo Conte R, Power C. Child-to-adult body mass index and height trajectories:
a comparison of 2 British birth cohorts. American Journal of Epidemiology 2008;168(9):1008-15.
WoS: 17 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 23 records (27 June 2013)
20. Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and adult cardiovascular disease risk:
a systematic review. International Journal of Obesity (London) 2010;34(1):18-28.
WoS: 22 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 55 records (27 June 2013)
21. Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and risk of the adult metabolic syndrome:
a systematic review. Journal of Obesity (London) 2012;36(1):1-11.
WoS: 10 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 21 records (27 June 2013)
22. Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, Dietz WH. Validity of body mass
index compared with other body-composition screening indexes for the assessment of body fatness in
children and adolescents. American Journal of Clinical Nutrition 2002;75(6):978-85.
WoS: 240 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 541 records (27 June 2013)
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23. Nichols J, Going S, Loftin M, Stewart D, Nowicki E, Pickrel J. Comparison of two bioelectrical
impedance analysis instruments for determining body composition in adolescent girls. International
Journal of Body Composition Research 2006;4(4):153-160.
WoS: 6 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 11 records (27 June 2013)
24. Nooyens AC, Koppes LL, Visscher TL, Twisk JW, Kemper HC, Schuit AJ, van Mechelen W, Seidell JC.
Adolescent skinfold thickness is a better predictor of high body fatness in adults than is body mass
index: the Amsterdam Growth and Health Longitudinal Study. American Journal of Clinical Nutrition
2007;85(6):1533-9.
WoS: 33 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 49 records (27 June 2013)
25. Park MH, Falconer C, Viner RM, Kinra S. The impact of childhood obesity on morbidity and mortality in
adulthood: a systematic review. Obesity Reviews 2012;13(11):985-1000.
WoS: 7 records (database updated 26 June 2013; searched 27 June 2013)
Google Scholar: 20 records (27 June 2013)
26. Power C, Lake JK, Cole TJ. Measurement and long-term health risks of child and adolescent fatness.
International Journal of Obesity and Related Metabolic Disorders 1997;21(7):507-26.
WoS: 354 records (database updated 26 June 2013; searched 28 June 2013)
Google Scholar: 619 records (28 June 2013)
27. Power C, Thomas C. Changes in BMI, duration of overweight and obesity, and glucose metabolism:
45 years of follow-up of a birth cohort. Diabetes Care 2011;34(9):1986-91.
WoS: 8 records (database updated 26 June 2013; searched 28 June 2013)
Google Scholar: 13 records (28 June 2013)
28. Reilly JJ, Kelly J, Wilson DC. Accuracy of simple clinical and epidemiological definitions of childhood
obesity: systematic review and evidence appraisal. Obesity Reviews 2010;11(9):645-55.
WoS: 20 records (database updated 26 June 2013; searched 28 June 2013)
Google Scholar: 35 records (28 June 2013)
29. Sardinha LB, Going SB, Teixeira PJ, Lohman TG. Receiver operating characteristic analysis of body mass
index, triceps skinfold thickness, and arm girth for obesity screening in children and adolescents.
American Journal of Clinical Nutrition 1999;70(6):1090-5.
WoS: 93 records (database updated 26 June 2013; searched 28 June 2013)
Google Scholar: 197 records (28 June 2013)
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30. Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese children become
obese adults? A review of the literature. Preventive Medicine 1993;22(2):167-77.
WoS: 706 records (database updated 26 June 2013; searched 28 June 2013)
Google Scholar: 1367 records (28 June 2013)
31. Thomas C, Hyppönen E, Power C. Obesity and type 2 diabetes risk in midadult life: the role of
childhood adversity. Pediatrics 2008 May;121(5):e1240-9.
WoS: 57 records (database updated 26 June 2013; searched 28 June 2013)
Google Scholar: 95 records (28 June 2013)
32. Wright CM, Parker L, Lamont D, Craft AW. Implications of childhood obesity for adult health: findings
from thousand families cohort study. BMJ 2001;323(7324):1280-4.
WoS: 155 records (database updated 26 June 2013; searched 28 June 2013)
Google Scholar: 298 records (28 June 2013)
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Review of adult morbidities: search for additional primary
studies
MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations (OvidSP)
1946–2013, September week 4. Searched 4 October 2013. Retrieved 2484 records in MEDLINE and 301
records in MEDLINE In-Process & Other Non-Indexed Citations.
1. exp *Obesity/ (99,951)
2. *Overweight/ (7376)
3. *Adiposity/ (2824)
4. obes$.ti,ab. (164,847)
5. (overweight or over weight).ti,ab. (35,402)
6. adiposity.ti,ab. (13,484)
7. or/1-6 (196,646)
8. exp child/ or exp Infant/ or Adolescent/ (2,882,142)
9. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).
ti,ab. (1,253,562)
10. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (250,426)
11. (girl or girls or boy or boys or kid or kids).ti,ab. (161,260)
12. or/8-11 (3,152,555)
13. *body mass index/ (12,267)
14. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (123,839)
15. 13 or 14 (125,030)
16. *Skinfold Thickness/ (866)
17. *Waist Circumference/ (1108)
18. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$ or ratio$)).ti,ab. (5000)
19. (waist adj3 circumference$).ti,ab. (14,012)
20. or/16-19 (18,848)
21. *Waist-Hip Ratio/ or *Electric Impedance/ (2810)
22. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (915)
23. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (370)
24. (body adipos$ adj3 (index$ or indices)).ti,ab. (41)
25. ((hip or neck) adj3 circumference$).ti,ab. (3136)
26. ((waist-to-hip or waist-hip) adj3 (ratio$ or test$ or measure$)).ti,ab. (6774)
27. ((waist-to-height or waist-height) adj3 (ratio$ or test$ or measure$)).ti,ab. (601)
28. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (11,001)
29. (near infrared interactance or NIR).ti,ab. (5084)
30. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (1030)
31. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (120)
32. or/21-31 (27,437)
33. exp *Cardiovascular Diseases/ (1,575,263)
34. exp *Stroke/ (63,420)
35. *Hypertension/ (139,094)
36. *Hypercholesterolemia/ or *Dyslipidemias/ (17,458)
37. ((cardiovascular or cardio or vascular or peripheral) adj3 (disease$ or disorder$ or failure$)).
ti,ab. (156,163)
38. ((heart or cardiac or myocardial) adj3 (disease$ or disorder$ or failure$ or attack$ or arrest$)).
ti,ab. (270,179)
39. (coronary adj3 (disease$ or disorder$ or failure$ or attack$ or arrest$ or syndrome$)).ti,ab. (121,849)
40. (CVD or CHD or IHD).ti,ab. (34,257)
41. (myocardial adj3 (infarc$ or disease$ or disorder$ or failure$ or attack$ or arrest$)).ti,ab. (146,283)
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42. (ami or mi).ti,ab. (39,951)
43. (circulatory adj3 (disease$ or disorder$)).ti,ab. (4271)
44. angina$.ti,ab. (44,684)
45. atrial fibril$.ti,ab. (35,395)
46. (stroke$ or poststroke$).ti,ab. (141,434)
47. (cerebrovascular or cerebral vascular).ti,ab. (40,112)
48. ((brain$ or cerebral$ or lacunar) adj3 (accident$ or infarc$)).ti,ab. (20,320)
49. hypertens$.ti,ab. (306,843)
50. high blood pressure.ti,ab. (10,087)
51. high cholesterol.ti,ab. (4917)
52. (hypercholesterol?emia$ or hypercholester?emia$).ti,ab. (22,466)
53. (dyslipid?emia$ or dyslipoprotein?emias$).ti,ab. (17,481)
54. or/33-53 (1,910,195)
55. *Diabetes Mellitus, Type 2/ (69,067)
56. *Metabolic Syndrome X/ (15,189)
57. (diabetes adj2 type 2).ti,ab. (61,812)
58. (diabetes adj2 type II).ti,ab. (6078)
59. (diabetes adj2 (non insulin or noninsulin)).ti,ab. (9514)
60. (NIDDM or T2DM or T2D).ti,ab. (14,261)
61. ((metabolic or dysmetabolic or reaven or insulin resistance) adj2 syndrome$).ti,ab. (27,945)
62. or/55-61 (121,005)
63. exp *Neoplasms/ (2,243,426)
64. cancer$.ti,ab. (1,054,643)
65. (neoplas$ or oncolog$ or malignan$ or tumo?r$ or carcinoma$ or adenocarcinoma$).ti,ab.
(1,673,022)
66. or/63-65 (2,819,554)
67. exp Animals/ not Humans/ (4,058,478)
68. (comment or editorial or letter).pt. (1,245,317)
69. 67 or 68 (5,253,117)
70. 7 and 12 and 15 and (54 or 62 or 66) (5576)
71. 70 not 69 (5547)
72. (2011$ or 2012$ or 2013$).ed,dc,ep. (2,547,833)
73. 71 and 72 (1862)
74. 7 and 12 and 20 and (54 or 62) (1542)
75. 74 not 69 (1538)
76. (2008$ or 2009$ or 2010$ or 2011$ or 2012$ or 2013$).ed,dc,ep. (5,017,455)
77. 75 and 76 (1076)
78. 7 and 12 and 20 and 66 (128)
79. 78 not 69 (128)
80. 7 and 12 and 32 and (54 or 62 or 66) (817)
81. 80 not 69 (812)
82. 73 or 77 or 79 or 81 (2980)
NB: After removal of duplicate records, the final total was 2484.
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EMBASE (OvidSP)
1974–2013, week 39. Searched 4 October 2013. Retrieved 3405 records.
1. exp *obesity/ (154,266)
2. obes$.ti,ab. (229,244)
3. (overweight or over weight).ti,ab. (50,550)
4. adiposity.ti,ab. (17,157)
5. or/1-4 (282,623)
6. child/ or preschool child/ or infant/ or adolescent/ (2,386,317)
7. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,ab.
(1,602,771)
8. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (320,105)
9. (girl or girls or boy or boys or kid or kids).ti,ab. (215,455)
10. or/6-9 (3,051,058)
11. *body mass/ (13,758)
12. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (191,016)
13. 11 or 12 (192,700)
14. *skinfold thickness/ (877)
15. *waist circumference/ (1514)
16. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$ or ratio$)).ti,ab. (6057)
17. (waist adj3 circumference$).ti,ab. (21,661)
18. or/14-17 (27,483)
19. *waist hip ratio/ or *waist to height ratio/ or *weight height ratio/ or *neck circumference/ (543)
20. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (1254)
21. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (537)
22. (body adipos$ adj3 (index$ or indices)).ti,ab. (83)
23. ((hip or neck) adj3 circumference$).ti,ab. (4655)
24. ((waist-to-hip or waist-hip) adj3 (ratio$ or test$ or measure$)).ti,ab. (9084)
25. ((waist-to-height or waist-height) adj3 (ratio$ or test$ or measure$)).ti,ab. (929)
26. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (14,541)
27. (near infrared interactance or NIR).ti,ab. (6862)
28. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (1246)
29. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (146)
30. or/19-29 (35,697)
31. exp *cardiovascular disease/ (2,055,464)
32. exp *cerebrovascular accident/ (31,720)
33. *hypertension/ (187,647)
34. *hypercholesterolemia/ or *dyslipidemia/ (26,658)
35. ((cardiovascular or cardio or vascular or peripheral) adj3 (disease$ or disorder$ or failure$)).ti,ab.
(213,224)
36. ((heart or cardiac or myocardial) adj3 (disease$ or disorder$ or failure$ or attack$ or arrest$)).ti,ab.
(376,201)
37. (coronary adj3 (disease$ or disorder$ or failure$ or attack$ or arrest$ or syndrome$)).ti,ab. (171,524)
38. (CVD or CHD or IHD).ti,ab. (49,922)
39. (myocardial adj3 (infarc$ or disease$ or disorder$ or failure$ or attack$ or arrest$)).ti,ab. (198,567)
40. (ami or mi).ti,ab. (62,188)
41. (circulatory adj3 (disease$ or disorder$)).ti,ab. (5203)
42. angina$.ti,ab. (60,695)
43. atrial fibril$.ti,ab. (57,424)
44. (stroke$ or poststroke$).ti,ab. (205,519)
45. (cerebrovascular or cerebral vascular).ti,ab. (55,507)
46. ((brain$ or cerebral$ or lacunar) adj3 (accident$ or infarc$)).ti,ab. (29,059)
47. hypertens$.ti,ab. (426,356)
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48. high blood pressure.ti,ab. (14,098)
49. high cholesterol.ti,ab. (6446)
50. (hypercholesterol?emia$ or hypercholester?emia$).ti,ab. (30,335)
51. (dyslipid?emia$ or dyslipoprotein?emias$).ti,ab. (27,695)
52. or/31-51 (2,547,699)
53. *non insulin dependent diabetes mellitus/ (81,799)
54. *metabolic syndrome X/ (23,897)
55. (diabetes adj2 type 2).ti,ab. (90,512)
56. (diabetes adj2 (non insulin or noninsulin)).ti,ab. (11,127)
57. (NIDDM or T2DM or T2D).ti,ab. (22,350)
58. ((metabolic or dysmetabolic or reaven or insulin resistance) adj2 syndrome$).ti,ab. (43,565)
59. or/53-58 (165,434)
60. exp *neoplasm/ (2,652,219)
61. cancer$.ti,ab. (1,389,393)
62. (neoplas$ or oncolog$ or malignan$ or carcinoma$ or adenocarcinoma$).ti,ab. (1,302,882)
63. or/60-62 (3,268,818)
64. (editorial or letter or note).pt. (1,885,479)
65. 5 and 10 and 13 and (52 or 59 or 63) (6295)
66. 65 not 64 (6277)
67. (2011$ or 2012$ or 2013$).em. (3,692,841)
68. 66 and 67 (2498)
69. 5 and 10 and 18 and (52 or 59) (1997)
70. 69 not 64 (1992)
71. (2008$ or 2009$ or 2010$ or 2011$ or 2012$ or 2013$).em. (6,973,364)
72. 70 and 71 (1525)
73. 5 and 10 and 18 and 63 (76)
74. 73 not 64 (76)
75. 5 and 10 and 30 and (52 or 59 or 63) (845)
76. 75 not 64 (843)
77. 68 or 72 or 74 or 76 (3802)
78. limit 77 to human (3405)
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Science Citation Index (Web of Science)
1900–1 October 2013. Searched 4 October 2013. Retrieved 3025 records.
Search term Number retrieved
# 32 #25 or #26 or #29 or #31
Databases=SCI-EXPANDED Timespan=All years
3025
# 31 #30 not #23
Databases=SCI-EXPANDED Timespan=All years
882
# 30 #1 and #2 and #5 and (#16 or #21 or #22)
Databases=SCI-EXPANDED Timespan=All years
898
# 29 #28 not #23
Databases=SCI-EXPANDED Timespan=All years
73
# 28 #1 and #2 and #4 and #22
Databases=SCI-EXPANDED Timespan=All years
75
# 27 #26 not #23
Databases=SCI-EXPANDED Timespan=2008-2013
1165
# 26 #1 and #2 and #4 and (#16 or #21)
Databases=SCI-EXPANDED Timespan=All years
1623
# 25 #24 not #23
Databases=SCI-EXPANDED Timespan=2011-2013
1809
# 24 #1 and #2 and #3 and (#16 or #21 or #22)
Databases=SCI-EXPANDED Timespan=All years
5340
# 23 (TS=(rat or rats or mouse or mice or murine or hamster or hamsters or animal or animals or
dogs or dog or pig or pigs or cats or bovine or cow or sheep or ovine or porcine or monkey))
Databases=SCI-EXPANDED Timespan=All years
3,694,533
# 22 (TS=(cancer* or neoplas* or oncolog* or malignan* or carcinoma* or adenocarcinoma*))
Databases=SCI-EXPANDED Timespan=All years
1,773,464
# 21 (#17 or #18 or #19 or #20)
Databases=SCI-EXPANDED Timespan=All years
128,589
# 20 TS=((metabolic or dysmetabolic or reaven or “insulin resistance”) NEAR/2 syndrome*))
Databases=SCI-EXPANDED Timespan=All years
48,002
# 19 TS=(NIDDM or T2DM or T2D))
Databases=SCI-EXPANDED Timespan=All years
18,476
# 18 TS=(diabetes NEAR/2 (“non insulin” or noninsulin)))
Databases=SCI-EXPANDED Timespan=All years
8853
# 17 TS=(diabetes NEAR/2 “type 2”) or TS=(diabetes NEAR/2 “type II”))
Databases=SCI-EXPANDED Timespan=All years
76,238
# 16 (#6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15) Databases=SCI-
EXPANDED Timespan=All years
1,067,535
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Search term Number retrieved
# 15 (TS=(hypertens* or “high blood pressure” or “high cholesterol” or hypercholesterol?emia*
or hypercholester?emia* or dyslipid?emia* or dyslipoprotein?emia*))
Databases=SCI-EXPANDED Timespan=All years
329,965
# 14 (TS=((brain* or cerebral* or lacunar) NEAR/3 (accident* or infarc*)))
Databases=SCI-EXPANDED Timespan=All years
21,191
# 13 (TS=(stroke* or poststroke* or cerebrovascular))
Databases=SCI-EXPANDED Timespan=All years
183,819
# 12 (TS=(angina* or “atrial fibril*”))
Databases=SCI-EXPANDED Timespan=All years
84,084
# 11 (TS=(circulatory NEAR/3 (disease* or disorder*)))
Databases=SCI-EXPANDED Timespan=All years
1415
# 10 (TS=(myocardial NEAR/3 (infarc* or disease* or disorder* or failure* or attack* or arrest*)))
Databases=SCI-EXPANDED Timespan=All years
196,005
# 9 (TS=(CVD or CHD or IHD))
Databases=SCI-EXPANDED Timespan=All years
52,225
# 8 (TS=(coronary NEAR/3 (disease* or disorder* or failure* or attack* or arrest* or syndrome*)))
Databases=SCI-EXPANDED Timespan=All years
183,720
# 7 (TS=((heart or cardiac or myocardial) NEAR/3 (disease* or disorder* or failure* or attack* or
arrest*)))
Databases=SCI-EXPANDED Timespan=All years
336,341
# 6 (TS=((cardiovascular or peripheral) NEAR/3 (disease* or disorder* or failure*)))
Databases=SCI-EXPANDED Timespan=All years
147,514
# 5 (TS=((“fat mass” NEAR/3 (index* or indices)) or fmi) or TS=((“fat free mass” NEAR/3 (index*
or indices)) or ffmi) or TS=(“body adiposity” NEAR/3 (index* or indices)) or TS=(“body fat”
NEAR/2 percentage*) or TS=((hip or neck) NEAR/3 circumference*) or TS=((waist-to-hip or
waist-hip) NEAR/3 ratio*) or TS=((waist-to-height or waist-height) NEAR/3 ratio*) or TS=
(((bioelectric* or electric*) NEAR/3 (impedance or resistance)) or bia) or TS=(“near infrared
interactance” or NIR) or TS=((benn* or rohrer* or ponderal or corpulence) NEAR/3 (index* or
indices)) or TS=(sagittal abdominal diameter* or supine abdominal diameter*))
Databases=SCI-EXPANDED Timespan=All years
58,595
# 4 (TS=((“skin fold” or skinfold) NEAR/3 (thickness* or test* or measure*)) or TS=(waist NEAR/3
circumference*))
Databases=SCI-EXPANDED Timespan=All years
16,378
# 3 (TS=((“body mass” NEAR/3 (index* or indices)) or bmi or quetelet*))
Databases=SCI-EXPANDED Timespan=All years
116,916
# 2 (TS=(child* or infant* or pediat* or paediat* or schoolchild* or “school age” or “school
aged” or schoolage* or adolescen* or juvenile* or youth* or teenage* or youngster* or girl
or girls or boy or boys or kid or kids or “young people” or “young person” or “young
persons” or “young adult” or “young adults”)) AND Language=(English)
Databases=SCI-EXPANDED Timespan=All years
1,281,780
# 1 (TS=(obes* or overweight or “over weight” or adiposity))
Databases=SCI-EXPANDED Timespan=All years
206,204
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The Cochrane Library: Cochrane Database of Systematic Reviews, Cochrane
Central Register of Controlled Trials, Database of Abstracts of Reviews of
Effects, Health Technology Assessment and NHS Economic Evaluation
Database (Wiley Online Library)
2013: CDSR Issue 10/12, CENTRAL Issue 10/12, DARE Issue 3/4, HTA Issue 3/4 and NHS EED Issue 3/4.
Searched 4 October 2013. Retrieved 2 records in CDSR, 125 records in CENTRAL, 1 record in DARE,
0 records in HTA and 0 records in NHS EED.
#1 MeSH descriptor: [Obesity] explode all trees (6646)
#2 MeSH descriptor: [Overweight] explode all trees (7151)
#3 MeSH descriptor: [Adiposity] explode all trees (213)
#4 (obes* or overweight or (over next weight) or adiposity):ti,ab,kw (11,502)
#5 #1 or #2 or #3 or #4 (11,529)
#6 MeSH descriptor: [Child] explode all trees (122)
#7 MeSH descriptor: [Infant] explode all trees (12,348)
#8 MeSH descriptor: [Adolescent] explode all trees (70,756)
#9 child* or infant* or pediat* or paediat* or schoolchild* or (school next age*) or schoolage*:ti,ab,
kw (84,824)
#10 adolescen* or juvenile* or youth$ or teenage* or youngster*:ti,ab,kw (84,511)
#11 girl or girls or boy or boys or kid or kids:ti,ab,kw (3991)
#12 #6 or #7 or #8 or #9 or #10 or #11 (141,741)
#13 MeSH descriptor: [Cardiovascular Diseases] explode all trees (69,868)
#14 MeSH descriptor: [Stroke] explode all trees (4580)
#15 MeSH descriptor: [Hypertension] this term only (13,068)
#16 MeSH descriptor: [Hypercholesterolemia] this term only (2328)
#17 MeSH descriptor: [Dyslipidemias] explode all trees (4660)
#18 ((cardiovascular or vascular or peripheral) near/3 (disease* or disorder* or failure*)):ti,ab,kw (12,157)
#19 ((heart or cardiac or myocardial) near/3 (disease* or disorder* or failure* or attack* or arrest*)):ti,ab,
kw (20,649)
#20 (coronary near/3 (disease* or disorder* or failure* or attack* or arrest* or syndrome*)):ti,ab,
kw (15,079)
#21 CVD or CHD or IHD:ti,ab,kw (2325)
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#22 (myocardial near/3 (infarc* or disease* or disorder* or failure* or attack* or arrest*)):ti,ab,
kw (14,322)
#23 circulatory near/3 (disease* or disorder*):ti,ab,kw (100)
#24 angina* or (atrial next fibril*):ti,ab,kw (11,477)
#25 stroke* or poststroke* or cerebrovascular:ti,ab,kw (22,044)
#26 ((brain* or cerebral* or lacunar) near/3 (accident* or infarc*)):ti,ab,kw (2104)
#27 hypertens* or (high next blood next pressure) or (high next cholesterol):ti,ab,kw (28,550)
#28 hypercholesterol?emia* or hypercholester?emia* or dyslipid?emia* or dyslipoprotein?emia*:ti,ab,
kw (790)
#29 #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26
or #27 or #28 (113,868)
#30 MeSH descriptor: [Diabetes Mellitus, Type 2] this term only (7914)
#31 MeSH descriptor: [Metabolic Syndrome X] explode all trees (717)
#32 diabetes near/2 (type next 2):ti,ab,kw (9705)
#33 diabetes near/2 (type next II):ti,ab,kw (610)
#34 (diabetes near/2 (“non insulin” or noninsulin)):ti,ab,kw (1755)
#35 NIDDM or T2DM or T2D:ti,ab,kw (1468)
#36 ((metabolic or dysmetabolic or reaven or “insulin resistance”) near/2 syndrome*):ti,ab,kw (1376)
#37 #30 or #31 or #32 or #33 or #34 or #35 or #36 (11,742)
#38 MeSH descriptor: [Neoplasms] explode all trees (47,634)
#39 cancer* or neoplas* or oncolog* or malignan* or carcinoma* or adenocarcinoma*:ti,ab,kw (73,437)
#40 (#38 or #39) (78,770)
#41 MeSH descriptor: [Body Mass Index] explode all trees (5177)
#42 ((“body mass” near/3 (index* or indices)) or bmi or quetelet*):ti,ab,kw (12,162)
#43 #41 or #42 (12,162)
#44 #5 and #12 and #43 and (#29 or #37 or #40) from 2011 to 2013 (65)
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#45 MeSH descriptor: [Skinfold Thickness] this term only (272)
#46 MeSH descriptor: [Waist Circumference] this term only (278)
#47 ((“skin fold” or skinfold) near/3 (thickness* or test* or measure*)):ti,ab,kw (595)
#48 (waist near/3 circumference*):ti,ab,kw (1260)
#49 #45 or #46 or #47 or #48 (1804)
#50 #5 and #12 and #49 (266)
#51 #50 and (#29 or #37) from 2008 to 2010 (20)
#52 #50 and #40 from 1900 to 2010 (2)
#53 MeSH descriptor: [Waist-Hip Ratio] explode all trees (163)
#54 MeSH descriptor: [Electric Impedance] this term only (318)
#55 ((“fat mass” near/3 (index* or indices)) or fmi):ti,ab,kw (52)
#56 ((“fat free mass” near/3 (index* or indices)) or ffmi):ti,ab,kw (28)
#57 (“body adipos*” near/3 (index* or indices)):ti,ab,kw (2)
#58 (“body fat” near/2 percentage*):ti,ab,kw (336)
#59 ((hip or neck) near/3 circumference*):ti,ab,kw (239)
#60 ((waist-to-hip or waist-hip) near/3 ratio*):ti,ab,kw (549)
#61 ((waist-to-height or waist-height) near/3 ratio*):ti,ab,kw (18)
#62 (((bioelectric* or electric*) near/3 (impedance or resistance)) or bia):ti,ab,kw (606)
#63 (“near infrared interactance” or NIR):ti,ab,kw (52)
#64 ((benn* or rohrer* or ponderal or corpulence) near/3 (index* or indices)):ti,ab,kw (32)
#65 (“sagittal abdominal diameter*” or “supine abdominal diameter*”):ti,ab,kw (8)
#66 #53 or #54 or #55 or #56 or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64 or #65 (1709)
#67 #5 and #12 and #66 and (#29 or #37 or #40) (49)
#68 #44 or #51 or #52 or #67 (127)
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Review of tracking of obesity into adulthood
Searches were limited by entry date 2007–13; Singh (ENL #454) tracking systematic review searches were
completed in February 2007.
MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations (OvidSP)
1946–2013, June week 1. Searched 17 June 2013. Retrieved 2677 records in MEDLINE and 126 records in
MEDLINE In-Process & Other Non-Indexed Citations.
1. exp Obesity/ (133,174)
2. Overweight/ (10,590)
3. Weight Gain/ (21,800)
4. Weight Loss/ (22,928)
5. obes$.ti,ab. (152,595)
6. (overweight or over weight).ti,ab. (32,221)
7. (weight gain or weight loss).ti,ab. (82,269)
8. or/1-7 (267,570)
9. Adiposity/ or Adipose Tissue/ (63,551)
10. exp Body Composition/ (35,621)
11. Body Weight/ (159,105)
12. (adiposity or adipose).ti,ab. (56,741)
13. (body adj2 (composition or fat)).ti,ab. (37,403)
14. fatness.ti,ab. (2835)
15. or/8-14 (468,298)
16. body mass index/ (75,120)
17. Skinfold Thickness/ (5477)
18. Waist Circumference/ (3853)
19. Waist-Hip Ratio/ (2715)
20. Electric Impedance/ (11,187)
21. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (113,508)
22. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (824)
23. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (345)
24. (body adipos$ adj3 (index$ or indices)).ti,ab. (35)
25. (body fat adj2 percentage$).ti,ab. (3478)
26. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$ or ratio$)).ti,ab. (4810)
27. ((waist or hip or neck) adj3 circumference$).ti,ab. (13,212)
28. ((waist-to-hip or waist-hip) adj3 (ratio$ or test$ or measure$)).ti,ab. (6373)
29. ((waist-to-height or waist-height) adj3 (ratio$ or test$ or measure$)).ti,ab. (523)
30. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (10,305)
31. (near infrared interactance or NIR).ti,ab. (4648)
32. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (1001)
33. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (108)
34. or/16-33 (169,256)
35. track$.ti,ab. (65,784)
36. traject$.ti,ab. (26,434)
37. (persistence or persistent$).ti,ab. (199,631)
38. (observ$ adj3 (repeat$ or regular$ or continu$ or frequent$ or period$ or recurr$ or perenn$ or
prolong$ or perpetu$ or long term)).ti,ab. (72,559)
39. (monitor$ adj3 (repeat$ or regular$ or continu$ or frequent$ or period$ or recurr$ or perenn$ or
prolong$ or perpetu$ or long term)).ti,ab. (34,703)
40. (surveil$ adj3 (repeat$ or regular$ or continu$ or frequent$ or period$ or recurr$ or perenn$ or
prolong$ or perpetu$ or long term)).ti,ab. (6320)
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
173
41. (measure$ adj3 (repeat$ or regular$ or continu$ or frequent$ or period$ or recurr$ or perenn$ or
prolong$ or perpetu$ or long term)).ti,ab. (58,971)
42. ((annual$ or regular$ or recurr$) adj3 (interview$ or questionnaire$)).ti,ab. (1252)
43. (lifespan or life span or lifecourse or life course).ti,ab. (32,271)
44. or/35-43 (482,887)
45. *Cohort Studies/ (916)
46. *Longitudinal Studies/ (1144)
47. ((cohort or panel) adj1 (study or studies or analy$)).ti,ab. (82,658)
48. (longitudinal adj1 (study or studies or survey or surveys or analy$ or pattern$ or data)).ti,ab. (50,985)
49. *Follow-up Studies/ (497)
50. (follow up adj1 (study or studies or survey or surveys or analy$ or data)).ti,ab. (50,500)
51. or/44-50 (646,777)
52. exp child/ (1,511,291)
53. exp Infant/ (917,072)
54. Adolescent/ (1,569,130)
55. Young Adult/ (311,210)
56. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,ab.
(1,205,816)
57. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (236,753)
58. (girl or girls or boy or boys or kid or kids).ti,ab. (155,425)
59. (young people or young person or young persons or young adult$).ti,ab. (67,269)
60. or/52-59 (3,200,696)
61. exp Adult/ (5,408,792)
62. (adult$ or midadult$ or middle age$ or later life).ti,ab. (765,494)
63. 61 or 62 (5,769,283)
64. 15 and 34 and 51 and 60 and 63 (2818)
65. (relation$ or association$ or predict$ or risk or risks or mortality).ti,ab. (3,350,562)
66. (obes$ or overweight or weight status or BMI or body mass index).ti,ab. (231,751)
67. (adult$ or middle-age$ or men or women or later life).ti,ab. (1,444,222)
68. (((relation$ or association$ or predict$ or risk or risks or mortality) adj5 (obes$ or overweight or weight
status or BMI or body mass index) adj6 (adult$ or middle-age$ or men or women or later life))).ti,ab.
[65 adj5 66 adj6 67] (3566)
69. 68 and 60 (1519)
70. 64 or 69 (4012)
71. (2007$ or 2008$ or 2009$ or 2010$ or 2011$ or 2012$ or 2013$).ed,dc,ep. (5,166,979)
72. 70 and 71 (2677)
PubMed (National Library of Medicine)
1946–17 June 2013. Searched 17 June 2013. Retrieved 2195 records.
#52 (#50 AND #51) (2195)
#51 2007:2013[edat] (5,408,518)
#50 (#46 OR #49) (3413)
#49 (#48 AND #42) (788)
#48 ((relation*[TI] or association*[TI] or predict*[TI] or risk[TI] or risks[TI] or mortality[TI]) AND (obes*[TI]
or overweight[TI] or “weight status”[TI] or BMI[TI] or “body mass index”[TI]) AND (adult*[TI] or
middle-age*[TI] or men[TI] or women[TI] or “later life”[TI])) (2583) [Title only]
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#47 (relation*[TIAB] or association*[TIAB] or predict*[TIAB] or risk[TIAB] or risks[TIAB] or mortality[TIAB])
AND (obes*[TIAB] or overweight[TIAB] or “weight status”[TIAB] or BMI[TIAB] or “body mass
index”[TIAB]) AND (adult*[TIAB] or middle-age*[TIAB] or men[TIAB] or women[TIAB] or “later
life”[tiab]) (59,518) [without adjacency this line is too sensitive]
#46 (#8 AND #24 AND #36 AND #42 AND #45) (2790)
#45 (#43 OR #44) (5,643,266)
#44 adult*[tiab] or midadult*[tiab] or middle age*[tiab] or later life[tiab] (785,580)
#43 “Adult”[Mesh] (5,240,400)
#42 (#37 OR #38 OR #39 OR #40 OR #41) (3,207,673)
#41 (“young people”[tiab] or “young person”[tiab] or “young persons”[tiab] or young adult*
[tiab]) (68,922)
#40 girl[tiab] or girls[tiab] or boy[tiab] or boys[tiab] or kid[tiab] or kids[tiab] (162,454)
#39 adolescen*[tiab] or juvenile*[tiab] or youth*[tiab] or teenage*[tiab] or youngster*[tiab] (247,200)
#38 child*[tiab] or infant*[tiab] or pediat*[tiab] or paediat*[tiab] or schoolchild*[tiab] or school age*
[tiab] or schoolage*[tiab] (1,248,537)
#37 (((“Child”[Mesh]) OR “Infant”[Mesh]) OR “Adolescent”[Mesh]) OR “Young
Adult”[Mesh] (2,838,299)
#36 (#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35) (660,605)
#35 “follow up study”[tiab] or “follow up studies”[tiab] or “follow up survey”[tiab] or “follow up
surveys”[tiab] or follow up analy*[tiab] or follow up pattern*[tiab] or “follow up data”[tiab] (50,170)
#34 “longitudinal study”[tiab] or “longitudinal studies”[tiab] or “longitudinal survey”[tiab] or
“longitudinal surveys”[tiab] or longitudinal analy*[tiab] or longitudinal pattern*[tiab] or “longitudinal
data”[tiab] (51,648)
#33 “cohort study”[tiab] or “cohort studies”[tiab] or cohort analy*[tiab] or “panel study”[tiab] or “panel
studies”[tiab] or panel analy*[tiab] (79,961)
#32 ((“Cohort Studies”[Majr]) OR “Longitudinal Studies”[Majr]) OR “Follow-Up Studies”[Majr] (2993)
#31 measure* repeat*[tiab] or measure* regular*[tiab] or measure* continu*[tiab] or measure*
frequent*[tiab] or measure* period*[tiab] or measure* recurr*[tiab] or measure* perenn*[tiab] or
measure* prolong*[tiab] or measure* perpetu*[tiab] or measure* long term[tiab] (78,057)
#30 annual* interview*[tiab] or annual* questionnaire*[tiab] or regular* interview*[tiab] or regular*
questionnaire*[tiab] or recurr* interview*[tiab] or recurr* questionnaire*[tiab] (8822)
#29 lifespan[tiab] or “life span”[tiab] or lifecourse[tiab] or “life course”[tiab] (32,727)
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
175
#28 surveil* repeat*[tiab] or surveil* regular*[tiab] or surveil* continu*[tiab] or surveil* frequent*[tiab] or
surveil* period*[tiab] or surveil* recurr*[tiab] or surveil* perenn*[tiab] or surveil* prolong*[tiab] or
surveil* perpetu*[tiab] or surveil* long term[tiab] (6687)
#27 (monito* repeat*[tiab] or monito* regular*[tiab] or monito* continu*[tiab] or monito* frequent*
[tiab] or monito* period*[tiab] or monito* recurr*[tiab] or monito* perenn*[tiab] or monito*
prolong*[tiab] or monito* perpetu*[tiab] or monito* long term[tiab]) (29,418)
#26 observ* repeat*[tiab] or observ* regular*[tiab] or observ* continu*[tiab] or observ* frequent*[tiab]
or observ* period*[tiab] or observ* recurr*[tiab] or observ* perenn*[tiab] or observ* prolong*[tiab]
or observ* perpetu*[tiab] or observ* long term[tiab] (85,510)
#25 track*[tiab] or traject*[tiab] or persistence[tiab] or persistent*[tiab] (302,985)
#24 (#9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR
#21 OR #22 OR #23) (174,219)
#23 (sagittal abdominal diameter*[tiab] or supine abdominal diameter*[tiab]) (114)
#22 benn* index[tiab] or benn* indices[tiab] or rohrer* index[tiab] or rohrer* indices[tiab] or “ponderal
index”[tiab] or “ponderal indices”[tiab] or “corpulence index”[tiab] or “corpulance
indices”[tiab] (973)
#21 ((((“Body Mass Index”[Mesh]) OR “Skinfold Thickness”[Mesh]) OR “Waist Circumference”[Mesh]) OR
“Waist-Hip Ratio”[Mesh]) OR “Electric Impedance”[Mesh] (85,824)
#20 (“body mass index”[tiab] or “body mass indices”[tiab] or bmi[tiab] or quetelet*[tiab]) (118,394)
#19 “fat mass index”[tiab] or “fat mass indices”[tiab] or fmi[tiab] (430)
#18 (“fat free mass index”[tiab] or “fat free mass indices”[tiab] or ffmi[tiab]) (244)
#17 “body adiposity index”[tiab] or “body adiposity indices”[tiab] or “body adiposie index”[tiab] or
“body adipose indices”[tiab] (43)
#16 (“body fat percentage”[tiab] or “body fat percentages”[tiab]) (1203)
#15 (“skin fold thickness”[tiab] or “skin fold test”[tiab] or “skin fold tests”[tiab] or “skin fold
measure”[tiab] or “skin fold measurement”[tiab] or “skin fold measures”[tiab] or “skin fold
measurements”[tiab]) (658)
#14 (“skinfold thickness”[tiab] or “skinfold test”[tiab] or “skinfold tests”[tiab] or “skinfold
measure”[tiab] or “skinfold measurement”[tiab] or “skinfold measures”[tiab] or “skinfold
measurements”[tiab]) (3340)
#13 “waist circumference”[tiab] or “hip circumference”[tiab] or “neck circumference”[tiab] (13,399)
#12 “waist-to-hip ratio”[tiab] or “waist-to-hip ratios”[tiab] or “waist-hip ratio”[tiab] or “waist-hip
ratios”[tiab] (6338)
#11 “waist-to-height ratio”[tiab] or “waist-to-height ratios”[tiab] or “waist-height ratio”[tiab] or
“waist-height ratios”[tiab] (587)
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#10 “bioelectric impedance”[tiab] or “bioelectrical impedance”[tiab] or “electric impedance”[tiab] or
“electrical impedance”[tiab] or “bioelectric resistance”[tiab] or “bioelectrical resistance”[tiab] or
“electric resistance”[tiab] or “electrical resistance”[tiab] or bia[tiab] (10,533)
#9 (“near infrared interactance”[tiab] or NIR[tiab]) (6556)
#8 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7) (579,710)
#7 adiposity[tiab] or adipose[tiab] or “body composition”[tiab] or “body fat”[tiab] or “body weight”[tiab]
or fatness[tiab] (214,862)
#6 (((“Adiposity”[Mesh]) OR “Adipose Tissue”[Mesh]) OR “Body Composition”[Mesh]) OR
“Body Weight”[Mesh] (384,283)
#5 “weight gain”[tiab] or “weight loss”[tiab] (85,952)
#4 overweight[tiab] or “over weight*”[tiab] (33,914)
#3 obes*[tiab] (159,094)
#2 ((“Overweight”[Mesh]) OR “Weight Gain”[Mesh]) OR “Weight Loss”[Mesh] (159,224)
#1 “Obesity”[Mesh] (126,355)
EMBASE (OvidSP)
1974–2013, week 24. Searched 17 June 2013. Retrieved 2287 records.
1. exp obesity/ (263,295)
2. weight gain/ (58,597)
3. weight reduction/ (85,394)
4. obes$.ti,ab. (214,390)
5. (overweight or over weight).ti,ab. (46,472)
6. (weight gain or weight loss).ti,ab. (112,861)
7. or/1-6 (442,794)
8. exp body composition/ (58,550)
9. body weight/ (180,005)
10. (adiposity or adipose).ti,ab. (73,719)
11. (body adj2 (composition or fat or weight)).ti,ab. (214,677)
12. fatness.ti,ab. (3315)
13. or/7-12 (717,815)
14. body mass/ (160,301)
15. skinfold thickness/ (7828)
16. waist circumference/ (18,940)
17. waist hip ratio/ (5962)
18. waist to height ratio/ (171)
19. weight height ratio/ (10)
20. neck circumference/ (152)
21. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (176,160)
22. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (1125)
23. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (494)
24. (body adipos$ adj3 (index$ or indices)).ti,ab. (60)
25. (body fat adj2 percentage$).ti,ab. (4433)
26. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$)).ti,ab. (5749)
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27. ((waist or hip or neck) adj3 circumference$).ti,ab. (20,813)
28. ((waist-to-hip or waist-hip) adj3 ratio$).ti,ab. (8313)
29. ((waist-to-height or waist-height) adj3 ratio$).ti,ab. (783)
30. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (13,714)
31. (near infrared interactance or NIR).ti,ab. (6331)
32. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (1205)
33. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (138)
34. or/14-33 (259,277)
35. track$.ti,ab. (87,589)
36. traject$.ti,ab. (32,963)
37. (persistence or persistent$).ti,ab. (256,530)
38. (observ$ adj3 (repeat$ or regular$ or continu$ or frequent$ or period$ or recurr$ or perenn$ or
prolong$ or perpetu$ or long term)).ti,ab. (97,714)
39. (monitor$ adj3 (repeat$ or regular$ or continu$ or frequent$ or period$ or recurr$ or perenn$ or
prolong$ or perpetu$ or long term)).ti,ab. (48,403)
40. (surveil$ adj3 (repeat$ or regular$ or continu$ or frequent$ or period$ or recurr$ or perenn$ or
prolong$ or perpetu$ or long term)).ti,ab. (8671)
41. (measure$ adj3 (repeat$ or regular$ or continu$ or frequent$ or period$ or recurr$ or perenn$ or
prolong$ or perpetu$ or long term)).ti,ab. (79,155)
42. ((annual$ or regular$ or recurr$) adj3 (interview$ or questionnaire$)).ti,ab. (1580)
43. (lifespan or life span or lifecourse or life course).ti,ab. (38,855)
44. or/35-43 (630,994)
45. *cohort analysis/ (4457)
46. *longitudinal study/ (2201)
47. *follow up/ (12,602)
48. ((cohort or panel) adj1 (study or studies or analy$)).ti,ab. (109,818)
49. (longitudinal adj1 (study or studies or survey or surveys or analy$ or pattern$ or data)).ti,ab. (62,065)
50. (follow up adj1 (study or studies or survey or surveys or analy$ or data)).ti,ab. (66,939)
51. or/44-50 (852,107)
52. child/ (1,267,520)
53. preschool child/ (500,626)
54. infant/ (522,480)
55. adolescent/ (1,241,285)
56. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,
ab. (1,546,923)
57. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (305,377)
58. (girl or girls or boy or boys or kid or kids).ti,ab. (207,250)
59. (young people or young person or young persons or young adult$).ti,ab. (86,569)
60. or/52-58 (2,954,917)
61. adult/ or middle aged/ (4,773,254)
62. (adult$ or midadult$ or middle age$ or later life).ti,ab. (962,049)
63. 61 or 62 (5,296,190)
64. 13 and 34 and 51 and 60 and 63 (2511)
65. (relation$ or association$ or predict$ or risk or risks or mortality).ti,ab. (4,479,904)
66. (obes$ or overweight or weight status or BMI or body mass index).ti,ab. (336,578)
67. (adult$ or middle-age$ or men or women or later life).ti,ab. (1,840,835)
68. ((relation$ or association$ or predict$ or risk or risks or mortality) adj4 (obes$ or overweight or weight
status or BMI or body mass index) adj5 (adult$ or middle-age$ or men or women or later life))
[65 adj4 66 adj5 67].ti,ab. (4263)
69. 60 and 68 (1181)
70. 64 or 69 (3419)
71. (2007$ or 2008$ or 2009$ or 2010$ or 2011$ or 2012$ or 2013$).em. (7,043,444)
72. 70 and 71 (2287)
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PsycINFO (OvidSP)
1806–2013, June week 2. Searched 17 June 2013. Retrieved 806 records.
1. obesity/ (13,943)
2. overweight/ (2266)
3. weight gain/ or weight loss/ (3366)
4. obes$.ti,ab. (20,620)
5. (overweight or over weight).ti,ab. (7922)
6. (weight gain or weight loss).ti,ab. (12,721)
7. or/1-6 (32,261)
8. body weight/ (9833)
9. (adiposity or adipose).ti,ab. (1914)
10. (body adj2 (composition or fat or weight)).ti,ab. (13,243)
11. fatness.ti,ab. (462)
12. or/7-11 (43,208)
13. body mass index/ (2147)
14. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (13,066)
15. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (87)
16. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (23)
17. (body adipos$ adj3 (index$ or indices)).ti,ab. (0)
18. (body fat adj2 percentage$).ti,ab. (315)
19. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$)).ti,ab. (256)
20. ((waist or hip or neck) adj3 circumference$).ti,ab. (1288)
21. ((waist-to-hip or waist-hip) adj3 ratio$).ti,ab. (508)
22. ((waist-to-height or waist-height) adj3 ratio$).ti,ab. (44)
23. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (456)
24. (near infrared interactance or NIR).ti,ab. (38)
25. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (79)
26. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (7)
27. or/13-26 (14,533)
28. (track$ or traject$ or persistence or persistent$).ti,ab. (69,027)
29. ((observ$ or monitor$ or surveil$ or measure$) adj3 (repeat$ or regular$ or continu$ or frequent$ or
period$ or recurr$ or perenn$ or prolong$ or perpetu$ or long term)).ti,ab. (26,566)
30. ((annual$ or regular$ or recurr$) adj3 (interview$ or questionnaire$)).ti,ab. (603)
31. (lifespan or life span or lifecourse or life course).ti,ab. (15,357)
32. or/28-31 (109,073)
33. cohort analysis/ (971)
34. exp *longitudinal studies/ (2561)
35. *followup studies/ (1496)
36. ((cohort or panel) adj1 (study or studies or analy$)).ti,ab. (11,031)
37. (longitudinal adj1 (study or studies or survey or surveys or analy$ or pattern$ or data)).ti,ab. (36,916)
38. (follow up adj1 (study or studies or survey or surveys or analy$ or data)).ti,ab. (13,649)
39. or/32-38 (164,950)
40. (adolescence 13 17 yrs or childhood birth 12 yrs or preschool age 2 5 yrs or school age 6 12
yrs).ag. (567,131)
41. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,ab.
(537,261)
42. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (207,480)
43. (girl or girls or boy or boys or kid or kids).ti,ab. (77,464)
44. (young people or young person or young persons or young adult$).ti,ab. (41,916)
45. or/40-44 (853,904)
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46. (adulthood 18 yrs older or middle age 40 64 yrs or thirties 30 39 yrs or young adulthood
18 29 yrs).ag. (1,223,100)
47. (adult$ or midadult$ or middle age$ or later life).ti,ab. (285,272)
48. 46 or 47 (1,336,121)
49. 12 and 27 and 39 and 45 and 48 (360)
50. (relation$ or association$ or predict$ or risk or risks or mortality).ti,ab. (1,068,050)
51. (obes$ or overweight or weight status or BMI or body mass index).ti,ab. (30,601)
52. (adult$ or middle-age$ or men or women or later life).ti,ab. (482,086)
53. ((relation$ or association$ or predict$ or risk or risks or mortality) adj5 (obes$ or overweight or weight
status or BMI or body mass index) adj6 (adult$ or middle-age$ or men or women or later life)).ti,ab.
[50 adj5 51 adj6 52] (798)
54. 49 or 53 (1106)
55. (2007$ or 2008$ or 2009$ or 2010$ or 2011$ or 2012$ or 2013$).dp. (1,005,336)
56. 54 and 55 (806)
Cumulative Index to Nursing and Allied Health Literature (EBSCOhost)
1981–7 June 2013. Searched 17 June 2013. Retrieved 1156 records.
Search term
Number
retrieved
S59 S57 AND S58 1156
S58 EM 2007 OR EM 2008 OR EM 2009 OR EM 2010 OR EM 2011 OR EM 2012 OR EM 2013 1,536,421
S57 S52 OR S56 1791
S56 S53 N5 S54 N6 S55 1342
S55 TI (adult* or middle-age* or men or women or “later life”) or AB (adult* or middle-age*
or men or women or “later life”)
239,088
S54 TI (obes* or overweight or “weight status” or BMI or “body mass index”) or AB (obes* or overweight
or “weight status” or BMI or “body mass index”)
40,211
S53 TI (relation* or association* or predict* or risk or risks or mortality) or AB (relation* or association*
or predict* or risk or risks or mortality)
449,134
S52 S10 AND S29 AND S42 AND S48 AND S51 555
S51 S49 OR S50 583,307
S50 TI (adult* or midadult* or “middle age*” or “later life”) or AB (adult* or midadult* or “middle age*”
or “later life”)
108,318
S49 (ZG “adult: 19-44 years”) or (ZG “middle aged: 45-64 years”) 533,351
S48 S43 OR S44 OR S45 OR S46 OR S47 413,550
S47 TI (“young people” or “young person” or “young persons” or “young adult*”) or AB (“young people”
or “young person” or “young persons” or “young adult*”)
14,989
S46 TI (girl or girls or boy or boys or kid or kids) or AB (girl or girls or boy or boys or kid or kids) 20,952
S45 TI (adolescen* or juvenile* or youth* or teenage* or youngster*) or AB (adolescen* or juvenile*
or youth* or teenage* or youngster*)
56,605
S44 TI (child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*)
or AB (child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*)
213,504
S43 (ZG “adolescent: 13-18 years”) or (ZG “child, preschool: 2-5 years”) or (ZG “child: 6-12 years”) 320,940
S42 S37 OR S38 OR S39 OR S40 OR S41 94,591
S41 TI (“follow up” N2 stud* or “follow up” N2 survey* or “follow up” N2 analy* or “follow up” data) or
AB (“follow up” N2 stud* or “follow up” N2 survey* or “follow up” N2 analy* or “follow up” data)
10,078
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Search term
Number
retrieved
S40 TI (longitudinal N2 stud* or longitudinal N2 survey* or longitudinal N2 analy* or longitudinal N2
pattern* or longitudinal N2 data) or AB (longitudinal N2 stud* or longitudinal N2 survey* or
longitudinal N2 analy* or longitudinal N2 pattern* or longitudinal N2 data)
14,785
S39 TI (cohort N2 stud* or cohort N2 analy* or panel N2 stud* or panel N2 analy*) or AB (cohort N2
stud* or cohort N2 analy* or panel N2 stud* or panel N2 analy*)
22,482
S38 (MM “Prospective Studies+”) 433
S37 S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 54,403
S36 TI (lifespan or “life span” or lifecourse or “life course”) or AB (lifespan or “life span” or lifecourse
or “life course”)
3428
S35 TI (annual* N3 interview* or annual* N3 questionnaire* or regular* N3 interview* or regular*
N3 questionnaire* or recurr* N3 interview* or recurr* N3 questionnaire*) or AB (annual* N3
interview* or annual* N3 questionnaire* or regular* N3 interview* or regular* N3 questionnaire*
or recurr* N3 interview* or recurr* N3 questionnaire*)
393
S34 TI (measure* N3 repeat* or measure* N3 regular* or measure* N3 continu* or measure*
N3 frequent* or measure* N3 period* or measure* N3 recurr* or measure* N3 perenn*
or measure* N3 prolong* or measure* N3 perpetu* or measure* N3 “long term”) or AB
(measure* N3 repeat* or measure* N3 regular* or measure* N3 continu* or measure*
N3 frequent* or measure* N3 period* or measure* N3 recurr* or measure* N3 perenn*
or measure* N3 prolong* or measure* N3 perpetu* or measure* N3 “long term”)
12,762
S33 TI (surveil* N3 repeat* or surveil* N3 regular* or surveil* N3 continu* or surveil* N3 frequent*
or surveil* N3 period* or surveil* N3 recurr* or surveil* N3 perenn* or surveil* N3 prolong*
or surveil* N3 perpetu* or surveil* N3 “long term”) or AB (surveil* N3 repeat* or surveil*
N3 regular* or surveil* N3 continu* or surveil* N3 frequent* or surveil* N3 period* or surveil*
N3 recurr* or surveil* N3 perenn* or surveil* N3 prolong* or surveil* N3 perpetu* or surveil*
N3 “long term”)
805
S32 TI (monitor* N3 repeat* or monitor* N3 regular* or monitor* N3 continu* or monitor*
N3 frequent* or monitor* N3 period* or monitor* N3 recurr* or monitor* N3 perenn* or
monitor* N3 prolong* or monitor* N3 perpetu* or monitor* N3 “long term”) or AB (monitor*
N3 repeat* or monitor* N3 regular* or monitor* N3 continu* or monitor* N3 frequent*
or monitor* N3 period* or monitor* N3 recurr* or monitor* N3 perenn* or monitor*
N3 prolong* or monitor* N3 perpetu* or monitor* N3 “long term”)
4382
S31 TI (observ* N3 repeat* or observ* N3 regular* or observ* N3 continu* or observ* N3 frequent*
or observ* N3 period* or observ* N3 recurr* or observ* N3 perenn* or observ* N3 prolong*
or observ* N3 perpetu* or observ* N3 “long term”) or AB (observ* N3 repeat* or observ*
N3 regular* or observ* N3 continu* or observ* N3 frequent* or observ* N3 period* or observ*
N3 recurr* or observ* N3 perenn* or observ* N3 prolong* or observ* N3 perpetu* or observ*
N3 “long term”)
4657
S30 TI (track* or traject* or persistence or persistent*) or AB (track* or traject* or persistence or persistent*) 29,753
S29 S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23
OR S24 OR S25 OR S26 OR S27 OR S28
40,956
S28 TI (“sagittal abdominal diameter*” or “supine abdominal diameter*”) or AB (“sagittal abdominal
diameter*” or “supine abdominal diameter*”)
21
S27 TI (benn* N3 index* or benn* N3 indices or rohrer* N3 index* or rohrer* N3 indices* or ponderal
N3 index* or ponderal N3 indices or corpulence N3 index* or corpulence N3 indices) or AB
(benn* N3 index* or benn* N3 indices or rohrer* N3 index* or rohrer* N3 indices* or ponderal
N3 index* or ponderal N3 indices or corpulence N3 index* or corpulence N3 indices)
79
S26 TI (“near infrared interactance” or NIR) or AB (“near infrared interactance” or NIR) 57
S25 TI (bioelectric* N3 impedance or electric* N3 impedance or bioelectric* N3 resistance or electric*
N3 resistance or bia) or AB (bioelectric* N3 impedance or electric* N3 impedance or bioelectric*
N3 resistance or electric* N3 resistance or bia)
883
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Search term
Number
retrieved
S24 TI (waist-to-height N3 ratio* or waist-height N3 ratio*) or AB (waist-to-height N3 ratio*
or waist-height N3 ratio*)
98
S23 TI (waist-to-hip N3 ratio* or waist-hip N3 ratio*) or AB (waist-to-hip N3 ratio* or waist-hip N3 ratio*) 855
S22 TI (waist N3 circumference* or hip N3 circumference* or neck N3 circumference*) or AB
(waist N3 circumference* or hip N3 circumference* or neck N3 circumference*)
2383
S21 TI (“skin fold” N3 thickness* or skinfold N3 thickness* or “skin fold” N3 test* or skinfold
N3 test* or “skin fold” N3 measure* or skinfold N3 measure*) or AB (“skin fold” N3 thickness*
or skinfold N3 thickness* or “skin fold” N3 test* or skinfold N3 test* or “skin fold” N3 measure*
or skinfold N3 measure*)
712
S20 TI (“body fat” N3 percentage*) or AB (“body fat” N3 percentage*) 783
S19 TI (“body adipos*” N3 index* or “body adipos*” N3 indices) or AB (“body adipos*” N3 index*
or “body adipos*” N3 indices)
9
S18 TI (“fat free mass” N3 index* or “fat free mass” N3 indices or ffmi) or AB (“fat free mass”
N3 index* or “fat free mass” N3 indices or ffmi)
78
S17 TI (“fat mass” N3 index* or “fat mass” N3 indices or fmi) or AB (“fat mass” N3 index*
or “fat mass” N3 indices or fmi)
144
S16 TI (“body mass” N3 index* or “body mass” N3 indices or bmi or quetelet*) or AB (“body mass”
N3 index* or “body mass” N3 indices or bmi or quetelet*)
19,190
S15 (MH “Electric Impedance”) 1562
S14 (MH “Waist-Hip Ratio”) 1252
S13 (MH “Waist Circumference”) 275
S12 (MH “Skinfold Thickness”) 2268
S11 (MH “Body Mass Index”) 28,392
S10 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 71,298
S9 TI (body N2 composition or body N2 fat or body N2 weight) or AB (body N2 composition or body
N2 fat or body N2 weight)
13,891
S8 TI (adiposity or adipose or fatness) or AB (adiposity or adipose or fatness) 3867
S7 (MH “Body Weight”) 8959
S6 (MH “Body Composition”) 7940
S5 (MH “Adipose Tissue”) 4511
S4 TI (“weight gain” or “weight loss”) or AB (“weight gain” or “weight loss”) 11,296
S3 TI (obes* or overweight or “over weight”) or AB (obes* or overweight or “over weight”) 27,898
S2 (MH “Weight Gain”) OR (MH “Weight Loss”) 12,531
S1 (MH “Obesity+”) 32,334
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The Cochrane Library: Cochrane Database of Systematic Reviews and
Cochrane Central Register of Controlled Trials (Wiley Online Library)
2013: CDSR Issue 6/12, CENTRAL Issue 5/12. Searched 17 June 2013. Retrieved 4 records in CDSR and
281 records in CENTRAL.
#1 MeSH descriptor: [Obesity] explode all trees (6452)
#2 MeSH descriptor: [Overweight] this term only (1072)
#3 MeSH descriptor: [Weight Gain] this term only (1416)
#4 MeSH descriptor: [Weight Loss] this term only (2918)
#5 (obes* or overweight or (over next weight)):ti,ab,kw (10,756)
#6 ((weight next gain) or (weight next loss)):ti,ab,kw (9014)
#7 MeSH descriptor: [Adiposity] this term only (203)
#8 MeSH descriptor: [Body Composition] explode all trees (2773)
#9 MeSH descriptor: [Body Weight] this term only (5538)
#10 (adiposity or adipose or fatness):ti,ab,kw (2168)
#11 (body near/2 (composition or fat or weight)):ti,ab,kw (18,126)
#12 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 (29,278)
#13 MeSH descriptor: [Body Mass Index] this term only (5044)
#14 MeSH descriptor: [Skinfold Thickness] this term only (269)
#15 MeSH descriptor: [Waist Circumference] this term only (261)
#16 MeSH descriptor: [Waist-Hip Ratio] this term only (158)
#17 MeSH descriptor: [Electric Impedance] this term only (313)
#18 ((“body mass” near/3 (index* or indices)) or bmi or quetelet*):ti,ab,kw (11,870)
#19 ((“fat mass” near/3 (index* or indices)) or fmi):ti,ab,kw (49)
#20 ((“fat free mass” near/3 (index* or indices)) or ffmi):ti,ab,kw (28)
#21 (“body adipos*” near/3 (index* or indices)):ti,ab,kw (1)
#22 (“body fat” near/2 percentage*):ti,ab,kw (328)
#23 ((“skin fold” or skinfold) near/3 (thickness* or test* or measure*)):ti,ab,kw (590)
#24 ((waist or hip or neck) near/3 circumference*):ti,ab,kw (1244)
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
183
#25 ((waist-to-hip or waist-hip) near/3 ratio*):ti,ab,kw (542)
#26 ((waist-to-height or waist-height) near/3 ratio*):ti,ab,kw (16)
#27 (((bioelectric* or electric*) near/3 (impedance or resistance)) or bia):ti,ab,kw (598)
#28 (“near infrared interactance” or NIR):ti,ab,kw (49)
#29 ((benn* or rohrer* or ponderal or corpulence) near/3 (index* or indices)):ti,ab,kw (32)
#30 (“sagittal abdominal diameter*” or “supine abdominal diameter*”):ti,ab,kw (8)
#31 #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26
or #27 or #28 or #29 or #30 (13,412)
#32 track* or traject* or persistence or persistent*:ti,ab,kw (11,683)
#33 (observ* or monitor* or surveil* or measure*) near/3 (repeat* or regular* or continu* or frequent*
or period* or recurr* or perenn* or prolong* or perpetu* or “long term”):ti,ab,kw (17,771)
#34 (annual* or regular* or recurr*) near/3 (interview* or questionnaire*):ti,ab,kw (348)
#35 lifespan or “life span” or lifecourse or “life course”:ti,ab,kw (286)
#36 MeSH descriptor: [Cohort Studies] this term only (5618)
#37 MeSH descriptor: [Longitudinal Studies] this term only (3807)
#38 MeSH descriptor: [Follow-Up Studies] this term only (38,849)
#39 (cohort or panel) near/1 (study or studies or analy*):ti,ab,kw (7541)
#40 longitudinal near/1 (study or studies or survey or surveys or analy* or pattern* or data):ti,ab,kw (5152)
#41 (followup or follow-up or “follow up”) near/1 (study or studies or survey or surveys or analy* or
pattern* or data):ti,ab,kw (42,804)
#42 #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 (78,737)
#43 MeSH descriptor: [Child] explode all trees (64)
#44 MeSH descriptor: [Infant] explode all trees (12,099)
#45 MeSH descriptor: [Adolescent] explode all trees (69,924)
#46 MeSH descriptor: [Young Adult] this term only (112)
#47 child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*:ti,ab,kw (83,100)
#48 adolescen* or juvenile* or youth* or teenage* or youngster*:ti,ab,kw (83,300)
#49 girl or girls or boy or boys or kid or kids:ti,ab,kw (3932)
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#50 “young people” or “young person” or “young persons” or “young adult*”:ti,ab,kw (21,570)
#51 #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 (149,377)
#52 MeSH descriptor: [Adult] explode all trees (863)
#53 adult* or midadult* or (middle next age*) or “later life”:ti,ab,kw (356,717)
#54 #52 or #53 (357,080)
#55 #12 and #31 and #42 and #51 and #54 (235)
#56 ((relation* or association* or predict* or risk or risks or mortality) near/5 (obes* or overweight or
weight status or BMI or body mass index) near/6 (adult* or middle-age* or men or women or later
life)):ti,ab,kw (264)
#57 #55 or #56 from 2007 (292)
Centre for Reviews and Dissemination databases: Database of Abstracts of
Reviews of Effects, Health Technology Assessment and NHS Economic
Evaluation Database (Centre for Reviews and Dissemination interface)
17 June 2013. Searched 17 June 2013. Retrieved 26 records in DARE, 2 records in HTA and 9 records in
NHS EED.
1. MeSH DESCRIPTOR Obesity EXPLODE ALL TREES (685)
2. MeSH DESCRIPTOR Overweight EXPLODE ALL TREES (698)
3. MeSH DESCRIPTOR Weight Gain EXPLODE ALL TREES (108)
4. MeSH DESCRIPTOR Weight Loss EXPLODE ALL TREES (309)
5. (obes* or overweight or “over weight” or “weight gain” or “weight loss”) (1773)
6. MeSH DESCRIPTOR Adiposity EXPLODE ALL TREES (11)
7. MeSH DESCRIPTOR Body Composition EXPLODE ALL TREES (72)
8. MeSH DESCRIPTOR Body Weight EXPLODE ALL TREES (1005)
9. (adiposity or adipose or fatness) (70)
10. ((body NEAR2 (composition or fat or weight))) (723)
11. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10) (2223)
12. MeSH DESCRIPTOR Body Mass Index EXPLODE ALL TREES (221)
13. MeSH DESCRIPTOR Skinfold Thickness EXPLODE ALL TREES (4)
14. MeSH DESCRIPTOR Waist Circumference EXPLODE ALL TREES (14)
15. MeSH DESCRIPTOR Waist-Hip Ratio EXPLODE ALL TREES (0)
16. MeSH DESCRIPTOR Electric Impedance EXPLODE ALL TREES (14)
17. (((“body mass” NEAR3 (index* or indices)) or bmi or quetelet*)) (930)
18. (((“fat mass” NEAR3 (index* or indices)) or fmi)) (5)
19. (((“fat free mass” NEAR3 (index* or indices)) or ffmi)) (0)
20. ((“body adipos*” NEAR3 (index* or indices))) (1)
21. ((“body fat” NEAR2 percentage*)) (9)
22. (((“skin fold” or skinfold) NEAR3 (thickness* or test* or measure*))) (48)
23. (((waist or hip or neck) NEAR3 circumference*)) (66)
24. (((waist-to-hip or waist-hip) NEAR3 ratio*)) (22)
25. (((waist-to-height or waist-height) NEAR3 ratio*)) (2)
26. ((((bioelectric* or electric*) NEAR3 (impedance or resistance)) or bia)) (28)
27. (((benn* or rohrer* or ponderal or corpulence) NEAR3 (index* or indices))) (6)
28. ((“infrared interactance” or NIR)) (7)
29. ((“sagittal abdominal diameter*” or “supine abdominal diameter*”)) (0)
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30. (#12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
or #26 or #27 or #28 or #29) (986)
31. (track* or traject* or persistence or persistent*) (17,333)
32. ((observ* or monitor* or surveil* or measure*) near3 (repeat* or regular* or continu* or frequent* or
period* or recurr* or perenn* or prolong* or perpetu* or “long term”)) (602)
33. ((annual* or regular* or recurr*) near3 (interview* or questionnaire*)) (6)
34. (lifespan or “life span” or lifecourse or “life course”) (108)
35. MeSH DESCRIPTOR Cohort Studies (1111)
36. MeSH DESCRIPTOR Longitudinal Studies (129)
37. MeSH DESCRIPTOR Follow-Up Studies EXPLODE ALL TREES (0)
38. ((cohort or panel) near2 (study or studies or analy*)) (3956)
39. (longitudinal near2 (study or studies or survey or surveys or analy* or pattern* or data)) (421)
40. ((“follow up” or followup) near2 (study or studies or survey or surveys or analy* or pattern* or data)) (3166)
41. #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 (23,434)
42. MeSH DESCRIPTOR Child EXPLODE ALL TREES (3678)
43. MeSH DESCRIPTOR Infant EXPLODE ALL TREES (2265)
44. (MeSH DESCRIPTOR Adolescent EXPLODE ALL TREES) (3457)
45. (MeSH DESCRIPTOR Young Adult EXPLODE ALL TREES) (1125)
46. (((child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*))) (9055)
47. (((adolescen* or juvenile* or youth* or teenage* or youngster*))) (4302)
48. (((girl or girls or boy or boys or kid or kids))) (278)
49. (((“young people” or “young person” or “young persons” or “young adult*”)) ) (1494)
50. #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 (11,257)
51. MeSH DESCRIPTOR Adult EXPLODE ALL TREES (13,312)
52. (adult* or midadult* or “middle age*” or “later life”) (16,889)
53. #51 OR #52 (18,319)
54. #11 AND #30 AND #41 AND #50 AND #53 (40)
55. (((relation* or association* or predict* or risk or risks or mortality) near5 (obes* or overweight or weight
status or BMI or body mass index) near6 (adult* or middle-age* or men or women or later life))) (15)
56. #54 OR #55 (52)
57. (* FROM 2007 TO 2013) (34,534)
58. #56 AND #57 (37)
Science Citation Index (Web of Science)
1900–14 June 2013. Searched 17 June 2013. Retrieved 1829 records.
Search term Number retrieved
# 19 #17 not #18
Databases=SCI-EXPANDED
1829
# 18 TS=(rat or rats or mouse or mice or murine or hamster or hamsters or animal or animals or
dogs or dog or pig or pigs or cats or bovine or cow or sheep or ovine or porcine or monkey)
Databases=SCI-EXPANDED
3,803,559
# 17 #15 AND #16
Databases=SCI-EXPANDED
1894
# 16 PY=(2007-2013)
Databases=SCI-EXPANDED
10,274,844
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Search term Number retrieved
# 15 #13 OR #14
Databases=SCI-EXPANDED
2927
# 14 TS=((relation* or association* or predict* or risk or risks or mortality) NEAR/3 (obes* or
overweight or “weight status” or BMI or “body mass index”) NEAR/4 (adult* or middle-age*
or men or women or “later life”)) AND TS=(child* or infant* or pediat* or paediat* or
schoolchild* or “school age” or “school aged” or schoolage* or adolescen* or juvenile* or
youth* or teenage* or youngster* or girl or girls or boy or boys or kid or kids or “young
people” or “young person” or “young persons” or “young adult” or “young adults”)
Databases=SCI-EXPANDED
1383
# 13 #1 AND #6 AND #10 AND #11 AND #12
Databases=SCI-EXPANDED
1873
# 12 TS=(adult* or midadult* or “middle age*” or “later life”)
Databases=SCI-EXPANDED
803,294
# 11 TS=(child* or infant* or pediat* or paediat* or schoolchild* or “school age” or “school aged” or
schoolage* or adolescen* or juvenile* or youth* or teenage* or youngster* or girl or girls or boy
or boys or kid or kids or “young people” or “young person” or “young persons” or “young
adult” or “young adults”)
Databases=SCI-EXPANDED
1,339,321
# 10 #7 OR #8 OR #9
Databases=SCI-EXPANDED
913,241
# 9 TS=((cohort or panel) NEAR/1 (study or studies or analy*)) or TS=((longitudinal or “follow
up” or followup) NEAR/1 (study or studies or survey or surveys or analy* or pattern* or
data))
Databases=SCI-EXPANDED
188,765
# 8 TS=((annual* or regular* or recur*) NEAR/3 (interview* or questionnaire*)) or TS=(lifespan
or “life span” or lifecourse or “life course”)
Databases=SCI-EXPANDED
41,054
# 7 TS=( track* or traject* or persistence or persistent*) or TS=((observ* or monitor* or surveil*
or measure*) NEAR/3 (repeat* or regular* or continu* or frequent* or period* or recur* or
perenn* or prolong* or perpetu* or “long term”))
Databases=SCI-EXPANDED
703,711
# 6 #2 OR #3 OR #4 OR #5
Databases=SCI-EXPANDED
169,737
# 5 TS=(((bioelectric* or electric*) NEAR/3 (impedance or resistance)) or bia) or TS=(“near
infrared interactance” or NIR) or TS=((benn* or rohrer* or ponderal or corpulence) NEAR/3
(index* or indices)) or TS=(sagittal abdominal diameter* or supine abdominal diameter*)
Databases=SCI-EXPANDED
48,466
# 4 TS=((waist or hip or neck) NEAR/3 circumference*) or TS=((waist-to-hip or waist-hip) NEAR/3
ratio*) or TS=((waist-to-height or waist-height) NEAR/3 ratio*)
Databases=SCI-EXPANDED
17,338
# 3 TS=(“body adiposity” NEAR/3 (index* or indices)) or TS=(“body fat” NEAR/2 percentage*)
or TS=((“skin fold” or skinfold) NEAR/3 (thickness* or test* or measure*))
Databases=SCI-EXPANDED
6792
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Search term Number retrieved
# 2 TS=((“body mass” NEAR/3 (index* or indices)) or bmi or quetelet*) or TS=((“fat mass” NEAR/3
(index* or indices)) or fmi) or TS=((“fat free mass” NEAR/3 (index* or indices)) or ffmi)
Databases=SCI-EXPANDED
115,482
# 1 TS=(obes* or overweight or “over weight” or “weight gain” or “weight loss” or adiposity
or adipose or fatness) or TS=(body NEAR/2 (composition or fat or weight))
Databases=SCI-EXPANDED
453,027
Conference Proceedings Citation Index – Science (Web of Science)
1990–14 June 2013. Searched 17 June 2013. Retrieved 152 records.
Search term Number retrieved
# 15 #13 OR #14
Databases=CPCI-S
152
# 14 TS=((relation* or association* or predict* or risk or risks or mortality) NEAR/3 (obes* or
overweight or “weight status” or BMI or “body mass index”) NEAR/4 (adult* or middle-age*
or men or women or “later life”)) AND TS=(child* or infant* or pediat* or paediat* or
schoolchild* or “school age” or “school aged” or schoolage* or adolescen* or juvenile* or
youth* or teenage* or youngster* or girl or girls or boy or boys or kid or kids or “young
people” or “young person” or “young persons” or “young adult” or “young adults”)
Databases=CPCI-S
91
# 13 #1 AND #6 AND #10 AND #11 AND #12
Databases=CPCI-S
69
# 12 TS=(adult* or midadult* or “middle age*” or “later life”)
Databases=CPCI-S
66,704
# 11 TS=(child* or infant* or pediat* or paediat* or schoolchild* or “school age” or “school
aged” or schoolage* or adolescen* or juvenile* or youth* or teenage* or youngster* or girl
or girls or boy or boys or kid or kids or “young people” or “young person” or “young
persons” or “young adult” or “young adults”)
Databases=CPCI-S
134,639
# 10 #7 OR #8 OR #9
Databases=CPCI-S
220,083
# 9 TS=((cohort or panel) NEAR/1 (study or studies or analy*)) or TS=((longitudinal or “follow
up” or followup) NEAR/1 (study or studies or survey or surveys or analy* or pattern* or
data))
Databases=CPCI-S
19,090
# 8 TS=((annual* or regular* or recur*) NEAR/3 (interview* or questionnaire*)) or TS=(lifespan
or “life span” or lifecourse or “life course”)
Databases=CPCI-S
4413
# 7 TS=(track* or traject* or persistence or persistent*) or TS=((observ* or monitor* or surveil*
or measure*) NEAR/3 (repeat* or regular* or continu* or frequent* or period* or recur* or
perenn* or prolong* or perpetu* or “long term”))
Databases=CPCI-S
198,195
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Search term Number retrieved
# 6 #2 OR #3 OR #4 OR #5
Databases=CPCI-S
23,836
# 5 TS=(((bioelectric* or electric*) NEAR/3 (impedance or resistance)) or bia) or TS=(“near
infrared interactance” or NIR) or TS=((benn* or rohrer* or ponderal or corpulence) NEAR/3
(index* or indices)) or TS=(sagittal abdominal diameter* or supine abdominal diameter*)
Databases=CPCI-S
14,260
# 4 TS=((waist or hip or neck) NEAR/3 circumference*) or TS=((waist-to-hip or waist-hip) NEAR/3
ratio*) or TS=((waist-to-height or waist-height) NEAR/3 ratio*)
Databases=CPCI-S
886
# 3 TS=(“body adiposity” NEAR/3 (index* or indices)) or TS=(“body fat” NEAR/2 percentage*)
or TS=((“skin fold” or skinfold) NEAR/3 (thickness* or test* or measure*))
Databases=CPCI-S
351
# 2 TS=((“body mass” NEAR/3 (index* or indices)) or bmi or quetelet*) or TS=((“fat mass”
NEAR/3 (index* or indices)) or fmi) or TS=((“fat free mass” NEAR/3 (index* or indices)) or
ffmi)
Databases=CPCI-S
9083
# 1 TS=(obes* or overweight or “over weight” or “weight gain” or “weight loss” or adiposity
or adipose or fatness) or TS=(body NEAR/2 (composition or fat or weight))
Databases=CPCI-S
48,448
Health Management Information Consortium (OvidSP)
1979–March 2013. Searched 17 June 2013. Retrieved 52 records.
1. exp Obesity/ (2727)
2. (obes$ or overweight or over weight or weight gain or weight loss).ti,ab. (3514)
3. exp Body weight/ (842)
4. (adiposity or adipose or (body adj2 (composition or fat or weight)) or fatness).ti,ab. (621)
5. or/1-4 (4574)
6. exp body mass index/ (496)
7. weight size ratios/ (72)
8. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (1674)
9. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (10)
10. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (4)
11. (body adipos$ adj3 (index$ or indices)).ti,ab. (0)
12. (body fat adj2 percentage$).ti,ab. (31)
13. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$)).ti,ab. (32)
14. ((waist or hip or neck) adj3 circumference$).ti,ab. (222)
15. ((waist-to-hip or waist-hip) adj3 ratio$).ti,ab. (72)
16. ((waist-to-height or waist-height) adj3 ratio$).ti,ab. (10)
17. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (15)
18. (near infrared interactance or NIR).ti,ab. (1)
19. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (5)
20. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (2)
21. or/6-20 (1881)
22. (track$ or traject$ or persistence or persistent$).ti,ab. (2602)
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23. ((observ$ or monitor$ or surveil$ or measure$) adj3 (repeat$ or regular$ or continu$ or frequent$ or
period$ or recurr$ or perenn$ or prolong$ or perpetu$ or long term)).ti,ab. (1287)
24. ((annual$ or regular$ or recurr$) adj3 (interview$ or questionnaire$)).ti,ab. (56)
25. (lifespan or life span or lifecourse or life course).ti,ab. (456)
26. cohort studies/ (757)
27. longitudinal studies/ (457)
28. ((cohort or panel) adj1 (study or studies or analy$)).ti,ab. (2763)
29. (longitudinal adj1 (study or studies or survey or surveys or analy$ or pattern$ or data)).ti,ab. (1552)
30. (follow up adj1 (study or studies or survey or surveys or analy$ or data)).ti,ab. (835)
31. or/22-30 (9166)
32. exp Children/ or exp Older children/ or exp Pre school children/ (17,728)
33. exp Infants/ (1520)
34. exp Young people/ (9377)
35. exp Young adults/ (281)
36. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,ab. (29,945)
37. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (6446)
38. (girl or girls or boy or boys or kid or kids).ti,ab. (1508)
39. (young people or young person or young persons or young adult$).ti,ab. (5502)
40. or/32-39 (40,506)
41. adults/ or middle aged people/ (2555)
42. (adult$ or midadult$ or middle age$ or later life).ti,ab. (12,127)
43. 41 or 42 (12,746)
44. 5 and 21 and 31 and 40 and 43 (67)
45. (2007$ or 2008$ or 2009$ or 2010$ or 2011$ or 2012$ or 2013$).dp,yr. (68,585)
46. 44 and 45 (52)
Trials Register of Promoting Health Interventions (Evidence for Policy and
Practice Information and Co-ordinating Centre)
18 June 2013. Searched 18 June 2013. Retrieved 14 records (post-2007).
1. Freetext: “obes*” OR overweight OR “over weight” OR “weight gain” OR “weight loss” (862)
2. Freetext: adiposity OR adipose OR fatness OR “body composition” or “body fat” or “body
weight” (280)
3. 1 OR 2 (918)
4. Freetext: “track*” OR “traject*” OR persistence OR “persistent*” (101)
5. Freetext: “cohort study” OR “cohort studies” OR “longitudinal study” OR “longitudinal studies” OR
“follow up study” OR “follow up studies” (129)
6. 4 OR 5 (223)
7. 3 AND 6 (27)
Obesity and Sedentary Behaviour Database (Evidence for Policy and Practice
Information and Co-ordinating Centre)
18 June 2013. Searched 18 June 2013. Retrieved 13 records (post-2007).
1. Freetext: “track*” OR “traject*” OR persistence OR “persistent*” (9)
2. Freetext: “cohort study” OR “cohort studies” OR “longitudinal study” OR “longitudinal studies” OR
“follow up study” OR “follow up studies” (27)
3. 1 OR 2 (32)
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OAIster (http://oaister.worldcat.org/)
Searched 18 June 2013. Retrieved 79 records.
kw:(obes* OR overweight OR “weight gain” OR adiposity) kw:(“body mass index*” OR bmi OR quetelet*
OR “fat mass index*” OR “fat free mass index*” OR “body adiposity index*” OR “body fat percentage”
OR “skin fold” OR skinfold OR “waist circumference*” OR “hip circumference*” OR “neck
circumference*” OR “waist-to-hip” OR “waist-hip” OR “waist-to-height” OR “waist-height” OR
“bioelectric* impedance” OR “electric* impedance” OR “benn* index*” OR “rohrer* index*” OR
“ponderal index*” OR “corpulence index*” OR “sagittal abdominal diameter*” OR “supine abdominal
diameter*”) AND (track* OR traject* OR persistence OR persistent* OR “cohort study” OR “cohort
studies” OR “longitudinal study” OR “longitudinal studies” OR “follow up study” OR “follow up studies”)
kw:(child* OR infant* OR pediat* OR paediat* OR schoolchild* OR “school age*” OR schoolage* OR
adolescen* OR juvenile* OR youth* OR teenage* OR youngster* OR “young people” OR “young person”
OR “young persons” OR “young adult*”) AND (adult* OR “middle age*”)' > '2007..2013' limited to
Libraries Worldwide
OpenGrey (www.opengrey.eu/)
Searched 18 June 2013. Retrieved 0 records.
(obes* OR overweight OR “weight gain” OR adiposity) AND (track* OR traject* OR persistence OR
persistent* OR “cohort study” OR “cohort studies” OR “longitudinal study” OR “longitudinal studies” OR
“follow up study” OR “follow up studies”)
Review of the diagnostic accuracy of childhood measures
of obesity
MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations (OvidSP)
1946–2013, May week 5. Searched 10 June 2013. Retrieved 2412 records in MEDLINE and 50 records in
MEDLINE In-Process & Other Non-Indexed Citations.
1. exp Obesity/ (133,014)
2. Overweight/ (10,556)
3. Weight Gain/ (21,776)
4. Weight Loss/ (22,903)
5. obes$.ti,ab. (152,384)
6. (overweight or over weight).ti,ab. (32,167)
7. (weight gain or weight loss).ti,ab. (82,180)
8. or/1-7 (267,262)
9. Adiposity/ or Adipose Tissue/ (63,489)
10. exp Body Composition/ (35,563)
11. Body Weight/ (159,038)
12. (adiposity or adipose).ti,ab. (56,647)
13. (body adj2 (composition or fat or weight)).ti,ab. (168,451)
14. fatness.ti,ab. (2834)
15. or/8-14 (541,557)
16. Body Mass Index/ (75,019)
17. Skinfold Thickness/ (5476)
18. Waist Circumference/ (3842)
19. Waist-Hip Ratio/ (2713)
20. Electric Impedance/ (11,165)
21. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (113,321)
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22. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (823)
23. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (343)
24. (body adipos$ adj3 (index$ or indices)).ti,ab. (35)
25. (body fat adj2 percentage$).ti,ab. (3469)
26. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$)).ti,ab. (4708)
27. ((waist or hip or neck) adj3 circumference$).ti,ab. (13,184)
28. ((waist-to-hip or waist-hip) adj3 ratio$).ti,ab. (6212)
29. ((waist-to-height or waist-height) adj3 ratio$).ti,ab. (514)
30. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (10,288)
31. (near infrared interactance or NIR).ti,ab. (4634)
32. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (999)
33. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (108)
34. or/16-33 (168,960)
35. exp Densitometry/ (28,031)
36. exp Plethysmography/ (18,381)
37. Neutron Activation Analysis/ (1682)
38. (body volume adj3 (index$ or indices)).ti,ab. (1)
39. (densitometr$ or hydrodensitometr$).ti,ab. (13,282)
40. ((hydrostatic or underwater or water) adj3 (weighing or analys$ or measure$)).ti,ab. (12,322)
41. (absorptiometry or DXA or DEXA).ti,ab. (18,761)
42. ((water or air) adj3 displacement).ti,ab. (999)
43. (air displacement plethysmograph$ or pea pod or peapod or infant body composition system$ or
bodpod or bod pod).ti,ab. (319)
44. (neutron$ adj3 activat$).ti,ab. (2611)
45. ((multicomponent$ or multi component$ or multimodal$ or multi modal$ or composit$) adj3
model$).ti,ab. (2039)
46. (deuterium adj3 dilut$).ti,ab. (452)
47. or/35-46 (80,449)
48. exp child/ (1,510,589)
49. exp Infant/ (916,662)
50. Adolescent/ (1,568,189)
51. Young Adult/ (310,115)
52. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,
ab. (1,205,015)
53. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (236,539)
54. (girl or girls or boy or boys or kid or kids).ti,ab. (155,309)
55. (young people or young person or young persons or young adult$).ti,ab. (67,202)
56. or/48-55 (3,198,543)
57. 15 and 34 and 47 and 56 (2417)
58. exp Animals/ not Humans/ (3,903,550)
59. 57 not 58 (2412)
PubMed (National Library of Medicine)
1946–10 June 2013. Searched 10 June 2013. Retrieved 2116 records.
#45 (#43 NOT #44) (2116)
#44 (animals [mh] NOT humans [mh]) (3,786,976)
#43 (#9 AND #25 AND #36 AND #42) (2120)
#42 ((#37 OR #38 OR #39 OR #40 OR #41)) (3,204,504)
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#41 “young people”[tiab] or “young person”[tiab] or “young persons”[tiab] or young adult*
[tiab] (68,815)
#40 girl[tiab] or girls[tiab] or boy[tiab] or boys[tiab] or kid[tiab] or kids[tiab] (162,265)
#39 adolescen*[tiab] or juvenile*[tiab] or youth*[tiab] or teenage*[tiab] or youngster*[tiab] (246,765)
#38 child*[tiab] or infant*[tiab] or pediat*[tiab] or paediat*[tiab] or schoolchild*[tiab] or school age*
[tiab] or schoolage*[tiab] (1,247,217)
#37 (((“Child”[Mesh]) OR “Infant”[Mesh]) OR “Adolescent”[Mesh]) OR “Young
Adult”[Mesh] (2,835,930)
#36 ((#26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35)) (70,730)
#35 Search deuterium dilut*[tiab] (255)
#34 (“multicomponent model”[tiab] or “multicomponent models”[tiab] or “multi component
model”[tiab] or “multi component models”[tiab] or “multimodal model”[tiab] or “multimodal
models”[tiab] or “multi modal model”[tiab] or “multi modal models”[tiab] or “composite
model”[tiab] or “composite models”[tiab]) (422)
#33 neutron* activat*[tiab] (3609)
#32 air displacement plethysmograph*[tiab] or “pea pod”[tiab] or peapod[tiab] or infant body
composition system*[tiab] or bodpod[tiab] or “bod pod”[tiab] (385)
#31 water displacement[tiab] or air displacement[tiab] (815)
#30 absorptiometry[tiab] or DXA[tiab] or DEXA[tiab] (19,261)
#29 (hydrostatic weighing[tiab] or hydrostatic analys*[tiab] or hydrostatic measure*[tiab] or underwater
weighing[tiab] or underwater analys*[tiab] or underwater measure*[tiab] or water weighing[tiab] or
water analys*[tiab] or water measure*[tiab]) (3067)
#28 densitometr*[tiab] or hydrodensitometr*[tiab] (13,428)
#27 “body volume index”[TIAB] or “body volume indices”[tiab] (0)
#26 ((“Densitometry”[Mesh]) OR “Plethysmography”[Mesh]) OR “Neutron Activation
Analysis”[Mesh] (46,668)
#25 ((#10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR
#22 OR #23 OR #24)) (173,811)
#24 (sagittal abdominal diameter*[tiab] or supine abdominal diameter*[tiab]) (114)
#23 benn* index[tiab] or benn* indices[tiab] or rohrer* index[tiab] or rohrer* indices[tiab] or “ponderal
index”[tiab] or “ponderal indices”[tiab] or “corpulence index”[tiab] or “corpulance
indices”[tiab] (972)
#22 (“near infrared interactance”[tiab] or NIR[tiab]) (6538)
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#21 “bioelectric impedance”[tiab] or “bioelectrical impedance”[tiab] or “electric impedance”[tiab] or
“electrical impedance”[tiab] or “bioelectric resistance”[tiab] or “bioelectrical resistance”[tiab] or
“electric resistance”[tiab] or “electrical resistance”[tiab] or bia[tiab] (10,514)
#20 “waist-to-height ratio”[tiab] or “waist-to-height ratios”[tiab] or “waist-height ratio”[tiab] or
“waist-height ratios”[tiab] (584)
#19 “waist-to-hip ratio”[tiab] or “waist-to-hip ratios”[tiab] or “waist-hip ratio”[tiab] or “waist-hip
ratios”[tiab] (6331)
#18 “waist circumference”[tiab] or “hip circumference”[tiab] or “neck circumference”[tiab] (13,353)
#17 (“skinfold thickness”[tiab] or “skinfold test”[tiab] or “skinfold tests”[tiab] or “skinfold
measure”[tiab] or “skinfold measurement”[tiab] or “skinfold measures”[tiab] or “skinfold
measurements”[tiab]) (3335)
#16 (“skin fold thickness”[tiab] or “skin fold test”[tiab] or “skin fold tests”[tiab] or “skin fold
measure”[tiab] or “skin fold measurement”[tiab] or “skin fold measures”[tiab] or “skin fold
measurements”[tiab]) (658)
#15 (“body fat percentage”[tiab] or “body fat percentages”[tiab]) (1198)
#14 “body adiposity index”[tiab] or “body adiposity indices”[tiab] or “body adiposie index”[tiab] or
“body adipose indices”[tiab] (43)
#13 (“fat free mass index”[tiab] or “fat free mass indices”[tiab] or ffmi[tiab]) (244)
#12 “fat mass index”[tiab] or “fat mass indices”[tiab] or fmi[tiab] (430)
#11 (“body mass index”[tiab] or “body mass indices”[tiab] or bmi[tiab] or quetelet*[tiab]) (118,076)
#10 ((((“Body Mass Index”[Mesh]) OR “Skinfold Thickness”[Mesh]) OR “Waist Circumference”[Mesh]) OR
“Waist-Hip Ratio”[Mesh]) OR “Electric Impedance”[Mesh] (85,640)
#9 (#6 OR #7 OR #8) (578,940)
#8 adiposity[tiab] or adipose[tiab] or “body composition”[tiab] or “body fat”[tiab] or “body weight”[tiab]
or fatness[tiab] (214,556)
#7 (((“Adiposity”[Mesh]) OR “Adipose Tissue”[Mesh]) OR “Body Composition”[Mesh]) OR “Body
Weight”[Mesh] (383,871)
#6 ((#1 OR #2 OR #3 OR #4 OR #5)) (278,389)
#5 “weight gain”[tiab] or “weight loss”[tiab] (85,808)
#4 overweight[tiab] or “over weight*”[tiab] (33,801)
#3 obes*[tiab] (158,729)
#2 ((“Overweight”[Mesh]) OR “Weight Gain”[Mesh]) OR “Weight Loss”[Mesh] (158,971)
#1 “Obesity”[Mesh] (126,162)
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EMBASE (OvidSP)
1974–2013, week 23. Searched 10 June 2013. Retrieved 2274 records.
1. exp obesity/ (262,617)
2. weight gain/ (58,401)
3. weight reduction/ (85,101)
4. obes$.ti,ab. (213,837)
5. (overweight or over weight).ti,ab. (46,324)
6. (weight gain or weight loss).ti,ab. (112,520)
7. or/1-6 (441,658)
8. exp body composition/ (58,421)
9. body weight/ (179,655)
10. (adiposity or adipose).ti,ab. (73,593)
11. (body adj2 (composition or fat or weight)).ti,ab. (214,271)
12. fatness.ti,ab. (3314)
13. or/7-12 (716,288)
14. body mass/ (159,745)
15. skinfold thickness/ (7810)
16. waist circumference/ (18,862)
17. waist hip ratio/ (5940)
18. waist to height ratio/ (166)
19. weight height ratio/ (10)
20. neck circumference/ (143)
21. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (175,493)
22. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (1119)
23. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (491)
24. (body adipos$ adj3 (index$ or indices)).ti,ab. (60)
25. (body fat adj2 percentage$).ti,ab. (4420)
26. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$)).ti,ab. (5741)
27. ((waist or hip or neck) adj3 circumference$).ti,ab. (20,733)
28. ((waist-to-hip or waist-hip) adj3 ratio$).ti,ab. (8299)
29. ((waist-to-height or waist-height) adj3 ratio$).ti,ab. (778)
30. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (13,679)
31. (near infrared interactance or NIR).ti,ab. (6312)
32. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (1205)
33. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (136)
34. or/14-33 (258,369)
35. densitometry/ (16,109)
36. exp plethysmograph/ (451)
37. neutron activation analysis/ (5326)
38. (body volume adj3 (index$ or indices)).ti,ab. (6)
39. (densitometr$ or hydrodensitometr$).ti,ab. (17,847)
40. ((hydrostatic or underwater or water) adj3 (weighing or analys$ or measure$)).ti,ab. (17,975)
41. (absorptiometry or DXA or DEXA).ti,ab. (25,906)
42. ((water or air) adj3 displacement).ti,ab. (1325)
43. (air displacement plethysmograph$ or pea pod or peapod or infant body composition system$ or
bodpod or bod pod).ti,ab. (511)
44. (neutron$ adj3 activat$).ti,ab. (5851)
45. ((multicomponent$ or multi component$ or multimodal$ or multi modal$ or composit$) adj3
model$).ti,ab. (2750)
46. (deuterium adj3 dilut$).ti,ab. (529)
47. or/35-46 (78,881)
48. child/ (1,266,225)
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49. preschool child/ (500,023)
50. infant/ (522,108)
51. adolescent/ (1,240,231)
52. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,
ab. (1,545,191)
53. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (304,919)
54. (girl or girls or boy or boys or kid or kids).ti,ab. (206,972)
55. (young people or young person or young persons or young adult$).ti,ab. (86,424)
56. or/48-55 (2,993,496)
57. 13 and 34 and 47 and 56 (2274)
PsycINFO (OvidSP)
1806–2013, June week 1. Searched 11 June 2013. Retrieved 133 records.
1. obesity/ (13,925)
2. overweight/ (2263)
3. weight gain/ or weight loss/ (3364)
4. obes$.ti,ab. (20,582)
5. (overweight or over weight).ti,ab. (7911)
6. (weight gain or weight loss).ti,ab. (12,709)
7. or/1-6 (32,209)
8. body weight/ (9825)
9. (adiposity or adipose).ti,ab. (1912)
10. (body adj2 (composition or fat or weight)).ti,ab. (13,234)
11. fatness.ti,ab. (462)
12. or/7-11 (43,149)
13. body mass index/ (2140)
14. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (13,043)
15. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (87)
16. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (23)
17. (body adipos$ adj3 (index$ or indices)).ti,ab. (0)
18. (body fat adj2 percentage$).ti,ab. (315)
19. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$)).ti,ab. (256)
20. ((waist or hip or neck) adj3 circumference$).ti,ab. (1284)
21. ((waist-to-hip or waist-hip) adj3 ratio$).ti,ab. (507)
22. ((waist-to-height or waist-height) adj3 ratio$).ti,ab. (43)
23. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (455)
24. (near infrared interactance or NIR).ti,ab. (37)
25. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (79)
26. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (7)
27. or/13-26 (14,507)
28. plethysmography/ (133)
29. (body volume adj3 (index$ or indices)).ti,ab. (0)
30. (densitometr$ or hydrodensitometr$).ti,ab. (210)
31. ((hydrostatic or underwater or water) adj3 (weighing or analys$ or measure$)).ti,ab. (516)
32. (absorptiometry or DXA or DEXA).ti,ab. (513)
33. ((water or air) adj3 displacement).ti,ab. (34)
34. (air displacement plethysmograph$ or pea pod or peapod or infant body composition system$ or
bodpod or bod pod).ti,ab. (18)
35. (neutron$ adj3 activat$).ti,ab. (13)
36. ((multicomponent$ or multi component$ or multimodal$ or multi modal$ or composit$) adj3
model$).ti,ab. (678)
37. (deuterium adj3 dilut$).ti,ab. (14)
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38. or/28-37 (2084)
39. (adolescence 13 17 yrs or childhood birth 12 yrs or preschool age 2 5 yrs or school age 6 12 yrs or
young adulthood 18 29 yrs).ag. (778,079)
40. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,
ab. (536,641)
41. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (207,223)
42. (girl or girls or boy or boys or kid or kids).ti,ab. (77,393)
43. (young people or young person or young persons or young adult$).ti,ab. (41,848)
44. or/39-43 (1,040,736)
45. 12 and 27 and 38 and 44 (133)
Cumulative Index to Nursing and Allied Health Literature (EBSCOhost)
1981–7 June 2013. Searched 11 June 2013. Retrieved 551 records.
Search term
Number
retrieved
S49 S10 AND S29 AND S42 AND S48 551
S48 S43 OR S44 OR S45 OR S46 OR S47 412,874
S47 TI (“young people” or “young person” or “young persons” or “young adult*”) or AB (“young
people” or “young person” or “young persons” or “young adult*”)
14,961
S46 TI (girl or girls or boy or boys or kid or kids) or AB (girl or girls or boy or boys or kid or kids) 20,926
S45 TI (adolescen* or juvenile* or youth* or teenage* or youngster*) or AB (adolescen* or juvenile* or
youth* or teenage* or youngster*)
56,494
S44 TI (child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*) or AB
(child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*)
213,146
S43 (ZG “adolescent: 13-18 years”) or (ZG “child, preschool: 2-5 years”) or (ZG “child: 6-12 years”) 320,453
S42 S30 OR S31 OR S32 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 6568
S41 TI (deuterium N3 dilut*) or AB (deuterium N3 dilut*) 72
S40 TI (multicomponent* N3 model* or “multi component*” N3 model* or multimodal* N3 model* or
“multi modal* N3 model or composit* N3 model*) or AB (multicomponent* N3 model* or “multi
component*” N3 model* or multimodal* N3 model* or “multi modal* N3 model or composit* N3
model*)
24
S39 TI (neutron* N3 activat*) or AB (neutron* N3 activat*) 32
S38 TI (“air displacement plethysmograph*” or “pea pod” or peapod or “infant body composition
system*” or bodpod or “bod pod”) or AB (“air displacement plethysmograph*” or “pea pod” or
peapod or “infant body composition system*” or bodpod or “bod pod”)
93
S37 TI (water N3 displacement or air N3 displacement) or AB (water N3 displacement or air N3 displacement) 147
S36 TI (absorptiometry or DXA or DEXA) or AB (absorptiometry or DXA or DEXA) 2237
S35 TI (hydrostatic N3 weighing or hydrostatic N3 analys* or hydrostatic N3 measure* or underwater
N3 weighing or underwater N3 analys* or underwater N3 measure* or water N3 weighing or
water N3 analys* or water N3 measure*) or AB (hydrostatic N3 weighing or hydrostatic N3 analys*
or hydrostatic N3 measure* or underwater N3 weighing or underwater N3 analys* or underwater
N3 measure* or water N3 weighing or water N3 analys* or water N3 measure*)
732
S34 TI (densitometr* or hydrodensitometr*) or AB (densitometr* or hydrodensitometr*) 520
S33 TI (“body volume” N3 index* or “body volume” N3 indices) or AB (“body volume” N3 index* or
“body volume” N3 indices)
178
S32 TI (“body volume” N3 index* or “body volume” N3 indices) or AB (“body volume” N3 index* or
“body volume” N3 indices) [CINAHL SmartText Searching – ignored]
0
S31 (MH “Plethysmography+”) 1090
S30 (MH “Densitometry+”) 3881
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Search term
Number
retrieved
S29 S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR
S23 OR S24 OR S25 OR S26 OR S27 OR S28
40,846
S28 TI (“sagittal abdominal diameter*” or “supine abdominal diameter*”) or AB (“sagittal abdominal
diameter*” or “supine abdominal diameter*”)
21
S27 TI (benn* N3 index* or benn* N3 indices or rohrer* N3 index* or rohrer* N3 indices* or ponderal
N3 index* or ponderal N3 indices or corpulence N3 index* or corpulence N3 indices) or AB (benn*
N3 index* or benn* N3 indices or rohrer* N3 index* or rohrer* N3 indices* or ponderal N3 index*
or ponderal N3 indices or corpulence N3 index* or corpulence N3 indices)
79
S26 TI (“near infrared interactance” or NIR) or AB (“near infrared interactance” or NIR) 57
S25 TI (bioelectric* N3 impedance or electric* N3 impedance or bioelectric* N3 resistance or electric*
N3 resistance or bia) or AB (bioelectric* N3 impedance or electric* N3 impedance or bioelectric*
N3 resistance or electric* N3 resistance or bia)
882
S24 TI (waist-to-height N3 ratio* or waist-height N3 ratio*) or AB (waist-to-height N3 ratio* or waist-
height N3 ratio*)
97
S23 TI (waist-to-hip N3 ratio* or waist-hip N3 ratio*) or AB (waist-to-hip N3 ratio* or waist-hip N3 ratio*) 853
S22 TI (waist N3 circumference* or hip N3 circumference* or neck N3 circumference*) or AB (waist N3
circumference* or hip N3 circumference* or neck N3 circumference*)
2378
S21 TI (“skin fold” N3 thickness* or skinfold N3 thickness* or “skin fold” N3 test* or skinfold N3 test*
or “skin fold” N3 measure* or skinfold N3 measure*) or AB (“skin fold” N3 thickness* or skinfold
N3 thickness* or “skin fold” N3 test* or skinfold N3 test* or “skin fold” N3 measure* or skinfold
N3 measure*)
712
S20 TI (“body fat” N3 percentage*) or AB (“body fat” N3 percentage*) 783
S19 TI (“body adipos*” N3 index* or “body adipos*” N3 indices) or AB (“body adipos*” N3 index* or
“body adipos*” N3 indices)
9
S18 TI (“fat free mass” N3 index* or “fat free mass” N3 indices or ffmi) or AB (“fat free mass”
N3 index* or “fat free mass” N3 indices or ffmi)
78
S17 TI (“fat mass” N3 index* or “fat mass” N3 indices or fmi) or AB (“fat mass” N3 index* or
“fat mass” N3 indices or fmi)
144
S16 TI (“body mass” N3 index* or “body mass” N3 indices or bmi or quetelet*) or AB (“body mass”
N3 index* or “body mass” N3 indices or bmi or quetelet*)
19,132
S15 (MH “Electric Impedance”) 1560
S14 (MH “Waist-Hip Ratio”) 1251
S13 (MH “Waist Circumference”) 271
S12 (MH “Skinfold Thickness”) 2268
S11 (MH “Body Mass Index”) 28,324
S10 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 71,129
S9 TI (body N2 composition or body N2 fat or body N2 weight) or AB (body N2 composition or body
N2 fat or body N2 weight)
13,869
S8 TI (adiposity or adipose or fatness) or AB (adiposity or adipose or fatness) 3860
S7 (MH “Body Weight”) 8937
S6 (MH “Body Composition”) 7934
S5 (MH “Adipose Tissue”) 4507
S4 TI (“weight gain” or “weight loss”) or AB (“weight gain” or “weight loss”) 11,268
S3 TI (obes* or overweight or “over weight”) or AB (obes* or overweight or “over weight”) 27,804
S2 (MH “Weight Gain”) OR (MH “Weight Loss”) 12,508
S1 (MH “Obesity+”) 32,251
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The Cochrane Library: Cochrane Database of Systematic Reviews and
Cochrane Central Register of Controlled Trials (Wiley Online Library)
2013: CDSR Issue 5/12, CENTRAL Issue 5/12. Searched 11 June 2013. Retrieved 0 records in CDSR and
169 records in CENTRAL.
#1 MeSH descriptor: [Obesity] explode all trees (6452)
#2 MeSH descriptor: [Overweight] this term only (1072)
#3 MeSH descriptor: [Weight Gain] this term only (1416)
#4 MeSH descriptor: [Weight Loss] this term only (2918)
#5 (obes* or overweight or (over next weight)):ti,ab,kw (10,756)
#6 ((weight next gain) or (weight next loss)):ti,ab,kw (9014)
#7 MeSH descriptor: [Adiposity] this term only (203)
#8 MeSH descriptor: [Body Composition] explode all trees (2773)
#9 MeSH descriptor: [Body Weight] this term only (5538)
#10 (adiposity or adipose or fatness):ti,ab,kw (2168)
#11 (body near/2 (composition or fat or weight)):ti,ab,kw (18,126)
#12 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 (29,278)
#13 MeSH descriptor: [Body Mass Index] this term only (5044)
#14 MeSH descriptor: [Skinfold Thickness] this term only (269)
#15 MeSH descriptor: [Waist Circumference] this term only (261)
#16 MeSH descriptor: [Waist-Hip Ratio] this term only (158)
#17 MeSH descriptor: [Electric Impedance] this term only (313)
#18 ((“body mass” near/3 (index* or indices)) or bmi or quetelet*):ti,ab,kw (11,870)
#19 ((“fat mass” near/3 (index* or indices)) or fmi):ti,ab,kw (49)
#20 ((“fat free mass” near/3 (index* or indices)) or ffmi):ti,ab,kw (28)
#21 (“body adipos*” near/3 (index* or indices)):ti,ab,kw (1)
#22 (“body fat” near/2 percentage*):ti,ab,kw (328)
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#23 ((“skin fold” or skinfold) near/3 (thickness* or test* or measure*)):ti,ab,kw (590)
#24 ((waist or hip or neck) near/3 circumference*):ti,ab,kw (1244)
#25 ((waist-to-hip or waist-hip) near/3 ratio*):ti,ab,kw (542)
#26 ((waist-to-height or waist-height) near/3 ratio*):ti,ab,kw (16)
#27 (((bioelectric* or electric*) near/3 (impedance or resistance)) or bia):ti,ab,kw (598)
#28 (“near infrared interactance” or NIR):ti,ab,kw (49)
#29 ((benn* or rohrer* or ponderal or corpulence) near/3 (index* or indices)):ti,ab,kw (32)
#30 (“sagittal abdominal diameter*” or “supine abdominal diameter*”):ti,ab,kw (8)
#31 #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26
or #27 or #28 or #29 or #30 (13,412)
#32 MeSH descriptor: [Densitometry] explode all trees (1365)
#33 MeSH descriptor: [Plethysmography] explode all trees (948)
#34 MeSH descriptor: [Neutron Activation Analysis] this term only (15)
#35 (“body volume” near/3 (index* or indices)):ti,ab,kw (0)
#36 (densitometr* or hydrodensitometr*):ti,ab,kw (610)
#37 ((hydrostatic or underwater or water) near/3 (weighing or analys* or measure*)):ti,ab,kw (517)
#38 absorptiometry or DXA or DEXA:ti,ab,kw (2626)
#39 ((water or air) near/3 displacement):ti,ab,kw (62)
#40 (“air displacement plethysmograph*” or “pea pod” or peapod or “infant body composition
system*” or bodpod or “bod pod”):ti,ab,kw (18)
#41 (neutron* near/3 activat*):ti,ab,kw (58)
#42 ((multicomponent* or “multi component*” or multimodal* or “multi modal*” or composit*)
near/3 model*):ti,ab,kw (44)
#43 (deuterium near/3 dilut*):ti,ab,kw (31)
#44 #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 or #43 (4645)
#45 MeSH descriptor: [Child] explode all trees (64)
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#46 MeSH descriptor: [Infant] explode all trees (12,099)
#47 MeSH descriptor: [Adolescent] this term only (69,925)
#48 MeSH descriptor: [Young Adult] this term only (112)
#49 (child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*):ti,ab,kw
(83,100)
#50 (adolescen* or juvenile* or youth* or teenage* or youngster*):ti,ab,kw (83,300)
#51 (girl or girls or boy or boys or kid or kids):ti,ab,kw (3932)
#52 (“young people” or “young person” or “young persons” or “young adult*”):ti,ab,kw (21,570)
#53 #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 (149,377)
#54 #12 and #31 and #44 and #53 (170)
Centre for Reviews and Dissemination databases: Database of Abstracts of
Reviews of Effects, Health Technology Assessment and NHS Economic
Evaluation Database (Centre for Reviews and Dissemination interface)
10 June 2013. Searched 11 June 2013. Retrieved 8 records in DARE, 1 record in HTA and 0 records in
NHS EED.
1. MeSH DESCRIPTOR Obesity EXPLODE ALL TREES (685)
2. MeSH DESCRIPTOR Overweight EXPLODE ALL TREES (698)
3. MeSH DESCRIPTOR Weight Gain EXPLODE ALL TREES (108)
4. MeSH DESCRIPTOR Weight Loss EXPLODE ALL TREES (310)
5. (obes* or overweight or “over weight” or “weight gain” or “weight loss”) (1772)
6. MeSH DESCRIPTOR Adiposity EXPLODE ALL TREES (11)
7. MeSH DESCRIPTOR Body Composition EXPLODE ALL TREES (72)
8. MeSH DESCRIPTOR Body Weight EXPLODE ALL TREES (1005)
9. (adiposity or adipose or fatness) (70)
10. ((body NEAR2 (composition or fat or weight))) (723)
11. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10) (2222)
12. MeSH DESCRIPTOR Body Mass Index EXPLODE ALL TREES (220)
13. MeSH DESCRIPTOR Skinfold Thickness EXPLODE ALL TREES (4)
14. MeSH DESCRIPTOR Waist Circumference EXPLODE ALL TREES (14)
15. MeSH DESCRIPTOR Waist-Hip Ratio EXPLODE ALL TREES (0)
16. MeSH DESCRIPTOR Electric Impedance EXPLODE ALL TREES (14)
17. (((“body mass” NEAR3 (index* or indices)) or bmi or quetelet*)) (927)
18. (((“fat mass” NEAR3 (index* or indices)) or fmi)) (5)
19. (((“fat free mass” NEAR3 (index* or indices)) or ffmi)) (0)
20. ((“body adipos*” NEAR3 (index* or indices))) (1)
21. ((“body fat” NEAR2 percentage*)) (9)
22. (((“skin fold” or skinfold) NEAR3 (thickness* or test* or measure*))) (48)
23. (((waist or hip or neck) NEAR3 circumference*)) (66)
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24. (((waist-to-hip or waist-hip) NEAR3 ratio*)) (22)
25. (((waist-to-height or waist-height) NEAR3 ratio*)) (2)
26. ((((bioelectric* or electric*) NEAR3 (impedance or resistance)) or bia)) (28)
27. (((benn* or rohrer* or ponderal or corpulence) NEAR3 (index* or indices))) (6)
28. ((“infrared interactance” or NIR)) (7)
29. ((“sagittal abdominal diameter*” or “supine abdominal diameter*”)) (0)
30. (#12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
or #26 or #27 or #28 or #29) (983)
31. MeSH DESCRIPTOR Densitometry EXPLODE ALL TREES (81)
32. MeSH DESCRIPTOR Plethysmography EXPLODE ALL TREES (21)
33. MeSH DESCRIPTOR Neutron Activation Analysis EXPLODE ALL TREES (0)
34. ((“body volume” NEAR3 (index* or indices))) (0)
35. ((densitometr* or hydrodensitometr*)) (61)
36. (((hydrostatic or underwater or water) NEAR3 (weighing or analys* or measure*))) (16)
37. (absorptiometry or DXA or DEXA) (137)
38. (((water or air) NEAR3 displacement)) (7)
39. ((“air displacement plethysmograph*” or “pea pod” or peapod or “infant body composition system*”
or bodpod or “bod pod”)) (4)
40. ((neutron* NEAR3 activat*)) (0)
41. (((multicomponent* or “multi component*” or multimodal* or “multi modal*” or composit*) NEAR3
model*)) (1)
42. ((deuterium NEAR3 dilut*)) (1)
43. (#31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42) (196)
44. MeSH DESCRIPTOR Child EXPLODE ALL TREES (3665)
45. MeSH DESCRIPTOR Infant EXPLODE ALL TREES (2258)
46. MeSH DESCRIPTOR Adolescent EXPLODE ALL TREES (3456)
47. MeSH DESCRIPTOR Young Adult EXPLODE ALL TREES (1124)
48. ((child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*)) (9033)
49. ((adolescen* or juvenile* or youth* or teenage* or youngster*)) (4300)
50. ((girl or girls or boy or boys or kid or kids)) (278)
51. ((“young people” or “young person” or “young persons” or “young adult*”)) (1492)
52. (#44 or #45 or #46 or #47 or #48 or #49 or #50 or #51) (11,234)
53. #11 AND #30 AND #43 AND #52 (9)
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Science Citation Index (Web of Science)
1900–7 June 2013. Searched 11 June 2013. Retrieved 1666 records.
Search term
Number
retrieved
# 13 #11 NOT #12
Databases=SCI-EXPANDED Timespan=All years
1666
# 12 TS=(rat or rats or mouse or mice or murine or hamster or hamsters or animal or animals or dogs or
dog or pig or pigs or cats or bovine or cow or sheep or ovine or porcine or monkey)
Databases=SCI-EXPANDED Timespan=All years
3,774,018
# 11 #1 AND #6 AND #9 AND #10
Databases=SCI-EXPANDED Timespan=All years
1721
# 10 TS=(child* or infant* or pediat* or paediat* or schoolchild* or “school age” or “school aged” or
schoolage* or adolescen* or juvenile* or youth* or teenage* or youngster* or girl or girls or boy
or boys or kid or kids or “young people” or “young person” or “young persons” or “young adult”
or “young adults”)
Databases=SCI-EXPANDED Timespan=All years
1,337,616
# 9 #7 OR #8
Databases=SCI-EXPANDED Timespan=All years
134,636
# 8 TS=((water or air) NEAR/3 displacement) or TS=(“air displacement plethysmography” or “pea pod”
or peapod or “infant body composition system” or bodpod or “bod pod”) or TS=(neutron* NEAR/
3 activat*) or TS=((multicomponent* or “multi component” or multimodal* or “multi modal” or
composit*) NEAR/3 model*) or TS=(deuterium NEAR/3 dilut*)
Databases=SCI-EXPANDED Timespan=All years
40,070
# 7 TS=(“body volume” NEAR/3 (index* or indices)) or TS=(densitometr* or hydrodensitometr*) or
TS=((hydrostatic or underwater or water) NEAR/3 (weighing or analys* or measure*)) or
TS=(absorptiometry or DXA or DEXA)
Databases=SCI-EXPANDED Timespan=All years
95,866
# 6 #2 OR #3 OR #4 OR #5
Databases=SCI-EXPANDED Timespan=All years
169,334
# 5 TS=(((bioelectric* or electric*) NEAR/3 (impedance or resistance)) or bia) or TS=(“near infrared
interactance” or NIR) or TS=((benn* or rohrer* or ponderal or corpulence) NEAR/3 (index* or
indices)) or TS=(sagittal abdominal diameter* or supine abdominal diameter*)
Databases=SCI-EXPANDED Timespan=All years
48,378
# 4 TS=((waist or hip or neck) NEAR/3 circumference*) or TS=((waist-to-hip or waist-hip) NEAR/3 ratio*)
or TS=((waist-to-height or waist-height) NEAR/3 ratio*)
Databases=SCI-EXPANDED Timespan=All years
17,295
# 3 TS=(“body adiposity” NEAR/3 (index* or indices)) or TS=(“body fat” NEAR/2 percentage*) or
TS=((“skin fold” or skinfold) NEAR/3 (thickness* or test* or measure*))
Databases=SCI-EXPANDED Timespan=All years
6781
# 2 TS=((“body mass” NEAR/3 (index* or indices)) or bmi or quetelet*) or TS=((“fat mass” NEAR/3
(index* or indices)) or fmi) or TS=((“fat free mass” NEAR/3 (index* or indices)) or ffmi)
Databases=SCI-EXPANDED Timespan=All years
115,175
# 1 TS=(obes* or overweight or “over weight” or “weight gain” or “weight loss” or adiposity or
adipose or fatness) or TS=(body NEAR/2 (composition or fat or weight))
Databases=SCI-EXPANDED Timespan=All years
452,263
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Conference Proceedings Citation Index – Science (Web of Science)
1990–7 June 2013. Searched 11 June 2013. Retrieved 80 records.
Search term
Number
retrieved
# 11 #1 AND #6 AND #9 AND #10
Databases=CPCI-S Timespan=All years
80
# 10 TS=(child* or infant* or pediat* or paediat* or schoolchild* or “school age” or “school aged” or
schoolage* or adolescen* or juvenile* or youth* or teenage* or youngster* or girl or girls or boy
or boys or kid or kids or “young people” or “young person” or “young persons” or “young adult”
or “young adults”)
Databases=CPCI-S Timespan=All years
134,449
# 9 #7 OR #8
Databases=CPCI-S Timespan=All years
26,397
# 8 TS=((water or air) NEAR/3 displacement) or TS=(“air displacement plethysmography” or “pea pod”
or peapod or “infant body composition system” or bodpod or “bod pod”) or TS=(neutron* NEAR/
3 activat*) or TS=((multicomponent* or “multi component” or multimodal* or “multi modal” or
composit*) NEAR/3 model*) or TS=(deuterium NEAR/3 dilut*)
Databases=CPCI-S Timespan=All years
10,641
# 7 TS=(“body volume” NEAR/3 (index* or indices)) or TS=(densitometr* or hydrodensitometr*) or
TS=((hydrostatic or underwater or water) NEAR/3 (weighing or analys* or measure*)) or
TS=(absorptiometry or DXA or DEXA)
Databases=CPCI-S Timespan=All years
15,925
# 6 #2 OR #3 OR #4 OR #5
Databases=CPCI-S Timespan=All years
23,800
# 5 TS=(((bioelectric* or electric*) NEAR/3 (impedance or resistance)) or bia) or TS=(“near infrared
interactance” or NIR) or TS=((benn* or rohrer* or ponderal or corpulence) NEAR/3 (index* or
indices)) or TS=(sagittal abdominal diameter* or supine abdominal diameter*)
Databases=CPCI-S Timespan=All years
14,242
# 4 TS=((waist or hip or neck) NEAR/3 circumference*) or TS=((waist-to-hip or waist-hip) NEAR/3 ratio*)
or TS=((waist-to-height or waist-height) NEAR/3 ratio*)
Databases=CPCI-S Timespan=All years
886
# 3 TS=(“body adiposity” NEAR/3 (index* or indices)) or TS=(“body fat” NEAR/2 percentage*) or
TS=((“skin fold” or skinfold) NEAR/3 (thickness* or test* or measure*))
Databases=CPCI-S Timespan=All years
351
# 2 TS=((“body mass” NEAR/3 (index* or indices)) or bmi or quetelet*) or TS=((“fat mass” NEAR/3
(index* or indices)) or fmi) or TS=((“fat free mass” NEAR/3 (index* or indices)) or ffmi)
Databases=CPCI-S Timespan=All years
9065
# 1 TS=(obes* or overweight or “over weight” or “weight gain” or “weight loss” or adiposity or
adipose or fatness) or TS=(body NEAR/2 (composition or fat or weight))
Databases=CPCI-S Timespan=All years
48,407
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Health Management Information Consortium (OvidSP)
1979–March 2013. Searched 11 June 2013. Retrieved 13 records.
1. exp Obesity/ (2727)
2. (obes$ or overweight or over weight or weight gain or weight loss).ti,ab. (3514)
3. exp Body weight/ (842)
4. (adiposity or adipose or (body adj2 (composition or fat or weight)) or fatness).ti,ab. (621)
5. or/1-4 (4574)
6. exp body mass index/ (496)
7. weight size ratios/ (72)
8. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (1674)
9. ((fat mass adj3 (index$ or indices)) or fmi).ti,ab. (10)
10. ((fat free mass adj3 (index$ or indices)) or ffmi).ti,ab. (4)
11. (body adipos$ adj3 (index$ or indices)).ti,ab. (0)
12. (body fat adj2 percentage$).ti,ab. (31)
13. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$)).ti,ab. (32)
14. ((waist or hip or neck) adj3 circumference$).ti,ab. (222)
15. ((waist-to-hip or waist-hip) adj3 ratio$).ti,ab. (72)
16. ((waist-to-height or waist-height) adj3 ratio$).ti,ab. (10)
17. (((bioelectric$ or electric$) adj3 (impedance or resistance)) or bia).ti,ab. (15)
18. (near infrared interactance or NIR).ti,ab. (1)
19. ((benn$ or rohrer$ or ponderal or corpulence) adj3 (index$ or indices)).ti,ab. (5)
20. (sagittal abdominal diameter$ or supine abdominal diameter$).ti,ab. (2)
21. or/6-20 (1881)
22. (body volume adj3 (index$ or indices)).ti,ab. (0)
23. (densitometr$ or hydrodensitometr$).ti,ab. (19)
24. ((hydrostatic or underwater or water) adj3 (weighing or analys$ or measure$)).ti,ab. (22)
25. (absorptiometry or DXA or DEXA).ti,ab. (55)
26. ((water or air) adj3 displacement).ti,ab. (2)
27. (air displacement plethysmograph$ or pea pod or peapod or infant body composition system$ or
bodpod or bod pod).ti,ab. (3)
28. (neutron$ adj3 activat$).ti,ab. (6)
29. ((multicomponent$ or multi component$ or multimodal$ or multi modal$ or composit$) adj3
model$).ti,ab. (9)
30. (deuterium adj3 dilut$).ti,ab. (1)
31. or/22-30 (110)
32. exp Children/ or exp Older children/ or exp Pre school children/ (17,728)
33. exp Infants/ (1520)
34. exp Young people/ (9377)
35. exp Young adults/ (281)
36. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,ab. (29,945)
37. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (6446)
38. (girl or girls or boy or boys or kid or kids).ti,ab. (1508)
39. (young people or young person or young persons or young adult$).ti,ab. (5502)
40. or/32-39 (40,506)
41. 5 and 21 and 31 and 40 (13)
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Trials Register of Promoting Health Interventions (Evidence for Policy and
Practice Information and Co-ordinating Centre)
12 June 2013. Searched 12 June 2013. Retrieved 22 records.
1 Freetext: “obes*” OR overweight OR “over weight” OR “weight gain” OR “weight loss” (862)
2 Freetext: adiposity OR adipose OR fatness OR “body composition” or “body fat” or “body weight” (280)
3 1 OR 2 (918)
4 Freetext: “body mass index*” OR “body mass indices” OR bmi OR quetelet* (459)
5 Freetext: “fat mass” NEAR “index*” OR “fat mass” NEAR “indices*” OR fmi (4)
6 Freetext: “fat free mass” NEAR “index*” OR “fat free mass” NEAR “indices*” OR ffmi (3)
7 Freetext: “fat free mass” NEAR “index*” OR “fat free mass” NEAR “indices*” OR ffmi (3)
8 Freetext: “body adipos*” NEAR “index*” OR “body adipos*” NEAR “indices*” (0)
9 Freetext: “body fat” NEAR “percentage*” (29)
10 Freetext: “skin fold” or skinfold (38)
11 Freetext: “waist” NEAR “circumference*” OR “hip” NEAR “circumference*” OR “neck” NEAR
“circumference*” (119)
12 Freetext: “waist-to-hip” OR “waist-hip” OR “waist-to-height” OR “waist-height” (36)
13 Freetext: “bioelectric*” NEAR “impedance” OR “electric*” NEAR “impedance” OR “bioelectric*”
NEAR “resistance” OR “electric*” NEAR “resistance” (7)
14 Freetext: “benn*” NEAR “index*” OR “rohrer*” NEAR “index*” OR “ponderal” NEAR “index*” OR
“corpulence” NEAR “index*” OR “benn*” NEAR “indices*” OR “rohrer*” NEAR “indices*” OR
“ponderal” NEAR “indices*” OR “corpulence” NEAR “indices*” (0)
15 Freetext: “infrared interactance” OR NIR OR “sagittal abdominal diameter*” OR “supine abdominal
diameter*” (2)
16 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 (520)
17 Freetext: “body volume” NEAR “index*” OR “body volume” NEAR “indices” (0)
18 Freetext: “densitometr*” OR “hydrodensitometr*” (2)
19 Freetext: “hydrostatic” NEAR “weighing” OR “underwater” NEAR “weighing” OR “water” NEAR
“weighing” OR “hydrostatic” NEAR “analys*” OR “underwater” NEAR “analys*” OR “water” NEAR
“analys*” OR “hydrostatic” NEAR “measure*” OR “underwater” NEAR “measure*” OR “water” NEAR
“measure*” (42)
20 Freetext: absorptiometry OR “DXA” OR “DEXA” (22)
21 Freetext: “water” NEAR “displacement” OR “air” NEAR “displacement” (0)
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22 Freetext: “plethysmograph*” OR “pea pod” OR “peapod” OR “infant body composition system*”
OR bodpod OR “bod pod” (0)
23 Freetext: “multicomponent*” NEAR “model*”OR “multi component*” NEAR “model*”OR
“multimodal*” NEAR “model*“OR “multi modal*” NEAR “model*”OR “composit*” NEAR “model*” (46)
24 Freetext: “deuterium” NEAR “dilut*” (0)
25 17 OR 18 OR 19 OR 23 OR 24 OR 25 OR 26 OR 27 (108)
26 Freetext: “child*” OR “infant*” OR “pediat*” OR “paediat*” OR “schoolchild*” OR “school age*”
OR “schoolage*” OR “adolescen*” OR “juvenile*” OR “youth*” OR “teenage*” OR “youngster*” OR
girl OR girls OR boy OR boys OR kid OR kids OR “young people” OR “young person” OR “young persons”
OR “young adult*” (2789)
27 3 AND 16 AND 28 AND 29 (22)
Obesity and Sedentary Behaviour Database (Evidence for Policy and Practice
Information and Co-ordinating Centre)
12 June 2013. Searched 12 June 2013. Retrieved 5 records.
1. Freetext: “body mass index*” OR “body mass indices” OR bmi OR quetelet* (226)
2. Freetext: “fat mass” NEAR “index*” OR “fat mass” NEAR “indices*” OR fmi (6)
3. Freetext: “fat free mass” NEAR “index*” OR “fat free mass” NEAR “indices*” OR ffmi (3)
4. Freetext: “body adipos*” NEAR “index*” OR “body adipos*” NEAR “indices*” (0)
5. Freetext: “body fat” NEAR “percentage*” (20)
6. Freetext: “skin fold” or skinfold (17)
7. Freetext: “waist” NEAR “circumference*” OR “hip” NEAR “circumference*” OR “neck” NEAR
“circumference*” (22)
8. Freetext: “waist-to-hip” OR “waist-hip” OR “waist-to-height” OR “waist-height” (3)
9. Freetext: “bioelectric*” NEAR “impedance” OR “electric*” NEAR “impedance” OR “bioelectric*”
NEAR “resistance” OR “electric*” NEAR “resistance” (9)
10. Freetext: “benn*” NEAR “index*” OR “rohrer*” NEAR “index*” OR “ponderal” NEAR “index*” OR
“corpulence” NEAR “index*” OR “benn*” NEAR “indices*” OR “rohrer*” NEAR “indices*” OR
“ponderal” NEAR “indices*” OR “corpulence” NEAR “indices*” (0)
11. Freetext: “infrared interactance” OR NIR OR “sagittal abdominal diameter*” OR “supine abdominal
diameter*” (0)
12. 1 OR 2 OR 3 OR 4 OR 5 OR 7 OR 8 OR 9 OR 10 OR 11 (236)
13. Freetext: “body volume” NEAR “index*” OR “body volume” NEAR “indices” (0)
14. Freetext: “densitometr*” OR “hydrodensitometr*” (0)
15. Freetext: “hydrostatic” NEAR “weighing” OR “underwater” NEAR “weighing” OR “water” NEAR
“weighing” OR “hydrostatic” NEAR “analys*” OR “underwater” NEAR “analys*” OR “water” NEAR
“analys*” OR “hydrostatic” NEAR “measure*” OR “underwater” NEAR “measure*” OR “water”
NEAR “measure*” (3)
16. Freetext: absorptiometry OR “DXA” OR “DEXA” (10)
17. Freetext: “water” NEAR “displacement” OR “air” NEAR “displacement” (1)
18. Freetext: “plethysmograph*” OR “pea pod” OR “peapod” OR “infant body composition system*” OR
bodpod (0)
19. Freetext: “multicomponent*” NEAR “model*”OR “multi component*” NEAR “model*”OR
“multimodal*” NEAR “model*”OR “multi modal*” NEAR “model*”OR “composit*” NEAR “model*” (3)
20. Freetext: “deuterium” NEAR “dilut*” (0)
21. 13 OR 14 OR 15 OR 17 OR 18 OR 19 OR 20 (6)
22. 12 AND 21 (5)
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OAIster (http://oaister.worldcat.org/)
Searched 12 June 2013. Retrieved 92 records.
Search results for 'kw:(obes* OR overweight OR “weight gain” OR adiposity) kw:(“body mass index*” OR
bmi OR quetelet* OR “fat mass index*” OR “fat free mass index*” OR “body adiposity index*” OR
“body fat percentage” OR “skin fold” OR skinfold OR “waist circumference*” OR “hip circumference*”
OR “neck circumference*” OR “waist-to-hip” OR “waist-hip” OR “waist-to-height” OR “waist-height” OR
“bioelectric* impedance” OR “electric* impedance” OR “benn* index*” OR “rohrer* index*” OR
“ponderal index*” OR “corpulence index*” OR “sagittal abdominal diameter*” OR “supine abdominal
diameter*”) AND (“body volume index*” OR densitometr* OR hydrodensitometr* OR hydrostatic OR
“water weighing” OR “water analys*” OR “water measure*” OR absorptiometry OR DXA OR DEXA OR
“water displacement” OR “air displacement” OR plethysmograph* OR “pea pod” OR peapod OR bodpod
OR “neutron* activat*” OR “multicomponent* model*” OR “multimodal* model*” OR “deuterium
dilute*”) kw:(child* OR infant* OR pediat* OR paediat* OR schoolchild* OR “school age*” OR
schoolage* OR adolescen* OR juvenile* OR youth* OR teenage* OR youngster* OR “young people” OR
“young person” OR “young persons” OR “young adult*”)' limited to Libraries Worldwide.
OpenGrey (www.opengrey.eu/)
Searched 12 June 2013. Retrieved 0 records.
(obes* OR overweight OR “weight gain” OR adiposity) AND (“body volume index*” OR densitometr* OR
hydrodensitometr* OR hydrostatic OR “water weighing” OR “water analys*” OR “water measure*” OR
absorptiometry OR DXA OR DEXA OR “water displacement” OR “air displacement” OR plethysmograph*
OR “pea pod” OR peapod OR bodpod OR “neutron* activat*” OR “multicomponent* model*” OR
“multimodal* model*” OR “deuterium dilute*”).
Review of the acceptability and ease of use of childhood
measures of obesity
MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations (OvidSP)
1946–2013, November week 3. Searched 29 November 2013. Retrieved 1786 records in MEDLINE and
160 records in MEDLINE In-Process & Other Non-Indexed Citations.
1. exp *Obesity/ (100,481)
2. *Overweight/ (7451)
3. *Adiposity/ (2859)
4. obes$.ti,ab. (165,769)
5. (overweight or over weight).ti,ab. (35,631)
6. adiposity.ti,ab. (13,580)
7. or/1-6 (197,718)
8. exp child/ or exp Infant/ or Adolescent/ (2,890,432)
9. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,
ab. (1,257,816)
10. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (251,350)
11. (girl or girls or boy or boys or kid or kids).ti,ab. (161,848)
12. or/8-11 (3,161,861)
13. *body mass index/ (12,360)
14. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (124,654)
15. *Skinfold Thickness/ (869)
16. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$ or ratio$)).ti,ab. (5012)
17. *Waist-Hip Ratio/ (559)
18. ((waist-to-hip or waist-hip) adj3 (ratio$ or test$ or measure$)).ti,ab. (6800)
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19. ((waist-to-height or waist-height) adj3 (ratio$ or test$ or measure$)).ti,ab. (612)
20. or/13-19 (130,736)
21. exp *qualitative research/ (1460)
22. exp *Interviews as Topic/ (4502)
23. exp *questionnaires/ (31,966)
24. qualitative.ti. (19,194)
25. (qualitative adj2 (research or design or analy$ or study or studies)).ab. (31,413)
26. ((semi structured or semistructured or “in depth” or indepth or “face to face” or structured) adj3
(interview$ or questionnaire$)).ti,ab. (57,395)
27. focus group$.ti,ab. (20,402)
28. (survey or surveys).ti,ab. (350,023)
29. or/21-28 (469,146)
30. 7 and 12 and 20 and 29 (2990)
31. limit 30 to yr=“2008 -Current” (1786)
EMBASE (OvidSP)
1974–2013, week 47. Searched 29 November 2013. Retrieved 1817 records.
1. exp *obesity/ (155,014)
2. obes$.ti,ab. (230,793)
3. (overweight or over weight).ti,ab. (50,932)
4. adiposity.ti,ab. (17,286)
5. or/1-4 (284,389)
6. child/ or preschool child/ or infant/ or adolescent/ (2,393,076)
7. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,ab.
(1,609,328)
8. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (321,701)
9. (girl or girls or boy or boys or kid or kids).ti,ab. (216,205)
10. or/6-9 (3,060,352)
11. *body mass/ (13,857)
12. *skinfold thickness/ (878)
13. *waist hip ratio/ (435)
14. *waist to height ratio/ (73)
15. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (192,624)
16. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$ or ratio$)).ti,ab. (6078)
17. ((waist-to-hip or waist-hip) adj3 (ratio$ or test$ or measure$)).ti,ab. (9123)
18. ((waist-to-height or waist-height) adj3 (ratio$ or test$ or measure$)).ti,ab. (943)
19. or/11-18 (200,267)
20. *qualitative research/ (1999)
21. exp *interview/ (4976)
22. exp *questionnaire/ (21,687)
23. qualitative.ti. (23,346)
24. (qualitative adj2 (research or design or analy$ or study or studies)).ab. (39,253)
25. ((semi structured or semistructured or “in depth” or indepth or “face to face” or structured) adj3
(interview$ or questionnaire$)).ti,ab. (73,258)
26. focus group$.ti,ab. (24,951)
27. (survey or surveys).ti,ab. (439,960)
28. or/20-27 (577,107)
29. 5 and 10 and 19 and 28 (3065)
30. limit 29 to yr=“2008 -Current” (1981)
31. limit 30 to human (1817)
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PsycINFO (OvidSP)
1806–2013, November week 4. Searched 29 November 2013. Retrieved 407 records.
1. obesity/ (14,582)
2. overweight/ (2395)
3. obes$.ti,ab. (21,761)
4. (overweight or over weight).ti,ab. (8389)
5. (adiposity or adipose).ti,ab. (2017)
6. or/1-5 (26,356)
7. (adolescence 13 17 yrs or childhood birth 12 yrs or preschool age 2 5 yrs or school age 6 12
yrs).ag. (580,191)
8. (child$ or infant$ or pediat$ or paediat$ or schoolchild$ or school age$ or schoolage$).ti,
ab. (548,894)
9. (adolescen$ or juvenile$ or youth$ or teenage$ or youngster$).ti,ab. (213,993)
10. (girl or girls or boy or boys or kid or kids).ti,ab. (79,108)
11. or/7-10 (857,627)
12. body mass index/ (2341)
13. ((body mass adj3 (index$ or indices)) or bmi or quetelet$).ti,ab. (13,959)
14. ((skin fold or skinfold) adj3 (thickness$ or test$ or measure$)).ti,ab. (266)
15. ((waist-to-hip or waist-hip) adj3 ratio$).ti,ab. (536)
16. ((waist-to-height or waist-height) adj3 ratio$).ti,ab. (49)
17. or/12-16 (14,433)
18. qualitative research/ (3954)
19. surveys/ (5716)
20. Interviews/ (6289)
21. questionnaires/ (13,293)
22. qualitative.ti. (12,856)
23. (qualitative adj2 (research or design or analy$ or study or studies)).ab. (39,640)
24. ((semi structured or semistructured or “in depth” or indepth or “face to face” or structured) adj3
(interview$ or questionnaire$)).ti,ab. (54,779)
25. focus group$.ti,ab. (18,305)
26. (survey or surveys).ti,ab. (167,456)
27. or/18-26 (277,935)
28. 6 and 11 and 17 and 27 (580)
29. limit 28 to (human and yr=“2008 -Current”) (407)
Cumulative Index to Nursing and Allied Health Literature (EBSCOhost)
1981–25 November 2013. Searched 29 November 2013. Retrieved 1087 records.
Search term
Number
retrieved
S32 S30 AND S31 1087
S31 EM 2008 OR EM 2009 OR EM 2010 OR EM 2011 OR EM 2012 OR EM 2013 2,101,609
S30 S4 AND S9 AND S17 AND S29 1436
S29 S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 237,317
S28 TI (survey or surveys) or AB (survey or surveys) 101,965
S27 TI (“focus group*”) or AB (“focus group*”) 13,696
S26 TI (“semi structured” N3 questionnaire* or semistructured N3 questionnaire* or “in depth”
N3 questionnaire* or indepth N3 questionnaire* or “face to face” N3 questionnaire* or structured
N3 questionnaire*) or AB (“semi structured” N3 questionnaire* or semistructured N3 questionnaire*
or “in depth” N3 questionnaire* or indepth N3 questionnaire* or “face to face” N3 questionnaire* or
structured N3 questionnaire*)
4055
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Search term
Number
retrieved
S25 TI (“semi structured” N3 interview* or semistructured N3 interview* or “in depth” N3 interview*
or indepth N3 interview* or “face to face” N3 interview* or structured N3 interview*) or AB (“semi
structured” N3 interview* or semistructured N3 interview* or “in depth” N3 interview* or indepth
N3 interview* or “face to face” N3 interview* or structured N3 interview*)
26,782
S24 AB (qualitative N2 research or qualitative N2 design or qualitative N2 analy* or qualitative N2 study
or qualitative N2 studies)
25,762
S23 TI (qualitative) 11,199
S22 (MH “Surveys”) 80,428
S21 (MH “Focus Groups”) 23,633
S20 (MH “Structured Questionnaires”) 3621
S19 (MH “Structured Interview”) 7582
S18 (MH “Qualitative Studies”) 54,848
S17 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 55,290
S16 TI (waist-to-height N3 ratio* or waist-height N3 ratio*) or AB (waist-to-height N3 ratio* or
waist-height N3 ratio*)
152
S15 TI (waist-to-hip N3 ratio* or waist-hip N3 ratio*) or AB (waist-to-hip N3 ratio* or waist-hip N3
ratio*)
1080
S14 TI (“skin fold” N3 thickness* or skinfold N3 thickness* or “skin fold” N3 test* or skinfold N3 test*
or “skin fold” N3 measure* or skinfold N3 measure*) or AB (“skin fold” N3 thickness* or skinfold
N3 thickness* or “skin fold” N3 test* or skinfold N3 test* or “skin fold” N3 measure* or skinfold
N3 measure*)
831
S13 TI (“body mass” N3 index* or “body mass” N3 indices or bmi or quetelet*) or AB (“body mass”
N3 index* or “body mass” N3 indices or bmi or quetelet*)
25,156
S12 (MH “Waist-Hip Ratio”) 1862
S11 (MH “Skinfold Thickness”) 2693
S10 (MH “Body Mass Index”) 41,875
S9 S5 OR S6 OR S7 OR S8 583,162
S8 TI (girl or girls or boy or boys or kid or kids) or AB (girl or girls or boy or boys or kid or kids) 27,490
S7 TI (adolescen* or juvenile* or youth* or teenage* or youngster*) or AB (adolescen* or juvenile* or
youth* or teenage* or youngster*)
78,940
S6 TI (child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*) or
AB (child* or infant* or pediat* or paediat* or schoolchild* or “school age*” or schoolage*)
288,578
S5 (ZG “adolescent: 13-18 years”) or (ZG “child, preschool: 2-5 years”) or (ZG “child: 6-12 years”) 464,855
S4 S1 or S2 or S3 60,863
S3 TI (adiposity) or AB (adiposity) 2421
S2 TI (obes* or overweight or “over weight”) or AB (obes* or overweight or “over weight”) 40,025
S1 (MH “Obesity”) 47,606
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Appendix 2 Protocol changes
Review of adult morbidities
Minimum study size of 1000.
Review of tracking of obesity into adulthood
Need for test accuracy data:
l reference standard in adulthood
l measures of effect.
Originally modelling and the tracking of obesity, regardless of measurement, increases data and reduces
uncertainty in model. As no model studies report RR OR of obesity in adulthood, or use same simple
measure as in childhood, do not give accuracy data – no evidence for accuracy in adulthood. Therefore
these studies have been identified for future modelling but have not informed the review of predictive
accuracy. Need reference standard and data from which accuracy estimates can be derived.
Review of the diagnostic accuracy of obesity measures
in childhood
No protocol changes.
Review of the acceptability and ease of use of childhood
measures of obesity
No protocol changes.
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Appendix 3 Data extraction tables
Review of adult morbidities
TABLE 49 Prediction of adult morbidity review: childhood weight category assessment measure
Study
Childhood
measurement Reference data
Ahlgren (2004)140 BMI Internally derived BMI at 14 years divided into median of each quintile
Baker (2007)142 BMI Internally derived age- and sex-specific z-scores based on health
examinations performed between 1955 and 1960
Baker (2007)141 BMI Internally derived age- and sex-specific z-scores based on health
examinations performed between 1955 and 1960
Barker (2002)143 BMI Internally derived age- and sex-specific z-scores based on piecewise linear
function, backtransformed into corresponding BMI values
Barker (2005)144 BMI Internally derived age- and sex-specific z-scores backtransformed into
corresponding BMI values
Berentzen (2013)145 BMI Internally derived
Bjorge (2004)146 BMI Externala
Bjorge (2008)147 BMI Externala
Cheng (2011)117 BMI, WC External CDC 2000219 (age 6 years) and Chinese government standard
Cheung (2004)118 BMI l Externalb
l Internally derived 95th centile at age 11 years
De Stavola (2004)148 BMI Internally derived age- and sex-specific z-scores
Engeland (2003)149 BMI Externala
Eriksson (2001)150 BMI Internally derived age- and sex-specific z-scores based on piecewise linear
function. z-scores were backtransformed into corresponding BMI values
Forsen (2000)151 BMI Internally derived age- and sex-specific z-scores based on piecewise linear
function. z-scores were backtransformed into corresponding BMI values
Forsen (2004)152 BMI Internally derived age- and sex-specific z-scores based on piecewise linear
function. z-scores were backtransformed into corresponding BMI values
Goldhaber-Fiebert (2013)123 BMI Externala
Gunnell (1998)153 BMI l Externalc (main analysis)
l Internally derived (secondary analysis)
Hilakivi-Clarke (2001)154 BMI Internally derived age- and sex-specific z-scores based on piecewise linear
function. z-scores were backtransformed into corresponding BMI values
Hypponen (2003)155 BMI Internally derived age- and sex-specific z-score
Israeli (2007)156 BMI Internal, using adult WHO cut-off points (O: ≥30kg/m2; OW: 25.0–29.9 kg/m2)
Janssen (2005)157 BMI Externala,b
Jeffreys (2004)158 BMI Internally derived sex-specific z-scores (adjusted for sex in analyses)
Lawlor (2005)159 BMI l Internally derived (main analysis) age- and sex-specific z-scores
l Externalb (secondary analysis)
Lawlor (2006)160 BMI Internally derived sex- and age-specific z-scores
Leiba (2012)161 BMI Externala
continued
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TABLE 49 Prediction of adult morbidity review: childhood weight category assessment measure (continued )
Study
Childhood
measurement Reference data
Leiba (2013)162 BMI Internally derived BMI quintiles and 2.5 BMI unit increments
Levi (2011)163 BMI Internally derived (main and secondary analyses) using 85th centile cut-off
point and by BMI quintiles
Levi (2012)164 BMI Internally derived (main and secondary analyses) using 85th centile cut-off
point and by BMI quintiles
Li (2007)165 BMI Externalb
Mattsson (2008)167 BMI Internally derived age- and sex-specific 80th centile (approximately
17 kg/m2 in children, 21.5 kg/m2 in adolescents)
Magnussen (2010)166 BMI Externalb
Merten (2010)129 BMI Externala
Morrison (2010)168 BMI, WCd Internally derived using 95th centile cut-off point (for both BMI and WC)
Osmond (2007)169 BMI Internally derived age-specific z-scores (adjusted for sex in analyses)
Sachdev (2009)170 BMI l Externala (main analysis)
l Internally derived age-specific z-scores (adjusted for sex in analyses)
(secondary analysis)
Schmidt (2011)171 BMI, WC, WHR,
sum of SFTe
Internally derived quartiles for BMI, WC, SFT (equation NR)
Tirosh (2011)172 BMI l Internally derived deciles at 17 years
l Externala
NR, not reported; O, obese; OW, overweight.
a CDC 2000.219
b Cole 2000.220
c Cole 1990.221
d WC site not reported.
e WC naval, sum SFT (triceps, biceps, scapula, suprailium).
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TABLE 52 Childhood measures of tracking studies
Study
Childhood
measure Reference data/standardisation
Cheng (2011)117 BMI CDC 2000219 > 85th centile (OW)/> 95th centile (O)
WC ‘Chinese reference population’
Cheung (2004)118 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O), ROC derived
Engeland (2004)119 BMI (kg/m2) CDC 2000219 > 85th centile (OW)/> 95th centile (O) (≥ 85th centile very
high weight)
Freedman (2001)120 BMI (kg/m2) The authors used cut-off points < 50th, 50th–74th, 75th–84th, 85th–94th
and ≥ 95th centiles. The cut-off point of ≥ 95th centile was defined as OW
in the paper, but extracted as O for the review
Freedman (2005)122 BMI (kg/m2) Children: BMI ≥ 95th centile OW
Freedman (2005)121 BMI (kg/m2) > 85th–94th centile at risk of OW, > 95th centile OW
Goldhaber-Fiebert (2013)123 BMI (kg/m2) CDC 2000219 > 85th centile (OW)/> 95th centile (O)
Gordon-Larsen (2004)124 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Juhola (2011)125 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Juonala (2006)126 BMI (kg/m2) BMI 80th–90th centile (OW)/90th centile (O)
Liddle (2012)127 BMI IOTF/Cole: > 17.42 kg/m2 OW/O for boys and > 17.15 kg/m2 OW/O for girls
SFT One site measured; measurements were converted to a z-score internally
adjusted for age and sex. Cut-off points generated proportions of OW/O
similar to Cole 2000 BMI subgroups
Mamun (2005)128 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Merten (2010)129 BMI (kg/m2) CDC 2000219 > 95th centile O
Nakano (2010)130 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Nakano (2010)131 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Patton (2011)132 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Power (1997)133 BMI (kg/m2) UK90 > 91st centile (OW)/≥ 98th centile (O); 95th centile used also
Reilly (2011)134 BMI (kg/m2) UK90 > 85th centile (OW)/> 95th centile (O)
Starc (2011)135 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Stovitz (2010)136 BMI (kg/m2) CDC 2000 reference growth charts BMI > 85th centile (OW)/>95th centile (O)
Thompson (2007)137 BMI (kg/m2) CDC 2000219 > 85th centile (OW)/> 95th centile (O). The authors used CDC
95th centile to define OW, but it was extracted as O in this review
Venn 2007 138 BMI (kg/m2) IOTF/Cole/WHO BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Wang (2008)139 BMI (kg/m2) CDC 2000 revised growth chart > 85th centile (OW)/> 95th centile (O)
O, obese; OW, overweight.
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TABLE 53 Adulta measures of tracking studies
Study Reference data/standardisation
Cheng (2011)117 CDC 2000219 > 85th centile (OW)/> 95th centile (O)
Cheung (2004)118 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O); cut-off points derived from ROC curves
Engeland (2004)119 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O); the authors used additional
intermediate cut-off points
Freedman (2001)120 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Freedman (2005)122 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Freedman (2005)121 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Goldhaber-Fiebert (2013)123 CDC 2000219 > 85th centile (OW)/> 95th centile (O)
Gordon-Larsen (2004)124 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Juhola (2011)125 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Juonala (2006)126 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Liddle (2012)127 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Mamun (2005)128 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Merten (2010)129 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Nakano (2010)130 IOTF (Cole 2000220) children cut-off points
Nakano (2010)131 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Patton (2011)132 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Power (1997)133 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Reilly (2011)134 > 85th centile (OW)/> 95th centile (O)
Starc (2011)135 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Stovitz (2010)136 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Thompson (2007)137 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Venn (2007)138 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
Wang (2008)139 IOTF/Cole/WHO adult BMI 25 kg/m2 (OW)/30 kg/m2 (O)
O, obese; OW, overweight.
a Adult refers to the second measure, and thus can include adolescence, i.e. in those studies that tracked weight status
from childhood to adolescence.
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TABLE 56 3× 3 data
Author Population
Obesity
measure
Childhood Adulthood
Age at
measure
(years)
Definition/cut-off point
Age at
measure
(years)HW OW O
Freedman120 Boys and girls BMI 2–17 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18–37
Liddle127 Boys and girls BMI 5 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18.2–23.1
Liddle127 Boys and girls Triceps SFT 5 NR NR NR 18.2–23.1
Reilly134 Boys and girls BMI 7 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
13
Reilly134 Boys BMI 7 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
13
Reilly134 Girls BMI 7 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
13
Freedman121 Boys and girls BMI 5–14 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18–37
Freedman121 Boys/blacks BMI 5–14 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18–37
Freedman121 Boys/whites BMI 5–14 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18–37
Freedman121 Girls/blacks BMI 5–14 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18–37
Freedman121 Girls/whites BMI 5–14 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18–37
Starc135 Boys BMI 7 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18
Starc135 Boys BMI 11 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18
Starc135 Girls BMI 7 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18
Starc135 Girls BMI 11 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
18
Venn138 Boys and girls BMI 7–15 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
24–34
Venn138 Boys BMI 7–15 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
24–34
Venn138 Girls BMI 7–15 ≤ 84th
centile
85th–94th
centile
≥ 95th
centile
24–34
Cheng117 Boys and girls BMI 6–16 NR NR NR 12–22
HW, healthy weight; NR, not reported; O, obese; OW, overweight.
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NumbersDefinition/cut-off point
HW OW O
O to
O
O to
OW
O to
HW
OW to
O
OW to
OW
OW to
HW
HW to
O
HW to
OW
HW to
HW
< 25 kg/m2 25–29 kg/m2 30 kg/m2 144 30 12 129 84 40 308 555 1315
< 25 kg/m2 25–29 kg/m2 30 kg/m2 18 15 11 67 85 78 122 273 1086
< 25 kg/m2 25–29 kg/m2 30 kg/m2 10 16 22 54 70 114 143 287 1039
≤ 84th
centile
85th–94th
centile
≥ 95th
centile
281 68 41 152 167 140 206 446 3674
≤ 84th
centile
85th–94th
centile
≥ 95th
centile
158 34 19 78 62 68 103 222 1816
≤ 84th
centile
85th–94th
centile
≥ 95th
centile
123 34 22 74 105 72 103 224 1858
< 25 kg/m2 25–29 kg/m2 30 kg/m2 128 29 16 112 81 32 279 505 1210
< 25 kg/m2 25–29 kg/m2 30 kg/m2 23 2 3 9 10 5 42 73 216
< 25 kg/m2 25–29 kg/m2 30 kg/m2 39 10 6 33 30 7 70 196 300
< 25 kg/m2 25–29 kg/m2 30 kg/m2 32 4 2 35 14 6 72 111 201
< 25 kg/m2 25–29 kg/m2 30 kg/m2 34 13 5 35 27 14 94 126 493
NR NR 30 kg/m2 24 70 27 20 128 131 15 281 1416
NR NR 30 kg/m2 23 50 14 23 181 154 3 196 1272
NR NR 30 kg/m2 17 45 38 13 88 195 6 118 1747
NR NR 30 kg/m2 16 24 9 13 118 196 2 83 1601
≤ 84th
centile
85th–94th
centile
≥ 95th
centile
37 19 9 174 152 88 354 1194 2544
≤ 84th
centile
85th–94th
centile
≥ 95th
centile
15 15 3 77 78 29 196 797 998
≤ 84th
centile
85th–94th
centile
≥ 95th
centile
22 4 6 97 74 59 158 397 1546
NR NR NR 309 136 38 33 85 63 10 57 452
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TABLE 75 Likelihood ratios: diagnosing ‘upper tertile’
Study Population
Age at
assessment
(years)
Index
test
Index
test
cut-off
point
Reference
standard
Reference
standard
cut-off
point Total n LR+ LR−
Fuller (2002)183 Unselected 8–12 BIA ? DEXA ? 37 6.3 0.3a
Fuller (2001)182 Unselected 8–12 NIR OD
940
? 4-C ? 38 4.3 0.4a
Fuller (2001)182 Unselected 8–12 NIR OD
950
? 4-C ? 38 4.3 0.4a
Fuller (2001)182 Unselected 8–12 SFT ? 4-C ? 38 3.1 0.5a
OD, optical density.
a LRs calculated from sensitivity and specificity.
TABLE 76 Likelihood ratios: diagnosing ‘upper and second tertile’
Study Population
Age at
assessment
(years)
Index
test
Index
test
cut-off
point
Reference
standard
Reference
standard
cut-off
point Total n LR+ LR−
Fuller (2002)183 Unselected 8–12 BIA ? DEXA ? 37 11.5 0.0
Fuller (2001)182 Unselected 8–12 NIR OD
940
? 4-C ? 38 2.7 0.2
Fuller (2001)182 Unselected 8–12 NIR OD
950
? 4-C ? 38 12.5 0.0
Fuller (2001)182 Unselected 8–12 SFT ? 4-C ? 38 12.5 0.0
OD, optical density.
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Appendix 4 Quality assessment tables
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Review of adult morbidities
TABLE 80 Review of adult morbidities: quality assessment results
Study
Representative
population?
Follow-up
sufficiently
complete?
Analysed sample
representative of
whole sample?
Valid
prognostic
factor used?
Prognostic
factor
measured
appropriately?
Prognostic
factor
measured
consistently
across sample?
Ahlgren (2004)140 Yes
Municipality of
Copenhagen
Yes
73%
UC Yes UC UC
Baker (2007)142 Yes
Public and
private schools
in Copenhagen
UC UC Yes UC UC
Baker (2007)141 Yes
Public and
private schools
in Copenhagen
Yes
88% in
register
UC Yes UC UC
Barker (2002)143 Yes Yes
83% follow-up
(8760/10,519)
UC Yes UC UC
Barker (2005)144 Yes Yes Yes Yes UC UC
Berentzen (2013)145 Yes
Copenhagen
school health
records
Yes
77% at
follow-up
UC Yes Yes UC
Bjorge (2004)146 Yes Yes Yes Yes Yes
Trained staff
Yes
Bjorge (2008)147 Yes Yes Yes Yes Yes Yes
Cheng (2011)117 Yes
Typical of city-
dwelling Chinese
No
Only 54.1%
followed up
No
Statistically
significantly higher
weight, BMI and
blood pressure in
those followed up
than in whole sample
Yes Yes for BMI
No for WC
Yes
Trained
personnel
Cheung (2004)118 Yes No
∼ 50% of
initial cohort
for analyses
UC Yes Yes Yes
Medical
personnel
De Stavola (2004)148 Yes
Or selected
because fewer
(1/4) fathers
were manual
workers
Yes
86% at
follow-up
Yes Yes UC UC
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Was a valid
outcome
measure
used?
Outcome
measured
appropriately?
Outcome
measured
consistently
across
sample?
Confounders
described?
Confounders
measured
appropriately?
At least age
and sex
adjusted for?
Data presented
and analysed
appropriately?
Selective
reporting
of outcomes?
Yes Yes
Registry data
Yes Yes Yes Yes Yes UC
Yes Yes Yes
Registry data
Yes Yes Yes Yes UC
Yes Yes
Registry data
Yes
Registry data
Yes Yes Yes Yes UC
Yes No
Hypertensive
medication use
(may exclude
undiagnosed
and include
false positive)
Yes
Hypertensive
drug
prescription
Yes Yes Yes Yes UC
Yes Yes UC Yes Yes Yes Yes UC
Yes Yes
National registry
UC Yes Yes Yes Yes UC
Yes Yes
Histology
Yes
Histology for
all
Yes Yes Yes Yes UC
Yes Yes
Registry data
Yes Yes Yes Yes Yes UC
Yes
BMI for
tracking;
hypertension
for morbidities
Yes Yes
Trained
personnel
Yes
Age, sex,
rural/urban
Yes Yes
Age, sex,
rural/urban
Yes UC
No
Definitions
for any of
the morbidities
No
Self-report
Yes Yes Yes No
Age only
Yes UC
Yes No
Self-report
Yes Yes Yes Yes
By age for
women only
Yes
Imputation
method OK
UC
continued
DOI: 10.3310/hta19430 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 43
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Simmonds et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
311
TABLE 80 Review of adult morbidities: quality assessment results (continued )
Study
Representative
population?
Follow-up
sufficiently
complete?
Analysed sample
representative of
whole sample?
Valid
prognostic
factor used?
Prognostic
factor
measured
appropriately?
Prognostic
factor
measured
consistently
across sample?
Engeland (2003)149 Yes Yes
Large
proportion
(exact
numbers NR)
Yes Yes Yes
Trained staff
Yes
Trained staff
Eriksson (2001)150 Yes No
64% at
follow-up
UC Yes UC Yes
Welfare clinics
and school
Forsen (2000)151 Yes Yes Yes Yes UC UC
Forsen (2004)152 Yes No
55%
UC Yes UC UC
Goldhaber-Fiebert
(2013)123
Yes UC UC Yes UC UC
Gunnell (1998)153 Yes
No evidence of
significant
difference
between eligible
participants and
non-participants
UC
Insufficient
reporting
No.
Differences in sex and
age between follow-up
and complete cohort
Yes Yes UC
Hilakivi-Clarke
(2001)154
Yes UC UC Yes UC UC
Hypponen (2003)155 Yes No
64% at
follow-up
UC Yes UC UC
Israeli (2007)156 Yes
Military career
service personnel
(likely more
athletic than
average?)
UC UC Yes Yes Yes
Janssen (2005)157 Yes
Note: semi-rural,
biracial with high
proportion of
black participants
(35%)
No
44% at
follow-up
UC Yes Yes UC
Jeffreys (2004)158 UC
Underprivileged
and working class
over-represented?
Yes
78%
UC Yes Yes Yes
Lawlor (2005)159 Yes Yes UC Yes Yes Yes
Lawlor (2006)160 Yes No
52% attrition
UC Yes UC UC
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Was a valid
outcome
measure
used?
Outcome
measured
appropriately?
Outcome
measured
consistently
across
sample?
Confounders
described?
Confounders
measured
appropriately?
At least age
and sex
adjusted for?
Data presented
and analysed
appropriately?
Selective
reporting
of outcomes?
Yes Yes
98% measured
histologically
Yes
98% measured
histologically
Yes Yes Yes Yes UC
Yes Yes Yes Yes
Age and birth
weight
Yes Yes Yes UC
Yes
Diabetes
requiring
medication
Yes Yes Yes Yes Yes Yes UC
Yes Yes Yes Yes Yes Yes Yes UC
Yes No
Self-reported for
morbidities
UC Yes Yes Yes Yes No
Yes Yes Yes Yes Yes Yes Yes UC
Yes Yes Yes Yes Yes Yes Yes UC
Yes No
Self-report
Yes
Self-report
Yes Yes Yes Yes UC
Yes Yes Yes Yes Yes Yes Yes UC
Yes Yes Yes Yes
Age, race, sex,
follow-up
length
UC Yes Yes UC
Yes Yes
Registry data or
death certificate
Yes Yes Yes Yes Yes UC
Site-specific
cancer results
NR
Yes UC UC Yes Yes Yes Yes UC
No
Self-report
UC UC Yes Yes Yes Yes UC
continued
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TABLE 80 Review of adult morbidities: quality assessment results (continued )
Study
Representative
population?
Follow-up
sufficiently
complete?
Analysed sample
representative of
whole sample?
Valid
prognostic
factor used?
Prognostic
factor
measured
appropriately?
Prognostic
factor
measured
consistently
across sample?
Leiba (2012)161 Yes UC UC Yes UC UC
Leiba (2013)162 Yes UC UC Yes Yes
Medical
examination
UC
Levi (2011)163 Yes
Males only,
military
recruitment
centre
UC
Loss to follow-
up NR
UC Yes Yes Yes
Levi (2012)164 Yes
Male only
UC
Loss to follow-
up NR
UC Yes Yes Yes
Li (2007)165 Yes No
70%
Yes Yes Yes Yes
‘Standard
protocols’
Magnussen (2010)166 UC
Characteristics of
large proportion
of eligible
non-participants
in Bogalusa
unknown
No
89% attrition
in Bogalusa
UC Yes UC UC
Mattsson (2008)167 Yes
Although only
46% male
No
51% at follow-
up
UC Yes UC UC
Merten (2010)129 Yes No
(50% at
follow-up)
UC Yes No
Self-reporting
data
No
Self-reporting
data
Morrison (2010)168 Yes
Note: large
proportion of
black participants
NGHS: girls only
No
PFS: 53% of
eligible at
22–30 years
follow-up;
NGHS: 80.2%
at 9 years
UC only some
covariates were
reported to be similar
between baseline and
follow-up (some only
after adjustments)
Yes UC NGHS: UC
how WC was
measured
Yes
Osmond (2007)169 Yes Yes
National
registry data
used
Yes Yes Yes Yes
Sachdev (2009)170 Yes No
18% at
follow-up UC.
High proportion
of boys
UC Yes Yes
Trained
personnel
Yes
Trained
personnel
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Was a valid
outcome
measure
used?
Outcome
measured
appropriately?
Outcome
measured
consistently
across
sample?
Confounders
described?
Confounders
measured
appropriately?
At least age
and sex
adjusted for?
Data presented
and analysed
appropriately?
Selective
reporting
of outcomes?
Yes Yes
Histology
Yes
Histology
Yes Yes Yes Yes UC
Yes Yes
Most appear to
have been
measured
histologically
Yes
Most classified
according to
standard
coding
Yes Yes Yes Yes UC
Yes Yes Yes
Histology
Yes Yes Yes Yes UC
Yes Yes Yes Yes Yes Yes Yes UC
Yes Yes Yes Yes Yes Yes Yes UC
Yes Yes
Two nurses
using standard
tool
Yes Yes Yes Yes Yes UC
Yes, IDF
definition
Yes Yes Yes Yes Yes Yes UC
Yes No
Self-reported
No
Self-reported
Yes UC Yes Yes UC for
morbidity
Yes No
No gold
standard for
distinguishing
between type 2
and type 1
diabetes, and
appears partially
self-reported
No
Collected
differently
across cohorts
Yes Yes No Yes UC
Yes UC UC Yes Yes No
Adjusted for
sex
Yes UC
Yes
IOTF criteria
Yes Yes Yes Yes Yes Yes UC
continued
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TABLE 80 Review of adult morbidities: quality assessment results (continued )
Study
Representative
population?
Follow-up
sufficiently
complete?
Analysed sample
representative of
whole sample?
Valid
prognostic
factor used?
Prognostic
factor
measured
appropriately?
Prognostic
factor
measured
consistently
across sample?
Schmidt (2011)171 Yes No
26% of
baseline group
No
Follow-up group had
lower BMI and were
more likely to have
lived in a higher SES
area in childhood
(p≤0.01)
Yes Yes
Or WC, BMI and
waist-to-hip UC
for sum of SFT
Yes
Tirosh (2011)172 Yes
Military career
service personnel
(likely more
athletic than
average?)
Yes Yes Yes UC UC
NGHS, National Growth and Health study; NR, not reported; PFS, Princeton follow-up study; UC, unclear.
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Was a valid
outcome
measure
used?
Outcome
measured
appropriately?
Outcome
measured
consistently
across
sample?
Confounders
described?
Confounders
measured
appropriately?
At least age
and sex
adjusted for?
Data presented
and analysed
appropriately?
Selective
reporting
of outcomes?
Yes Yes Yes Yes Yes Yes
Adjusted for
sex and change
in WC
Yes UC
Yes Yes Yes Yes Yes Yes Yes UC
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Review of tracking of obesity into adulthood
TABLE 81 Tracking review: quality assessment results
Study
Representative
population?
Follow-up
sufficiently
complete?
Analysed sample
representative of
whole sample?
Valid
prognostic
factor used?
Prognostic
factor measured
appropriately?
Prognostic
factor measured
consistently
across sample?
Cheng (2011)
117
Yes
Typical of city
dwelling Chinese
No
Only 54.1%
followed up
No
Statistically significantly
higher weight, BMI and
blood pressure in
those followed up
than whole sample
Yes Yes for BMI, no for
WC
Yes
Trained personnel
Cheung (2004)
118
Yes No
Approximately
50% of initial
cohort not
available for
analyses
Unclear Yes Yes Yes
Medical personnel
Engeland (2004)
119
Yes No Unclear Yes Yes Unclear
Freedman (2001)
120
Yes No Yes Yes Yes Unclear
Freedman (2005)
122
Yes No Yes Yes Yes Yes
Freedman (2005)
121
Yes No Unclear Yes Yes Yes
Goldhaber-Fiebert
(2013)
123
Yes Unclear Unclear Yes Unclear Unclear
Gordon-Larsen
(2004)
124
Yes No Unclear Yes Yes Yes
Juhola (2011)
125
Yes No
61.3%
Unclear Yes Unclear Unclear
Juonala (2006)
126
Yes No No
There were more males
than females in the
dropouts. The people
in the dropouts were
older than participants
Yes Yes Unclear
It was unclear
whether or not
the measurement
was performed
consistently across
the sample
Liddle (2012)
127
Yes No No
Those who lost
to follow-up were
younger, less well
educated and have
lower family income
Yes Yes Yes
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Was a valid
outcome
measure used?
Outcome
measured
appropriately?
Outcome
measured
consistently
across sample?
Confounders
described?
Confounders
measured
appropriately?
At least age
and sex
adjusted for?
Data presented
and analysed
appropriately?
Selective
reporting
of outcomes?
Yes
BMI for
tracking;
hypertension for
morbidities
Yes Yes
Trained
personnel
Yes
Age, sex, rural/
urban
Yes Yes
Age, sex, rural/
urban
Yes Unclear
No
Definitions NR
for any of the
morbidities
No
Self-report
Yes Yes Yes Yes
For tracking; no
for morbidity:
age only
Yes Unclear
Yes Yes Unclear Yes Yes Yes Yes No
Yes Yes Unclear Yes Unclear Unclear
The authors
reported that
they adjusted
race and sex,
but was unclear
if they also
adjusted age
Yes No
Yes Yes Yes Yes Yes Yes Yes No
Yes Yes Yes Yes Yes Yes Yes No
Yes No
Self-reported for
morbidities;
unclear for
tracking
Unclear Yes Yes Yes Yes No
Yes Yes No
Self-reported
data were used
for a large
number of
respondents
who refused
measurements.
71 weighed in
excess of the
scale capacity.
Yes Yes Yes
But not
the data we
extracted
Yes No
Yes Unclear Unclear Yes Yes Yes Yes No
Yes Yes Unclear
The authors
did not state
whether or
not the
measurement
was performed
consistently
across sample
No Unclear No Yes No
Yes No
Some
self-report
No
Objective and
subjective
methods
Yes Yes No Yes No
continued
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TABLE 81 Tracking review: quality assessment results (continued )
Study
Representative
population?
Follow-up
sufficiently
complete?
Analysed sample
representative of
whole sample?
Valid
prognostic
factor used?
Prognostic
factor measured
appropriately?
Prognostic
factor measured
consistently
across sample?
Mamun (2005)
128
Yes No Unclear Yes Yes Yes
Merten (2010)
129
Yes No Unclear Yes No
Self-reporting data
No
Self-reporting
data
Nakano (2010)
130
Yes No Unclear Yes Yes Yes
Nakano (2010)
131
Yes No Unclear Yes Yes Yes
Patton (2011)
132
Yes No Unclear Yes Yes No
Self-reported
data were used
for those who
had left school in
the later teenage
waves
Power (1997)
133
Yes Yes Unclear Yes Yes Yes
Reilly (2011)
134
Yes No No Yes Yes Yes
Starc (2010)
135
Yes No Yes
The authors reported
that the mean values
and SDs of the
population sample and
the subsample analysed
were very similar
Yes Yes Yes
Stovitz (2010)
136
Yes No Unclear Yes Yes Yes
Thompson (2007)
137
Yes Yes Unclear Yes Yes Yes
Venn 2007
138
Yes No Yes Yes Yes Unclear
Wang (2008)
139
Yes No Yes Yes No
Self-reported data
No
Self-reported
data
NR, not reported.
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Was a valid
outcome
measure used?
Outcome
measured
appropriately?
Outcome
measured
consistently
across sample?
Confounders
described?
Confounders
measured
appropriately?
At least age
and sex
adjusted for?
Data presented
and analysed
appropriately?
Selective
reporting
of outcomes?
Yes Yes Yes Yes
The studies
described age-
or sex- adjusted
values for other
outcomes but
not for tracking
data
Yes No
Tracking data
were not
stratified by
age/sex
Yes No
Yes No
Self-reported
No
Self-reported
No No No Yes No
For tracking;
unclear for
morbidity
Yes Yes Yes Yes Yes Yes Yes No
Yes Yes Yes Yes Yes Yes Yes No
Yes No
Self-reported data
were used in the
adult phase
No
Self-reported
data were used
Yes Yes Yes Yes No
Yes Yes Yes Yes Yes Yes Yes No
Yes Yes Yes Yes Unclear Yes Yes No
Yes Yes Yes Yes Yes Yes Yes No
Yes Yes Yes Yes Yes No Yes No
Yes No
Self-reporting
data
No
Self-reporting
data
Yes
Age, race
Yes Yes
Only girls
included
Yes No
Yes Yes No
It appears
that some
self-reported
outcome data
were included
Yes Yes No Yes No
Yes No
Self-reported data
No
Self-reported
data
Yes Yes Yes Yes No
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Review of the diagnostic accuracy of childhood measures of obesity
TABLE 83 Diagnostics review: quality assessment results
Short title
1.
Representative
population
2.
Progression
bias
3.
Partial
verification
bias
4.
Differential
verification
bias
5.
Incorporation
bias
6.
Description
of selection
criteria
7.
Appropriateness
of RS
Alvero-Cruz (2010)
173
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Bartok (2011)
174
No UC Avoided Avoided Avoided Adequate Imperfect
Bray (2002)
175
No Probably
avoided
Avoided Avoided Avoided Adequate Gold standard
Dung (2006)
176
No Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Ellis (1999)
177
Yes Probably
avoided
Avoided Avoided Avoided Inadequate Imperfect
Field (2003)
178
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Freedman (2009)
179
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Freedman (2013)
180
Yes Probably
avoided
Present
d
Avoided Avoided Adequate Imperfect
Fujita (2011)
181
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Fuller (2001)
182
UC Probably
avoided
Avoided Avoided Avoided Inadequate Gold standard
Fuller (2002)
183
UC Probably
avoided
Avoided Avoided Avoided Inadequate Imperfect
Guntsche (2010)
184
No Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Harrington (2013)
185
No
f
Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Himes (1989)
186
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Johnston (1985)
187
No Probably
avoided
Avoided Avoided Avoided Inadequate Imperfect
Khadgawat (2013)
188
Yes
g
Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Marshall (1991)
189
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Mei (2007)
190
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Moreno (2006)
191
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Neovius (2004)
192
Yes UC Avoided Avoided Avoided Adequate Imperfect
Neovius (2005)
193
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Pandit (2009)
194
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Reilly (2010)
195
Yes UC Avoided Avoided Avoided Adequate Imperfect
Sardinha (1999)
196
No Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Sarria (2001)
197
No Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
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8.
Description
of index
text
9.
Used
validated
index
text
10.
Description
of RS
11.
Uninterpretable/
intermediate
results reported
12.
Withdrawals
explained
13. Measurement bias
13a.
Training/
experience
Index test
personnel
13b.
Number
of index
text
assessors
13c.
Training/
experience
RS test
personnel
13d.
Number
of RS
assessors
Inadequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none No UC UC UC UC
Inadequate Yes Inadequate Apparently none No
a
UC UC UC UC
Adequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none None Yes
b
Multi
b
UC UC
Adequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Yes None
c
UC UC UC UC
Adequate
for BMI
Inadequate
for SFT
Yes Inadequate Yes No
e
UC UC UC UC
Adequate Yes Inadequate Apparently none Yes UC UC UC UC
Adequate Yes Adequate Completer analysis Yes UC UC UC UC
Adequate Yes Inadequate Completer analysis Yes UC UC UC UC
Inadequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none Yes UC UC UC UC
Inadequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none Yes UC UC UC UC
Adequate Yes Inadequate Apparently none Yes UC UC UC UC
Adequate Yes Inadequate Apparently none Yes Yes
h
2 UC UC
Adequate Yes Inadequate Apparently none Yes UC UC Yes
h
1
Adequate Yes Inadequate Apparently none Yes UC UC UC UC
Inadequate Yes Inadequate Apparently none Yes UC UC UC UC
Adequate Yes Inadequate Apparently none None UC UC UC 1
Inadequate
i
Yes Inadequate Apparently none Yes UC UC UC UC
Inadequate Yes Inadequate Apparently none None Yes
h
UC UC 1
Adequate Yes Adequate Yes Yes UC UC UC UC
continued
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TABLE 83 Diagnostics review: quality assessment results (continued )
Short title
1.
Representative
population
2.
Progression
bias
3.
Partial
verification
bias
4.
Differential
verification
bias
5.
Incorporation
bias
6.
Description
of selection
criteria
7.
Appropriateness
of RS
Sproule (2009)
198
No Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Taylor (2000)
199
No
j
Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Taylor (2003)
200
No
j
Probably
avoided
Avoided Avoided Avoided Inadequate Imperfect
Telford (2008)
201
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Vitolo (2007)
202
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Warner (1997)
203
No Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Wickramasinghe
(2005)
204
No Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Wickramasinghe
(2009)
205
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
Zhang (2004)
206
Yes Probably
avoided
Avoided Avoided Avoided Adequate Imperfect
RS, reference standard; UC, unclear.
a 114/131 participated in follow-up study.
b Appropriately trained multiple assessors.
c Appropriate exclusions from subgroup analyses.
d DEXA was imputed for some children.
e 9.5% had missing data not at random.
f Restriction on ethnicity; exclusion of an outlier.
g Yes for India; no for UK.
h Suitably trained/experienced.
i Site for WC not reported.
j White children only.
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8.
Description
of index
text
9.
Used
validated
index
text
10.
Description
of RS
11.
Uninterpretable/
intermediate
results reported
12.
Withdrawals
explained
13. Measurement bias
13a.
Training/
experience
Index test
personnel
13b.
Number
of index
text
assessors
13c.
Training/
experience
RS test
personnel
13d.
Number
of RS
assessors
Adequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none None UC UC Yes
h
2
Adequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none Yes UC UC UC UC
Adequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Adequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none None UC UC UC UC
Adequate Yes Inadequate Apparently none No Yes UC UC UC
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BOX 1 Diagnostics review: guidance for quality assessment completion
Was the patient spectrum representative of the full range of patients who will
receive the test in practice?
Yes: unselected children, or children randomly selected from a representative population, recruited prospectively.
No: all other patient spectra including a retrospectively selected patient population.
Unclear: insufficient details were provided to make a judgement on whether or not the patient spectrum
was representative.
Was the study subject to progression bias?
Avoided: the index test and reference standard were conducted within days or weeks of each other; therefore,
progression bias was avoided.
Probably avoided: there was not specific information regarding the timing of the index test and reference
standard, but the description of the study design makes progression bias unlikely.
Not avoided: there was a substantial delay between the index test and reference standard during which weight
status could have changed.
Unclear: there was insufficient information to determine whether or not progression bias was present or absent.
Was the study subject to partial verification bias?
Avoided: all children had their adiposity determined using a reference standard and partial verification bias
was avoided.
Not avoided: some children did not have their adiposity determined using a reference standard.
Unclear: there was insufficient information to determine whether or not all children had their adiposity
determined using a reference standard.
Was the study subject to differential verification bias?
Avoided: all children had the same reference standard and differential verification bias was avoided.
Not avoided: children underwent different reference standards.
Unclear: there was insufficient information to determine whether or not all children had the same
reference standard.
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Was the study subject to incorporation bias?
Avoided: the index test was independent of the reference standard and incorporation bias was avoided.
Not avoided: the results of the index test formed part of the reference standard.
Unclear: there was insufficient information to determine whether or not the index test was independent of the
reference standard.
Was the description of the selection criteria adequately described to
allow replication?
Adequate: sufficient details were reported.
Inadequate: insufficient details were reported.
Was the reference standard used appropriate?
Gold standard: a four or more component model was used.
Imperfect: underwater (hydrostatic) weighting, D2O, ADP or DEXA alone was used.
Was the description of the conduct of the index test adequate to
allow replication?
Adequate: sufficient details were reported.
Inadequate: insufficient details were reported.
Was the index test used a validated measure?
Yes: the index test used was validated and used recognised cut-off points and reference data.
No: the index test used was not validated.
Unclear: insufficient details were reported to determine whether or not the index test used was validated.
Was the description of the conduct of the reference standard adequate to
allow replication?
Adequate: sufficient details were reported.
Inadequate: insufficient details were reported.
BOX 1 Diagnostics review: guidance for quality assessment completion (continued)
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Were uninterpretable/intermediate results reported?
None: there were no uninterpretable results.
Apparently none: given the data in the analysis, it seems that there were no uninterpretable results or they
were accounted for but details not provided.
Yes: uninterpretable results occurred and these were reported and accounted for in the analysis.
Completer analysis: uninterpretable results occurred and only those with interpretable results were included
in the analysis.
Unclear: it was not clear whether or not there were any uninterpretable/intermediate test results.
Were withdrawals from the study reported/explained?
None: there were no withdrawals.
Yes: withdrawals occurred, but these were explained.
No: there appeared to be patients who were recruited who were not accounted for.
Unclear: it was not clear whether or not any withdrawals occurred.
Did the study avoid measurement bias:
Yes: the study used a single, appropriately trained individual for the conduct of all childhood measures
of obesity.
No: the study used multiple assessors, or inadequately trained individual(s).
Unclear: insufficient details were reported on the number and/or experience of assessors.
BOX 1 Diagnostics review: guidance for quality assessment completion (continued)
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BOX 2 Acceptability review: guidance for quality assessment completion
1. Clear statement of aims?
Yes: the aims of the study were clearly stated and relevant.
No: the aims of the study were not clearly stated and/or were not relevant.
2. Qualitative methodology appropriate?
Yes: the study was seeking to interpret subjective experiences of participants, making qualitative methodology
the correct methodology to use.
No: the study was not seeking to interpret subjective experiences of participants.
3. Appropriate research design?
Yes: a prospective cohort of children, parents/guardians and/or health professionals.
No: any other study design.
Unclear: insufficient details of the study methodology were reported.
4. Appropriate recruitment strategy
Yes: unselected consecutive participants, or randomly selected participants, from a population of children,
parents/guardians and/or health professionals representative of those who will (whose children will) undergo
the test(s) for which opinions were being sought in clinical practice.
No: non-consecutive or random selection, or selection from a population not representative of those who will
undergo the test(s) for which opinions were being sought in clinical practice.
Unclear: insufficient details of recruitment were reported.
5. Data collected appropriately?
Yes: focus groups or structured interviews or questionnaires were used to elicit opinions.
No: other methods of elicitation.
Unclear: insufficient details of the method of elicitation of opinions were reported.
6. Relationship between researcher and participants considered?
Yes: the relationship between the researcher and participants, and the researcher’s responses to events during
the study, were discussed.
No: the relationship between the researcher and participants was not discussed.
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7. Ethical considerations considered?
Yes: ethical considerations were discussed, or ethical approval obtained.
No: ethical considerations were neither discussed nor was ethical approval obtained.
Not applicable: the study was conducted in adults for whom ethical approval was not required, and ethical
considerations were thought to be relevant.
8. Rigorous data analysis?
Yes: the methods used to evaluate findings was rigorous, although simple in some cases.
No: the methods used to evaluate findings was not rigorous, or insufficient data were presented to support
the findings.
Unclear: insufficient details were reported as to how the synthesis was conducted.
9. Clear statement of findings?
Yes: the findings were explicitly stated.
No: the findings were not explicitly stated.
10. Research of value?
Yes: the value of the research was considered by the study authors, recommendations were reported and the
research was considered to be of value by the review team.
No: the value of the research was either not considered by the study authors, or recommendations were not
reported, and/or the research was considered to be of value by the review team.
Unclear: the value of the research was not discussed by the study authors and was unclear to the review team.
BOX 2 Acceptability review: guidance for quality assessment completion (continued)
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Appendix 5 Review of adult morbidities:
additional results from the meta-analyses
Cohort
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British birth cohort 1958
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Breast cancer DiabetesCHD
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Other cancerLiver cancer
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Israeli army
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FIGURE 34 Odds ratios for all adult morbidities. BCAMSS, Beijing Child and Adolescent Metabolic Syndrome study;
MRC NSHD, Medical Research Council National Survey of Health and Development; NGHS, National Growth and
Health study; PFS, Princeton follow-up study; SPEC, Staff Periodic Examination Center.
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